var title_f40_51_41776="Algorithm refractory Crohns";
var content_f40_51_41776=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 613px\">",
"   <div class=\"ttl\">",
"    Algorithm for management of refractory Crohn's disease in children",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 593px; height: 740px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     6MP: 6-mercaptopurine; AZA: azathioprine; MTX: methotrexate.",
"     <br/>",
"     * Either infliximab or MTX are reasonable choices in this situation. Infliximab has been better studied than methotrexate, and often induces remission in patients who fail immunomodulators. The decision is based on any patient-specific risk factors (eg, risk of pregnancy for patients on MTX), and patient-specific values and preferences (eg, concerns about subcutaneous route of administration for MTX, or intravenous infusions and risk of pulmonary infections on infliximab). Infliximab with low dose methotrexate (7.5 mg/M",
"     <sup>",
"      2",
"     </sup>",
"     /week) is being increasingly used as combination therapy. For a discussion of these issues, refer to the text of the UpToDate topics on management of Crohn's disease with these medications.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Expert opinion varies about how long to continue combination therapy after starting infliximab. For a discussion of the relative risks and benefits, refer to the text of the topic on management of Crohn's disease in children and adolescents.",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Faubion WA, Bousvaros A. Medical therapy for refractory pediatric Crohn's disease. Clin Gastroenterol Hepatol 2006; 4:1199.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41776=[""].join("\n");
var outline_f40_51_41776=null;
var title_f40_51_41777="Hepatic metastases GI neuroendocrine tumor";
var content_f40_51_41777=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F61729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F61729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Extensive hepatic metastases from a neuroendocrine tumor arising in the gastrointestinal tract",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photograph courtesy of Matthew Kulke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41777=[""].join("\n");
var outline_f40_51_41777=null;
var title_f40_51_41778="Adson forceps";
var content_f40_51_41778=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F56348&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F56348&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 493px\">",
"   <div class=\"ttl\">",
"    Adson forceps",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 473px; height: 403px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Notice the gripping mechanism of (A) the Adson forceps versus (B) the Brown-Adson forceps.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41778=[""].join("\n");
var outline_f40_51_41778=null;
var title_f40_51_41779="Left colon resection for a splenic flexure lesion";
var content_f40_51_41779=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F75381&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F75381&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left colon resection for a splenic flexure lesion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 434px; height: 544px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts a left colectomy for a malignant lesion located at the splenic flexure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41779=[""].join("\n");
var outline_f40_51_41779=null;
var title_f40_51_41780="Dextromethorphan and phenylephrine: Patient drug information";
var content_f40_51_41780=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Dextromethorphan and phenylephrine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/40/11908?source=see_link\">",
"     see \"Dextromethorphan and phenylephrine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F7414659\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      PediaCare&reg; Children&rsquo;s Multi-Symptom Cold [OTC];",
"     </li>",
"     <li>",
"      Safetussin&reg; CD [OTC];",
"     </li>",
"     <li>",
"      Sudafed PE&reg; Children's Cold &amp; Cough [OTC];",
"     </li>",
"     <li>",
"      Triaminic&reg; Day Time Cold &amp; Cough [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10018957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before giving this drug to a child. Check all of your child's drugs, including OTC, with doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10018959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691646",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop coughing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691980",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat nose stuffiness.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10018958\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705244",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to dextromethorphan, phenylephrine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10018963\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697679",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is not for coughs due to smoking or lung disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697161",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an enlarged prostate, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your use of caffeine (for example, tea, coffee, cola) and chocolate. Use with this drug may cause nervousness, shakiness, and a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10018964\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10018966\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10018961\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695517",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Place oral strip on your tongue and let melt.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10018962\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10018967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10018968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12165 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-07C1274D5D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41780=[""].join("\n");
var outline_f40_51_41780=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7414659\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018957\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018959\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018958\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018963\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018964\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018966\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018961\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018962\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018967\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018968\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?11/40/11908?source=related_link\">",
"      Dextromethorphan and phenylephrine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_51_41781="Treatment of Guillain-Barré syndrome in children";
var content_f40_51_41781=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of Guillain-Barr&eacute; syndrome in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/51/41781/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41781/contributors\">",
"     Robert P Cruse, DO",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/51/41781/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41781/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/51/41781/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41781/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/51/41781/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main modalities of therapy for Guillain-Barr&eacute; syndrome (GBS) include plasmapheresis and administration of intravenous immune globulin. Even before initiating specific therapy, common problems are when and whether to admit the patient to the intensive care unit (ICU) and when to consider mechanical ventilation.",
"   </p>",
"   <p>",
"    This topic will discuss the management of GBS in children. The epidemiology, pathophysiology, clinical features, diagnosis, and prognosis of GBS in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/3/27705?source=see_link\">",
"     \"Overview of Guillain-Barr&eacute; syndrome in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MONITORING AND SUPPORTIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the initial phase of GBS, all patients require close monitoring of motor, autonomic (blood pressure, heart rate and sphincter function), and respiratory function. Any patient admitted with GBS should be evaluated frequently, and serial lung function testing should be performed in those at highest risk for developing respiratory failure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Need for intensive care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with the following should be admitted to a pediatric intensive care unit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Flaccid quadriparesis",
"     </li>",
"     <li>",
"      Rapidly progressive weakness",
"     </li>",
"     <li>",
"      Reduced vital capacity (&le;20",
"      <span class=\"nowrap\">",
"       mL/kg)",
"      </span>",
"     </li>",
"     <li>",
"      Bulbar palsy",
"     </li>",
"     <li>",
"      Autonomic cardiovascular instability",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hospitalization is continued until the child's condition has clearly stabilized.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Need for assisted ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 20 percent of children with GBS require mechanical ventilation for respiratory failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/2\">",
"     2",
"    </a>",
"    ]. The need for tracheal intubation should be anticipated so that it can be performed as an elective procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children with vital capacity approximately one half the normal value for age or &le;20",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    body weight generally progress to require ventilatory support. In a study of patients with GBS that included some children, serial measurements of pulmonary function tests were most helpful in detecting the risk of developing respiratory failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/4\">",
"     4",
"    </a>",
"    ]. Progression to the need for mechanical ventilation was likely to occur in patients with rapid disease progression, bulbar dysfunction, bilateral facial weakness, or dysautonomia.",
"   </p>",
"   <p>",
"    The following parameters warn of impending respiratory arrest and are an indication for intubation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Vital capacity &le;20",
"      <span class=\"nowrap\">",
"       mL/kg",
"      </span>",
"     </li>",
"     <li>",
"      Maximum inspiratory pressure &le;30 cmH2O",
"     </li>",
"     <li>",
"      Maximum expiratory pressure &le;40 cmH2O",
"     </li>",
"     <li>",
"      Tidal volume &lt;5",
"      <span class=\"nowrap\">",
"       mL/kg",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pulmonary testing and measuring vital capacity is difficult in children who cannot cooperate, typically those younger than six years of age. These patients should be closely monitored and observed for fatigue and other clinical signs of impending respiratory muscle failure. These signs include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A sustained increase of pCO2 to &ge;50 mmHg (normally 35 to 40 mmHg)",
"     </li>",
"     <li>",
"      An increasing respiratory rate",
"     </li>",
"     <li>",
"      Increasing oxygen requirement and increasing alveolar to arterial oxygen difference (normally 5 to 10 mmHg)",
"     </li>",
"     <li>",
"      An increased use of accessory muscles (eg, sternocleidomastoid use, flaring of the ala nasae, intercostal retractions) and decreased or paradoxical diaphragm movements; these reflect restrictive lung-chest wall movement and low lung volumes",
"     </li>",
"     <li>",
"      Sweating about the head and neck, wide pulse pressure, and bounding pulses portend CO2 retention.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Children have less metabolic and muscle reserve than adults. They can deteriorate quite rapidly and become apneic or develop alveolar hypoventilation \"right under your nose.\" Generally, it is wise to have a pediatric pulmonologist involved early in the clinical course.",
"   </p>",
"   <p>",
"    Sedation and neuromuscular blockade should be avoided in ventilated patients because they obscure the course of the illness. Providing scrupulous airway care and chest physiotherapy reduce the risk of pneumonia. Tracheostomy may need to be performed if prolonged ventilation is required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Autonomic dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autonomic dysfunction is a well-recognized feature of GBS and is a significant source of mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. Consequently, close monitoring of blood pressure, fluid status, and cardiac rhythm are essential to the management of these patients. Care must also be taken when vasoactive or sedative drugs are used, because the dysautonomia may exaggerate the hypotensive responses to these drugs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Other supportive measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nutritional needs should be addressed early in the disease course. Orogastric tube feeding, gastrostomy, or parental nutrition often is necessary.",
"   </p>",
"   <p>",
"    The patient's position should be changed frequently for comfort and to avoid skin breakdown. Intermittent pressure leg boots and subcutaneous",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/39/7801?source=see_link\">",
"     heparin",
"    </a>",
"    treatment should be initiated to prevent deep vein thrombosis.",
"   </p>",
"   <p>",
"    Physical therapy, occupational therapy, and social service should be involved early. Provide the patient with a method of communication is important if normal speech is not possible. Pencil and paper, a \"magic slate,\" or a communication board can be given to those old enough to write.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     INTRAVENOUS IMMUNE GLOBULIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reports of the use of intravenous immune globulin (IVIG) in children with GBS are limited, as no large randomized controlled trials exist. Nevertheless, data from the few available small open randomized trials in children suggest that IVIG shortens the time to recovery compared with supportive care alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. While these studies in children are not definitive because of design limitations, their results are consistent with the larger randomized trials in adults that show a beneficial effect for IVIG treatment of GBS. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/16/265?source=see_link\">",
"     \"Treatment and prognosis of Guillain-Barr&eacute; syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similarly, most observational studies show that IVIG hastens recovery in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/9-13\">",
"     9-13",
"    </a>",
"    ], although one study found that IVIG may not be effective in children with EMG evidence of axon involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism of improvement with IVIG is uncertain, but is it thought to involve suppression of inflammatory and immune-mediated processes. This is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/11/28857?source=see_link&amp;anchor=H9#H9\">",
"     \"General principles in the use of immune globulin\", section on 'Autoimmune disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Methodologic differences between reports make it difficult to generalize about when children with GBS begin to improve after IVIG treatment. Nevertheless, strength generally begins to improve in most children within 14 days after initiation of IVIG therapy and most are walking within three months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. Early transient relapse after IVIG treatment has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/7,15-17\">",
"     7,15-17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The total dose of IVIG for the treatment of GBS in children is 2",
"    <span class=\"nowrap\">",
"     g/kg,",
"    </span>",
"    given as 1",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    for two days or 400",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    for five days. This dose is empiric and is based upon treatment of patients with immune deficiency disorders. The dosage schedule is also empiric as little is known of the pharmacokinetics of serum IgG [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While the optimal dosage schedule for IVIG has not been established, a small open-label randomized multicenter trial in Germany found that early relapses were significantly more frequent following the two-day regimen compared with the five-day regimen (22 versus 0 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/7\">",
"     7",
"    </a>",
"    ]. However, there was no significant difference between the two-day and five-day regimens for the primary outcome measure, time to regain unaided walking. Given these data, we suggest using IVIG 400",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day for five days when treating children with GBS.",
"   </p>",
"   <p>",
"    Typically, patients are given only a single course of IVIG treatment. One study in adults found that a second course of IVIG treatment may benefit patients who have a limited response to the initial course [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complications and side effects of IVIG treatment are those related to transfusion reactions and are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/31/11769?source=see_link\">",
"     \"Immunologic blood transfusion reactions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    IVIG is preferred to plasma exchange in children because of the relative safety and ease of administration, although it has not been shown to have better results. In one series of 26 children, either form of treatment showed no benefit compared to historical controls managed with supportive care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PLASMA EXCHANGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Large, multicenter trials have established the effectiveness of plasma exchange in adult patients with severe GBS. The mechanism is thought to be removal of antibodies directed against nerves from the circulation. Increased muscle strength, earlier improvement, and a lower requirement for mechanical ventilation have been demonstrated, as discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/16/265?source=see_link&amp;anchor=H12#H12\">",
"     \"Treatment and prognosis of Guillain-Barr&eacute; syndrome in adults\", section on 'Plasma exchange'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Experience with plasma exchange in children with GBS is limited. A meta-analysis of six trials and 649 patients with GBS included a small number of children who were all &ge;10 years of age and found that treatment with plasma exchange superior to supportive care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/21\">",
"     21",
"    </a>",
"    ]. Even patients with mild disease treated with two exchanges had improved outcomes when compared to controls who did not undergo plasma exchange. Plasma exchange was most effective when started within seven days of symptom onset. However, in a single study that allowed enrollment up to 30 days after symptom onset, an improvement in outcome in the plasma exchange group compared to controls still occurred. Subjects with severe disease showed no incremental improvement in outcome when six exchanges were compared with four.",
"   </p>",
"   <p>",
"    In general, results of treatment in pediatric patients appear to be similar to those in adults, with a shortened course and reduced incidence of respiratory failure. The main benefit has been to decrease the interval from maximum weakness to recovery of independent walking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/22\">",
"     22",
"    </a>",
"    ]. However, two studies have shown a variable response and questioned the benefits of this procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Plasma exchange generally is considered more effective if begun within three weeks of initial symptoms. Approximately 10 percent of these patients will have a relapse within 10 days after treatment.",
"   </p>",
"   <p>",
"    Plasma exchange requires special equipment and trained personnel and can be performed only at centers with expertise in the treatment of children. Because of technical considerations, this procedure generally is not performed in children younger than two years of age. Younger children require placement of a central catheter, which increases the risks of developing thrombosis and infection. Complications are uncommon but include hypotension, hypocalcemia, arrhythmias, and cardiac arrest [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/25-27\">",
"     25-27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The procedure usually consists of four double-volume exchanges performed on alternate days over one week. Immunoglobulin levels may be decreased by 30 to 40 percent after plasma exchange.",
"   </p>",
"   <p>",
"    Plasma exchange is recommended for those patients who have rapidly progressing weakness, worsening respiratory status, are unable to walk unaided, require mechanical ventilation, or have significant bulbar weakness. As a result of the cost, risk, and discomfort to the patient, plasma exchange generally is not used for ambulatory patients with mild disease or for patients whose symptoms have stabilized.",
"   </p>",
"   <p>",
"    We use plasma exchange in children who have had a previous adverse reaction to intravenous immune globulin (IVIG) treatment and in those who do not respond to IVIG.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     OTHER THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Corticosteroids, once the mainstay of therapy for GBS, have not been shown to be beneficial and no longer have a role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Interferon-beta has been reported to be beneficial in individual cases, but its safety and efficacy have not been established in clinical trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;While acknowledging the limitations of data for children, guidelines from the American Academy of Neurology (AAN) concluded that intravenous immune globulin (IVIG) and plasma exchange are options for children with severe GBS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. IVIG and plasma exchange are not recommended for ambulatory children with GBS who have mild disease or for children whose symptoms have stabilized.",
"   </p>",
"   <p>",
"    IVIG and plasma exchange for children with GBS should be reserved for those with:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rapidly progressing weakness",
"     </li>",
"     <li>",
"      Worsening respiratory status or need for mechanical ventilation",
"     </li>",
"     <li>",
"      Significant bulbar weakness",
"     </li>",
"     <li>",
"      Inability to walk unaided",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Children who have rapid progression followed by stabilization of symptoms within the first or second week of GBS onset may still be considered candidates for treatment by some child neurologists. As noted above, IVIG is preferred to plasma exchange in children because of the relative safety and ease of administration, although it has not been shown to have better results.",
"   </p>",
"   <p>",
"    Time to treatment onset may be important in children although data are lacking. In adults, IVIG is recommended by the AAN for patients who are unable to walk unaided if treatment is started within two or possibly four weeks of onset. Similarly, plasma exchange is recommended for adult patients who are unable to walk unaided if treatment is started within four weeks of symptom onset [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41781/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/1\">",
"      Agrawal S, Peake D, Whitehouse WP. Management of children with Guillain-Barr&eacute; syndrome. Arch Dis Child Educ Pract Ed 2007; 92:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/2\">",
"      Evans OB, Vedanarayanan V. Guillain-Barr&eacute; syndrome. Pediatr Rev 1997; 18:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/3\">",
"      Hughes RA, Wijdicks EF, Benson E, et al. Supportive care for patients with Guillain-Barr&eacute; syndrome. Arch Neurol 2005; 62:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/4\">",
"      Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain-Barr&eacute; syndrome. Arch Neurol 2001; 58:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/5\">",
"      Hund EF, Borel CO, Cornblath DR, et al. Intensive management and treatment of severe Guillain-Barr&eacute; syndrome. Crit Care Med 1993; 21:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/6\">",
"      G&uuml;rses N, Uysal S, Cetinkaya F, et al. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome. Scand J Infect Dis 1995; 27:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/7\">",
"      Korinthenberg R, Schessl J, Kirschner J, M&ouml;nting JS. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barr&eacute; syndrome: a randomized trial. Pediatrics 2005; 116:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/8\">",
"      Hughes RA, Swan AV, Rapha&euml;l JC, et al. Immunotherapy for Guillain-Barr&eacute; syndrome: a systematic review. Brain 2007; 130:2245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/9\">",
"      Kanra G, Ozon A, Vajsar J, et al. Intravenous immunoglobulin treatment in children with Guillain-Barr&eacute; syndrome. Eur J Paediatr Neurol 1997; 1:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/10\">",
"      Shahar E, Shorer Z, Roifman CM, et al. Immune globulins are effective in severe pediatric Guillain-Barr&eacute; syndrome. Pediatr Neurol 1997; 16:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/11\">",
"      Singhi SC, Jayshree M, Singhi P, et al. Intravenous immunoglobulin in very severe childhood Guillain-Barr&eacute; syndrome. Ann Trop Paediatr 1999; 19:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/12\">",
"      Shahar E, Leiderman M. Outcome of severe Guillain-Barr&eacute; syndrome in children: comparison between untreated cases versus gamma-globulin therapy. Clin Neuropharmacol 2003; 26:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/13\">",
"      Yata J, Nihei K, Ohya T, et al. High-dose immunoglobulin therapy for Guillain-Barr&eacute; syndrome in Japanese children. Pediatr Int 2003; 45:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/14\">",
"      Reisin RC, Pociecha J, Rodriguez E, et al. Severe Guillain-Barr&eacute; syndrome in childhood treated with human immune globulin. Pediatr Neurol 1996; 14:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/15\">",
"      Irani DN, Cornblath DR, Chaudhry V, et al. Relapse in Guillain-Barr&eacute; syndrome after treatment with human immune globulin. Neurology 1993; 43:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/16\">",
"      Castro LH, Ropper AH. Human immune globulin infusion in Guillain-Barr&eacute; syndrome: worsening during and after treatment. Neurology 1993; 43:1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/17\">",
"      Koul R, Chacko A, Ahmed R, et al. Ten-year prospective study (clinical spectrum) of childhood Guillain-Barr&eacute; syndrome in the Arabian peninsula: comparison of outcome in patients in the pre- and post-intravenous immunoglobulin eras. J Child Neurol 2003; 18:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/18\">",
"      Kuitwaard K, de Gelder J, Tio-Gillen AP, et al. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barr&eacute; syndrome. Ann Neurol 2009; 66:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/19\">",
"      Farcas P, Avnun L, Frisher S, et al. Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barr&eacute; syndrome. Lancet 1997; 350:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/20\">",
"      Graf WD, Katz JS, Eder DN, et al. Outcome in severe pediatric Guillain-Barr&eacute; syndrome after immunotherapy or supportive care. Neurology 1999; 52:1494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/21\">",
"      Rapha&euml;l JC, Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barr&eacute; syndrome. Cochrane Database Syst Rev 2002; :CD001798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/22\">",
"      Epstein MA, Sladky JT. The role of plasmapheresis in childhood Guillain-Barr&eacute; syndrome. Ann Neurol 1990; 28:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/23\">",
"      Vajsar J, Sloane A, Wood E, Murphy EG. Plasmapheresis vs intravenous immunoglobulin treatment in childhood Guillain-Barr&eacute; syndrome. Arch Pediatr Adolesc Med 1994; 148:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/24\">",
"      Hammersj&ouml; JA. Plasma exchange in childhood Guillain-Barr&eacute; syndrome. Acta Paediatr 1995; 84:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/25\">",
"      Jansen PW, Perkin RM, Ashwal S. Guillain-Barr&eacute; syndrome in childhood: natural course and efficacy of plasmapheresis. Pediatr Neurol 1993; 9:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/26\">",
"      Lamont PJ, Johnston HM, Berdoukas VA. Plasmapheresis in children with Guillain-Barr&eacute; syndrome. Neurology 1991; 41:1928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/27\">",
"      Kasprisin DO. Techniques, indications, and toxicity of therapeutic hemapheresis in children. J Clin Apher 1989; 5:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/28\">",
"      Hughes RA. Ineffectiveness of high-dose intravenous methylprednisolone in Guillain-Barr&eacute; syndrome. Lancet 1991; 338:1142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/29\">",
"      Korinthenberg R, M&ouml;nting JS. Natural history and treatment effects in Guillain-Barr&eacute; syndrome: a multicentre study. Arch Dis Child 1996; 74:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/30\">",
"      Cr&eacute;ange A, Lerat H, Meyrignac C, et al. Treatment of Guillain-Barr&eacute; syndrome with interferon-beta. Lancet 1998; 352:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/31\">",
"      Hughes RA, Wijdicks EF, Barohn R, et al. Practice parameter: immunotherapy for Guillain-Barr&eacute; syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003; 61:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41781/abstract/32\">",
"      Patwa HS, Chaudhry V, Katzberg H, et al. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2012; 78:1009.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6204 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.166.191.243-382E3F64B8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41781=[""].join("\n");
var outline_f40_51_41781=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MONITORING AND SUPPORTIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Need for intensive care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Need for assisted ventilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Autonomic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Other supportive measures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      INTRAVENOUS IMMUNE GLOBULIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PLASMA EXCHANGE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      OTHER THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/11/28857?source=related_link\">",
"      General principles in the use of immune globulin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/31/11769?source=related_link\">",
"      Immunologic blood transfusion reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/3/27705?source=related_link\">",
"      Overview of Guillain-Barr&eacute; syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/16/265?source=related_link\">",
"      Treatment and prognosis of Guillain-Barr&eacute; syndrome in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_51_41782="Heliotrope eruption b";
var content_f40_51_41782=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F53713&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F53713&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Heliotrope eruption in dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 334px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFOAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDmC/lkkDPHIFXbd3dAA2Bnp1/H3qkih1LHknrj+lXbbMILchj0H4UmdyLeR5iHBIAwcnr6VpQSJbITL97b8q7eR6fWsNx5kbqxKh1IBHr2NVdO+1x26S26yTxR5WS0ZstGw6+UT+ew9c8Ukrjeh0xuPmVtuZT1+lK2x24Q+Y5A57Z6Vm211DLEs0Em6F8gOBypHbHYjuDTrtniiSe2C8nDB3Kg8cYIz+tCQaD5Y8wy7PvZ2Yxxx1we9RSjyodjcbVCg9Me3+eaz7nVGRFNzDJDITv+WRGB+vOR+Ipp1CGeH5GZnLEn5sH3OD1q7aXM+bUtG6MALxW8kpQYZFlVXQYyGCnh1+hBFQQ6tA9xu84C6UHak+Y23d8Ajn8KozsjxKu/5lIKSddh/wAPr1qje33mfurgKhjGG3Dcp/2hntVqKYnO3U3Lq704IoZ7mR5F3+bKwjQAddoyScH1I+lVm8S3rWkcSyGNPlJaL5NxXodw+bPQ4zxXKyzRu5KJlc/wnaufXP8AWjzJGEiyyEqRjyt+0/7ynuf5irVNdTndfXQ2p9TtpNm5pGPJkZ3Pzn2A6D9aqPqCeW4tYf3h6Pj7v59frVFoYYgolSQbsMGDKcj1+vtT1CZzuOB/B5PI/WqUUhOrN7loXkhI3zyPjjgbT/Uf40jNCpDN+8d+rEEP/UY+nPtVaS4Mu4RQKsXQbwN35/4U+KNiPnZioA+VQFAGehP/AOunYnnb03LxtIXsftUkBjgZionU+blvTC42n2JH40W2nPNKHtNRtUc8iAOyuPf96Vyc9lJqGIWloJZLbUbpZpF2MkMJ8tx6OWIDL1/hOKtWmix6sgih/tBb6RvlDwboTHjn7pJH5dKlu25Wr1SG3ttfIIlvrC8idwRl49u9unHqayIwkokjRrN5iCD9oQxyoe+DnGetdbJ4M8TaXDCbMT3FvId6DT5hNjGBu2AgqckdRmmt4dvLlFg1CS3tpU4MeqQyWhLE8fMy7Mn2Ye+KXOlqmJxc/wCv6/I5NVaNlEkRPQH3/KhoUKuXwypwTj5l+v8A9eupuvAXiG0BI0W8jh3BfPinW4gOT/eUkY/l7VlJa6jpU73J8ofY5CjSnBRWA+6W+6cjseoquZPYFHo0R21+DGyM0krNxIJJNyyx/wB0qc9OCD2p8NtNHCJ7J5JGiISaCVQJkXqCNpxIn05H60+WOLUpWuWtobHJDM1spMIHqEAOPU4P4UiRJA0Zu5lMIYeTd2jFx9Qw5H0PPtUPyNU3fUs2WuPaxqZ/Nlslb5QzAlSfRvT2PFap1XT5FjebNyhG7crLARjoR6MD3/pVe2tobGEJfCSe1nQyQ31vtPU8qQeG91ODVCfw2VME1la/brK4kKQ3dudql8Z2EN91h6HGe1Z+7fU2VSa6XLV7f6XcTzx3sNu9x5hb7XZSKBNnsyhSpbPPAwecVkS6ibNgLUlT02mMxk/XbgH8qp6vALW6W3gnkAkGXDKUMfqD/wDWqvah4iduH3E5cPkn61ooK1zN4iSfKlY6m18X3Lyf6SrSqcZV3kTtgYIzirz+J7K4gjt20+F8YAQ3zuAR32tjaR7elcpHflAVdpQrdQZWX+R5qVHM28yuhLA5LMOnvkZP1qJQXY3hWe17npGhapo4RxKuoq8vzPcpKUaQ9cllbBPoDXRxai90JVsbnWSiDcEu0jHbrlnB/LmvGLWW1jcNNDsZDzLbzBSR9M1u2mqaVA7NfW896w+aGSTMoHP3ZEP3lx0APXvWMqfY6FUjLU9btbfX7JIZo9StniJVpLSYNEoOMgAgHgDv0J/Gtm08SrcssM1rbPNyvkPe7lZschTtCnj0z1xXl2leKPCc8SPc6QlleKPle2Lbfbbk8e6kdq7XTdZtb2CG3h1NooJGKtHem2cKQQeFYAk993BrN3izOUVNXav+H5Ha2ix20Ql0y4ubeN9uYri3LIjnjByQV4GPl+ta0F0LctKbeYk43vFmWNyfYcg9e2AO9efNo9/MstzBr1vBKhLj92ChUgDIYH94vOMZyCcDFY8l5rljLd215rMsXlnkMC25cgFlcHcV5HPbJzzRzOK0Ri8PGf2j2Z7yz063BuJ4kdyG2qcs7H2HJ+tXB5ZcOSuW4we5xx+NeT6PrT2irC0mjQS7ihle2nYsemS4Y8n3Pet2y1lHsQh1TSbSWJwwDxOvIxjbvbJ4zzntihVfI554NrqdrNEGRWYEOhDFo8gkD2HX6GqNzeSQah5LW4khMY3uo+YEk8Y/u+pqPz7iWL7TZajaTK0YYvsJjAJ4Iw39aiYamsirdx6a8rsQNjyLvGMcEg44Pf3NU5XRjGnbcnJTzGDwyiAAsJicrx1yM5xx09BTGMUt4yIsql+GBQ7Vk6qytnAz6Z5FVJ2vrKNGFqTZRqysbY+bJEAMcA/fTHp8w9+08FxZ3wLabc2890oHmoCY2UHA5GQRwOhHuKTehpy2V+n9blh7KGVVlYED+Nw2A5z3HfnI55FLdwLdLIgC+Ww3uSRuAXpgH0/pVtFYEx+cXdSQ27B8vP5cemaglWMXMMhIIZV3SKSCxHQ5Hb/Para0MU3chWGWZnZ8LEy5dSMbhjPHoTxn6VWjK2cn+j8xlAEZSTsGOu3oAfbqK1JP3kcke/O8D5+Mp6exwen61hBJ3ltXt4vN80/vGyVZcZCk+3DDHOOT3qXoaU/eTuaHmwBYYzhJSOYgc7WIxj2z7e9VkikaSWKAhXRlyTtYEZ+ZSccYz+XYVZiJBM7nzCc4LAA5PXpxn7o6gfWnokxMryJG8u/JjBJHQdfVu/Tt602m9RXsULgI8qugQRxZV0Awx3MCcDPQ8HH/AOqjDTFw4kQKQpUsP3nGcY9zzx6Yq3dRLJOJpXVQUKDng5OF+bvn86rysk1mRMnmzhimSuCvHAI/hz6+tTa12UndIrvCkUKxqXRc4YB8ocDJBHTPJGT16H1rISzSR7hdi/vcDZvwB82T9M9Mf45q9KkkccUk7tIztH5oA6kk4U/Ud+/epZYoLoRgQNEjyFWixhh16exPGfwrPdmqfKU/s5WWJYHRYnB3QhMbGx09Bj1qAqDKQjO7xF22Dqm3OG/+t0OKtXc8iKyQoyTHBwg3ZUdc+w4OP8KaGUOhaTLsAzKnzCUc5wB9cfgKadyle12fPFqSp6/59avsxZC2AV7MO9VAm+LKfKw5Ix0/CrsbnZtALSHgAjOfxrpbN0iO3LzliceWnf396InMV2zZGJyFOOu4dPzHFWUXyoAu3lvve4qoYTJPtYgBjgdtp6ikihb21E4kltH2TyEbgG2iUjkZx91gejfnxWLJql6y/ZLsSDaxaVUXByO5Hb3K8HsBmumjUKcYIbGfmIHNYOtW0ImkmnlghvWII2SsX49lBz/9atY66Mwqd4szpdQgBIit0VO20DH681BPfxttJWNTjksVyCPpUkdushdru8MZDbUEVsztJ78FcenNQpGlvcp9oeaOIn50tXBkXnsxBGTWuhyylMikuLhX2Sean+zt25/E/wA6jeJmBZyZHYghj8x/MmtEwaIbjIl1UR88TRRtzjhQc88+tQqunhfKiDPIc7vNQ/L6bSB19jVXS2RHK38T/EpLL/FI0RVejORjP0rQ0+e2MxS6vLe0gdd7SxWonZT/AHQvXJ9f1oFykORbwBWDbf3sYbOPTjI+lSvPHcWp+RHuUfKrLuUBfXKcA9ck8HikykrdSIaikKyBDHcRMcbnJjOOgxtOQ35j697Mlpb34jkgjuYbbKr509zkAfxIkZXdIeuCmR64qZLqzvzFLc21srQAq0g80jB/urgrnryQB7HinahLBJdQyaVqOsO6MoWa8MWYh/suACoHGOgHtU3KtfzQxbXRRZSJH/a8cxOYrtjCUZRn/lnuBUHjJyT7VbUaCbSEpqD2GqcmQLma3YAcHGd6nPXBI56CqGoWeo3EjpJG8iREGSWNAASeQzFchifXvVZY5bdzHE0TNgjMQUnB9T+dFrrcpaPRHRwX2YUSHULWQtjBQSI2eegC8/l61sWOvpbPJ5msQM5UAC+t454GPQ73CJJtx6elcxY6fe3KrKLe98sY+dE85Ub8DvH5H8a05n1OziEwX7QOjSKEmCjp8wKCRD7sOfWsXCOyNU77nQWOoJp99eSW2m+Hria5Ty5LrSdSkhVgfRZgUznnB6frW/K0N3ZRWurDUTYonliOfVIbsTO33SI1cg4Ax6denWvNBcWbjdO1/Dc8gYcyJ7fKdp/U4q2BdSp8k1tcREAsrRFWOM8g/K4P51EoFqNzYvNC1jT7y4/sWaJUQc/2FfOjxYH/AC0hU7wO25dwHfI6QXPjbV44Ihq1vPP5T+QJZdqSYUcrvjCk9idwPODmst9iO5jiurSaHDpJbOJwjdeTjcFz6E4pkusajdyLJdyW2rHaIzI6hZ9uc43HBb2zyOlNRXVA7ks4029hkvrC4m0rUY0BCPbt+8fnIDJgr16lSOtU7yceeo1dbO4hAAOoWgYspI4LNGBuxzwwzxRq32Ly0e1kucMSrQyMRsGcrz3647dKz8xr5iMkyuflIL7ckdieD+eateYOPY3njGnWtvOLuNbGc7obsKJLK5cY+R2UcP14IVhUmi3lposvmSaZM5uSVdob3y4ZVPVSCrIR25AIznisjTZbDTJGuLXVdV0e8dMFri1S5tZxnG2TbjKnPVlIHPNXtZjZZ0m0u4021uCo84WU7pbsxA5USDC59ASvpScbf1/X6iWujX9f1/wweKfDU/mwXOn6Vf20cymSC3Oy5XZ/szKfmH15rkZYE+Z5QTsJUqhKMp9NrdK6m2XxHbRoYrWeeONg4S2xMnXO4BSQD9MUl7M1+JG1GEXGovyZLrck0Q7ZIwSPqDRGcktdSZU4yehyEX2cgLvMeM/MVzn6/wCNReQRtMeOejIetXpbOIXBhuLWMSMc/JJsJHqrfdP0qtPam0uM4miPJxMpUj+hre99jncH1RPYNPPcRReXZ3L8BEnIjZvYOcAfia1INY+zXRTzJLSRRsMVxGCB7bv64rJM7PGFk8uQMcEtjGPqKWNztAVcgcCOTDD6fSs2r7m8JOOzN+6ureQSvJbb2IyNrhGB+h4YfT1qvb30lqyssUU0L/KYpm3qPTH90/jWepjCsBBJbqAP3fmebG/qRnBX8KikgyxW2DTREFipG0pjtno3tip5FsbOu1qdXZamIcGW8kKAsjW9lc/ZXVm5yEIIboBwcGtrU/GF/qogtdavZIIYWDRztZqtztxjAmQ459s+9eb6bfW0UTx3FsJVHJbbyPQ+1ajzeSFGky6hAhG5opIhNGPfjgjp1HeplS1sXGupLm3/AD/Q9I0LW7KymZIrlWuCRKk1uMCReCUI5G5ScFXBU9iK7HR9StWiYtOslkQV3R7pFjbsGhPzQtk5ypK+xFeB3uo3s9sF1K3iJdw6zyW5Xd6KCO3tWhYXtpbzC70ue4sLrG2QQyHch9NjH5l47c4rKVK2o+eNTQ940+S1nkP+j2sMwXNvdWpws7LnOGHG7uFOQSPwrZN/qttphlNtJfpv2s6oVk2Y7qeufUcYz9a8Q0zxbfXQuo3uYDPdne8cYVUmkXoWVsc99y49a7fw/wCOZopRp9/9pSRlCxwXUnksO+4Nggt3Dcj1xzWTi46EypOWq1PSNM1ixvZEW2mdUVRhCWjZjjPbg8ds8VavIXOpx3lskDsVKndyTkcfN1HQeq+wrjLOWPzY/wC1LK/sbhkMhv7O5j3x7em8RnLA8cspGTzgVo3P9pDULSaK5inRo2DzIRBIuOTnblGAB64HU003Y53SSleLNdr6R7a4km03ygQwmR7kbiBx1xz8ucc0abfRi1f7TJZ21sJCqkyq2Oww/TggdfwrG1K41LTtO+3Bo5rVlMs8RI805/3flYjk5GCRmrz6m9xp4h1HRbtrWQBjNYjzoyjc7hsJOO4+9QnqNwVtNvX/ADNWbU7U7biO/gKM2xBvUlm/PpxnBod5mxLbPFJIWALc7h68dvf6Vi2t/Y6iWtlube5S1WNDCyBWdcja5BAIB5yPUHoK2StvFZxQNgTodgRlKqvPYdCP6U9WZygoWVhZSqSvMXhdIuTIASD7tjqeT+ftUNhLdSTTPdRqVQGVGtWI4HqPU9Mf4mlia0W/WKMFTEScIFIY5+9x69Pw56VZFnjy2mlQb2MhZOCAOmD6Ace9JO4pWSsytDdLeu2394qRqjRgcjLfKGA75zgjj9aq387u05Td/o5VWdOjR5IPA9OD65p+nRqt7Dc5ANzvREwQzKWyHwP4QM9eMntmpZ5ohFMSXCKyLgjJkBG0g+pFS9ty7JSskUbqZlt4o7ZWmVgCIlYksA2Sx9+fx+vFSx2yzwCJpWSRB5ivjJ256Z6AY5554NR2ds1mreUfLBBDuwziReFDZ7EbTj3os3ljjj3vHFCUNyw5JYbsFjn16AelJWT1HJae6LehUtyAzCLgFskjGevfqM8Hr9ahtpEjFx5kw3AbRsz2PXPUEHkc9jU7os9jMYnCM5xhjlQM5Xj6Y/Om2YM9gUhhZPK2gF+oySGB7/p/FVXuxLSOp87hNwCMTk4wQeTV5I2LjG0g9vT8vaqlsoZwxzz7VpQ4Dgjnd0z2zmuhnWNbzTKBuIRQcqF+96c9qqXLtPuiSQRwnJkC/Kxx/D6+9a0e0lyzHA9eo/zj9KozW0czkOvysPvE4Knsc9qEyWrlJpI47byZM2ynpLANhPsWHINULgxxjbZBUQjloxknnuT1P1zV+/07y4lSOe4Lt284kenTHIrDmtHtpNqmIbeDkYH0zW0UZSdughTdIQuNm3AO3Jz3yfpViHRr64tQ8FpcyQoDumjjLK2OR05H4VB9mJyJN+WH3d5GTSPBaAjdbuWHVWY5+uT0/WruYtXIru3uYbcebBvhIz5o6e2SOQfrinWtxMjj7dG8qr0byVZh9cjOfz+lW7f7H5uYIblGPGRIRn2GBk1dt7fzMO0UsMPI3eZKSD27dOvak523Gqd3oZYt1vmLW9oHKrkrEzAd+TuJx9PUcVD9jMh8kEKcAmPcfm/Dv+tdHdWOn386SPeNBc8KDK8hO0DruOfyxxTYvD8MsgWS8vFjAJLqwbHGe4FT7RGipXWxRitreeFBDcus6HKREKq8diO46VI+nRxylXufsrnGxJQGWQ9wHTgkemBWnL4N1Sbyki3X9ofmkUOgYovcMeAcHvwfriqt/okejyvJcQztFnKzrEjR5P8ADJGV+RsdQQQexI5pcy6MbjrsVYtJkSNbm31K2hl3FdsR2Ej146g8/L14qzZ2l5fSGK5VLlkySGAyy+uQMkHsc8elW9P0+6m2TaXqUbxHOEfYqNx1bacrx64Ax7VcnUiJF1axFs5IIuUuC4BHQh8kD6GplO2hoqfkZn9nPDOFgWW1LPtw+51OSeD1A+uM8Vdjs7t45ZY7Ce4WEYcQpIT17FeMVs2ltPp0Uc82npc27Mp823iJI7gnAKkdfuk/Sup07U7Z0F6lrLJHDwZdPuPkLcnBAIZTk5/mDWTqX3RfK1seXrNYXCFHJRsn5DKCT+DYz+Bq/Z6UbsKLS9sLSYksJGnEJJ6EcHt7+td/qFnYXbSSXcCNJPwJrmxUFgAApbblTnnscVRl8F2l9+80+ys7+FPkkjhl8py2M5B59hjYPype0XQPU4i50e9tx5ja9ZLxyGfB57A9+nr/AEqrc+HtRuYTMk1vNGFO6VVztGAMHbz6c11I0cWAEN1FqVqrH5d+wN/u5ZCD0q5p+iwR3cyrYTzM3zIwYx3MZUcHar4b6FSD6U/atMvkTWv5nmz2mqWqdVkXbxtG9SPr2/8A11UjxfXPlzW5FznG5H2MfpngjjvXs/2BmSTJtPMI8qSKZHtZdpP395XaSOm7CnHXIriPEXhoozIlmjyg/wCpYbXIz/CR8pI74PPGBVxrJvUzdJvZ/eck8CxgiG4eNQcjzVwD64IyKrKJrfFxaXJhk6boG8vcPTj5T9DmrsVqbe4K2U80UgbDW7NsdT6YIxn6j8ac091E6x3AsrsE/wDHvewGHjGcB0I+vB7e1ap9jOUbrVFGw1q80y686xneznGAZrdfKJHowHyn8RWpd+Jb69hZdSmW8k6q9wmWT/dYc4/P+lZFzDKWQPYyxscnesvmI4J45xzx71AUMThNrr3MbjAYfT+oocIPW2pmpSWnQuvfWwz9qDR5HLbRPDIPpwyn86lhurTy/Kt7uSGMjlJB58BzxkfxIfzqnDaBzm3GR/EolG5T9D1qC6sTCwkEcsTZ+Zl+Xn+VHKhtzWtjSvNFZ7driN7d4AMiaL95GD6MR8yH/eH41iS280JG4umTlCfnU/QitC2ubtZEkgnYTIMFwCj49Mjr+ORUsV44dklK7JDudpI+mfUDgj8BQnJbilCMtVoZa3nmoUuAj9MOvb6qf50qxoIwbeUoufujOD/ga0bjaJC8eNvdSuR+BNVJYY97SLgYODsboT3H/wBequS4Pq7lcblIYiIv/A7L19ifX0NSq9qyL9mMttMOHhlHGe+1hz+BFSRhukhBPQEr972I7014lKM8BUS/xx5+VwOeD6079yORrVf1/X9XLFvqN7ao0cSlt4I2OBLE+cdAeh9wadb6mkcvm3caSMg2mKaM4Cn+HOcgeh7duKzVkK/NCxCkZ2kZH4irMV1L5ySw4EiAAIf4h3HPDD2NJxQ41W+p0U8Fjq9n5+mwTCRPmV9ytjvhlycY9RVB7y9+wra3LCS3UnEb/N5ZzyUJ5Q+3Q1WzDdzCbT4ntr1OSsDbFlHtjoR/kVrWIkuI57m3uI7vaNk9pcfurhQB1DAEHHqRzWL0OqLvqvw6mpo/jzW7ZYLWTVp1hjwIX2qJIuMckjnjjPTmuv03VtQl1JJp9VihvJEDj94tqzZIBYfKUfOBn6VwEtjbBkFzp8kHGUDZlWaP+8dmQMf3l9siraXEmm2WNPZL7SWcB4ZGVpLZu3zeh/vDA7NWM0n8J0Q0T5j1N9V1rTJlu7q2S70qIgTeTIqLv7MqnhWz2B2n0UmptL1+W2uzPoUiPpV3JsitJBs+yznkxBj9wseVDfKW44yDXEeHdSiY/wBn2s1zpl3LMqm2YEW8vHBZTzE/bOCpB4q7qMEtrczXWnQKLa72297YXTGJWl52pu6JnB2PnAYAZrFprQfJB9DtLnVIjfQXts92NYsEaS4tJlCzLb4HnEAjD/3lwSPlwOtdPBczrK6rHZSgxLPBKzMY5EI4KkZIHv3yvSua8KanBrOmLYagXmv7Jhse4XbMMd8fejkTowU46MMq3EmlGTTc6KA8qWqrc6dGeHuLdnwykjqUO5ccAAoaSujnnFPTqvy/r/gmqs09xdiSUi2mkfypZ0wEQHhRg+/c92rQvpIbW3LNcK80caxBm/utjjHb/wCt7VmawzXenXZsv9I8uAToWGN0Zx+7HuCFYHruGOhNSWLRX2i/2pOPMe4gAaOIBcKxAYEdjnd+WOKO6IaTSbNaSWGyhWytmQ3qLsDBSeOSefp/hSTLFI1mS37wyoVjwMBQCcn+eO5AqpP5yaa8Txwy3M0ZjYo2N5TO08c9snsMYrRSX/RbBYkZZ54hI0mARnbn/P0FWmYONtV/X/AM5POn1K+JMkoDRhY8/ePK5P0259B69KsaiImhgMbeYeUdAhG7tgenGPyrHEs0+pttIij8jDg8jAZCT1+Y5atq3tpoYpox/r/NEcpbndkfK2R0HepT5tC5rlsyrIHgWKJQUmdVLqozhSMDHuAB/wDrNWisK6fE6MFAcM7E/eB56Dvgfp1qbfE6NBzcSMpGVHLsOCMdl6Yxiq94Fs7eGBoG4AQhSP3nAJ5/Ttiq2uZ35rI+cbccYDAMfetRFL4wxGPun1/zms+zxkjaBnvn7taGPLkVhjb1HNdDO0mmUkIo++x/PjpU5tTt8oANI3G0jOT6YqoZxI7GQHdjIx2H9TUiXqqskpVy4G0fL0yPWktydivevKk5UAfuuBG3G3HpWSy+Y/70ZBOWU+pPv39as3U7ySBvImkcfeLfKfzpluJZpSQkSR4yS53H/CtYmchJra1jtwy2yqWYgy4JwO/APFZ0qW9y6Ktz5aHKnczYUfj0/Crd1FcfbC0rNNMcYOQNoHQFRwfxzTYo7jbJuigiLHBO0qQc5yADjpx06VV7IhK+liGBZrVs297HcIMnaFLMvvyBn8DmtLTdRdcLJD5oXLbRMUbk8/eH171btLS/MQkV4RsB2gDDHPfj8K6DT9CkuFAv4rTaqNIPMZlbA4IB/hzn6dazlJM3jHlJNPljuWjSWznVpgdplKkMAM/ezjnHWuhtdHs7uNI4befP3ykRLkDH3iOceg/M1gjSpLMebbef5JIO4FQTkfeKngjORnP4VsWN2+Ve6lt1jH8YUwMD6EEc++DXO5FuLeqHrpNtaXBZnBTkbo1w44yAVUgEe/8ASpZtLa4sftsNzK3zBQ3BITHO49+3B464rQtry2mh23VtdQozERuse/jryw7e348V0GlzQuIJDvkiypFwq5BYDIGV6jjkHPI9aSaluRKUoK9jzu88LxlI7m50u1klOVYXCFIzu44kHKk4yDmruiWFpPb3C2slzbyeaUaJLjLxAdYyknrn1OT7V31ze2y6TJCJozPIQyhT0DH3x056iuPv9NXU5Zb23VEvkfaV2nbImCAGC8nofmByOo9KHK2gQbne6sQJ4euYSbnR7m3EquC6kPZupBPJMeY2OfVe9U7a1urnVUluYFjvY2ytwkyxyvwCAsseN3UfeFdPp15dxwraQTm31GFNxsNRAkOAMho5F++uSSDzjvg0SGcXcE76VNDcqjq81oqTI5wPmA4PbBOOnfrRcpOSbT/r+vK5QsNC1iKK8NtfQ2rbcNHKvzY5YbiuAT15xmtTT/tix/6fphViQFnt4xcwE9zjh0J7jpUun31vIZRemIlmZxHcBo3zkkOA20ccDj863o1gla2MMqSSPH88kRBI4xu9DnIHPv17CSZnUnJfEjHuZbJQ8MySJBIGVSm6WMk9B833ORnBGOvNWbDSbIWMwnihlEIVMAbkb0Kgk7ev8J6dBmr0iz28qPdJCsqny45VPTHYk8gYPHUj1rMEtrezb4kkWdWOSj7XJzyy8AEjGcHgjpSe+pCvJabFjT7CBA6lmiihCtEgkL7SGII2nPHHT9KZqEcU082bZREh8rzNwDsMBvLKng4OevUH2qdxZzSrOyypdoAFCLgFgOBgd8YGfb2qWG1a4gEk20oqEhCCpwR8oyeo/L9KtdkQ3Z8zPPdc0KDV9p1KCJ0HAOzoM8AH7y9uOlcfe+DlktpEtbpbiBjzDdHJwD2cc5HqQelexybNxRCI2Vsc/PuIxkg449MDI+lMumgMkguEgbc2QVXYB3yPYH8/TvSUmup0Ko0tj5zuNImsG+z38F2sXmbHWGbChh0IzwrY5xgZxxU505bqIPZvqE9sMxc2o82Nu+SOCeOO/wBa9d1bSIZpGuonOVUpLGFDFlzxx3x3HcdOaxP+Ecs5kSW0229yVBV4ZCpdc8Opxhl9uSOhAqnUZtFxaPJb7SrvTJ1kmTCg4E0sBCsewcfwn3/Kn2l8V3reQKhVTkKv8Pc5zgj3r1O40qVNq6jFbXMMowfMi2llHdgCQceo/KuZk8ISmZhpDb9hDLHK/A9Nrj7vpz6VaqqWjGoJap6HHajo8M6NdaO8s4UZaNeHAx95F7j2rJjL5807ZEY7SzccjsR2PXrXo2naYba6WG4j2XxPOn3gCh/9qGVf6cdiveofEHhtrhBeabG9pertYpKBiQ54BYcHnocnv0qlV6MiVHXmicRpz2qsttdqYwx+WRWwB6DP8j+Bq3c6X5FysbSohk+WO4DDy5M9AT0H8jU01rFdxkfZJLG/QlXh6qzY5GD0J7AfrVWCF4EMLgBSAxRj8skZHYdPbPb+V37C5LaNFa/sZ7KRxPEYJAcBlHyH0yO38qdYiW6YrA0ck8gyYW43j1U9M/rWrHO0Vii3Eaz2QUhJ5RuMYP8AC4HVeMe34VmT28FrKjR7ACc7C+5HH1GCGHqOe9NSvoRKnyvmWxSvIyy+dJE0T5KliMq2DyG9GFRopiYsDiMrlmT51A9f8812dgRfFGuYbiSMqBJcRYdlUf3yBiRR64DD0PWqWteHRbuLq1ZGgYFhPCcq47kEd8c7SM4zwaSqLZmc6GvMv6/r5HPiORdsoRG28Er0YeqkdG71Gs7PcxyiaUS8COcNhiP7re/uf0q99lm06ON1V3jf5/lOMrnqvZh69CpqeXT49QuC1hxM2FMONrGT0HbB7dieKrmRHJLpv2Oo0HUrgW3kJdwiaOQSR7f3VxC/qVPDLg4wDyCcda7OTRLDxJYi8hgOm6pCfKuZogCsR7B0P3lPbPUdDXlmn2Mki+XmVJ4ThomhDlfZkPzAe/IrptAur3Sp/OhuLm2upV2BrdY3t3UH7uGPDDPAbvxxXLNJO6Z2pOS8xt9Zw2ko0jXLc/ZItoiuYuWjVuBtbqYyTwD91htOeDWteSXtjp8ml+IZnvtOVRBHeBP39suPlLjHzxEDhh/dweldUujya5pdvZTi2u1kQvbXkYMc4BGCFUnGQMggnB4GOlZdmt7ILjQ7i5U6jBE0dnOUIW6QAYTH8LL1x14yOhrLmuiua7Keh3t4lxBqDTBdZtgLeC6l/eQ3iDjyJyOckEbJPcetdnqc7XWi2uv6Ykq6xprs5tjwUGSs0De5XOAOhCkdK82tkXT9UWG6UQWuoJtRHGVtrhW2shA6rkFSM8ZGO2O/8D6vLBeXNizOWSVpo/PwGMhABQn+Ig8HHX5T35T0FUjdcy3Rp6bOLa9tGtp3dNSSWawfIxsZA7DnuGAOeuCwHSi7hW5h8TRRSBYoppVicJ0eRFLjr03E/gPeodfsW0bSdOl01fNuINUW4tbYpjyw29jDn+6QXXn1HfFWbdiyadZeablLlHugI8EgkHljnn72T7CpeisZJ39+P9W/r8zZtLq3vJbCZ95VoDNHEAf4woHX2PboDTo7j7APIkjCyW0CReRD90swJP8AIHd7VneCLma8XTEjZIPL0uNHkUZJCsynGfZR/WtKzjh/tycwxvsjgRVZjwpYElyc5JIx74yKaXYwmlFuL6f5jJfLGoabDbxrDFJBK439ySoGO/J6H8asK4t4INrNII5CQTwu7PIUe3P4/pkXl5Emsz3UsUrRQIsCsGyWlb7qqMd8AAYx1JxVqMyWDKZoy9/c4VCpJSId1AHZeobuee9LmuEoaITS3MV3OzSSKEbeYl6gHk844Pr9asyZuiZP3ipHt2EHaMA9z1xx+lXdMtorO5m2Ss0hUMW+8u3uT75rOsCPtOyFHlg9JHGDznPbn0x061b6XMlZ3a6Hz9ACdpCkEjGev4itBPmDbVDeuTj/ACarQxlLUso7c/jUgI8lGcsCv8J649OK6TsHSOArIFBIO4AHnH+f8Ko3EgKkq4Ax35H51ZWQGNsgcHPI6VXuoFlK7FJYjmVSQSepz24qomcmZL6pJET58JZsgfK3ynBqc61K6giEopP8W4549hTRpqD5g5IPG0tjH1NVpbMRhVt7mSBf7okDKe/TPH51quVmHv7ly3uJZW8yZsEA4KIwP4FhV6zTyZU36dcy7huXzdykj1G7gj6VmwJflSHS5kxk5jnAz9AR/WtfSxOpdZv7cithyFjVJCT/ACH1FRPTY2p67m3Y3kflBorOaIKCPMbB5x/d+lbemXty0cuy1Wd2Xy/mXYcdcgng4I6Yrn1hglHmMbobgAyTQt9Dg7fT2xzWjps2nzS+VJFCvA37ogrKewBPXt61zSR0pJ6HWR3T+UPNtpLcFsBd4k5xk9M8kcY4pZls7m5VCZJIkjzHtkG7PT5sf5FGni2jjQsq28z5YiBNvA46+5zzTw8ciiPy94iZgwKcqB3B6nPNZtXFFa6FVQ9leEQTT26yMsYuIgEDnAK7gON3JycDPY9q2I9KvQzxBoklddzToSrNzyDjIb5sg5HvWY1skcJSAhrd3EsqyHKmPAyuc9M++RjpUmn6hIscwVBcK7YUZyQMnAGeo9T9KOXuXKDavE3BeXFvFLp9/AJ2YLHFJCQVyOOmcljjoOuOnWpnurHIAiYTj50Lx7GVwwGexzgHPpUNhqESI00f7yVI2lyyEEnIwAfYZGRzUeoX6pCJJ4ttxI/CHg/dOXyfptx6+uKq1kYezblsLfWtrPFPbSWzTqCssRyT5Z6kxuDlO3Ocj15pplk0y8lSS9e48yJf3kpDSBW446Kx7EEDP41XjllDPLGqgkAJ8w+UA8FuxHUE9MkGoNTKtGPtNxdWhjlbyiRu8sY79yD71OqNo076M6a3uYr+KGKRv9KZSqJORtdeyk+h/Hn0ptrc2thfTwKV+2KSQUjOODkBh6+4H8zXLaZNevAIYbRZI1yxngZiSMZ5z0wc1oX2pJPBH5NmzSOu6YwqVKtgFW3EcHOQcZBHfpVcxEsPry9DSv8AV7qa4tplX7HslKB5I2IOR8vXgE56kdCOanaOK3O+4IlmkYfu4h5m18c/UE4AU8DPFZlzNfzGS5e2YRunkkOxDMg5BDE4BGeeO2fWovJvHjFuk4t7OQEMn2gOXAPzDccgcHtwO1J2D2asktDdlulFlHJcBoxNzCqygPBgnnPXjJB/I1WaWa5iiknv12vkDyyNzfNkhuOAOp+pFZtpCZshp5GkP8QUDHrhie4Iz0z26ikW5tLViGuZFlhchyYyEOOflbtnBHPT070XbEqSWi39DXiNsYfLVXGcH/WEdsDOM4IPHAxz7VJ56xuPsscb+bGFAz97nknvngD0OfasldYcAR2lqRcS+WUberjgc+4Y9wee1Xv7QvMHzp/s4Axl1w7568D0Iweh9uad9DKVKS3/ADH3ImuIj5sRRy+9W2bWX2PY/XHHGaxL3R/K3un+j3MjFzBJveCQkffJHMbHnLKfqDWxDCzohXykOARJkjYM9R6nsTz9KqIu6aMRTPJI2GV1jLFDnGCP4jjPI44oauKF1szn5pUgU/2xBc28QHMoZZY2HbMgBA6Y+YAn25qu3kXMKS6dcxTOoJHl8jIHsT24IPOea6Jo4ozMkTwrJGhLeccFTnsB0z/jWbe6fpt4hMqafJIRuEghMDhgMkAqNx/T19Kmx0Rl/X9f5mRfWlte2MkBVJFHzFJ4slcHgkZOOw4P0rNWzX7OZEeVQh2vFJKSUYdcSdfpnPXrzW42nvvDwahKjqdqs1wXwuck/vEO4depJHtVZLTUQGZL6B/3mwSLHGWJxnuRngjnHIpa2ubRdjEu9MEzI09nHe+WoBZ3Ibb2B7MOfX3rNHhkRXH2ZpZUt/MDWrH5vKz1QP8Awkc/eypFdeun6g0aZeHZtJzG6jdk424GeTnOOvvTzZTRRFmaGVpeSiyFZAOCCFOO5Bx3INXdjckcJd6TLpxkuohbyiMETxQrtS6jJ+cFSCFcDByOCO1Zk2mW0EMjW0UVxYyjzPsxO97YZ5GOrL9CGHB5FelTPcaYjtdfaREV+RmQEo38O8Ecjnr0/nWSmmRRm4bT5lhmBDi2ePEZGMkZ7D0x93PHHFPnsKyep5pHp6Qt5mnXsloGYAEMSu7+4zDjkcgkdjmt1dQvBbvZai2m3RmGWgvUNuz9spLH8jH34rpb/SGvrd7uC0SOeNSJ0bC/aV67CRwfVWGCD1xmsOXRzA8MQEUkMhzAlymY5G7xtnlJBzxxmq509yOSK0Rky2rW223vT5AZgiSs4MZJ4CyHor9g/Ru9QPpr6crN5BubTOyaBRhoz/dK5yMjkfgVJHFdTbWItZhBDaXNnHcKVfT7gCeGcA8pGT325IBx0xVw6LJaxwvYTyNbIALW7xulgHUwyL/y0T0zyp4OOtLnBxXUzdNtP7UtFl0jUvtFxGQsbSf6yJuwWQYZT7NkVe0rXQ6PH4vtgXfpe7VEZ/hw5HCsCMfNgfzp2seH7h7hZ5YX03WpGXF1atuhuFPQEr+qnn0ziq0buuq+TeSFJ5ZAri9KlBLjgb8YaOQfKdw4YLkdahtDSuatgx0ad4Y7mY2Vy4ZRG6uuezjIIGCCCPTB61b1q3e11NbnUpUlguQiNeWsfyow/wBXJtPzRurY55DBjyM1jQabp0VrOYYHtbmIl5rNSylUHMkaDuMfNtOSrLwcEGuh0iSQ2/8AZN5cSTWV1EyWchxtuUIyVBHR8Hlf4uCO4EaDa+0QarpC31zcW0eZvtsYu7Zycr9oRQsw9gw2k+2fTNZGk3JkmVrqdoxHKkU8jYLIM7Ek/wB4fcYewbtXV+HLtLaz+xXoja4tGMRmVhuYBRsDDPAKbeev3hz0qhrX2W28aTZgeK1v7MR3qzrkhycc5/ixxu9cdzSugi2ny2Ops2/ttLe2iDRyWt+rThz8oKKSWx75B/H2qTQoYre2MCoz3Vre7oAoyDCSDt9lAc9fSsHw3MdI11NLncuFQwGeRsbxk+TIfdlJQg/xAV1OmBk1uS1tyrRyoZ2cEKWZGXJz3wSR7c1Njnqe7dLbcTwTb266a5mAWcXM8OBzlFlfGPYZP8+2K1rW5VRNNtjSCWVnZpOhQDYvHU525zVHTYG0m4WwtN08s0RbzCmMfvGLHJ6A7gPr61dMby6gTPJK8aqM+UgU7sZAXPJwAKuO3Y5alpSbfU5h7d/Ok1jUn2qw2W0KnuTt3EZ5ZjwB/CCe+a6C2sfKu0PmNcSrAUPybV3secn1GD64A+lUbxFbVNKgX5GWZS7K+7n5mAA6knZn8a27q5d2Cqskp2kA++cdAee3TrUqKKqTbtb+kMuYSiQxM+22UkP5eVAOeOSeh79e9ODxqpVAjMVyPLXaBzzye34ZrPmnuLi7EQbDJiSRP7uMYJ/McelNt5oWef7Tc7Ah25CE5x3B/E8dsd81V9dDPkdtTwO3kZMAPgHnPOM0t2C4AUlS3JI71CXRoyCPoe9ADsAY3yF7f4V1o7BZEeKEFGJY9ec8f0pPJzAGOV3LzsbGQKLmVI7cF2JcnkDjA9vWqZn1F0Y28SBSefMGMfTHNWkYyYTQRMisyyuvq0hOalgFohWKIR5HOQDnNVIbW9uLnNw0JCnoynYP+A/41u22i3nmkSzx7VAJSJUA/LtQ3bqEFd3sXNNmml3OLWSZEz9wqCB9DWrptzbS3Sj97FJ0ZJ3WM5A5x2P4darW+ihIf3TXUMqjBcOdp+oHGPWtGxsy4e3upVkYqcxTxZB4ONrDH59vSsJPsdMUb+joWtvNkAjLnbjvjqccccfhVaaO2kMaTRhm3/KflGATx9MfiPSstLT7HPCiT3NsoH8IO0nGcAE8Y/Wr1svmxO15iRGPMqx5AG3GCOueOxqN9C1GzuLHzbxRkt8j7FwWGF78dwcAVJFLFb3qJK8jRsTzE2WXPXrgcHioAkrCUmeBoGDKqDI249QcEHP1qG7hZYrQtGQXRg7ZycqcDkexH5e9I6IxT0Ls0iTwxWyn94743E53PklcjuCcj+dSJcTFgGJ+0xJwpTadpb74PfPYcmq8EUiw3UxaOG4kwuSwUqc5UKPTgH2zVh7J1nj8tGuQD5R80mMxMOfX34//AFU7XRXurQvXTubhpg0q2zSdDGGcL1zn1B/TiraWjSWZawuIZ5kYybH3NJnnPJ4IJznOMEe2KoWyWagySSzQTTSeWXC7hGuOmMfdJ6k96l0u8uDcQo8ZkiG6RYi6/IuPTr1APscUIyknb3ehVgmup0gdreFP4fk4UkEjDduRwQetJDqV5I0KywW6oinc7tuchunBOcgdT6ehGahn1aWN7hbqZ0nkkBmAwY2A52ng/N9ccntU0lxaXdwVhtJtp+428Jng9ecHtyOo96SfY15e6NQXV9cssMM0e+PP71XCHJ/hGOCMDI4B7HrQ9xLbxxQ2t48iLCEV4oDlcknY2SBjAznHpWPEgacLbyi7SRd80bNtKYHUkenrT5J5reWWP7LMElCrIyfKoOcYbdnPXGT+gpXe5Hs1si/CDdGLzpJnjhbEqSTrv8sjhsdgO5+uDVoPCblNzWsk2FfzWk3B/wDYckcEDJHTsOc1ikKQxlSGJ1zF95jtx2GeRtz06HPFRXEqOBtt4FCoE8tiXJPUbumD7Dr+FK9inT5jfn1hZFjt71pshdixwptMwJwwLkZ9vQ4GPWqcMqNb/vo1i0wzl98zHaSeOo5DD8cdwaZDPbRoiG2mJkG2R9uNoODlVHoR+XvVee5kS5he2hg45UzREjg5G1ehOCex4/OnfuTGCWiViae9uhfNPZNNFE4CMY4fKAT+Ernpz1IPWpWlazihnvYt6+bgu0/zIcZKsOoZhjBI5HNVIdSuXkjMj7lG0osjDy1C9CB3xzgdOabcm7vWjdmtF6Ru7zqCccDepI5A6dsA0XuNw6PYS71Kfz0M4R42Py5Q4Ldsj19cdabbTTEGX7aLZE+ZCVYq4HB+cDpg+5OahQQxRHzJEncgKrBgfl5yUz05Hv3plpJKxltorkC3dwJpWYBApP8AF369vpTsVyq2hoxXoXdv4O3Blj5Z8jI3A9OuOMcDND38l15yIj3Dsm1QMB1/iJGBkjrn6c1QlubWx3LbzQ3Eyt8rncExgYIP8XPI4ps2ovPHHH5f+jmPGEIGem4g45zxnqTRYjku72LlxcEhW+yH7MWBI3EHnqd3Y546dvxqIy2955gjhvZpIcRrJGVKnBwc55HPTkj+dUYb26mkSyE4iilk+bMxEZJ4JYdOfw5FW5PtMfmXpWO4SxCiRYnAVowcYwMHbzyeTnFFiuRRJXVAJTbPcFw4QRMU4H+0QecnGD+GKZK8w84y207BAQ5WXJQ9B6g89uM84qvcxgRwSJcW8yzgr5G0+bw3Q9zwRzycdahljkSON4jN9nyIw8hZFORwADzwPxwadgUUXftipFHkxNKEXcQUcMMZwcdcDPB5BJHtT3mihRkHnqBISNsauo5BzHtxxn8BWdDC0mbiSUNDGm6QxL5jQpkDJXrjscjP1qxprmGaXyYLSRfvq5uXtywH8Cqp78denTNITgiMC9vC0RVnhBJO4bW6chh6+49KlWztr2wltbxlmjlAjIkGTgYxx1BH9KI1hMG97pAzkAgAsAM85brnnHT9KtRw52NGjuj53MrB++M47duD/WotYma6GdJpEhsvLjma3MTBhI5MiBwOGGfmHGQV6c9+Klslu4EaeIeXO2GmtWbIOeN8TdGOM4HXHoeK2beNvKJ2sADsLtkr75464+lPjtA0bKWK7T1UZHHQn/6/XFJmTna9yl9lgvdGfyZCrMwaIrkZdSGAYH7pJBGOCM9qbqtml4QPssL3e3yvLkPyXCH78Ug78cgjkFQR3q2tmouRcIPInP8ArtrArOB0LL0YdcOACOlNvmiSM+cpXfwzHAKk4+6R93GAQfb0qVsLd6GPc6bcW8CpKst7BanfDeROPtHlheQ5/iZRyG6MFKnGeY9DspLZhp1/DE+n3LhrOUNtgkPUKo/gOfmTJ9Rk4GdNLqWaSU+c8d/bYMpjI5jxgPs+7t6Zx3yD2qfSNsVxNaTqklsVDwF+FK9QhxxnOdp6Y7jHLv3HdpGbJBJ/wkYksoMTyQo3lLgecm4hgM8bhwQTx1B65q3rmivHeWzTeZ5k9rOjs5BJ27HA/wB5Rk+mVrYvoxe32nyKjRz2rtDcxxphljdOcqeMghG46jJqDWreSfTHVlHnW6yyrKucSBoXQ/TqOvQr6Gh+YlUbtYg1O1huLjT8b4d7NZzuR827OEYc84YBu2MnmuqVLg6rbSttd4oHcbiPl3AB+g5wyg49zWFe201x4flmDlCFivUZlzyVXdjk+gPaulu2eG1tLlEO6JlYbuf3bYDc9R1B9sZpLR6nPVldJeqHiIremZpWhh2lpc5jGAOAByeCM5qpbzCUWE9xO7NdvJOoIzsQDI4PfGwYP/16n1OZjaXUAneW42yQgbPn5GApx2/w96h126Gn6VaxWxi+2BfKU7RkIFwc5+7xjP4DvVaas543dl3LNpp0F2011JCwi3hoxjaWCLsDfTliPrirknkxW0jIf3aLuLLgF8AZGSeR+VGlRLawQwyOzyQxDPykDYBwee315z6VFeweeE3K0ihhwrBioB9O5z7dM5qrWWhk3eWr0KKpLbmR5UZp52D7lQHY+MBSSe2P/wBVN3xKhjWR7lIihOFxlvRcdeD+dWj57yopkVkjfe4C7lU46H/P8qITBJBcFA4KEpkQ/Kcjv7nPf2pK+yNL9WfOarE6JtYZ6FG4/PsaglmNszCQbVzjI5x+VCBMkncGYYAHrVqCIqoIjXPr6fSu1HW1oZ32u3VjJb/MwGMgFv51dtr2QQjEM8jEjAWLH6mq89lIWDyTNG5G7cg2Hr3/AAogsLyNy0kX2qIHPMmGH1HQ03YyszUsrm4lmjgS0XLHdh51z39Oa24PPkZfO2DZx+Z7n0rMsCrzgNbLGMYBSPBBP6GumgiMVi527lxkg9Sv+ecGspam0VYryP8AZbqTawVFO1VkOevTB7j24p1ncRG4DXG1QM/mPb9PwrMmgYPujyQ7HCs3B/D06VHALiK4kfymVymzAGTj/Gotc6YxVjegkguYZvtGxPMUlBnCK475P3fXB9OvNXopHuC8ckbxmMjaRyGyOOemePxya5/T5nhkPl+WyBQcTKVI5PQ+vNa+mo0MQENvHLBj955bk4HvxwO+MfjSTtoOSSFuP9cHWIsGO7cnHPfr60+yRIE81vMIjYKjHhfo47HoMCm3s4kEatFcIxyCypx1wcDPJ7Giz82ONokWdSsbCQOn8Wev5/yx3qdmWn7ti++RMyxrJvZmBITeSCOMN3GDik8yZRBcW52Ro2V2DJXoAwHc4xx7ClE8tvFC87eRcD5vmUbVzzlQDwQfxGQRUT20ktxHHDMXDkziRQEETAEtk+nf37VXoC8yCe+8+SNLXdKFDLuYYDMT/FnqT6jnoKdMLiW1guEzaTMzIGBOWx/HgfMp7YAwRxVd5ocb8hmYE7WQJk5Pftn/AAqJZEuVhe3muVLHBEp2ouePl7noD255qWbW7E0Vw97NKbqePzdpw83D8Hntge5PX1rW+3W8Nuwihg8l4jGwUs3PUEDHyjjrisqI28d8jPtZTlOCJDk9+vr3PPSrkl3qE0MgWZmiAJQyDhV4OPU5GDn659y+hE0m/IibVDKsEVn9oURSBowhyY/9wD+LHUnrTZrl5ZhJfSecysNzByXbsAfXHTHPOam3NbRywxzRxeWCWdVDh2x96MnGO3Y9apJO72TWEQMl5OVDyZBBwSw2nqvOfrihjSXRG8dHlh0yS6uGbcuJGI4CjbnJOckA5U+9UoLmLT5izQb5TGQqIwyrYI3ADn6r/Ks61tvtt5NHczzSSLvkDRjl2HJUZOOSQfetZNOivZbN7dmRpI9gwx2h8ZwWwTn/AOt7UW7EP3dJu5E+r27oAlqkkpG+VFlMYbkhlGP4fRexwc1HBfXCpF9itXSWTLAk7W25x9SOw557itSDSYha3LLqG26d3id5AAuM8hQO/wB7OM8VlxSm1aWaK8QpKVT5wHc/PwVHbA2kjIpMIuMrqK/MZLMsV2Yn+zxNHIVYRYLsAOCGPy+hOPWqc1z50QGd9w2AxKdj3bPQ9CBVqWFru6R54o8RvsYLwrBf4eOx5wec+vWrtpAzQbkmt1cyFkiACqhB9ACe+O+adrl3UUZdvDA1m81xcvK5mW3zt+7kZ3E9u/1/Ons1o+jPiHfIyvI7Km0KQflfJ68dVHUHuelGaG5LyyqkMhhkzuDqQMjGAOCwJH5ela+nNa6stnZaluWdWYyckF3YgKQBwoUA8nuAMU1boE9PeM1bmCWOb7PHLlFCpDLHhvL6LvY+/cDnIxUDwOs0VvPiNrVjvwu8gFs8jpkcjnt9K6DW7S6tBcnU8yXAVIbK6WQsZIxncpX7pbBzz6dO9ZerX9rPdzsYmkkilCzRq4VZDswW3Zyc8dB1B+tN22CE+b4djKvLeSO7IhxtJO6IL8oHYDtj/D8ak1Wx/s7VAt1M/wC9hEkckYH3GABA6jPBBB44qfytKe4tjfSTx2hjPywnMkz9M8fd57n0PrShYbuUx+RBc391cB0jiIEPHytg9dx+U9vzzSZpzWLnhnTVuphdWeqrb6haOTsSASAjkKdvPHXPb+dNtpnsL3ZBfl3iXZJPEh8zcDyhZxwexIHpU3hm8h0zUopbtriCOBXZrcDLM2MbCCOFIPOfQHPNNvpTJNFOIy0szOCSu5nGB8h7kDj05FM5225tPb5EsMUt3Z+Yl0HlmQtcb32bm7ryAGbpkZOajhsVaaPyYGupMAhVbyghb+GQn7p4JDZqGxlktEu57eW0JZQskcxD7+cZ245wevQinaZqTWt39pltYJIVUQT74gFYHkYGMFjz1HPrRZCfMr2Ld+Zk1DzJpNs6ABWXqMAAZ4+bjvj0NQNMhc5zGI5cs6x53nqW+XA446daqajJZtItzYzkwyru8mRdoiYE8DjhSeg7d81JLdyyST+X8ruS7uMIWx0GB8vXoKloqMdEbFjdM0O5bmIAchvNMe4n+AAjLccnIx2+t2GW3dhGscjSA/KY23g8fd9yfasC3b/SBvkkQxgyF5WU5A5IBxkkngDpx1q9q1q9nDDIqt5BBk2q4VlUkbSTzwd2Qf5UmtDGcI3t3NWZXZHUnlfvZQ8YGTnIwDWXNZoXVnjXd6t97GcHBzx9PrT1u2clp38yQLuIcnJ7ZU/xcDOfyqferxKske1sb8kFlYdjgn+Xeoa6ohRcCitgtvcCYK8rINy5XmME46Z78Dg0s+2O4gexRERo2jmCAjAODnaegyMEf7Wam3SqF2gIT8uCc7c9qRYI7lXWZtku3cCp6n2qC2+shgmni1CCUjyXdNvB3+YFOfLYcYBXB6nGMg8kV18bpMEdMiRF5iVgSEI+buf/AK9cjc5lSKMtGsiusiTY+6y9M9+5BHHBrVhMXmxSGFJPLG5V8vlSBg/Ud/zqkzGrFNJmxDa200EeneaI0e3eHn7jcADHocZ6+lGkXsNxpdpFcvGJJYRH5TH5pGXhkJ9iD+BphcukLr+5VSJC5zypUjgDnucmooIjcRGSBVjMRZmZcfNKD3PcE9T7/hTvY5mrrU1LORIpL2EKIZUKKoPzbsrjk+vHUVWeOK81C8uxFE32Zfs9uzAbcjDORn1JVe/3Kkt5UuImnCSO0wX77YAIBABI75J5x2qHd9pkms5J2k8ghJFYEfOPmyMdQMnk/wB4emKb2ISs2x63k00zKiK0kLgbnIKhWXJGPX3PWr7SxBVO5pGjQJ8g+9xwqjoSePXFUr+ERxRA7hI06fKQCQSevA9s1ZkuFEdywdVt0I8zJOTgE5+nGcUJ2Jkk7WKjpP8AYHiuVLzyElxGerZ+5x6DjPerVzBcPbDZKYnABA4UA+pC9CKraLPJNDCPs7L5i7jvzuBJyMj6EHH/ANert8MQkZZto+YrkAc8gAe1CSSbFJtSsfNsQDllCDvntV3G2FASDtIBwOlVrYlpfmXgjJ+XmpvtCO/lMV3ep5wPf2rrO3cnlMUw2swweMf41Z/s25wJbeYp8pO1iHBI9Mc5+lUdPle5jgZYfsUpG4pIA5XGeCfwz24IyK1sypE2+NQT3jPJPpSuCRWsQbaXa8aMysTuic8+vB6VtHUXPmK6mYyIB8pA4B9DwTWZYsrM3nKylXGCDwCe/rWotuTM7phio5Yjr69OvXrU7M2supX3wqVDyKH3FijfKAB7n/GpHkVXeYy5XI9MkHqMdc1YEUabSQzv16AY+vqarLDEI2JBiljcruTHPsR+Pb1qH2NVuaNgY2lEbZKZyWzjt79f8mrlhNAHlsyYzGflRlYqFIPy4Oe/IrDjnkaU5uCARtII49h09jWjNFugHnPBICAFmRdvQcYzj1xQhyiad28hghaMGKWKPDLy2/JyAc9f657VBcXw+0QzO0f2gEIyxkqT9fw/PHeoZr6N4rcTBXIG1XII4XnDY7H17GkuXRwwzlA2zyt2SCPQ9+p9PrR6Exj3IoZvLDyJG8UJOJAhDAP6FW6j0PUe+KZKIJnMrFhKI/vKuFU56den0/KmNLEl60oCJB8oaIYPOOSMntjoenWkcyzWIUKz+Q3zcqBt64A6n69KLG601JT5ohEiQmTzGOMIxEnXo3T0NDgJ+485igXJ8ofLuI5BJ6nHH/1qrXNyz2myUzxoR8mTgIvp9D7VC8haUSSjzyTz8xC+oOetS0iki9b3cEFu6cjzA21tmEUdCSM8/pj8Kat5IS7CQqCAhQDjjocevPOMZ5rKuZ49wHln5RmV92RnPBA7YHb6mnG8zauIdsYlwA+BwQeQPY8fiO1OzHy9S1OFheVbxPLMUg/csSWbn5gRnjjk/wBKTzn8lDbISzTZR1XhQWHQDOD8uPxqi7qN7YzIUG0beMZ5I9j/AI0+0dN/mB2M4TaATwB/QfnRYZrSNK7XTWWI4YXDuXGxwx+8B+ORjpx2ojvpLSNJ90jW6SZiTzW2o/cgA98f41lXFw/nv9qEbuSGkRww3AEHgDAAI4z3zmtGWd1SeOKxjiimkMgjePB2lRwB2HQjAzxSauK1tBRf3Onp54lbYsoMcLKGJDKWLA87OuD9R6U4atFHqMk/LRyRiJ1iiEQaJh8wGeQ2TgE9e9TwWKJZXkt6ttbuyrHCZIy5yMt8ijHzHAGSQPrUFvZWxjBlv3kldf8AV5BU8ZIPv6D17DrSSsT7rvdFm71C5khDxLEPIUBdhBXaeAu0cZ4ye2W7VTnih2nN1brIIid5YqWPpj6cY/oKnl0SQQKxRrW3kyP3oKkAEDcScAjkcjjipLbRJPKmmtC1zHHuUtbuG3HHYEemOg+lCEpQitGVUuomjKQCXzWzul27tsQ+6MAcEDgn8avefcLf2uoRB7acEHzF8sJ5QGA2B1PXpxj1pW0tnaNYZQ8soK5WYBGAHXfwPbBxyOahu9FVQ8LgxuvLhAX3A89jjseR0p37icoMqyvJMRf38iSJJIGQg+YBzzleAM7cYx79KzmaznaVordLWeS4IXecRxxnOVbHUcjp05rSSzjC+S9qYLg4O+N2SVxj7oz8pJ64/wD1VmvBFEqSOjyw7SrIhCnPvnIH4/0prU0i10JZZzDbTgwi+ui4DyoVEceDhdg/iHX29amSS1sZEZZ7hLnBcXLKQiN3QKOoyfvAiqjTbJkljme4lRQRJtKsVxgZ7HAJU/1qBZEYpG8jxQnBCMvyp+fbpz70xNFya5S7ieZLQBpSzuyyszMhIwAG7cH1685xWza3tjMkmn3GhoZGYGF1uGk8tiMZLAkknj27HpXLmOW8J8hGmndjgRpgkeuPXHWtDRZza/Ojyq9mRIm4AJCdwHze57ds/nQZzimv+CzRh097zT2kl8mFYNxV4sGRkDbWQ5wXUE5B7c9RirmiRhNUsrUeTdK7RyfOS204yGA9FI79uTS6HbwXJujdB8vG0/njKCEg5O5ueCN2PyqpYQC3sdUu4X3SBBbpdRgBcE5IGOVLDuc5waPMxk73j/Wpq22kz6xbxSW0dpd2UhzFcTzlC8pY5Uc5AUcBec1S07T9Mtbm4069Z2a2Zy1xCSGlKjJUA8L9TnP51PY+IF0nTY7TT5GN7FIQHkX924OGZgD1yCNucVlabrMdpfXUrxw3MV0jQtGBkgHB3D+HPbAodiUqnvduhatdPknhtvsEkarchtiOyDfg8qobqw4445FPtpWS6nlmvGiu0cbEFu7Rrt6AtnHXgD0zwKguzpIt5L3TLye0uYyoSxuYzlWBH3GHXpn24qPTZ7SS3eS4Fz5m4yOsbFEjHOGHY859+2KRortO/wCQTT7ZmCJbzR4UEggkMxz26nPY59KvJPHIY4wxjJ53SjBUdjkdePoQBVaeey/skuy21vcOfNjcZYzjPPGP3a9uRk81XSVYi7Wq7ozycbWEfPfHK4zyOlJxLS5lsbEbFwVUkKvzLhc4GCM+oBHr681daEZlWJxLswAWyA/4Hp9D6VgR3ruwV5o94PAVTuX6kc8fyrRtrmT/AFYaKVmG/qVz9QcD06VEomU4NGptjZfmVA4xtLAE/Qn6j68CltLk2+/KgwrtOG4UH1+nPH9Kqxy/vCuTGB97fzjgfj/nFQM4VVZ3GOABt5Ppk/X6VLujFQvozY06+3RCJwqPGxQPnaOuM+mCO/b3qSBzaidZ2GTKeeo38fKTzkZAwfTNYUMpkDR+nI6547fT9K0rdorqHf5e+WFsk7vvKMdu3179am4pU0tTTs5nke4tEuBGI5hIpC4Xay9vocj2NWtNthbqJIS5nmffKcAl3LEE47Aj8qpwxuodYOV3FUUt2xnHvx/SrdpKwhWEqvKlUCnd37nqf5007anPNaaEoVZXjRyY0XMgZyCA3OM9sY//AF1lSRveMIJWaF7iZhI3TapGSueoJGR7Z6VZ8+S4jjihjKIjBQ5xmUbs8dsA8/UgnpUjT7kmgQtNGrk7VwvPqPXv/OjmW4ldPQ0La4hGWnnSKR5OY1ycAAgKCO4p5ktNql5lSMEbFOecDPA+vtWP54PlSBQJCCoKDqc/d5+g6/1qVZVmnYbT5oY992Dzn0H8v6VpzXMnT6nhFvkFGJV1YcEH7px6VLFAXmDBAw6nA4zzVW3XaN7YyeACcEf41p2hYqAD8vTJ4z+NdJ6PKLFCo+XBAJyACOPx7/Srw2yFQ4IJXAkXjP8AMZqmMhN7ASbeCBxnB45+vrWvpcrSTiMnnjAbgAn1qSuW2oW8e4hAARkZIHzLVxW3gorZMkZ3cYDD+lKYllkcOpCngYOCpz3Ios12u0I3+Xncre+Ofw+nNJgu5XWVjJGpJGVAAY/eqS6lMcDeUEIy2VCZKk9QB6VdNgjQbkji6AFSSSTnt2/OqjObFyrpgkE42kfUe3Hf3qd0WmnsVreUuG3PGV4ADEtnA6/0/wAaNziGRfLZcODG+4bTk4IohzGzupfywMOSMH8u3b+lJgylmjdWBwQd2VJ/H+ZpI2RKv7qMLDcHODlwuVJ9AO3TNJcSO9qjB0RVbMgxyff0Hpj/AOvUbv8AvXKgExgBejA+49+tV5ncxmJ4NuCGJYZJ+tHmNIehhW4jm2PJGuSFwTx7etPa8kKASSEEkucnKqSeoHrVFHWPdiRgxG1uclfYe1RsSAzIWDuMY6HbzkfnTLsupLHdBpsu3mLgjk/5/wA56Urygx/KNrYI2gcMe4PpVBMoxBG0HqcHA96lZ4WjMYyBuOB1z+PpTsF0WXkd5BJyVJxjAxkDpn8KimeVov4oxKFYLt52HONueNuR+lQXUjSHbGVjRGz8oG7PXj/PY1at5GPmHDPMBgN0CD8evX8CaBcwREpdIjmVVfkBV+fb6c9Rx06VauJJ5S7zMzs+C2QOX79O386asJVQ8iB/m2lTnIHUDPY854qRYUXClwAQeeuTxx7D60mF9QhWZgpXC7WyWDfM3YgHucfoatIxt2ZhtY5OAQSgI6Ybr6YPHpTfs0rTZkER2nKRZwGHt7fqaIp/Kk+aHft+72KHplSB3J6mkwvcs6dbC9kka4uIlDDM08iltg9NvVh04GOPStqwhgiaWFdT02KNAzNcsWjlfsNr8/LkDsCCeM4rIt98qMttFbQsqnzJPOKuABgtkkLk88H3xVqztIPIM8kdzIkYJaXClS2P4N3Ax1JOTnoKlGc9d3+RYSeNVR2uIjqD7WL7DPIw6fvJG+SIEHoBznPBOKN3mLvtU8q98whZvtw+XaOAo4zgfxYGc1ceHRVN0bK4F7K33IpreR029ScgD5s/hioprjSpI5IpI7aBhtfYITHE2OowBnPPUnoe+KRlzX2THXVpcNK8V6iSXJQMXeY7JSecg9FLYPHfgiqssN9axqVsbeR8rvTcs7sf905CnHB7Y96RLdJlcWX9ow2kki4jKGRFB6gvjnnJGD0A71V1m4mVkMl1vCqAXjhMUjLngsSAWP19fxphFO9hl4JEhTz0/wBchby0kVFUEnjaOSD3Kj5TjjnNYs0o89NjG0fcpKylmKDPU5HzAce9acs1xb3bpZSyiNjuWRodshA6fXt371l3s8l1JPNcTTee8u9gyjD5+9kjoc9hVJG8BbqXyCzxHaN+J0iJKN7r6ZzjHb+VJJkY4HHm5XZnAGOR1HT/ABpDPI7ptESLH8qsBjIPqepHJH0NQKocuu9RkbiMEYz/AEqkith0cskdwskLMk6/cZMht3QdO3bH860hfXN095HKiRzS/NO2AoCR9VIHYHHv1FUJLdjahmbYUIJ2nBwejDHb+WKgtSiZEjlSSep6/wCff1ptEuzN/wAOX9wkkMdtKVkiP2k/vAoCoCQGY8H7x46noKs3sz3DLcLaSW0jM05xHsiaI4KqueGOcnuTk1zS+SkqiUAKF52KNw745684/CrIuppLQ201xI8QKyBd5wCOOM+xP60rESjrc37AQrJFeC6s4mDBFhnUOVU9WKAY46+tWorSyu76YrdpsZiPtL4SMAdMKMY/+v8AjXNs8aRxkAGRME8YBXjkfTpmnwXEaLLFcgyqcFNrfdOP/rjilYlxb1R0K29lZzx28zRtG8pb7So+Xy933gevXPWq9jc6RcebBqMCoSjyQyouCrdAob+4eW5/OsyZlvnt0kCxiONYS8vY9cqF/vdMfn3q0dMnupI4bSIHayxq4kGW7Mp/Pv8ASgOVfaYy3vEhkgZ7KzuVZlJ3/MXwRyeeOBwM4p0UEV1d3EtlemxcElVc5V1zyA46Z47VoXFi2ixTR3MOx0fZLOGViOOEGTxwfvYpkGlWF7bNex3aW+4iJ4JiVMbAdM4545+ho8h88d1t95T0q5FvZ3SKLqK+kDL5qkASqw+63PzAHJyPXvmjTpolt5YbgFWZD5WCSpOe+Ogx3pJbZI7RkgUIVYEFpN2Qf4c+uMc1JYaZNFBHqonhsYlO6Jrgbiz5+7gdRwaXLctuKTb6luSeeayhLx+XcRAqXVuZB1xj1H9SPSiEmYbQS27lVzjbx0J/CqkUrXN48yWqQxschYs7VPGWU9cZ6D3x2rYitmyrDy3Q85J9P8/zqGjObUVZmdErwuSGJI/iA9f881sWNyIHDRqsDHAYjkN/n8vWqzQiSQlXAdR83zY/SmKqMzgvtUEEA4JP+NZtEOSludSjGVYGUq0mVYbB8pXrge+P6de9xRHHcqITvdg2SFx/n8Oa5+1ZWnjd3YoCCo29enP0478cVqreq6L5ZOFOGPJwT1K44Xualu2pxTg+g53/AH7iSULEhUqFGcnHT6cD60y5nUOVYbY8BTk5AY4wfc1GlsLaOLJwrKzKXOQq9OnuRmoUlQy7pGMp2BwX7geg/D2zT6XY0k3p0J47tFjKqhdEQttLDBOcAn2yO3J6VDJM9x5axqqqylSMd89unT+lLEkTEOzFWzg7OuM9ew/yKU20Udyix4EQBZic5UdB7cf1J4qt0GiZ4tEzELvCsVBH4elasAja0Kg/NjJOOM9v8/yrMiK52jOc4XPrVmPcGK/KQMZ/+t712HbykiD94A5yoXGRwc1p2i7ZBhjkjOcZOfTnqOKoxhA5OSUxzxgn0q1B5bRSEAg9R2Oe+ahsqxfhuEKhbhgJtpIwOh+lWZbqQx72ILAbVJ/hU+grNiAHlPJkMOjE529cfrVozmWPdCEOOAyjH+c1AcquaTMzR7lIUMx3bk9T69+n6VFPdiNi6uriQfMXYEfTHaqu9Zon+TLMQcbsjd3z6VXl3AkyNGNnOW6r9aAjBGgy28ipmPO7hgATz2z65qKeFvs2ISUwf4sAf/X7iqkc+dw3kKckAjpgdc1CxEwLSSExZ+8xP5Y9zQjRRsxXjCsHybhC3zjP3fYEevp06etQz4ETkKhQn5CzZKj+WfWgs0UTYGBtwqZ3c59fWq4LM7FpAVU5DYxuP0/rRYsazO5VeiL8vTHTtU9ltyyHCFsK0kgztHt/PtS3AEzMyYAwAdgHOBzgdc1UWUeYF8zzI92Txx9PaqE3cmcyxySJuVjuwXVgffPXkd6r28asyo0nlxliAWXp6kj6cnrUyCLJjjd93lszbx1bPygfT+lQsdsSI8qsI+A38Wc8/wCFMSfYkt3JVBuDEZ2ErwV7j9OOvWp7ZnEvlqWPPyqG+vr07f8A66hR1ReNyKSSVHVR681ciIMBEqOQPmyvH5+vvUhYs4IgaSNi8Wdp3cNjH+fxojQggDa+85YsSMfWoYpHQmVIyWUZVy2MH1I/D/OKijciEu0gUsSTGx469fT/APXSY0maJKKiISwgXO51784+Udx25+tMMcs4UySRpCoyXkHfrgDrnvgVV+1RAeW2So4KKvIP1px1F3VR5Z2qBtBHT6UrDs1saFjGtwBDjzCeBkgF/qfT6dK2rRVs7mJ74RyRiQ5jaQCOPoNxTPBwB1Ge5rlYndpUVYgH7KxJJPXAI+lAuJWRRmGMGTaxOdwPvzkjr/KhXJlC/U9It73TLVJZ5WMk+5iJIijxP6YXgdPXnI59Kki13S7W2SG3ub9CpG7ybZcnuck8Z5/DivPfK2bnlkKHPzKqBW7cE4/HPpXR6VoiM1r9qMDNMwQxStKGXjlgBgsOnPAOccUXZy1KFOKvJm/L4q02UOJY9RmZmO1Z1jZFweDk9PyNY15q1lcKf9BZJRMVVROAqr143DOTzhiBjj6Ulxot3HLai30+2ii83yo5biIx+Zj+8pYjJzgDHOBzUc3hm6aaaaXTVUqA6xvMqo/GDkFtyjOMfUfSq95kRjRjrf8AEoX82nXk07blhDAsPsm9g7DjGDhQDnJxn2HNYUiRsBvIJAwMcDGOB/ielaEuiSpJJHLBNFNEcTBycoD93j+LjPT+lYlzbuoV03JGrGPOSDn39eg4+lFjrgltFlcwlWG0qJUb72AQfeqrRAqFIVHGc9TUk0U6A/vG2hsBcjrUDGdMfccjsVwSffH8qtIp9yaKRFYrcLIznG5kk4GOQffpRIAxdZGQFiNshB7Z4+nr+FVfNJ4kj45J2nv7ULctjy3HJ5Bx1/GmIlT5kAG4vkY56DHOR+X6/hP5pClS2UYjPHYHj/PeqUgaMER7tx64HWkF0DKd5znrjrxRYHqbMYeeyiVXi3xgIEJy0mSTkeuO/p1qopKF1XcqAcZyMHt+PX8DUtrvuUtobcb55PkAAx1PTPt3+lW5oCpliEizSQlg+TwFGAeSeRnsPrUgnZkS3JljXehBcAFhwNw75/Tirx1GWfahm2xRAmONQML35HftyazwH3w+YMRMuFQccd8Af5+tXrC3tzC437WZ9gdjjaOwJx8wxke1SyrLc2tF1y6tc77kPbYUNE0QkXZ3UZ54zkc4FY+obJrub7Nk2juWPmSDJ9O2B3q6mh/aZUxdyR2wyzNKMAgd1HU1Bd6ZeWEdtcxqkkMqEqyZAYdAee//ANelbQiPIpabjlW1gsvLPlSyOqqCrEGN+ckDvx1OKWW+8/SLDTbXLtA7lbmUhEcMckbT9B82c44HFY5WYsVnTBZflkweB+HTmoliZ7j5AThiRG/QjHamXyK92zRt3ZEjmZkiO7BxwSMZ6dfp6V0WmTq7ZG05GShIyQPU/ia5bzt/yyrzuIUDJYnA7+lW9OZwgYH5ycEDJY/0NLYipBSWp0U8aJLNLGCWK5B7D05/DFZcFw/2kR7lSQuNpfgL9T6f4U77WsSqG4DYA5PT06dc/TrWXc3ieaSgOPTjOP8APpUWMoRZ0VvcMsT9AQRxjqD149CcGtCC+ZsQMQhwQCvG45PX2ya5W0vpHkWMONp43n0z2PpkVoTXTR3B2iMKzkAhg2fb6fzqWrMiVO+50M14yYKzZEcZXdng5GenQDjFCcyOx2vJjqoxnkf19fSsaG4MzR+a52gjjGMf54qz9saOGR1jLFjx/sjHJx+J5pNWM3BrRGwrhky21WYFVBx0Oc8/56UtrdRhyiu+Izw6qeCOMH/PTFYkN9O8iCR2QgYRF67ccA/zqWPULmSUBI3IGG3BRjcBjP6dfxpXE6TPMVymPu7u4x1/wq2i7lycj29f88VBHHuOTkY7nv71Zt4HE21Wwp5PGMf4Guu52EsJLtmLaHOc4bHH1+lXolaNPMTllIBB4OP8KrxqLeQZXgscYAyD6itNAqwYA/eMODnof61NxMpXDEyN5bK4HzKcYHPSnw7mba6MMjcOcce34d6iVSkuSqk5ByefrT0bbLwxUfeyuCF96ktIlU+SGRsqpJUFeHU+4qGeG4kO+FS0vqVzyeMY6VZiczZAZZVC9SOTz2qMXAGVMhBY8gHgj/a/lSGkNijlacsx+b5fmUgDd6U6KY2szrOxTdlSuwEbefXjNVpBk/OpwRhkB6nsQaSGR0lCq3nZOFVkB5PUc0ytx8zwCF8SHHTcBkr6D3757VC25tqRKV3AYOcA+vPbpS3MbCNWkjGM9R0Ueg9c+vrUUgmMluqvgbsDccMvP3fqBmqJGMSkiEuQyKSMDIJJ6ZpI0VriKKTILOAR1IycAZ7etWrKw+2LPdLIogjl2yPnlS2cEp1AOOo71WS7ZHSR9zAEsFDYb3GR7Yp9QvcLhEDsSFUbsKSDwOn48jP41GrbVxkDf1K8gY7+9JNKkilkQlSACT2qFQ0jZUk9+F5/GgaLImCrsGWPqv8An/OamaZxgZYd/vfh0qGKLBVuMn0H8yf59Kmk2bW2D515GeT/APWH50hkJaZw25z0wMnaPwHepFt0GAVLYyN/Xgf5IoWNo0Vi2B2O3+R/pUmzYxzywHTOM57g+nTj9KLlokhVyeG3NtyATyV7/XinRtH5flMrO2SFUDGD6k+9RphiRdMQxYEEE4X6joasxvDuBkuCNu5lcAsxPoDxnIzwcelJgy67rcTJBY2eyPhtkG5mY7eWy3PbkdOKihim81hujRyhLBnGD0zgc8859+o6VGPsschQyPNCuQksQKMD2I3YOOe/51L5zqHlgCqYSuGj7tjgknv7jmpI6aFi2G6OeJDbzzgcyksQFGec9s/7Q7e1dVpMc6TQzatqMlohUJCY2eR5CCMkEjO08j+mDXF2d8FgNvO8SNHkKfs+XdW6rIR95OfQ+gxW/omoxRzRWu25vLyM7bRoyBtYrj7zFWHAABzjH6swrRdmdNMukWiXdpqlzcS3SsPKnlON/HChiABhcbhkZPvW7pMkFvbrHDBa/YjEGW5jOYiCfmjyckEMSQDjlvrXP6BJdajKljq9xfWlzCN00c8SGNo2JClQwyoPKEGq+ofabZLi6kuJFs0mMUVw0DMzqMB964w4wMBiOq8E54tPqcEqfM+RvX+th+vI2l3VtPI0lxb7Xi2oSZogDuwP4XKZIAPPJ9OeT1GAQyzwQh5EmCT27t0cfe6jqDnGR+hrRvLy6eaP7VKk9pKUyjPlWzyj7vvbecLIPmXGHzg5wNcumtXurOWFMIzwyFlIIII4J6ZOBnHB68cVNjtpQasmZuouqNKJIpIzn5VYn5TxxnqRj8+tZ7Sl8shwcYwT97FaEhlntXY3KHL/AHHU5xgY6/TGPp71nMI0tSzMqSCQAA88Y545B5HP16elI6BYQGheQsiqrKuMcsce/bjvikaKN3ET8r0G7p/kVPcpIulRX6vw920ChV+XIUNkt6+3bmmJJAdZgM6BrdrpWcE9ULDdnH1P51Zm32KcbXFowEblgePm9P51elhjuYIbm5iZA5KiQYKsRjIyOhAIyPxqneDZe3MTlPllkXAbKgBiAF9uMVo36y2ltZRTYMc8SXaEKQQSCM+5IAPHBoZRFYxyLIsUEyxyyAp+8G1R04DHgA+vbHPWoG3bQ0qglhkds89cVtRaS3/CKf2uWRoxdfZzEw5zgcj1HFVPLMgJdt0CAHaB90HjI+hOKlgmmRQg+UD5kRRdpJAPB7CtmwmitLVYpLVprnhhEyH5TwcnFZkVttkE0KMYFfbudflZscA+/tVkXc73aSSO1tIkZiLj5Wxg5z789+1S7FNXRrLPcXjKZpFmDcMhPRjycn0/zxV3UNQuBMbfUXgQxQ4RMDJ+UBRgcZHGPT3rO0C/msrdwm1ogNxLkAFyNoJ9Rgngdc1q3j6bPpdzcRBRexubeVQVdIXAyVw3Oc4PHTilYxnaMrNaHJtcyyPGJpkyVywOFDY6E47+9MikjV5Q8cm/qIjyB9P6VSRRDJI29TkFSGXPr61GLkBHjI24+bcG5BH9KdjokuxoTlWfKuFyCQm7BPvVyU2cDRNBdXMjKv7xmQRhWx0HtXPwXDLGYwQUfDElM4IHr9D0qf7YwC7CVIG35fpzj0oaIaZc1C7cyBcuEOCdhA+hx2rPRlZ5Gm3qVwEGf4vX8u1RSS7lQKwIUYDdBSIJAd7MFI75/HkUWsBp2FxjKgYZugUDg5/IdKnMzNdeZGw8tQFXsMe/15rOgZVTLZzgY2jFXLZQ0iwxuqSPyu47Vz9T64796mVlqO3U1oHVWeWV2OCQRzjPYH/P8qsSTwsyF8bUGFDruPbJFZce7J+ZQO55z06+3HPNWIkV4zIg5znOeW56jvgYGazZEorqWxKqgGN2Un5QOBjvu9/p05p7TyFGZWUxLnhVIJPpms9pdqnMeAgO0sM5OO3tRC7yqy/OAmF2gck+5/woDlM63C9XYBm5IIP5/pV2KAYRgheMDjAxmixTznLMqjJHAHf0rdFiYI0ZWGPzPv1rW5lKVmYaQSB0yuUII4HQe9XraBBE8fzLjnOOh9c9iK0EWVJpNwyqjGBjBqKW4VIy8uC3APAJwOOB/n2qb3FzNmddRAMHfnGcgnH41E8bLKiuxQYwGVeD9fer9w8N3HHj5N3AYr1PoTSIYl3BwSQPunkD1we9FzSLKCANEwD8g7tvbOOg/wA+tPW3luJk8mN3kIA3KueByf8AGr7hI4FmTyzEoMZxjcD/ALQ/zmq8t3IPmTfGXQI+3v2BoKUm9jKIEc2JVwxyCWOBinyTxklLfKBcncGG7aeoJ9M/iamaZTG6yu6IuNwIBzzVW4iiErqkmUH8Z4APXAqitxktw5cO20s0m7cnXpwB7U2EpJ5YYMxyTIo+UsT0FNljV1DiUKNuQcAAj0FQJKY2MakIuDkDuOpzTJZNIv2Zv9WUJXI55P1x/Wqz+bIq5zg8cfe/z/jU67dr85cngH+M+5/Pmlt0SWcKGb5iNpOPXp/+qmFxoQCNVKhnJG3PftwBSuU3bW5C5wfUgHk9wfapI1LzNHhg4ZujDGQc5JP8qrOSynqyk5fPTnuB260ajRbLJtUnAmbBJPIAx3X06EEepon8hQwZ2lUdMAlkPv6j/HtUHlsfmYAKpByRgnJwGPqPpVuUNCMXAVWDYVB+tFhpjHuUMJGCGY8bcBce3f3pzTszKZB/q/mUknaPovbtSXETQv5SDaHUuOm/HfB/A8HBx19a0NMRLlo7VVInllXyimTnIHyn1H5d/WgblbUpXN7NdY3qssuzqsQBPHQ+uO1V/wB5nLs+Vzk5HH41s39hDG88UQWWaBysssLful5wAD/ET1OOnAHrVJIFuVuhL5zT2+UVB+7zz1x6AckDmgFJW0K0WJ4neeZVKj5FYEhufXt+NSoECxiSRPLzjCjJJPOCO3bB/Kreh2iPdvDLD9siG2VmQlX8osAXB7kDnGM4/KrVzpzWl/d2dxHGEYlUfBAdNx2yKCctxz165B5pWB1EnYgW5SKBYvsm6dgUWVSf3iZxtfsQD0I+hq9/aa+RFFcq630a/Z4ZHLKFQkZUMOWPbnG0EDvkY0mQYreWVY4DgqpY7AxOGOf4SfX860vLa60ycOsRu7PMcm//AFrMTxkdGA+7nryAcjBC5RO27NaO5uY4ba7nS+ngt90FyJ03yJGwxKnmDjZkfckG4EA981fi8S325obaaDUbORPKSOZtm9Ovl/MeWI+UMST2zmudsw8tvGYy6S7EhMqsUeGReBuIOJEOFxuG4YAycVo6lc6pfJtvLK2ligmktzLHGEUtgF8qOjcAbgcDGaLGMopvVL+v6/4czrWW0l0kW7oplsnb7Okm793GT88WCBlx19SoPcVnNIzxziaSSQlAVbdu2njB568ZBPUVY1a+knRpD8zkYeTCh9wYDt/HnB3Dr19azrhTNGLhI/LhljYgv0LgjO0euex61SRqvMmtneQXEDOjRzhJMyMAylTjcp5+Ye3b16Vn3sbm4dMjcDnn5eRx09far89rHBbW141ygv3bItUBc7Cu4Ozj5VI67euKx7u5eaKSW2h/cW+NzqD8z45JJ5OfT2ppCvrobViqajoOl6PbRSG9e8e4kcpkRxfMM/7oxknjHvxWa8iabqYW2AnubK9QxzDIEm0+nIwSBz165qTVjLo9zbjT5Xjme3Dyuku5pN5BIbsF/wBn09ayijRTNL5hOCzrIw25z3x26/hVEq2/QluSs800yxIizSO5RD8ignJUDr7CtbxHqZvGtYAjiKzt0giQuXO7g9cnjJwB6CueeeGPaqM5VRnI4PXGD/nvTUu2WUSZcENkHvnPBFPlYOSvc7DWb61i0mw0uxeaRbePM7lz5bzE5LIufwz+neobdiGigijPmQwFW2KSzSs3APPUZwD7e2a5eO7wVOdoPTPQn/Panx6gY2Zo2+bH3gTwOn5/41LixJpaXOsltJtOsbVL5sXM7K0Fkjhjgj5ndOxIIwPfJqjqTiGaSMyY8r9221t3I6555PYnms2w1MW5bydpnkXZ5zDJRe+09iR3rVtr1LCNXhBt7uKF3FwwBZpD0CoRgADjcc+tQ4msZtESSu+yJBO/H+qAJ6c9Ov1NSXMkTRxyI6lV+QBicHv7c57d67VJ9Cg0yzt7SeC21Pyg80kalpGkZf4mPPXPeuDVI2hlknu/KYnZ5ZiMjSHucjgfXPNSpBCbnd2sUbqdHdmwFYYCoOgxxVZptz42rk44PTjpVgLG0iNdrI6gFmSIqpI28Ee+cZ9s0y+a2is0too98vDtcg7c5H3R3wPXvWgN2IpZldgpGMLnHQE/Qc96JJyo+UYzxk8n/wDXVcKGAyMsckk9T6D8qlVWdECJnqBjoc/p/wDWp2JvccoDIGBfdkq2eme2D9Km6gttJKgDaoyQfXn/ADzSxws2xNmGJCrz3J6EVY/eRocMHVT0z3x6+v8AhxSZSHIVaFBCrYK7WZZN6t7r6emOfw6VZDxJbqJW6sFQdy3oO5P/ANeobAIWdwibnJIJXbuOOpx949OT+JrRt7RY2VlK/N2LHPJ9fTv+lZyV9GVsMt0kcKWcKOM454Hqe/4DmrZjmQNtJJbkYH54/l602O1AZUYlzn5f5/nxn9O1alpxnaAUHGW5I68/zqWRKXVGVsmmWNdpKA8xn19P1/nWhFbNCCIAiu6lclsZJ9Bjrz1/wqzCIInHlp8jHlt2foAOgp85/wBWr7VkcYU+3pntxUMhzb0OdsElWRiAGZWGeeh9K3YZZZJSJXYNkDg9T/k/oaztPglB3kHBOeRyBjvWoEWTYodFKZCs3r2GP61qyZ6slMnlwMpUELJ8394epx+Y61RkuIJBmQ/JIT16/TPrV2BHW32ocuW+ZWGevUA1RvrTbArOCu08ZH+NS00RC1ypNLiMqqq+D0zjj3oZmKbk8t8kKUydwIHBx6VZazEcfmEE4BG4HBH4d6qXMawx5cMJCc7gQcjtTWhtFp7ALkK0c0QNssalTt+YE/T0/wAaUzP5W3nyw+7K/Ng9uvPNVbiSEAKh+UgMct396jPkmNVinMh5UDGBj/GmaW0JLtvJkJj2o5G9kADANjp7VVVw7YRcP26bT9RTZ4wgRmOFJwoI4zUlwJkZGdcZAC8YGOe9MaRVfuTknnCjoAKc0JcKV5JPJTvx6/WnBJY96jcJFG3aBnbn+fFSxiSKHa7OkcgJBYfeI4xn+nSmJxK7KPmZ1VIAACcZx69e+f502wjEk8aebFHKThWkb5cnjlj0+p4qzaxzMfLtjBMBgb92SpI+771PBpt9dmO1Ekc147ELahctjB3HPQcc8mq3Ik7IULbLHcpfLJbX0B4lRww3D1HTHX+h7UzStkzsshjYldwywKkc5B9O/vnArGuPtMdu8isjRg+Xn+76cdqyJhLbHzIwFJIwUzlj6e1Uomc5WR1UYb7JFCsLNfeYWWbfwYgD8uOnXkH8K2LlNLgt45IHmla4h37wSiI3HDZzkgjjHU9688g1LUUvRHaziVs7slcrjHPPHHJFW49YuZkLymM7iOSeiAYHT/PSqdNoxVeMnudVcRhJIkuZWa2Lb0lAJIyMlD+PX8+auQvFI9q/lfeiZHjUMN6kEYGMZOB1HNcpFrRjASQHymBYRlyRkjk4PTtzV7S9fntpEaIskzMnlrvzliT82e2Bls+uKlwaRr7RPqdJqgie187LM0Q2SPjKLJtGBngnsuD/AHSeaZ4gu7a7s9Fa1lkbUJrcR3EsmDGQvbd1J+vbFcyNdFrfssbOWVd0iuflYhec+vPGRzUFxqVtcrIVgNvGWV9owSWPAH165xjpS5WKMo332N+31L+ztXtr+BoWEWVaB2KqUxjaefc4HOCBWjNqdvZut7bJJnzCIZCxMyMAMyyHnPUDBODg1xguLQoVmVzhdxOeV5IAA6EkjGK1bSeWK7ht7aYxrtLZMmxQv95iexP1pWLcoPU0LmO1llvFt2aG08prhYU2OFycoqnJA5IHXIGasx6mhvo5r6UO7xeVJM0ZccLjI5G7oBhs85qlfX9jDYtF9uS5uJJFtwkKMoiCEEk54K88D1+lZCXUU0qAQOS5PlHOB7Hrx0oSYKcWtTcsdXiglkLGUF4BHGkTAESLgh2HAKHGCM5/nVmLXZooZcCV3Ys5PZ2YfeA6Lg9u/XtWLcardWOnWAmt4o7e7RpLeU7GYgNscgjlfm4I/wD10Q6rdSWNxeKqpbxzCI7cjazLkNjvlRjj1zT5XuS6kGye5nvb9PIc+WpAwAu0OVGAzerAd6elq07WlvdXpksFcHyEfCxsw649WA6/WsIagJYNPS5uWImzI4UcoFYjbxznBz34FZk16I5gIpXZon2iWNyCVB+RlH1AYfUCq5GxSrK2h1ninWrWfX3+xtGkUYZYobYEIZMbCQepJGBk9hjFYF1q0k4jtZPlRAwQsvHIyCQOuD+lZcc07WpuJl3Pbu3mnHXeTn6HOce+KS4JNi00YZ5rNgwfPEkJOAT79vx+lXyJGCqO2hLJctc3MyyuIo3C5UdF7HnrgHoaprK6zPHLhmi+VsnjPTd9CD/XtUluxW8hmiUsrM2UI3BhjdtP16j3BrQk0pPluIZIvkC9TnYrcKW9VHQ+zA9qq6WjFaUlddCnbgrII2GRnYAwwfYH0I7djW1BbedHIryIXjYDyW4k57r/AF7UWGiXMzSKbZ1hjGGJPyp/s5PI9gea2oNNCmNZDtmT5VZ/4s44J7D3rOUzphC25krpc6KrPbTKkudjFcbtp5wPQHriqslvOqEoxCOckY+Uj1GeldJezLF5UMvnNCshcqH/AIWwGzj6Dp1xUj29tNGYoZHOT8zy/LGAT0OfXAqOdmigupgDTA0SyCdVkLYCISM8dSPxFTxWcgiwS8vVlwvP0A9PetqORWa0F9gqqGBcKCEwMAHoOPrk8ZpbaNBcPnftVCSkff8AH07/AFxUOTNFFIS0s5ls54Zlhj2KwIYgSZByAv8AtHNUvKVIlDYZyPujlgSOhxWlqcggkkCpHHLKiO67iTHkY5z/ABEc57VHI6pFG1xaLBEIikTlizOTzljwTweOB6ZpC5rK5iXBhMT7xib76DdgYAycjvms0SQtaygoTc5wGI6g45+o5q4xjljdZAQfuxu2Onpj/PWs1U3yADqTjg9/Q1oiW7jo1zk7fnABUL3/AD9qvWcCmddj4XPPy9e2Ofy/WoreElc5IIHUdAOn+NXo7cx4+fsD1waGwjEdJDEsrR24dgPldyc5Pueh/rTTvbcu52HH8XB96vIf3Y2DZkZOACDjv/n1qui7pvLMXGctznryefWouaxViSz2tHnGMZOW5xWkFRsxsOg5AOAPofT6etVoF2NGm35cjaCcYzxz+taIVXgRBuwFOVxgDB9e/Wok9BSJYUZVLofnHOSflH4fjx/9aolWWWOQyMwbOAAMc/5xSTzCKHG/dgfMVGDz/I01GdYQckEcAE9vr7VmyLFhJXMZt4DnDKeBkZHSpVn/AHzJIC8vGMjH5H/PFV4LdstI0hGGwAvGPr+tWoFxkI7E4wwI4Oehz6UMh2KllcyQ3LySHduBXCjP+fxrTgJYHy4z06nkH6+9YkQYwLljuU44x6+lb+mmSO2ZiMFWBXJBwf6VoZ1LLUu2hbeiTAbl7vxkf/Wpt5CZVZdoXGSOSQO+ff0pYcEySOQxQchunH/6qqTtIjF34QDdtK5PfFSYLfQrT5hhKuQFB3FCcHPb/wDVXP3N1GTIQpB6AdhV7VJuRGw3NjPUd/8APWsR9yvKd+cNjjGB+H+elOK6nZSjpqPZvvGNcsv5D6GnlmG0YVUYZy3Bb0/lUKnc7ANlgMBlNLG67kZsqqDBVj2+o6GrNixapGZXR93I+VsgMD9Kux2LSwLKhcSxjH708A+wJzx71lRyKJGaIkFepYZPp+tWHmuGUlZDJtUDKqTkdM89KB8ut0x7LkmYPIHwV2uCWIA6g9x7/Srg1BJdPe0vYMwOS29CA6nHB78Z649Kosqy42N84+6wbqPfP5Uy8szbOjSlHWTODG2R7c9ulA3FPcjs2js7h/OgMsWOBuwM+vFW9O1W4sryW5tJB9pIYO5ON24YOB2Yjj2xUF1FdxyIt3BNEzIGA2EEqemR374qokDtOMRckFwoHLAdQO/HenclwUlqJe3g+ymOJPMmBZ3IOQAe2exz3HNc5qayGJ2mC7EGQOV2Dp1/iJrq3igljijcNBOFLM25djLjIwM8HOPr+Fc3rTRkRxbtiFw7KG3FR3GetaQetjmrR91szo9ttpwlaB1e4JClmxheMcDk4GfzqC0LOrZOScn0z3J/AcVav7iW7i3xq+ATDBGx4QMeVX3Pc9hxUohFtaCQDJdxHGwH3lHLP9Mg/lXTfQ89xbemyQm9Yp3fIbycFt3RivUfTJAqKF5JQSfmYLnHqW4x/IfQGq94wEKRAtiRxux3x1/U10Om2L2cbC6jKyRp50ueisw4H0VMn6nNTKyVx07znyroY1wnk3U8ZwWt0IYnuxwP1Ofyq/pbpAZZ5PMEVvGz5C5O8piMEn16/jWJFO89wZZyzmb98w7nk7R+RzV25lFtp/k5Km4k82YeuB8oH0HP1YU5R6ChNazX9f1oSafHulYzyAbIxJI2fusQWGfcKM/jUs5uLaGGa5Ux/aoxKin/AJ5npx9ADjtUWmQTXoSGMFo5n3SBBzIOuP8AdGDz/s+1TeLrws6IzsFSEqqf3Qe1Ta8rF35abl2MoXcsirkk4Vic9i57ehrbu7mQiBXBIhh2RhWK5ZQOT7An8ar6RpzE2pYYVp9z5UEKsa7m/Uqv1rX8VxSRWdtcI58xHUEnGFTaVC49h39aUmr2Q6cGoNyOU1W7ke3tWckrArogIwAN2T+Ga2bI3EmhXS7SII50dmzgbgqr+OA3b1qlqIjU3kJwfKFwuCckZ2uM/n+lX/DsD3HhqVQvzTeZ86nJzgdR+FOTXJcmEX7Vry/LQhtA8VtpcodVO8oG6kZLL+FVtSsmgnSPCbJlaRRu6MvOPxwavQxibw/YyR7sARycc8qWJ/QGr3iCBhps1xFEXkgUOu3nK9x7cNip5rSN3TUqd/JP8NfwRSZSImvAxVJo/KukU8KO4b3DKDT9MsJbYoJly0TERKy585cAuuOv3DuHrjjoa6zQ7W0spLieW2jvb3908KEAwbXQZZ8fewc4X165qJtPVLgJcu0tnOAu0hmdQnK4wc4HIBHTNZe06I29nrc5q40hrfU7O3hZWhnlRY5c4CHd8pJ9RnB9Rj3rsbSANp0IlFu8wlkVbZUyVBzvXj+DklRyOR6VnX0Fs8TQrc3M2SpUthmBXBVhxz0GOfXNXILbULmCeWGLakcW+UovbJBYjv71MpNoqNNR9Cza6v8A2dYf2a8Vu0kDf69xl3j/AIfUA9QxxknmqBvZHfaGOw4GWYk4zwR7g1bTRyb1YHiP2h2ER3AjY2R+GAcH6Vo3mlDTrVpjMspS48iSHO07sbsg5OVPXselI0XJHTuYd2lwlqlxMsZEw4LYOcdh6VLpFz9mv/NYxTqME27Blil6ZjI5yADkE9cVqRXktxIbi5kEltZxuY4iAsrs33mC4wSMk7j6CswJFFCsR8pIFDIGHzB+hyB13Dj060ir6WY7UZbBRbRWMBQRnfLK5yz8/wAIHAUAYHfmooJvOLBTIqLwdy7sBj1HYY64qW5ghW2e5t7qG7XEZCEESZwAzAdxuGOazbhQdMimELiWOUp52zEZzztY/wB7r+Bp2uJNJGw6W9nqVxau63canh/MKxyRn+9jqT1GSOBWJeyoXIRSrD5WJkLBz/ezj9KSS6SNHdN/mMoIbcWBYY5z1A9qypZWaSQmTcWON2MZyPT86aiZ3YGZsFVznOBgdPU/X3pkKkkY4+XcSOB+H8qaFM2ccZGM4zzV+3gBfoMhQcsCce5/Km9CkrjoUAKYXaTy3OfTp9K147dGkb5iGUk5cfd+vbiokRUco2NpzuUOMjpzU0b7D8m7ao78n6GobLt2JZgk+dgJiX5htGOfUDvzUUdqrTqVYjOc9OCT/wDrqWOQKPLP+rUfdHP5+3Sr8NuZfkeRYkBHzO23AAHWobG3yognWMSq7Lxt+Vf7x7dP88VGS7SK5DFiflAH3c98/lz71Y8lvMZsg7WI4kz0/u+o98UyYMCArFAV3Ag9Pr7GoumK/QqSQmOYKgbKk7mU7QTjjr9KvWIAwowo3ZKmq1tDNFchnyAOhDZA/D+tWbiNxIgg24xxuOcntii5MnfQtsPlyjtGw7dCf880W8kduirvYKe7Akt+Pb/PNUfNEMiK5IBB4Izn6/rWhEizmMuAoAKhsc/U/hxmjqYzuloRQWobCrwRhiAenua17QJbKEkAGCPu8Bvx7UQwqzLIGCk8YJ6f56VLeTRRtg8jI27TjJ/pVo5pT5nYkQON7bgFX5tuOSf6VQuZV8lWYAIOeRnHt7VXv9UxKYkBHGC2e/tWTezu/wA0xI3DgD0x7duaW7LhTe7Kt9dRyuTGfnPyknuPQVmTHIw6AE45I7D6dqLhwZCy8gHgHp+dVJZGUsflckYw3GP/AK9aJWO2CJjKuNxznHVTnmlhIcgPuy3ZSQc/5/rTbdB84UEv1xt6fgamij2u7f8ALQghiTjj0puxqiyEDbASpBON3QqKtGcjfvDgD5Pl+Vfy7iqTKFQHqc46c4/p7U15HVsdWPYjKqO34/8A16RVrmh9oihjniiWJ94+Q9Nh6kgevHXtSadIkVz5jBZQpDmNjtRvUHrg47nimaeC0jIY4pXOQyohZgPXA6fQ09nAeNYYRFFsKsN5VW5OCc9BSJ02JY51t9TjkL3E0EaEvBccMVzlYy3fB5B+lMt7q4ktWtJEfy45RcKxwkytnorY5HtUR2AGR7uaVuQTg8HHU+uaS4kMfzQ/IMZ3kbiT9T0zRcGkzTXyIzI+n2xQyEFkuJFDhuQCBjknviud1aJLq4E3lqriTfLgAK7dDgfwjnpV+Av5kTqQGyAcE7lYc9T3q1NZgxSSBGUBSxR3AAAGTnvmmpWMnBJ6nF3Fr5kpgC4MRMSA8fOeWf8AAcfWmarcxMGSIvEv+qiR1GI0HLsx9gFroorQl0UbnEa5UpgYLck/y61gNYvc6g4iB2tIVV2GAAuOefTr7nAreEtdTmq03b3epS0GJJbz7XMhEUJ2ojcnAGcn3x+prY1Vmm0iSJWJa4xvCDks5ACe4Ax+WPWtSPS4UtDEoIXHloEHPUZz+uao6tamGWZwjiS2h8wnGcu52pj04JPftTdTmlcSo+zhyv5mFAgEl1MqoCW8tBnjYg2jn3POfaqdtAdQvBIVdrZTtCjq/PT2yf8APFbDae7BYo1JVACyhTnptQE+/wD8Ua0tL0iQQo3mYWRCd2B0Pv2Lc/Rap1FFXMFR5movYuadB5VsbqbaY1BjDp07DK457KB6gD1NYFxEmq+I2kuI28uEh9jHJMaKOv1Yrx+prsH09wq7mibysGRQdyIMcDGfTrjtx1NU9C0GS5M160g3TOxKhS24BwAAO2Tk4OOAKxjO12dE4J2T2uLpkJF1IgUt5Nou7nrLI+5hnrwAB3q14hhW90eXzB5YHVTgMQGGSCOnGSAeQOtbOm+HndbmVZJjmYYZgEDryF25Gc8Hk9galuLK3+ykTSzEujRyI5G0ccHIBzjg/n2qebUTcdjyLV4GtUnV5FZ5GNucD72AhU/8CXJrb8OH7PppilDMViNyhAxtVgeD6YIH51Z12ziuJ1FihDNMjMfvbv3agAcf3s/gav2OnXc0OmmGDCBhCzONwVc7efQbwvXqTWspXjYzhHlqOZF4X08tZ6bb3bRw+UJVlZu2SyDjtjk/lWxetbx6HcWqFpI5rUxPuRU3Ps6r1P3sd+auWmmmK7uba6WXEczApacuxKhsZHfrn+VSW1unyiCzUyHgKW3buRxkcDHTPB696wc7u5vFLlSMvSX2WsEdqi5hXYeeShxtGSPQgf8AAe9WZNPMlysdzLtkIDBVbapU8qAc9898cetaLSGNmcJ5ETZR/Izt569+gzjsPrT7aa3a2WEqViTLBIzuM5Jydx6qnA5Pf86m/UtXKWnWERXMSRLvyjb2OQevB7Hp145rQtPM0m5WaYQTgfIFyJFY44IPTgke3HNU9QmeW7kl2xx5ABSL5lUd8nqTz/KhnKssV0ytIW+aJ/l8sL/DnotO5bXMtTSZy+mziTzJWUvLPcN8oWViBnaOMfTjv0rLuYp7m8X/AEWUeWPMeKEcM3dzk4UEdSCfap7aeymkMckNwqy7fKR5gI1ywByTjggHI+lZ+vamtxIY0DQ6dCxSKJTz0AyT0Y/Lnn+lAoxadrFbUAEtIQBHLNMTuVG3FATj5e/PvRrqNZLaRSqqSBWLorBwMnBLMOuQFGOnFU9Lv2ttXs5/J+2LBKrCIYXzMdF4+72x6cVe8TRStrMwuo9Pt5njDO9uAvmbuQHIyGYHI3d8VSKldSSZRvVeC1hh8sgSKLkyoDuAOVK9cYXHp1qhLOWjMARfLjbLMvBPGASDnrWlftvj0wzhhJDbhHjjIyFzySR65GB+NZV1EpXz4wLeByfLhVyzAYwCx/T9elUZ3voVJJGlROgAJG5s9B2/n/KonjKAkgqAehHJ9qn2H+AFlUYx15/qKkljyBuU49V64ovY0jAbbhHZV2v0wcjrx/8AXq9bws7gg5XODjPI9P0/zmltIQsbB4i25N2WJ4/LpVgpulXayjIC5YkDb2JqGzRRJkkaUJGCm1clMjJXHH8quW6kQgYbIbKn2PfHfPNV15lBnKRAckquCR0xjp0q/ap5sZIGVAyI/wC7jpkeh5P6VLYPRC28caYZW+TjZlccf57U6SMRCRS247TtbO7dzjPoBzgVPjG0EE7TkEjqT3A9/SnTwCNCr5D9+cnP+cfSoZm2VLS2BIkPz7T/AHvT/AVfaNpGyyg5y2QMYxj8cdKREaHbhjkdsde/erRl3D58ZY8kccfXtUmU5O5nPHgjyyVY8EY9/wBP51BcRncAm4Z5K/Q9a1J1SGPaPnP8TMep68+nXFRWsS3DNh8jucYJ9v6fjQyVOyuUrOyLBGkJDdSSO1aum2yurMeEB+5nJPv70kjCOTamNoORg5P0qOO52sVQZQ568Dr6fjVb6ESk5Iq/bJ+HIHl4yFzgD8azp792ud7bVTOUwf0xUzuwcZG4455xz2FUZrZQxctlmOPpVJDgkSeazjKKQM8/7X6VS1W5ilOyNmXHAxyc+n50l1IUOEJB5w5PUVk3BEjBs5GRjH5Zq0jSMRzH5/mbLD+PPT8PWkhBaUA8lTjYKfaREfMpzjHUdf8AD1qy1qBggnzCPl459yKo2iKsbAAF1UY4B7574qyYHGWTDMTyAeNvv/hUNgITlrgFokzwoAOf948DtzTnLyLyMDblQvTA9+/1pFXHskQgJkuz5w+7Eqb/AM2HAqRWtoolWNHkk6lCc4OM9B9KqwhI7fdgKDwcjI/z9KkikIwyeZlsh2UYIzwfzH86Blm4v7i5dWWKKCMLs2W37vPcFscsc+tZ7oWYlc7hwwySB+ArVtSUVRGdrkgBR98semP8aatr5k5DShZGbG3GQcnoPXmloNOxQDPuUYKowJxzz9Pan+cURmbZGxznDEDGOmO9X001UYLMjddhDYUA+nB7037DAJDHcQkODgqSD29ewo0DmRDArEEqvzHAD7gAc9xUu4q3yx7wTggnqRwcjPHtmq627mZAkBUAfKVkwOPfp+FXpI1eRHM+4kAO4Pyrn370iW0QxfNCVJMeGPydBg9SKLWKFY/KmQBZDgFD9wZPAHc8k8+wq5JZzFS0kQCAgHO44+gzUQhG5QH8tXODiL/E9fegnRlh4rZNxj8uRE5aSNgA68+vIP4Z9qyZxC0awhtytJ58xbnPYAH0x+lXpIRC2JYJUYfMTKyqAM9hjj6U9LGFy/nhYjwV2oWLf/X54zTvYlrTUrQmKVZROcgs0nyrtLyMMAHvtXjHbrXT22oWsR8uEWplPyvI6qwZcfwqRgAYHuKzIdJG4FdpY5DKBk4HO7OcD6Vq21rbufMERk4C5QEh+eueBjHcfSk2zGbiM8+yiVjZRujuNrHCNyT29D+vWrkV5CjRXEem3MhiUKolOUbA46Y4POc5JzSpaRNCpWWJFJZCobOTjOcnAH55qRLixB8zzEXBJIiBOGIAPGcY9896m7MnJPZEDW2rmJbe3j+zIiZmM6+YwbqX6YQ47U4aT9qh/wBPu5Jgz52xvnt19MnoDzSSahYRt8zq0ij5U2Ft3XAxwOMk5Oartr+xnSKG7csSdvmrCoB4JOAWPb06CgVpvZFYWtna65BMfPmijhA8tQYyjhjgg9z3HHYZ9KsWsCtFfxAyiVwSqqCWIJ3KHx1wep65rMudSaOMu0iW6H5AU+QngdTnJ/8Ar1AmrSyRrClxcMY1wvzMoRQeOnfv+FNmqpyZuXFqsz/a7h5Y4ppDtMkw6hRyQBxz6LngCqd5eQLCyQxNNEABuZmjUHuQhOWPufyrMklkAz8vbAZTubPv/nrUPngNj5Rn7rbuevb+9QkzWNMu32pPcruwtvGwwVt49qcf3ieWJ49QKhstRe2RzabFjbCOGQENg5xz24zVKQ7wp+bYRj5zkDr0qJUkUl5liUkgKqksT6Fhz9eaaRqoq1i09/MIjE0+2LIbG3bk4xkn1qq120akh8KO2ctnrmkyjAFm3sASeg3Y4/rVywsXe+0+K2liUzOkZkkZUEYJB4zglhz0z1HrQ0kVdK5Bc3FpJtW1G24CL5schypcE7tp7g/L75NN04vJHc2pSEiGN5SjnBRiuM4PUjt/PmqFui3E5it455ZmlKWsagljg4AJ7nGOM4FNube40+IGaGeMPKY3DnHzgZ2sM/U/SqQ3ZaDLdR9sZZcAqSQQDk47D68ce9TzsFmkR5FjaAAeUG+UYPAA6DB7Vct7/VH09LNFaGBibmPeArSEDIKH73QfT5QM1ntbvLdBwNxL7zjkFzycepPNBm7vUXfKd5XDSNljLjODn73tjkVVd5ZW3EJx3jXHUYH6CrLxkRASMFU5UYwc/X1AqNYSiggkZIIPIyR3x/ShlRjYhQqXJYcDoCen5fUfnVkoGXERccfxdd3pVdwqyDbtAzjb0H4/rV2ACQoUTdIWwAen/wBf1oKsWIzuUREgAEHYOAv5dfxqYRRCcLlTuPzs/Ktx/wDW9qijt/IIZQXJOGcdj9fwNaNsiPIjZCIx3HGdo9/cVLDpcfHCssbtKiPjACyDfyccbe/HY1atUUMx2hgeS+7JLA8ge1VXeR5I0GM7gCGOMAnjP+e/5bttb77dYTvLqNpjUbeMc8jnvUXMpuyKkCk2/mXJI2HBI7f7Pv26VbuE/dFckluQCe3p70sYhEYhDBAmckjgY/z/APqqCO78yQs6x+YvTJyT9D6ZqGYybbuRzpscKofecAMD3Ht/TtUioETcshcsOeecdsUjzBY2IADgHkHH4/59apyXG5CRkADAGAOPehojclluiFUDJBG1iO1MikMY3A5IHp2//V+NZb3jbyi4xtycjGOe/rxUkTs8WOFJb+dNIbRqG4TA4P48BT/nFRyOIkxJtBx0HAH0/wA81WeV4oSI2CseOn3R6f59ah8x5iUK8dOnt+lVYlR6k8zBk8lDxt5JGd2f/r1TmkdVO4sMDBJ6n8KSeYhQ4YElskoerDiqV/N5jKD1PJJbkj3q4qwooq3lwJZdsJdMDBPr6mqlvAXfEhOccn+lSKPmC5YKT0P8VXbKParsAAcE7+mSO30qzdaIhaJxG2xCATzz0A9+2KcflVGJJDLnPekvb9P3MVvtMirh3Uk7jnuOlMRnG5nfDtjBbnOPT0xQWmXLdm81OMZ+c5YAH8+nfrV5jamNFjlLO3Dux2j6fT3/AKVhu+BtBwxO7DnHNTQwOxUSHJYcjqT9B2pMbXUuXaqJDGrhgx+ZgeB64b6elLAmIV2w+Yf4FPQHPt1/z606K0EkpTA4GFUj9OKVkSHKm5WPqMYyQfTA49e9JjT6EgjeQea+WLElokPLOP0//VTns2lkkWP92mQ58o9OADyecU22uisZMdvtjHBaTJx+X9asPcy3NuD5zB+ETYMR8H6Z/mf0oY+ZotWVjL5aAsGA5DKmMnpjPXj1OKlhtykUhZra3wcfwu7HPTOTk9+9ZLXMjSRwzTS3BUgIrFsdOmO4qe3OyYyRxBI2O1jjcv09qRLTNS7tYAWK6hHIgG/zb19pz/sg8nk47dKh223yJLeSuZCc7I8Kg6c5Gf8AvkHNUYo4XLeWlxNOFLjCgYwemSOQfbmmX9qzxjftjVidiyEkqevPcUWJS6XNWK50d5RFFJNuwNoSAncTngljk46ds1OX0uzhk8uO8lZiCGlCxgeoAyefQ/zrlkXyyIyvm4H3k43fXvnNWWAWMPO44Jy0nQr1HHXpx+AoE4eZoSaraW0imzt5mjI2s0swdix67WwcdR79KH1hvLmRUtY1dR+7KGYocYbDn+91PX0rLkmtTt2l2/2NoUKfTPQ1EJ5GjiCRCBQ3D8k5xjJJ/wAO1Ow+VPoXm1KYqoWRUiHzKjBQucYyq9M474Puac2t3hyYpZ1OzYCHzhcdB2AqlFC+0hlDHueCMU+SNkZWk+VR8xAGMjHU0rIHGLZE3ns+2Z5H6euM9+OntV6F5MYjdNxO3aee/UdqgR2NtuwVQkkEjnHbApm97hpCgOHzlum00WRXLdFtmnCjDLz8oc8YP1/zmhy67ZAQhOMADdntj6mkht5EAEhXAOEOAV6dOenpk1I1u7QNHIVWQEttJwT7n09qBWsZtxFFNM5IV2OCcZHf9PWrSrHGrNj72ChXv69etLbRgEGTKYOJIwc7v6fhVmRhcl3s2LzRkbkKkjjv/iaGVbUpncQwLEoQSAeAvTkev0oijUtvB+6COOGBPQH6c1KZXvE2zrGoC7lAABY/lzmlkhWKYIVLTnIAX5tp68/h+dNFFIkKzP5mUJY7OoB9/XmoZLh4s7VcnkDd8wNalzHJGd0jKFOd4yDjJ64Hf2qhdGKOLch8xtp3yE8Y45pWLWuxYijt5DczZitn8oPEJFLiQ9Co469TnBxin3NjHKJI40QHyllKuM7VGF4/vOxI+UcAHHWjT7Rbu68vzHkhkhLxOiZD7QCSoxkqDncfYmmxq63EYimRyHBaYSERqAcEbhzjjt2PHNMhKz0Et5Z9PiMtpfM0s4eGQKnktCeDjf2ZsABl6D60/X9R1XVYbe01yK2t/ssjOYoAqMSxCkuv94Dv3BzRLdtZvEiKrJbvJ5fmfOi5ONyBv588Y9Kp2UIZoI1LPGOV3csFPXOe3ejrcXKm+ZojnL3l15rD964GXQYBAGMHHQDA/KkRPs8SiM7g4IcjIGQehP5Hjsa1mtlKMIwGbBAUY+ufb1rPm8yR3B+Yr94vyBx/nn0pXKWpQmeWUnYigRjG1evXr7/5+lRw27THbIHB9WHA54wO5z6VoxR+cVVm2hnySD1P+f0FWGtwQdjYRSQBjDEnHUdeaLlbGbcWiRyALPH93rnJLZ6CmGZFiGwsZSuAScBcd8+n86vyDYQ0ShJ1z8uOF9yP6fSoDY+ZHumZgM7hjALe4pBYfoyvdSAupMKjCj37/wBc/St5pFKDe5YIMhByqrjt9OPxrP0rCqy+Zsj4yQOQcdqklSN5UH97GGHRvc+uOKCWrss2q/6SplUSckhF5bbjPfitnz1G6OMFASEzu5z9R1xzzWVp9o0sgDu2wrmQIuPMU9sngfj71oxRqFGIAg3bFA7genr/ADqHtYyqNNkNxFsQlWKsRyS+CuP68c1RMn2M+avLEEYOG/ycetXZpx5gPABBwSOMDj8+P1qg7faHbymOwDr0+pqUjK76jo5UaMBmyU5KE/z/AMis+e7WRnbAB9+OR7Ul05VCpOAD34GP8O9ZM77lREJIBzzitIxEWN+5iQxJJ4GOTV+N5ImVUznpkcg+9UrVSEJ7tkbe+OO9XIkZzg5wSS2e/wBKbVhssxqzfe2vjr/TNWvLAjyRsUnnA9KqszGMiI5x6dRx39KkHmyQlGZtmCM/56UiWjHgOSF2s3GBg9u34Ujwjazssj8dcYP41o2lqrsFwMAfdBzuPuf6CotZuIY4mTHBHHt7/XFaIhS1sjPhWI2izlikefQZGPSqFzes+IVVggPruOKbdXG/aANqLgLH1H40ghOwswJIwoHTH+TVmsSukYWdXhAMi9W7L7VfgjkMa+YwYZ+pPtgdKrxwbfmJ+Yn7nb8a0LbIDEqSSeoHT6eppNm2xJHAGRn3RgM/U44I4yeOf/1VYCrbOYwxllLYcKQDj/e/z6VCVXysGQOzcZRvu89BUyQCJFMZBIYYRCNzntkDtx1qdgCN5HMkaL5agHhScD6nqTTm2bo4ow0gUEcJ1ODyT2qtdee8uYV2s3KoeQT7fhWmY2hgBuTlyTguoxx1BA/T6UD2IELR2wjDNuDYbYMhiR0z+fJqW3w8UkAyqk4/ejOD1GCOM/T0qxawzPG0pVdjfIAwC8+w7dh61Mlk0I/eBVcnLg5J+o9u2R06UhOS2IbaxeNxItwgdwAxCltwz2PXPIzWqloAPLlJmjQlSjKI2PP44PTrUtqn2KASXM8cT48tonTLt2OF6gehNR3mqxTShbG28sE4UM29xz3P4Um7GEpuT0Kr27pJ5Ks0SsSFWJ2y2OMA9/rRJYfYTsvES1QnHlsN0kg9lOT7jOKdqGtSSqhTZb9RvUZfJPLFjyT7jFYMkss0o+R2dicysAcsepzQXFSe5flvNgeOKKJJchd7qWYAHgddoyOpwenas+9kfz5jNgvkfOZNxz6e/wD9amwpMJVEjFwewOffv0pyWyvKRHuL85OABjqSao0SSILaNSy7cuAxCqRyV9/SroDr5adJDzhjy3/1/b2qK4hVX8xGDY+6kfO73H68/lU9qZ7qJZ3AUR8bO/TkE9c+5/SjcbESS48sNCI1B4z3XB5wO3NV7qMbh9oMrytj5Dzj8fy9a0Y4wDP8jDGPnZsAH2P0xUttEiS+dCq+bjG1/lCZHU57+5pNhexSliBdXB2gfKM/PtGcdehNXLaIxKw+Ry5IDIeTnjGO1OwGkxCnlDqU5YE+v068/lT4rOW5xHDbZP3sq2SCf73pxzz2pbg9tSv5CpavGi/xAn5eT/h9Kimafz4migBl6Bm5DH6n8vQVoXMKwWksMm+ORvnM2Ms3PX2HbPesm0MMe3O8MWwCX6j09s4oKi73ZNClzMsjyRFGO5goA2DHXB6Hr0pEWMfvTKylhztAHIOdvPbpzz0xVwzG6tGSAiJVJbaQWz7e1Z0TGaIArvkySFPPPrx/ninuCuy0jPKCbYEkk7yWwMkHoPzqL/SvNkSPahf5AmcZHt+f61JE0ceEeRlk/iwOgUdefXpViC4M0m1F2mMBcFiSR6UmrBsKIfskFwsuyZ1ixGsZ+Uvu7k9OOcjr2rPNpDLtMxQsp3OqfKBjpgjr9BVm+kSR1Bi2OVz5bc4H19KZFEhLAbnQZckgg+xwPejQa0VxdSvLm6uftc3/AB8CIR5JwVA6YUdOD0HH41UuoNioxbLyAZO3hcdeK1pIkLxzPyxAUMRwG5znjnviovsvmuzSSyFVJ2MvJx0ximCkkjCfc0sYijM0j52oxwOnUj6D8qv2LrGy/uhj+KNugJ75HXoOKuramFXjWPymyFZkJPA7A465I6GkSBSMEhHbBEfJHTufek2NyTJGZo49isqlxj/e9CW6n0rNdjMu1kVdg+/uxk9yF9PWriCVRKjhC7L8pC5yPp/Sq99aSRxhk2h2I2ycAEd//wBXX9ai4o2RImFsc2z73Ubd23HJI/KpUiWNULhXkkjwWYbgPfjpTUgItHkkUggZA5+QAe3TPaksmkvJJvOBYyDdncBkfQcZoAp3UZfplTvClieWH07/AP6hQYgwTzX+ViQE3bFUdSSfTHJNW7hAHnMKlkUDAxhh64ojt/NeOOA/MQVAAzyTk8+1V6F3sgs4pwxZcI5G7PU4GAcD8RWqlukqXECDEoCgAEhC2T8zfQEj/OKk0ezDWssm8eYWUKY+VyDubk88AY9Oaru8jXC/ZsyySHhc5Yk9/rzSehi5czaXQvwHEwMI3eSpJD8gn+XWmzErdtIZ1M+1VcKpAA6kY6LjJ6YP5VYtY5OCrsWT7yg8BehYnkdTjFMl5YgbWY5ySNwA9frxSZzyaMbUUZppVYqqghVUHjGM854/x4+lVN6wW5Kj5s4yRWlfIqwEoDgLjPocnJ5rm9Sm5AIGR1xSigvzaFe7uQ0hB4H3sdsmokYSu7nHoeM4HrVdhuJ3bQfQ8VLHhuC+4d/ettgRqW8ieVhSBzgYHHrVuykBzkEZPy8f49+azrZQHByckcHP61ZhQlvnIwfbG7/AVDL5S/D+8R2VRhunGMj3NTRbjCq7CQfXv9aWEBYgi7juIP1qefcLcbfusMk84P8An+VFjNmXe3JtvMaPAkP8QPHTt7e1c5eM7fe4djuPHQ/0q7PKLhzLkshzjJ2gcdhVC7ZTKqKMgdVB5P41qu5EEQQAkkxOBt4UHnJ9a0ktwEWWV8SHoCefqfQVRiwrFmIUgYPGT+X06enersGx42eUEueuDk/Qevahm9iDJaV/KjdixznuT7evp+FXGDR2/lYIYDk9SM/wir1tZiRGIjEa54wOWB/z0qwbVlZWCCMK2Ex2Pt6nNSVzop2EZ8o7oSw5Rto7enPap/s4MJ2jLHBGw4AHXGfTGKsPECjFHKDfsAyCXbGeR6f5xViaG4kjSGOPeWIjCgbs89AP71SO5ShjRWJaRQQwASPv1+bPYcflV+G0W4jjcIZJJMgqqttUZwP949+Og61ds7NLeWIzyx+UPmdGUgOxGCi8c4wCT09Kfd62RK7ad5kMTDDMGw7joQTjI+gI4/GjQzcnJ2iT3FvbabMxvZoppd24QwjcQQOMn7q/rj0JrN1LWLlAYrDFlGp37Y/mkf6u2SSPwHtUcyiGCMpASNoOT/Fz2x0H55psBVHxMi+btw5YZK5PAOOpz/jSuEYdXqUoFkuB0zI5I+dssW5OSe/vmlEUgYSbpAQAcZz5n+7itA6aFYGRFjQndhRkkAcnI/zzk1JLHbQqGclUBKF+SH/2V9R0z/PtQVzX2MifdPBklZAcbi+cDj9T/wDXqVbf/Rw8xxECB5jKcNzxj16U+42SSCRlVF5Kxk8KfTd/TH5VG12Gfy4GlkGN7v1yOB+A9qZaTewr2/myI5YsS2OVHODn8KbOHy63EUjRElTHj+H39asW8LtFvbKgHG1yRkZ6DHU989qtfZxLEhuA0bfMyhR99c55PqfXoOaLNj0W5RFnHN5UiFx5e3Yp5DZ7Gr06QWbvFcyO065AjQgKnfccckY7dfwotXt4Y7dp9rSzEpEigsEHqV6hfTufpV8WtlpiDzyJL+4JkK7htWP0bHc56Z56dqegpPWxlxwBYDdTrIElbCE4JOMdu/r/APqqTfbuS5VUjLfNgZZh6/T39+/Snaheb4mkuWYIrbeegOOgUduBT7O2iv5N0CqJARuOd27HOfYDv6UMOl2OtDavceWjEzFS25mIBAOeAOvHGT6ZppkljJRpZY0XO51OPMGepx24/Oqt4Y7gzC0keZG/5aMNu5j22joPb0q3HahrWRJml8+N8HK5Lc/xfSluDSWpm3NyslqQS3lqS/BGT6DnrjP9BVXTRA8AkVI1lQYAxkE9a3XhEyqZLdAytjexBKnvj/H2qg+nKquYpZNsgAYRAdCenTvS2LUlYpx6g/lKVR8gY3A4LfT8+tJFcvHOqyAeYcYCcADg8+3BqYWpt4boo8uApV7hODBkfwnH3s57YGKfpv7zymMbPGFVJMtu3ntz6nANLYrTdIZPEjrvErGQyAHJHOe4q/Z23kCPGGXO0AEEsfTNakVilxCGlARVG8gL97HYdqejiaZgtrK4iQF2UjKjn8h2qmu5g6l9EZ0zQG32XIRSu3CsOd3TA+nX8afNFbwxqJnXaAWDNx6cn+VTyskNyhnjXyeikngZPfuBitmHTXW1e6jhR1Vl2+YFOPTGecZ71OopTUUjl7icxR+RG+yOTBdAT26HHfGTirWmESqyRNh9vzAYDN9D0BreSyjjUM1uZGdvMO8gbRnqR6fnVZ/KWAvGrhTkkY7e3TjOT680he1TVkitdWEduVQyADaVDbtyr34/qfWsO5kV32W80SeUuxmK8uDyOPT9cYrcurwBAUdChG1gw4z29z65H61zuqyW9rMIrKQGR+Pu/MvuB60XZdJN7iXDLDG8alml4ww6hvf3pk5Ehjd3LOpOAwx5eP4Qo7nJz+FMhkNwpCAhh80rKpOMEc8Z5PQE8VdhSKIySyfKpCygRgs/0LN0479CaXQ3egs126wNGwYpKcMxG0qOMYHII9MfjUYnaRP3aiNoxukZeckH6fL2GO9WcO6h44z8y7kweQuMkfT39sipQfJto1hRsvIXiXy8554Azz39P8KCNF0K9/H5wZLZCASNox8xPfJqXSwJZJoPId5GXAVOdgzyc/TmrF+GhtZrd5QGgxGyJhSj9hx7g5P/ANaq+nDdLcQwthjF5RPIbnG7aPfpVW1Fe8SxbMZFS2gk8tD8uWfAVcjJPoTx0q7LCrJiEEMkW5ztzt5Ocd8/rVqwhjt7F4kiERmUyE+VxtB9T1yf8mta5VLa1gVmG5o+WCj5uOp/lQ1oclSrZ2RiiGGOz/0ZlUy4Ux7jkD1/z61SlmClsKymLhVJxkehqzcSrHuZOfLwo9AuP5dcVj310oillLlt3zDJ69QCTUiV2Zuq3DRw+WF2jHzDPT1rnp5PMcHI+UAZxwfarep3ZlLMD9/AIPf3/wA+lZOV81Wly0efmx3x7VrGOhQ8qS3zEjHWtC0Tc3J4PoM845+lZ6AsPlyQenHbmt2wjKjnjpjHf/PpRI0irK5bhsw6qclT069KlmtGMiDOxN2CfX2qzFbyLGMflyMe3/16lRJN6Ljgd/58+9Z3C5JBAFAVg2Bk1MrF8ZBVQOCB+n6flV+K3zAgZiOuPw/niiO2EO9pCSCckcnPp7e1U0YOaZ55DIioFjZSSvzEHkD0qsFRDkDGcnPPH+f8ajFxImIeVHUDAyc9zV+NfkOVwpxnH8h/nNajTsMisi3yKcR9WLDoO3/6qtwWsbT7yWwp4bIXHuRTrJXhKk8Kg4GMnn+vtV/dvZEO3y0fLvt79ee9S2PmZNEBBOylS+0Bhnjk+h789fwp6x7zGzKjysSyhRjPHPPc9f5U1yZbXe4ZU3Z6cnnH8uBmp9Lt38+ae6lEnnOFhhCAeSgH3eefck8E5qSea2pOkcQ8n7NbIGAJeRwAFb15/P8AKpI57ezkcSM0kysyxopw7HpuJ/hHYHr1+tSXN2wjJV1i+Z8OB97jjbn27/jx0rMiIeVnkCgsQo3j7x65J+mf0qWhxfMtSzbQy3UgeVwZmzuVuI04xgD0wKZJZq067/OcFRsAGM/hycAZ59asiLzmBLCKNeVAXBIAHJH5D+ZqZFURrcSmRHk54BJIGRnn34p6Fc9tisrJDHHFFLJ5mDl8YAPf5e+Omfc062tRvJ3DzlUkvtzjP8RHQAce9aDRyTRvJKYDEBja4w2em0ew7+lFpO0CbrZPNkY7nkIGeDxjPGf8etGlyed20HX0SJZRNN5sg5wMbSx5JJzk4z27/TisSfazSSENKVwOeBj+6g7Ct1oZLhSQGV0YgjBYnAx1zjt978azL2Lb5cdvbbi4KxuPlcZPJUddx/l2FHUqm1sZ8jK+9JViIzwoAxkAZ9+M/wAwKlTRN8SRPMIUckBePMJAyfwxnnoCQOtLBbLYpBJbW/muzFxE4JdcDPm89F57nt0zW2JvKFvG9sLi7OJbkzfchUfdXH4gkDAHQnJqk11NJTa+EW20dIrWW6vzHsVgu4S/MCOkKjGM+p5757VUuriFJdli/nTSAGZpVCq5BzsCnjaCOg69waffTyeT58qqYooykTqNoJJOAE7e+Mk5HJNVLK1eVIbZkW5uXAcyFSSCDlVPoM9T6gim30RMb/FJlS3SSJ3kZnmuZlZpHdQuTzuYnsOvA9enarFnalYtrkmZuigAlGPIHpx6/wCFdBBb2qRIFZ5GB3vcCPDSSE4IUMcgZxgDt7ULZWMQZDvZNpYoEAXO7BVye5PXFHLYHWTMGLR4lWGOe6E9/O2I7dMMQvJbPZcDuCefpin3wFtBGttEscJP7lVYscEYyT3GB079aljjt5byWWVJ7yS4YJGi4Tj0yOFXg9Om2tiK2W3jiSMLMJCZMlx8mMZ7ex474qWEqlnqYmn2FxLChuFEQ3bTsx8xzwfX6AVoNo+I22tLtcbmzjjspOe+R/kitCWSCKYBipuH7bsDGOgHcgd+AAOhp9o8UpaRvMaFsMsKkldo7jPUdOOKpW6GUqsnrsc9LbLbXazSAkt8gC9GYdh3PTJFPdY51cqZEmdgdqJgKc5BYev6VsyyRMsUqwh1UBck7vM55GDjbx2HXvQiuEfDlbeUeXIyr2/us5/n6elZle17nJJbRrNced88ZYBWZt3mE9h3P9OaWwmRE2KgXexCxZLhDjp2Pr16VvQrIJIlliXyowXjLAKPQBBz0PqcnrSXUcRaI/MgJ+7syuc8DI/D86T0Rq6t3Zgk8bzLEVWNVBLSEYDHpjjsOB2/rVu8ige3kPmH7QAwDDClj9D/ACqA20cThsqJDlnU5bcOPlI9ep444+taNrDbFhIxt3MgyrI4wg9m9++KEzCckrNGfBZkpEtwvmeVyvykDA/znn0qaWeRWhsYZZfKXcU2Lk8kkkep/lV3z5biJotjxhnG2PGNy4xkt+vGB+dMBgiBEMjgBdqOAMjP8KjkemQOahu5PO29SJZbhfnnU7AmQjLkkd8HpgH1pkCST7jHDKrMww8mDjjOAO/fn2xVcvcSPFHcMDCQVV5TyM9zz8vbmrPmfaZBbvdxvP1MceWxjpnjr3xT9SrW2MjULd1WKVIN9wG4lY4ABHZe2OK5nUUa4y7xlFXCvIxAAywycDr17V2tzdJbwOGVyc5ZAcKccjn1HJI46iudjt/PlWaR1miQ7SfvfNnPA7+v4UX1OqlPTUrabbx7CsMTTBgXaRsoqKDw2OpHfn16UgO0NsheYA42hvlY549yPc1fuJ02TBjkMQqJnJPPJBxwT19h060+xtCILqdn+zx+ZscdIkXsXc8ZHUKMk+1Va5o521ZdvJpodOaC3WGNyoaUwoAXUAfMzHkAAhSO59qyHlaymilkYeYISCEcMUyMD6E9PUfWr1uoeSCe3uWeNfndsLvIBxlue5Pyjr0rN1BHkfyREI/KZiEX7yAZLfU/n0p2JgktB9wby8sbVCpSyWQpEqEAb8DcSerHGByav6RbzTsQgmaN5Qir/wA9enyk/TP0zSpD9sgh42xKBENvA3MM7lOOg4B9WNbttAYbKO4W8CXEcCpIGJUtyCOcYGQT8386aRlUqcqsXrR4msY2mgaW4ysTSE/K6q33V9FHTFGuvCwvZdqJLJIsYj5KouBk479OlNvb6SVGjV0WETYA27QrYyT7D0xWD4gu4nHmKe24HpnH+eopTehxRi5SuUJZWg82NG3NjIxyPr+tc9qsrNFFG+CwxnnPbke1WHkkMTglh/ED2A75NYN5fJ+8diN4bAB7cUQgzpehUvpVMxEQKpnIB7e/vVQkl9qj5BwATUZnZ2R3JYkYXkZ/zxVizh8zkDjPr1roegoO5f06Bmb5cE9mPc/WugtomWZPlfJPOR0PTH6/oazrJfKAJLHI249s859cYzW7ZorrvILN34z/AJFYydzW5aM391NqgY64/X0/xrQtVjkiBkAAJwxAOf8A69Zdu4aXAyS5wDntWxbW+IcIQCWyDjJXPf8AnUGc7JWLPk4IZWGOMgHn8MdKZHH9oYupwRjg8VO8Wy3AAJI4x/gP89KksoeCrDczgHa3r/hTOZytqeNxBvPAZiAwyR1xWjAHjcqNrPkHhun+f61R3FZCp+YjIGffirkNu6mNVcbmPJ9s5/OtvI0uWXkQKS5IAIO4nBLdh/LJ7Vo2wEZeaRykSBW3ZwScdMd6yrDa9+HmBaBCcr1O1e386huJzdDDZ+ZiRzjAz0qGhrXQ2DcvcqWATyyQy9+ewx361oQBLVt86O4UYLb+p6kD1PI4rNgCz+e6llWMEkHHOM9B+FSyXLX09tbugEOPlUHpjOc+vT/PaR76LYs316z28ly6F8Z2gL09gOn1p2mzLcQiViHfBbA4UA4yg/IVXOMoMsFQEsB/EfT2Hr61Np8RDpDGxGCUJJ6kH+XIpbMrRKxqx7BMzSMU2gqNnU92PPb3qO4EjXDNGrgRDzJNoyVUD8McHp70yQkrlcBVU4GM5HqffP6Co798CY4yscSNIuf9ZlyACaGyYrUmhuZ2vDM6QyKqfuxIuQB0Jx9Dx6mm2MtxJLLHGWVAy5Unk5yV3EcZHXtxwOlV4hIXM2VRd2xQoztB+YnnvyBmtTSrIWUQ82Qu2DJkAEcZByO546mktS5NRTNC3Uj965YAgvLKeoXb91eOfy+ma1EgghjimvYkRxHiOIHIgXtk9e2fXP0rPur/AMp7W0hiyklsjkueSShcg8fd29uOaRIPtMnnzSN5CnaI14yVwCD/ALJJrS9jld5K70RFbSQXc63EKABH2IzggEeme+BnA4BJz2q0vl/a54EVA78yO+5gRg8D255Hc9KksY/td3KuTvAbBztVQByAAOPT6VXj+a5aCU/LuKggZzjO3gnjBpa7Db3I7l7ZYWaaItGgKKcE+exHUnsAcgAdD3qM3bwh7O2hRLyTK+XEuEjGR1GfU/4mnwN9rvTYktsVhCWB2lu/boODwPWq8vkS2UzxBkhmVoyNo3Kqn+E9u/55pO72NVbZg09ujpM0zSCEKqyR4KI4+9nJ+8cnPp+NUXMWoXJD3DXERzIxCELD6ZHrjPA6fjmtBBA8y2EEKwiGMmVwM5UDOAM45wBzz1OaW2srdXngG6N5V86VkH3zgHH6/jSSuVzKOvUdbBL1Ta6SJRwXMQxs256n15HQdz3qwHg0zAIA37ysrfdc9yWHTH+z6VX89Le2k+zxlbl1Hzq5QICSoAx+v5Vl6jcTtHb2iEAiGSWUFjtZE5I9znoOBVNsSjzu3Q3JbkvZ+dcLG8UbK2/ywoGQThVPPzY4GfrVaB5p5Uh80mSfq5JbpztPGdvpWfHp07w2z3M+YnYSKU+8oYHaD64xWzayEagtpbs+HjJZpMEspJzn3OKh3e4StFaGhJYKEaONgZJAMYGTGeuAQeBjnHWkaxWTymvEaNFJEYRhtcADACdx3JGOTVl7eVZoY4VijZ0BZgxyf0pt3DDGsnns7PEQ7ADKrnpt5689T+tVyI5ed9WI62kQSOe3QR/ffeSN/bA6jOcHPQCoLu3jLbbWMMjYLMpxwT0C56j27GiOeLbEV8wMzAIMA5O4jk9uR2p6E313FszEHGQm4lQSeP6/pSvzDV07mZfQGFWlt3eQqQkgBAEZ7Ar2Ppj8elWLW1ub1X8gL+7yVMZGFJ7Yx/8AWqTVEhtZ2j+zhiUdny54Cnt6k5HXpVO2mZo/MZmI2bV3cnGcfhjt14qG9TW7cbhfx3hZfJnRJt2wxmMtuXBBBIPA7gjp3BHFQtJKiJtjEaId0RD4CY754547fSpre72WrSBSBjbheoA/hH1PftUdxcm5lMzRq8Pyx7XJByc/kMj9Pc1CV2VG5Ra+xcJ5Me5z8wJO1cd+OxB5zUhljkQGFmUEbm2NtUZPGT3/AJUeW0jqFCi5UqPOJycHpx078jpVXURHDG7oWdhuOHAIGOMfz/Oqs+hrdCQ3qtPEwlcYyqHh9nuuRj3JIpsEIT93DcEmQ7vtEqny1XHLDg7iegHeqNhYzXCtJNO28h2AQ7RsThs+5HAHSphqINpJsTa0IUF9v3QeRtXpn65z7VXLZmitJXiT6pBbRXKrsnuZF2Itvv2bUADYY9Q3BPA4BqxChuLGI3aqYOI7S2jK7EJ5ZznkuckA85OegFUoxDKktyTKzMgw7HLnc2ck9zxzV3VbifTHZwwz5q9fnbPpuI+77Y71aG76R6jPskAgjtYbdIWZmJYkllx0U8gLz3745PAFYkHmTyzBWSY+YEDxkEFR1Kt3z+tXrgC71G0jlyIbgswX7wUA5IweuSTW0iHSr9HjRBDGFfylOBkgjIOOODRYrn5V3ZK5hF3bR2zDyVj2pbo/zBsEEkZ+XkA/jUtlLHPKArzNHCeVl4BwOgXGeOBnGBx9ax9LfZqU80qrgEhFX+L0Dew9qk04S/2Yb68YNJdRNNIYjtIBbauO3VefrRdnPONlqyzNdK9vcI4YSXDkACTdtX1x34x6965vUr0uTCpbdtKHpgev5U+/uHtFh8qRnCAmOQrtY59Rk1z97cN5LOSy8jG31JApKLBWtdEt7qEdu6CIid3TZ5bDPJ/XPSuVumkZwJAQ4PKnsaTUHkWRXJ6rkYOMd6rxuSxLEkk7ie9dMY2Rk3d6FhRkELk981r2oCxKB14BHp71lwDuOv8AnityxASJio6DcPzqZs2gi/aozAgRByASsecbjjgZ7ZP/ANet+03bQvBB4/T+nvWHpjEEKM5Pv/n866jS8BQzcgE5GO3Arneo6krK5DFEyyERqwPfnqD/APXrfsTtj2SOpOcDnj8R/P2oEKHMm3HPHPII6UmCHCsSRJg/Tuf8KTuc0586Lk7ql0iIOM/xYHf8PfmpJ5lWNW2sXyMDoffFQSKSAScnhfzGRU8K/uSWOV6c9e/+BqtzBtJJn//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John H Stone, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41782=[""].join("\n");
var outline_f40_51_41782=null;
var title_f40_51_41783="Community public health issues and the thalassemic syndromes: Lessons from other countries";
var content_f40_51_41783=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"16\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Community public health issues and the thalassemic syndromes: Lessons from other countries",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/51/41783/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41783/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/51/41783/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41783/contributors\">",
"     William C Mentzer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/51/41783/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41783/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/51/41783/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beta thalassemia occurs in the Mediterranean littoral and all over South East Asia (Burma, Thailand, Cambodia, Viet Nam, China, Malaysia, Indonesia and the Philippines). Alpha thalassemia is even more common, occurring with high frequency in South East Asia, Africa and India [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/1\">",
"     1",
"    </a>",
"    ]. Some variants of thalassemia (eg, Hydrops Fetalis-Hemoglobin Barts) are incompatible with life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/2\">",
"     2",
"    </a>",
"    ], while others (eg, beta thalassemia major) are associated with life-long transfusion-dependent anemia, short stature, facial abnormalities, delayed or absent puberty, and attendant stigmas and psycho-social problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Individuals with alpha and beta thalassemia trait may be entirely asymptomatic, unaware of their diagnosis, and marry other individuals with the same trait, thereby perpetuating the disorder within these communities. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38106?source=see_link\">",
"     \"Clinical manifestations and diagnosis of the thalassemias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An interesting anecdote illustrates our changing perceptions about these disorders. Thalassemia was not diagnosed in Cyprus before 1944 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/1\">",
"     1",
"    </a>",
"    ]. After World War II, following improvements in public health, along with malarial eradication programs, it became apparent that there was a newly recognized but common hypochromic microcytic anemia in children not due to iron deficiency (ie, severe beta thalassemia) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/3\">",
"     3",
"    </a>",
"    ]. It was quickly realized that, for example, the cost of red blood cell transfusions and chelation therapy per year for a patient with beta thalassemia major exceeded by three to four orders of magnitude the per capita funds available for health care in that country, as well as in much of the developing world.",
"   </p>",
"   <p>",
"    By 1970, it was projected that, if this disease was not controlled, by the year 2000 the cost of treatment of these children would consume the entire health care budget of Cyprus and require all of the blood that the island could supply, even supposing that 40 percent of the adults would enlist as regular blood donors.",
"   </p>",
"   <p>",
"    In the past, in many of the underdeveloped nations, at a time when the infant mortality rate was above",
"    <span class=\"nowrap\">",
"     50/1000",
"    </span>",
"    births, affected countries devoted their public health efforts to controlling neonatal infectious diseases and malnutrition. Thus, of the well over 300,000 infants with major forms of severe hemoglobin disorders, including the thalassemias, who were born every year, many died untreated or even undiagnosed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/3\">",
"     3",
"    </a>",
"    ]. However, when the infant mortality rate fell below",
"    <span class=\"nowrap\">",
"     40/1000,",
"    </span>",
"    genetic diseases such as the thalassemias \"emerged\", along with a demand for appropriate medical services [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/3\">",
"     3",
"    </a>",
"    ], as occurred in Cyprus (see above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SEVERE THALASSEMIA IN THE DEVELOPED WORLD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before 1980, Hb E was not recognized in California [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/5\">",
"     5",
"    </a>",
"    ]. Now that the California population is 10 percent Asian, the number of children born with thalassemia has been increasing. As a result, the number of births in California of children with homozygous hemoglobin E disease now exceeds the number of births of children with sickle cell disease. In addition, there are now 11 new cases of Hb",
"    <span class=\"nowrap\">",
"     E/beta",
"    </span>",
"    thalassemia per year, as well as 30 new cases per year of HbH disease (severe alpha thalassemia) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/5\">",
"     5",
"    </a>",
"    ]. Other examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the United Kingdom (UK), there are now more than 50 patients with severe Hb",
"      <span class=\"nowrap\">",
"       E/beta",
"      </span>",
"      thalassemia, mostly of Bengali or Southeast Asian origin [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A 1998 lead article in the journal \"Blood\" dealt with an emerging health care problem due to an increased frequency of stillbirths secondary to severe alpha thalassemia (ie, Hydrops Fetalis Hb-Barts) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/2\">",
"       2",
"      </a>",
"      ]. The article came not from China, Singapore, or Hong Kong, where this syndrome had been well described, but from Ontario, Canada [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/2\">",
"       2",
"      </a>",
"      ]. Similar experience from Boston has been reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The demographics in these three countries (United Kingdom, Canada, USA) have obviously changed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]; simple arithmetic indicates that many patients with thalassemia have not been diagnosed",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    appropriately treated, and that there is clearly a need to improve community education programs, as well as opportunities for genetic and prenatal counseling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EFFECTIVE CONTROL OF THALASSEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Control of thalassemia requires treatment of the individual patient as well as a community-based educational effort to increase awareness of this problem.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Individual patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;For individual patients with beta thalassemia major, appropriate treatment includes all of the following (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/39/7802?source=see_link\">",
"     \"Treatment of beta thalassemia\"",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/1,3,10,11\">",
"     1,3,10,11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lifelong red cell transfusions",
"     </li>",
"     <li>",
"      Control of the blood supply to avoid transfusing hepatitis and HIV",
"     </li>",
"     <li>",
"      Chelation programs to minimize transfusional iron overload",
"     </li>",
"     <li>",
"      Prompt treatment of all infections",
"     </li>",
"     <li>",
"      Treatment of endocrine complications related to iron overload, including hormone supplementation to allow normal puberty and growth",
"     </li>",
"     <li>",
"      Splenectomy when and if hypersplenism occurs",
"     </li>",
"     <li>",
"      Control of osteoporosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Hematopoietic cell transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the patient has an HLA-matched sibling hematopoietic cell donor (approximately 30 percent of patients), lives in an affluent country,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    has the financial resources, an allogeneic hematopoietic cell transplantation (HCT) is essentially curative in 80 percent or more of such patients. In response to this need, the HCT program in Pesaro, Italy has completed over 1000 such transplants. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/25/5529?source=see_link\">",
"     \"Efficacy of hematopoietic cell transplantation in beta thalassemia major\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If non-myeloablative HCT is successful in thalassemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/12\">",
"     12",
"    </a>",
"    ], it would be possible in the wealthier countries to extend transplantation to partially matched donors. However, this is not a solution for most of the developing world. Unrelated donor HCT has also been used in severely affected adult patients, but only if the potential candidates are rigidly screened and fully informed about the risks of this procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/17/25880?source=see_link&amp;anchor=H18#H18\">",
"     \"Specific issues related to hematopoietic cell transplantation in beta thalassemia\", section on 'Persistent mixed chimerism'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/34/25130?source=see_link&amp;anchor=H13#H13\">",
"     \"Preparative regimens for hematopoietic cell transplantation\", section on 'Nonmyeloablative and reduced intensity preparative regimens'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Improved diagnostic and screening methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;The underlying cause of the defective and deficient globin chain synthesis in the thalassemias has been explored. For the beta thalassemias, most are problems in gene transcription, while for the alpha thalassemias, gene deletions are the usual cause. Using reliable probes it is now possible to screen populations for these defects. Despite the vast heterogeneity of these disorders, it has turned out in practice that in each given geographic and ethnic area there is a reproducible pattern of recurrent abnormalities, such that diagnostic accuracy can be achieved using relatively small numbers of probes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/60/968?source=see_link\">",
"     \"Laboratory diagnosis of the hemoglobinopathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effectiveness and difficulties of screening is illustrated in a report from Indonesia where issues of education, awareness of the disorder, and stigmatization emerged [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Search for an orally active iron chelating agent",
"    </span>",
"    &nbsp;&mdash;&nbsp;Development of a cheap, orally-effective iron chelator is an additional biologic intervention that would dramatically reduce costs and increase the effectiveness of available medical treatment of thalassemia.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/18/3365?source=see_link\">",
"     Deferiprone",
"    </a>",
"    is in use in Europe and the UK, but not in Canada or the USA. An orally active tridentate iron chelator,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/19/2360?source=see_link\">",
"     deferasirox",
"    </a>",
"    , which can be given once daily, has been approved for use in the USA. Its long range benefits have not yet been determined. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/49/25370?source=see_link\">",
"     \"Chelation therapy for iron overload states\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Biological problems",
"    </span>",
"    &nbsp;&mdash;&nbsp;It was originally thought that Hb",
"    <span class=\"nowrap\">",
"     E/beta",
"    </span>",
"    thalassemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/6\">",
"     6",
"    </a>",
"    ], Hb H disease, and Hb",
"    <span class=\"nowrap\">",
"     H/Constant",
"    </span>",
"    Spring is more severe in the developing world because of the existence of co-morbid conditions such as malaria, other infectious disease, contaminated water, and malnutrition. However, preliminary data indicate that patients with Hb",
"    <span class=\"nowrap\">",
"     E/beta",
"    </span>",
"    thalassemia and Hb H are as anemic in the UK and Oakland, California as they are in Thailand.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Financial problems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transfusion support requires a blood procurement program that has appropriate storage capacity, excellent donor identification, and the capability of screening for blood-borne infections, such as hepatitis and HIV. These screening tests are sophisticated and expensive. The problems of supporting the medical needs of these patients fall primarily on local programs in developed countries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Community wide problems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Understanding of the molecular and genetic basis of the thalassemias has allowed us to apply this information to communities and entire countries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/3\">",
"     3",
"    </a>",
"    ]. For example, the frequency of the hemoglobin Constant Spring (HbCS) gene in Bangkok is 8 percent, while the frequency of the Hb E trait in the South East Asian triangle is 40 to 60 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21397857\">",
"    <span class=\"h3\">",
"     Genetic counseling of couples",
"    </span>",
"    &nbsp;&mdash;&nbsp;To be clinically useful, this screening information has to be coupled with an education program (see below) informing local physicians and the affected population about the disease, its manifestations, cause, and clinical course. Following this, there must be accessible opportunities for genetic counseling. As an example, if both parents have beta thalassemia trait, they can be told the following about the chances of an affected child:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Child with severe disease (beta thalassemia major) &mdash; one chance in four",
"     </li>",
"     <li>",
"      Asymptomatic carrier (beta thalassemia trait) &mdash; one chance in two",
"     </li>",
"     <li>",
"      Unaffected child &mdash; one chance in four",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Genetic counseling has generally had little or no impact on the choice of spouse, although separating and finding another spouse was a major option in Iran before prenatal testing was generally available and abortion of an affected fetus was permitted by the government [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/15\">",
"     15",
"    </a>",
"    ]. On the other hand, once pregnancy has occurred, given that community educational programs have been effective, the couple will almost invariably seek prenatal diagnosis, which can be achieved before 13 weeks, using chorionic villus biopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/26/24999?source=see_link&amp;anchor=H8#H8\">",
"     \"Prenatal testing for the hemoglobinopathies and thalassemias\", section on 'Testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Depending on the ethnic group and the society, the couple then has an opportunity to make a choice as to whether to terminate or continue the pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/15\">",
"     15",
"    </a>",
"    ]. As an example, in Cyprus, Sardinia, Italy, and Greece [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/3\">",
"     3",
"    </a>",
"    ], when the couple has been informed that the fetus is affected with beta thalassemia major, over 97 percent of the couples terminated the pregnancy to try again (",
"    <a class=\"graphic graphic_table graphicRef82751 \" href=\"mobipreview.htm?15/38/15979\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A pilot hospital-based screening and education program on the southeastern coast of China has had similar success [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/17\">",
"     17",
"    </a>",
"    ]. Over an 11-year period from 1993 through 2003, 4587 out of 49,221 screened pregnant women were found to be carriers of alpha- or beta-thalassemia. Ninety-eight percent of the husbands of these women agreed to screening, and 281 of the couples were found to be at risk for severe thalassemia. Prenatal diagnosis was performed in 269 (95.7 percent) of the 281 at-risk pregnancies, which identified 69 severely affected fetuses (25.6 percent). All pregnancies with severely affected fetuses were voluntarily terminated.",
"   </p>",
"   <p>",
"    During this time there were only two affected children born at this large regional hospital, both with homozygous alpha (0) thalassemia. These children were from the 12 couples that refused to accept prenatal diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Ethical issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;The techniques for preimplantation genetic diagnosis and therapy have been developed for single gene disorders, such as the thalassemias. These techniques might be employed by a couple at risk in order to select an uninvolved embryo for implantation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/26/24999?source=see_link&amp;anchor=H8#H8\">",
"     \"Prenatal testing for the hemoglobinopathies and thalassemias\", section on 'Testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These techniques might also be employed by a family that had a severely affected child with thalassemia major, but no HLA-matched sibling donor for a curative allogeneic hematopoietic cell transplantation. Through the use of these single cell genetic methods, the parents' fertilized eggs might be screened to select one that is not thalassemic and is also HLA compatible with the affected child [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. This fertilized egg is then implanted in the mother, and, at the time of delivery, cord blood stem cells are harvested for use in the subsequent allogeneic HCT for the affected child.",
"   </p>",
"   <p>",
"    Clearly, there are very important ethical and financial issues involved in these two scenarios. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/18/11562?source=see_link&amp;anchor=H16#H16\">",
"     \"Hematopoietic cell transplantation for idiopathic severe aplastic anemia and Fanconi anemia in children\", section on 'Use of umbilical cord blood for transplantation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     IMMIGRATION PATTERNS AND PROVISION OF HEALTH CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the individual Mediterranean countries such as Greece and Italy, there is a commonality of language, culture, and religion, and there are strong state-supported health care systems. However, with current immigration patterns, Southeast Asians are now being cared for in countries with different languages, cultural norms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/3,4,20\">",
"     3,4,20",
"    </a>",
"    ] and health care systems. This has led to a number of problems in education, occurring at several different, but interrelated levels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Physician education",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few physicians in the UK, Canada and the USA have experience in caring for patients with severe thalassemia. This care requires knowledgeable physicians with the requisite diagnostic facilities, including relevant molecular biologic probes, laboratory and transfusion support, knowledge about stunted growth, endocrine disorders, bone disease, facial deformities, delayed puberty, and management of infections, splenomegaly, and viral hepatitis.",
"   </p>",
"   <p>",
"    Thus, physicians in communities of the developed world, to which Southeast Asians have immigrated, now must be trained in all of the above subjects. Furthermore, since patients with severe thalassemia are surviving into their 30s and 40s, one or two other changes have to occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/21\">",
"     21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physicians who care primarily for adults and are currently inexperienced in caring for thalassemics, must be taught to care for these patients,",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      Pediatricians, the traditional care-givers of the past, will have to continue to take care of such patients well after the onset of puberty.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Translators and nurse practitioners",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the short run, insuring effective communication between the affected families, community facilities, and the medical community requires the provision of adequate numbers of language translators and appropriate community role models, such as nurse practitioners and other health care providers of the same ethnic background [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Community educational programs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The community and its leaders must be educated about these diseases, options for management, and the available facilities. Community leaders, in turn, must make sure that opportunities exist for locally obtaining the necessary genetic counseling, prenatal testing, and appropriate medical care.",
"   </p>",
"   <p>",
"    The most effective intervention thus far has been population screening to identify ethnic-specific patterns of molecular abnormalities, genetic counseling combined with highly reliable prenatal diagnosis, followed by community and social support that allows the affected couple to choose to act on the information and terminate an affected pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/1,3,4,22-24\">",
"     1,3,4,22-24",
"    </a>",
"    ]. While such molecular diagnostic programs are expensive, they are remarkably cost-effective, as demonstrated in Cyprus, Sardinia, Italy, and Greece [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/1,3,22\">",
"     1,3,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Examples of effective community action",
"    </span>",
"    &nbsp;&mdash;&nbsp;The experience of three countries has given us a clear description of an optimal support system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/4,25,26\">",
"     4,25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Greece",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are 3500 patients with severe beta thalassemia major in Greece, who consume one-quarter of the country's total blood supply. Iron chelation therapy alone costs 7 million dollars a year. Accordingly, Greece has generated an extensive educational program to produce public awareness. This is coupled with easy access to a program of prenatal diagnosis and screening, along with a very extensive social support program (",
"    <a class=\"graphic graphic_table graphicRef79598 \" href=\"mobipreview.htm?7/19/7483\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/4\">",
"     4",
"    </a>",
"    ]. Considering the ongoing financial crisis in Greece, it is not clear which, if any, of these benefits persist.",
"   </p>",
"   <p>",
"    Parent groups have been encouraged to an extent such that 90 percent of thalassemic patients use the support system and are aware of the issues surrounding this disorder (",
"    <a class=\"graphic graphic_table graphicRef78796 \" href=\"mobipreview.htm?2/17/2331\">",
"     table 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/4\">",
"     4",
"    </a>",
"    ]. Psycho-social support is also provided as an integral part of this scheme, such that the psycho-social burden has changed significantly (",
"    <a class=\"graphic graphic_table graphicRef62593 \" href=\"mobipreview.htm?2/60/3019\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef76407 \" href=\"mobipreview.htm?22/12/22731\">",
"     table 5",
"    </a>",
"    ), [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/4\">",
"     4",
"    </a>",
"    ]. It would be difficult to envision a more extensive and comprehensive program. As a direct result of this effort, the average age of beta thalassemia major patients in Greece is now 27 and very few new patients with beta thalassemia major are being born (",
"    <a class=\"graphic graphic_figure graphicRef65994 \" href=\"mobipreview.htm?6/54/7022\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Italy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A very similar program, although not quite so extensive, is provided in Italy by the Pediatric Program in Ferrara, which cares for 170 patients with beta thalassemia major [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/25\">",
"     25",
"    </a>",
"    ]. The key to the Ferrara Program is outpatient care and a strong parent association. However, no psychiatric or social support is provided [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study compared the 170 Ferrara patients with 300 patients in the Athens Thalassemia Program. Surprisingly, the psycho-social adjustment in Ferrara, when formally assessed, was better than that in Athens, where there was considerable hostility and only 30 percent of patients were compliant with chelation therapy. It has been stated that \"Illness dominates all aspects of life\" in Athens, Greece, but not in Ferrara [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/4,25\">",
"     4,25",
"    </a>",
"    ]. In Ferrara, adjustment was good, even leading to marriage and families, with the social support being provided mainly by the family and its religion. One wonders whether the maximal program in Greece has led to unrealistic expectations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Cyprus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before 1976, the birth rate for severe thalassemia in north Cyprus was 18 to 20 cases per year. The following actions were taken to reduce this serious health problem [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/26\">",
"     26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Screening high-risk families for thalassemia was started in 1979",
"     </li>",
"     <li>",
"      Premarital screening was made compulsory in 1980",
"     </li>",
"     <li>",
"      Prenatal diagnosis with fetal blood sampling was started in 1984",
"     </li>",
"     <li>",
"      DNA techniques replaced fetal blood sampling in 1991",
"     </li>",
"     <li>",
"      Facilities were provided for treatment of existing thalassemic patients",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As a result of these actions, the birth rate for severe thalassemia between 1991 and 2001 had dropped to one case every 2 to 3 years, and there were no such births in the following five years. Two-thirds of the existing patients with severe thalassemia are now &gt;25 years of age, living and working in the same way as the normal population; 38 percent are married with children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     COMPONENTS OF A SUCCESSFUL PROGRAM",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is certainly a need to educate physicians about this disease and its management, as well as to have an explicit local, regional, and national policy to cover antenatal and prenatal screening for these hemoglobinopathies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/27\">",
"     27",
"    </a>",
"    ]. It is, however, critical to inform and empower the affected ethnic groups now living in the developed world. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/26/24999?source=see_link&amp;anchor=H8#H8\">",
"     \"Prenatal testing for the hemoglobinopathies and thalassemias\", section on 'Testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Oakland, California group has found that language translators and nurse practitioners from the affected ethnic groups are very important for the success of these programs. Contact also needs to be made with community leaders to educate, inform, and get them involved in community educational programs. Weekly meetings among patients, parents, community leaders, and the medical staff to discuss issues and problems are of paramount importance. Other effective programs would include Special Family Nights, health fairs, and language- specific literature, including information concerning such subjects as genetic counseling, prenatal diagnosis, intercurrent illness, sexual development, pregnancy, and osteopenia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41783/abstract/5,20,21,28,29\">",
"     5,20,21,28,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21397601\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21397661\">",
"    <span class=\"h2\">",
"     Problem overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beta thalassemia occurs in the Mediterranean littoral and all over South East Asia (Burma, Thailand, Cambodia, Viet Nam, China, Malaysia, Indonesia and the Philippines). Alpha thalassemia is even more common, occurring with high frequency in South East Asia, Africa and India. A number of issues concerning thalassemia have important public health implications in these countries as well as in the developed world. These include the following. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H2\">",
"     'Severe thalassemia in the developed world'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      By 1970, it was projected that, if thalassemia was not controlled in Cyprus, by the year 2000 the cost of treatment of these children would consume the entire health care budget of Cyprus and require all of the blood that the island could supply.",
"     </li>",
"     <li>",
"      There are 3500 patients with severe beta thalassemia major in Greece, who consume one-quarter of the country's total blood supply. Iron chelation therapy alone costs 7 million dollars a year.",
"     </li>",
"     <li>",
"      Before 1980, Hb E was not recognized in California. Now that the California population is 10 percent Asian, the number of children born with thalassemia has been increasing. As a result, the number of births in California of children with homozygous hemoglobin E disease now exceeds the number of births of children with sickle cell disease.",
"     </li>",
"     <li>",
"      In the individual Mediterranean countries such as Greece and Italy, there is a commonality of language, culture, and religion, and there are strong state-supported health care systems. However, with current immigration patterns, Southeast Asians are now being cared for in countries with different languages, cultural norms and health care systems.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21397759\">",
"    <span class=\"h2\">",
"     Potential solutions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solution of the above problems requires action on the following levels. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Components of a successful program'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H16\">",
"     'Examples of effective community action'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Education of health care providers. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Physician education'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Translators and nurse practitioners'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Effective community educational programs. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Community educational programs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Effective counseling of couples at risk of having an affected child. (See",
"      <a class=\"local\" href=\"#H21397857\">",
"       'Genetic counseling of couples'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/1\">",
"      Weatherall DJ. Thalassemia in the next millennium. Keynote address. Ann N Y Acad Sci 1998; 850:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/2\">",
"      Chui DH, Waye JS. Hydrops fetalis caused by alpha-thalassemia: an emerging health care problem. Blood 1998; 91:2213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/3\">",
"      Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci 1998; 850:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/4\">",
"      Politis C. The psychosocial impact of chronic illness. Ann N Y Acad Sci 1998; 850:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/5\">",
"      Lorey F, Cunningham G. Impact of Asian immigration on thalassemia in California. Ann N Y Acad Sci 1998; 850:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/6\">",
"      Rees DC, Styles L, Vichinsky EP, et al. The hemoglobin E syndromes. Ann N Y Acad Sci 1998; 850:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/7\">",
"      Chui DH, Cunningham MJ, Luo HY, et al. Screening and counseling for thalassemia. Blood 2006; 107:1735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/8\">",
"      Luo HY, Boudreaux J, Steinberg MH, Chui DH. Patients with thalassemia in the United States. Blood 2005; 105:4896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/9\">",
"      Vichinsky EP, MacKlin EA, Waye JS, et al. Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics 2005; 116:e818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/10\">",
"      Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and disease complications in thalassemia major. Ann N Y Acad Sci 1998; 850:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/11\">",
"      Hershko C, Link G, Cabantchik I. Pathophysiology of iron overload. Ann N Y Acad Sci 1998; 850:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/12\">",
"      Storb R, Yu C, Deeg HJ, et al. Current and future preparative regimens for bone marrow transplantation in thalassemia. Ann N Y Acad Sci 1998; 850:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/13\">",
"      Caocci G, La Nasa G, d'Aloja E, et al. Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients. BMC Med Ethics 2011; 12:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/14\">",
"      Widayanti CG, Ediati A, Tamam M, et al. Feasibility of preconception screening for thalassaemia in Indonesia: exploring the opinion of Javanese mothers. Ethn Health 2011; 16:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/15\">",
"      Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ 2004; 329:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/16\">",
"      Beris P, Darbellay R, Extermann P. Prevention of beta-thalassemia major and Hb Bart's hydrops fetalis syndrome. Semin Hematol 1995; 32:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/17\">",
"      Liao C, Mo QH, Li J, et al. Carrier screening for alpha- and beta-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital. Prenat Diagn 2005; 25:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/18\">",
"      Fiorentino F, Biricik A, Karadayi H, et al. Development and clinical application of a strategy for preimplantation genetic diagnosis of single gene disorders combined with HLA matching. Mol Hum Reprod 2004; 10:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/19\">",
"      Verlinsky Y, Rechitsky S, Sharapova T, et al. Preimplantation HLA testing. JAMA 2004; 291:2079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/20\">",
"      Choy J, Yamashita RC, Foote D, et al. Outreach strategies for Asian Pacific Island (API) communities. Ann N Y Acad Sci 1998; 850:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/21\">",
"      Weissman L, Treadwell M, Foote D, et al. Approaches to working with adult thalassemia patients in pediatric settings. Ann N Y Acad Sci 1998; 850:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/22\">",
"      Weatherall DJ, Clegg JB. Thalassemia--a global public health problem. Nat Med 1996; 2:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/23\">",
"      Ahmed S, Saleem M, Modell B, Petrou M. Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med 2002; 347:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/24\">",
"      Cao A, Galanello R. Effect of consanguinity on screening for thalassemia. N Engl J Med 2002; 347:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/25\">",
"      Di Palma A, Vullo C, Zani B, Facchini A. Psychosocial integration of adolescents and young adults with thalassemia major. Ann N Y Acad Sci 1998; 850:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/26\">",
"      Bozkurt G. Results from the north cyprus thalassemia prevention program. Hemoglobin 2007; 31:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/27\">",
"      Streetly A. A national screening policy for sickle cell disease and thalassaemia major for the United Kingdom. Questions are left after two evidence based reports. BMJ 2000; 320:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/28\">",
"      Heer N, Choy J, Vichinsky EP. The social impact of migration on disease. Cooley's anemia, thalassemia, and new Asian immigrants. Ann N Y Acad Sci 1998; 850:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41783/abstract/29\">",
"      Garofalo F, Piga A, Lala R, et al. Bone metabolism in thalassemia. Ann N Y Acad Sci 1998; 850:475.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7117 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-27.109.116.13-B9B7D38986-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41783=[""].join("\n");
var outline_f40_51_41783=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21397601\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SEVERE THALASSEMIA IN THE DEVELOPED WORLD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EFFECTIVE CONTROL OF THALASSEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Individual patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Improved diagnostic and screening methods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Search for an orally active iron chelating agent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Biological problems",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Financial problems",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Community wide problems",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21397857\">",
"      - Genetic counseling of couples",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Ethical issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      IMMIGRATION PATTERNS AND PROVISION OF HEALTH CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Physician education",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Translators and nurse practitioners",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Community educational programs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Examples of effective community action",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Greece",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Italy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Cyprus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      COMPONENTS OF A SUCCESSFUL PROGRAM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21397601\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21397661\">",
"      Problem overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21397759\">",
"      Potential solutions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7117\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7117|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?6/54/7022\" title=\"figure 1\">",
"      Fall in thalassemia birthrate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7117|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/38/15979\" title=\"table 1\">",
"      Fetal testing for thalassemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/19/7483\" title=\"table 2\">",
"      Social benefits thal Greece",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/17/2331\" title=\"table 3\">",
"      Public awareness thalassemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/60/3019\" title=\"table 4\">",
"      Psychosoc issues thal past",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/12/22731\" title=\"table 5\">",
"      Psychosoc issues thal present",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/49/25370?source=related_link\">",
"      Chelation therapy for iron overload states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38106?source=related_link\">",
"      Clinical manifestations and diagnosis of the thalassemias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/25/5529?source=related_link\">",
"      Efficacy of hematopoietic cell transplantation in beta thalassemia major",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/18/11562?source=related_link\">",
"      Hematopoietic cell transplantation for idiopathic severe aplastic anemia and Fanconi anemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/60/968?source=related_link\">",
"      Laboratory diagnosis of the hemoglobinopathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/26/24999?source=related_link\">",
"      Prenatal testing for the hemoglobinopathies and thalassemias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/34/25130?source=related_link\">",
"      Preparative regimens for hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/17/25880?source=related_link\">",
"      Specific issues related to hematopoietic cell transplantation in beta thalassemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/39/7802?source=related_link\">",
"      Treatment of beta thalassemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_51_41784="Isolated left ventricular noncompaction";
var content_f40_51_41784=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Isolated left ventricular noncompaction",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/51/41784/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41784/contributors\">",
"     Heidi M Connolly, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41784/contributors\">",
"     Christine H Attenhofer Jost, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/51/41784/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41784/contributors\">",
"     William J McKenna, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/51/41784/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41784/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/51/41784/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated noncompaction of the left ventricle (LVNC) is a rare disorder, classified as a primary genetic cardiomyopathy by the American Heart Association [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/1\">",
"     1",
"    </a>",
"    ]. The European Society of Cardiology Working Group on Myocardial and Pericardial Diseases classified LVNC as an unclassified cardiomyopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/2\">",
"     2",
"    </a>",
"    ]. LVNC was previously also named spongy myocardium or hypertrabeculation syndrome; these terms should not be used as interchangeable terms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    LVNC is characterized by the following features:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An altered myocardial wall with prominent trabeculae and deep intertrabecular recesses resulting in thickened myocardium with two layers consisting of compacted and noncompacted myocardium (",
"      <a class=\"graphic graphic_picture graphicRef57125 \" href=\"mobipreview.htm?39/31/40435\">",
"       picture 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/4,5\">",
"       4,5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Continuity between the left ventricular cavity and the deep intratrabecular recesses, which are filled with blood from the ventricular cavity without evidence of communication to the epicardial coronary artery system.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    LVNC as an isolated disorder will be reviewed here. Noncompacted myocardium may also be seen in association with other abnormalities:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Noncompacted myocardium with intramyocardial sinusoids and coronary artery fistulae may be associated with congenital right or left ventricular outflow tract abnormalities, such as pulmonary atresia with intact ventricular septum [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/6\">",
"       6",
"      </a>",
"      ]. Coronary artery abnormalities are common, which differentiate right or left ventricular outflow tract abnormalities from LVNC. In LVNC, coronary artery circulation is usually normal.",
"     </li>",
"     <li>",
"      Noncompacted myocardium is occasionally seen accompanying other congenital cardiac disorders, such as Ebstein's anomaly, bicuspid aortic valve, aorta-to-left ventricular tunnel, congenitally corrected transposition, hypoplastic left heart syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/7\">",
"       7",
"      </a>",
"      ], and isomerism of the left atrial appendage [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/8-10\">",
"       8-10",
"      </a>",
"      ]. Noncompacted myocardium has also been found in patients with ventricular and atrial septal defects and patent ductus arteriosus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/10,11\">",
"       10,11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Noncompacted myocardium has also been noted in patients with cardiomyopathies due to neuromuscular disorders [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnosis'",
"      </a>",
"      below.) Noncompaction of the left ventricle can occur in metabolic diseases and genetic syndromes, including Barth syndrome, Charcot-Marie-Tooth disease 1A, and Melnick-Needles syndrome, as well as nail-patella syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Features of LVNC can overlap with dilated cardiomyopathy, hypertrophic cardiomyopathy (especially the apical variant), and restrictive cardiomyopathy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/14-17\">",
"       14-17",
"      </a>",
"      ]. Within the same family, the phenotypic expression can vary considerably [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It has been suggested that LVNC may be due to intrauterine arrest of compaction of the loose interwoven meshwork that makes up the fetal myocardial primordium. However, the term \"noncompaction\" may be a misnomer: some authors have suggested that noncompaction of the ventricular myocardium results from abnormal persistence of the trabecular layer, rather than from noncompaction of the ventricular wall [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/19\">",
"     19",
"    </a>",
"    ]. Pronounced hypertrabeculation may be the result of altered regulation in cell proliferation, differentiation, and maturation during ventricular wall formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of LVNC in the general population is not known but has been described among patients undergoing echocardiography. A review from Switzerland identified 34 cases within 15 years, which represented 0.014 percent of echocardiograms that were performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/21\">",
"     21",
"    </a>",
"    ]. However, this is probably an underestimate, since improved echocardiographic image quality and increasing awareness of LVNC will likely lead to enhanced recognition. Among heart failure patients, the prevalence of LVNC has been reported as 3 to 4 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is concern that echocardiographic criteria for LVNC may be non-specific, particularly in black individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/24\">",
"     24",
"    </a>",
"    ]&nbsp;(see",
"    <a class=\"local\" href=\"#H12\">",
"     'Echocardiography'",
"    </a>",
"    below). Diagnostic criteria of LVNC will need to be standardized in relation to clinical endpoints that are relevant to management and prognosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     GENETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;LVNC can be either sporadic or familial. Rarely, LVNC can occur as a transient phenomenon during myocarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/25\">",
"     25",
"    </a>",
"    ]. In various reports, 12 to 50 percent of those with LVNC had a family history of LVNC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/5,21\">",
"     5,21",
"    </a>",
"    ]. Other affected individuals can be detected by screening asymptomatic relatives of affected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/26\">",
"     26",
"    </a>",
"    ]. Autosomal dominant inheritance is more common than X-linked inheritance or autosomal recessive inheritance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/13\">",
"     13",
"    </a>",
"    ]. Differentiation of genotypes is not possible on the basis of current phenotypic data.",
"   </p>",
"   <p>",
"    There is increasing recognition of considerable overlap in the genetic loci implicated in the major cardiomyopathies. Shared molecular etiology has been found for different cardiomyopathic phenotypes, including overlapping phenotypes between LVNC and hypertrophic cardiomyopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/27\">",
"     27",
"    </a>",
"    ] and between LVNC and apical hypertrophic cardiomyopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/28\">",
"     28",
"    </a>",
"    ]. Despite the genetic overlap between LVNC and hypertrophic cardiomyopathies, in contrast to hypertrophic cardiomyopathy, LVNC co-occurs more commonly with congenital heart disease or Wolff-Parkinson-White syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Identified genes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations have been reported in at least nine genes in patients with LVNC including genes encoding LIM domain binding protein 3 (LDB3), &alpha;-dystrobrenin (DTNA), tafazzin (TAZ), lamin",
"    <span class=\"nowrap\">",
"     A/C",
"    </span>",
"    (LMNA), beta-myosin heavy chain (MYH7), alpha-cardiac actin (ACTC), cardiac troponin T (TNNT2), SCN5A, and tropomyosin 1 (TPM1).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Tafazzin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in the Tafazzin gene (aka G4.5 or TAZ) that result in truncation of tafazzin proteins lead to severe cardiolipin deficiency in the mitochondrial membrane and are responsible for Barth's syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/14,29-31\">",
"     14,29-31",
"    </a>",
"    ]. Barth's syndrome is an X-linked recessive disorder with associated cardiomyopathy, neutropenia, and skeletal myopathy. In a study, 90 percent of patients had a cardiomyopathy, and 53 percent increased left ventricular trabeculations or true LVNC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/20/1351?source=see_link&amp;anchor=H10#H10\">",
"     \"Inherited syndromes associated with cardiac disease\", section on 'Barth's syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Alpha-dystrobrevin (DTNA)",
"    </span>",
"    &nbsp;&mdash;&nbsp;A mutation (P121L) in the gene coding for alpha-dystrobrevin, a cytoskeleton protein, has been identified as a rare cause of LVNC, occasionally in conjunction with congenital heart disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/14,31\">",
"     14,31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Sarcomeric protein genes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The E101K mutation in the alpha-cardiac actin gene (ACTC) has been identified in families with LVNC, septal defects, and apical hypertrophic cardiomyopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/17\">",
"     17",
"    </a>",
"    ]. In a study with 63 unrelated subjects with LVNC, 11 mutations in three sarcomeric protein genes were found (cardiac beta-myosin heavy chain, alpha-cardiac actin and troponin T2) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/33\">",
"     33",
"    </a>",
"    ]. A description of cardiac beta-myosin heavy chain defect in two families with LVNC links noncompaction to hypertrophic, restrictive, and dilated cardiomyopathies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Additional loci",
"    </span>",
"    &nbsp;&mdash;&nbsp;Case reports have linked LVNC to additional loci, including Lamin",
"    <span class=\"nowrap\">",
"     A/C",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/35\">",
"     35",
"    </a>",
"    ], Lim Domain Binding 3 (aka",
"    <span class=\"nowrap\">",
"     Cypher/ZASP)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/31,36\">",
"     31,36",
"    </a>",
"    ], tropomyosin1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/37\">",
"     37",
"    </a>",
"    ] and Chromosome 11p15 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Genetic evaluation and family screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;A careful family history for &ge;3 generations is recommended in all patients with LVNC. Genetic studies of family members are not yet routinely recommended, but clinical evaluation, including electrocardiographic and echocardiographic evaluation of first-degree family members, is suggested. The potential value of this approach was illustrated in a study of systematic family screening in a series of 45 patients with LVNC; 8 of 32 asymptomatic relatives had echocardiographic abnormalities that included LVNC, LVNC with systolic dysfunction, and left ventricular enlargement without LVNC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Guidelines for family screening for cardiomyopathy and for genetic testing are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/28/39369?source=see_link&amp;anchor=H28#H28\">",
"     \"Evaluation of the patient with heart failure or cardiomyopathy\", section on 'Genetic evaluation of cardiomyopathy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/28/39369?source=see_link&amp;anchor=H30#H30\">",
"     \"Evaluation of the patient with heart failure or cardiomyopathy\", section on 'Family screening'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major clinical manifestations of LVNC are heart failure, atrial and ventricular arrhythmias, and thromboembolic events, including stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/4,21,26,39\">",
"     4,21,26,39",
"    </a>",
"    ]. In an initial report from Switzerland describing 16 patients, the mean time from the onset of symptoms to the correct diagnosis was 3.5 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequency of these manifestations was illustrated in a later series of 34 patients from the same authors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/21\">",
"     21",
"    </a>",
"    ]. At diagnosis, the clinical manifestations included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dyspnea &mdash; 27 patients (79 percent)",
"     </li>",
"     <li>",
"      New York Heart Association class III or IV heart failure (",
"      <a class=\"graphic graphic_table graphicRef52683 \" href=\"mobipreview.htm?3/2/3117\">",
"       table 1",
"      </a>",
"      ) &mdash; 12 patients (35 percent)",
"     </li>",
"     <li>",
"      Chest pain &mdash; 9 patients (26 percent)",
"     </li>",
"     <li>",
"      Chronic atrial fibrillation &mdash; 9 patients (26 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The electrocardiogram is usually abnormal (32 of 34 patients in the above report), but there are no characteristic changes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/21\">",
"     21",
"    </a>",
"    ]. The abnormalities that can be seen include left or right bundle branch block, fascicular block, atrial fibrillation, and ventricular tachycardia. An association of LVNC with sinus bradycardia or with Wolff-Parkinson-White syndrome has been described in up to 18 percent of pediatric patients with LVNC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/14,29,40\">",
"     14,29,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A more favorable prognosis was suggested in a series of 45 patients with LVNC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/26\">",
"     26",
"    </a>",
"    ]. At a mean follow-up of 46 months, the survival without transplantation was 97 percent. The prognosis appears to be more favorable among patients who are asymptomatic at the time of diagnosis. In a series of 65 patients, asymptomatic patients had no major cardiovascular events over a mean follow-up of 43 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/41\">",
"     41",
"    </a>",
"    ]. Compared to patients with symptoms, these patients were young, had a lower prevalence of ECG abnormalities, and had better systolic function.",
"   </p>",
"   <p>",
"    Although most reported cases involved adults, LVNC has been recognized in children and fetuses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/29,42\">",
"     29,42",
"    </a>",
"    ]. Some children who present in the neonatal period may have a transient recovery of ventricular function followed by late deterioration that can lead to presentation in adulthood. Fetuses with enlarged left ventricles and reduced left ventricular function should be evaluated for LVNC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of LVNC is usually established by echocardiography. Cardiovascular magnetic resonance (CMR) imaging, computed tomography, and left ventriculography are other imaging modalities that may be diagnostic or raise the initial clinical suspicion.",
"   </p>",
"   <p>",
"    The differential diagnosis of LVNC includes dilated cardiomyopathy, hypertensive heart disease, apical hypertrophic cardiomyopathy, infiltrative cardiomyopathy, and eosinophilic endomyocardial disease.",
"   </p>",
"   <p>",
"    As discussed above, the E101K mutation in the alpha-cardiac actin gene (ACTC) has been identified in families with LVNC, septal defects, and apical hypertrophic cardiomyopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/17\">",
"     17",
"    </a>",
"    ]. This and other observations suggest that there may be overlap between LVNC and hypertrophic cardiomyopathy when current diagnostic criteria are applied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiography has been used both to establish the diagnosis of LVNC and as an aid during follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/21,43\">",
"     21,43",
"    </a>",
"    ]. However, there is no universally accepted definition of LVNC. Proposed echocardiographic criteria for LVNC include those based on the following observations from different centers. A problem with all of these criteria is that there is no gold standard for the diagnosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Jenni et al proposed the following criteria in patients without coexisting cardiac abnormalities; the criteria were validated in a second population [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/43,44\">",
"       43,44",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A thickened left ventricular wall consisting of two layers: a thin compacted epicardial layer; and a markedly thickened endocardial layer with numerous prominent trabeculations and deep recesses with a maximum ratio of noncompacted to compacted myocardium &gt; 2:1 at end-systole in the parasternal short-axis view (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef59614 \" href=\"mobipreview.htm?41/59/42929\">",
"       image 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Color Doppler evidence of flow within the deep intertrabecular recesses.",
"     </li>",
"     <li>",
"      Prominent trabecular meshwork in the LV apex or midventricular segments of the inferior and lateral wall.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All three echocardiographic criteria were required for diagnosis. The criteria are assessed in the parasternal short-axis view at base, mid and apical levels. In addition, hypokinesis of noncompacted segments and possibly other adjoining segments may be present.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chin et al proposed the following criterion based upon observations from eight patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/45\">",
"       45",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The presence of",
"      <span class=\"nowrap\">",
"       X/Y",
"      </span>",
"      &le;0.5, where X is the distance from the epicardial surface to the trough of the trabecular recess and Y is the distance from the epicardial surface to peak of trabeculation. This criterion is applied to trabeculae at the left ventricular apex on subxiphoid or apical four-chamber views at end-diastole.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      St&ouml;llberger, et al proposed criteria that emphasize hypertrabeculation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/12\">",
"       12",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      More than three trabeculations protruding from the left ventricular wall, apically to the papillary muscles, visible in a single image plane.",
"     </li>",
"     <li>",
"      Intertrabecular spaces perfused from the ventricular cavity, visualized on color Doppler imaging.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The degree of concordance between different criteria was evaluated in a series of 45 patients with a diagnosis of LVNC based upon fulfillment of the Jenni",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    Chin criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/26\">",
"     26",
"    </a>",
"    ]. The Jenni criteria were present in 41, the Chin criteria were present in 32, and both criteria were present in 22.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Specificity of criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The criteria proposed by Jenni et al were validated by a blinded retrospective review of records for 19 patients with LVNC, 31 with dilated cardiomyopathy, 22 with hypertensive heart disease, and 86 with chronic severe valvular disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/44\">",
"     44",
"    </a>",
"    ]. Of the LVNC cases, a two-layered structure and thickened walls were present in 100 percent, perfused recesses were visible in 95 percent, and hypokinetic segments in 89 percent. The presence of all three compaction criteria was rare in diseases other than LVNC. Among the 31 patients with dilated cardiomyopathy, perfused recesses and, less often, a two-layered structure were seen, but (with one exception) without thickened walls.",
"   </p>",
"   <p>",
"    In contrast, lack of specificity for all of the above echocardiographic LVNC criteria was noted in a retrospective study of 199 patients with systolic dysfunction referred to a heart failure clinic and 60 normal controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/24\">",
"     24",
"    </a>",
"    ]. In this study, 24 percent of patients with systolic dysfunction and five (including four blacks) of the 60 normal controls fulfilled one or more of the three sets of echocardiographic criteria for LVNC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10427926\">",
"    <span class=\"h3\">",
"     Overreporting",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been occasional reports that LVNC has been overdiagnosed especially in athletes or people of African descent. The diagnostic criteria must be carefully applied and may differ in Caucasians and African blacks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/46\">",
"     46",
"    </a>",
"    ]. This underscores the point that hypertrabeculation per se should not be taken as the sole diagnostic criterion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Other echocardiographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other nonspecific findings that can be seen on echocardiography include reduced global left ventricular systolic function, diastolic dysfunction, left ventricular thrombi, and abnormal papillary muscle structure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There was no correlation between the number of noncompacted segments in the left ventricular systolic dysfunction in a recent multicenter study involving 238 patients from an Italian registry [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tissue Doppler imaging has been used to assess patients with LVNC: tissue Doppler velocities were significantly decreased in children with LVNC and may predict an adverse outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/48\">",
"     48",
"    </a>",
"    ]. The diagnostic benefit of strain and strain rate imaging and speckle tracking in LVNC has yet to be determined.",
"   </p>",
"   <p>",
"    It is important to realize that the echocardiographic image of isolated LVNC can be very heterogenous including dilated forms, hypertrophic variant and restrictive types [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Cardiovascular magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;LVNC is characterized by a noncompacted myocardial layer in the left ventricle, a finding that can be imaged by cardiovascular magnetic resonance imaging (CMR). Trabeculations and recesses appear differently on CMR compared to echocardiography and computed tomography. CMR offers good spatial resolution of the left ventricular apex and lateral wall.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     CMR criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Case series suggest that optimum criteria for diagnosis of LVNC by CMRI differ slightly from the above-described echocardiographic criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/50-52\">",
"     50-52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One report compared CMR features in seven patients with LVNC (in whom the diagnosis was supported by other features) with CMR results in 170 healthy volunteers, athletes, or patients with dilated or hypertrophic cardiomyopathy, hypertensive heart disease, or aortic stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/50\">",
"     50",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Regions of apparent \"noncompaction\" (two-layered appearance of trabeculated and compacted myocardium) were common in patients with LVNC, as well as in the other groups with and without cardiovascular disease. The two-layered appearance was most common in the apical, anterior, and lateral segments in all groups.",
"     </li>",
"     <li>",
"      The best distinguishing feature for LVNC was a maximum ratio in diastole of noncompacted to compacted myocardial thickness of &gt;2.3 as assessed in three long-axis views (sensitivity 86 percent and specificity 99 percent). Similar findings were noted in another report of eight LVNC patients, in which a ratio in diastole of noncompacted to compacted myocardium of &gt;2.5 (in short-axis and four-chamber views) was identified as a criterion for LVNC [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    CMR imaging was compared with echocardiography in 16 patients with LVNC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/53\">",
"     53",
"    </a>",
"    ]. There was no difference between CMR and echocardiography at end diastole. Echocardiography at end systole underestimated the ratio of",
"    <span class=\"nowrap\">",
"     noncompaction/compaction",
"    </span>",
"    compared to CMR. Therefore, CMR appears to be superior to standard echocardiography in assessing the extent of noncompaction.",
"   </p>",
"   <p>",
"    The St&ouml;llberger echocardiographic criteria for LVNC appear to be insensitive when applied to CMR [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Specificity of criteria'",
"    </a>",
"    above.) In a series of 19 LVNC patients diagnosed by echocardiography using the St&ouml;llberger criteria, only nine met these criteria on CMR (obtained in short- and long-axis views). However, the overall CMR morphologic appearance in all cases confirmed the diagnosis of LVNC.",
"   </p>",
"   <p>",
"    Late gadolinium enhancement (LGE, also known as delayed hyperenhancement) of trabeculae has also been observed in LVNC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/54\">",
"     54",
"    </a>",
"    ]. General use of LGE is discussed, and use and risks of gadolinium contrast is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34874?source=see_link\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Findings at autopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;At autopsy, a variety of gross patterns of noncompaction have been noted, including anastomosing broad trabeculae, coarse trabeculae resembling multiple papillary muscles, and sponge-like, interlacing, smaller muscle bundles. Perhaps the absence of well-formed papillary muscles is the best clue to the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/55\">",
"     55",
"    </a>",
"    ]. The histologic findings are nonspecific, and interstitial fibrosis can be found adjacent to normal myocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Published series have found that LVNC is associated with high rates of morbidity and mortality in adults. Patients with or without atrial fibrillation are at high risk for arterial thromboembolism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This was illustrated in the study of 34 patients (mean age 42) described above [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/21\">",
"     21",
"    </a>",
"    ]. The following findings were noted at 44-month follow-up:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      53 percent had heart failure requiring hospitalization",
"     </li>",
"     <li>",
"      41 percent had ventricular tachyarrhythmias, with 12 percent receiving an implantable cardioverter-defibrillator (ICD)",
"     </li>",
"     <li>",
"      24 percent had a thromboembolic event",
"     </li>",
"     <li>",
"      35 percent died, including six sudden deaths",
"     </li>",
"     <li>",
"      12 percent underwent heart transplantation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The probability of survival free of death or heart transplantation at five years was 58 percent. Other studies have also noted that atrial and ventricular arrhythmias are common causes of morbidity and mortality in patients with LVNC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, these study populations represent a group of severely affected patients with a poor prognosis. With the increasing awareness of LVNC, more subtle forms in minimally symptomatic patients or severe forms in asymptomatic patients will be detected, which may change the prognosis. This hypothesis is supported by the following reports:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a series of 45 adults (mean age 37) seen at a referral center for cardiomyopathy, mean survival without death or transplantation was 97 percent at almost four years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/26\">",
"       26",
"      </a>",
"      ]. Two patients had three thromboembolic events.",
"     </li>",
"     <li>",
"      In a series of 65 patients identified at two referral centers, prognosis differed according to the presence or absence of symptoms at presentation . Among 48 patients who presented with symptoms, 15 (31 percent) experienced cardiovascular death or transplantation during a median follow-up of 46 months. However, there were no deaths or cardiac transplantations among the 17 patients who were asymptomatic at diagnosis (most referred based upon a family member with LVNC).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The short-term prognosis may also be better in children, who present in the neonatal period. This was illustrated in a series of 36 children with LVNC (median age 90 days, range 1 day to 17 years at diagnosis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/29\">",
"     29",
"    </a>",
"    ]. The mortality rate at three years was 14 percent. Some children who presented in the neonatal period had a transient recovery of function followed by later deterioration at 3 to 12 years that can lead to presentation in adulthood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data on treatment of LVNC are limited, and there is no specific therapy for LVNC. Medical management varies with the clinical manifestations, left ventricular ejection fraction (LVEF), the presence or absence of arrhythmias, and perceived risk of thromboembolism.",
"   </p>",
"   <p>",
"    For patients with LVNC with reduced LVEF, heart failure and asymptomatic systolic dysfunction should be treated according to standard guidelines. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/63/38906?source=see_link\">",
"     \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/59/28601?source=see_link\">",
"     \"Evaluation and management of asymptomatic left ventricular systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with LVNC with or without atrial fibrillation are at high risk for thromboembolism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/56\">",
"     56",
"    </a>",
"    ]. However, the impact of risk factors such as CHADS2 score (",
"    <a class=\"graphic graphic_table graphicRef61615 \" href=\"mobipreview.htm?39/45/40668\">",
"     table 2",
"    </a>",
"    ) and therapy to prevent thromboemboli in this population has not been directly assessed. Patients with LVNC and atrial fibrillation who meet standard criteria for anticoagulation should be anticoagulated according to standard guidelines. In addition, given the high thromboembolic risk in LVNC patients, we recommend chronic",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy in patients with LVNC and atrial fibrillation who do not otherwise have an indication for anticoagulation. We also recommend anticoagulation with warfarin in patients with LVNC without atrial fibrillation with LVEF &lt;40 percent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Since patients with LVNC are at risk for atrial and ventricular arrhythmias, we suggest annual Holter monitoring to detect asymptomatic arrhythmias.",
"   </p>",
"   <p>",
"    Patients with LVNC should be counseled to refrain from competitive endurance sports or weight lifting similar to patients with hypertrophic cardiomyopathy.",
"   </p>",
"   <p>",
"    Patients with LVNC should receive ICD therapy according to standard indications for ICD therapy in patients with nonischemic cardiomyopathy. Patients with history of sustained ventricular tachycardia or sudden cardiac arrest (SCA) should receive an implantable cardioverter-defibrillator (ICD) therapy for secondary prevention of SCA. ICD implantation for primary prevention is indicated in patients with LVNC with an LVEF &le;35 percent and NYHA class II to III HF. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/55/19322?source=see_link\">",
"     \"Secondary and primary prevention of sudden cardiac death in heart failure and cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, since patients with LVNC are at high risk for SCA, broader use of ICD therapy may be beneficial, although data are lacking. We suggest the following criteria for implantable cardioverter-defibrillator (ICD) therapy for primary prevention: syncope, non-sustained ventricular tachycardia, severe left ventricular dysfunction (LVEF &le;35 percent) OR family history of SCA. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/3/22586?source=see_link\">",
"     \"Ventricular arrhythmias and sudden cardiac arrest in hypertrophic cardiomyopathy\"",
"    </a>",
"    .) There have been several reports of unsuccessful defibrillation by an ICD in LVNC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/57,58\">",
"     57,58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Successful cardiac transplantation in patients with end-stage heart failure with LVNC has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41784/abstract/21,59\">",
"     21,59",
"    </a>",
"    ]. Patients with LVNC who have end-stage heart failure are candidates for cardiac transplantation evaluation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/31/34297?source=see_link\">",
"     \"Indications and contraindications for cardiac transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Isolated left ventricular noncompaction (LVNC) is a sporadic or familial cardiomyopathy characterized by prominent trabeculae and deep intertrabecular recesses. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Definition'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Genetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical manifestations and prognosis of LVNC are variable. Clinical manifestations include heart failure, chest pain, thromboembolic events, and atrial and ventricular arrhythmias, including risk of sudden cardiac arrest (SCA). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical manifestations'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Various echocardiographic criteria for diagnosis of LVNC have been proposed. The Jenni criteria include the presence of a maximum ratio of noncompacted to compacted myocardium &gt;2:1 at end-systole in the parasternal short-axis view. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Echocardiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with LVNC with reduced LVEF and HF, we use standard medical therapy for HF due to systolic dysfunction. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with LVNC with reduced LVEF without HF, we use standard medical therapy for asymptomatic systolic dysfunction.",
"     </li>",
"     <li>",
"      Patients with LVNC and atrial fibrillation who meet standard criteria for anticoagulation should be anticoagulated according to standard guidelines. In addition, given the high thromboembolic risk in LVNC patients, we recommend chronic",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      therapy in patients with LVNC and atrial fibrillation who do not otherwise have an indication for anticoagulation (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      We recommend anticoagulation with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      in patients with LVNC without atrial fibrillation with LVEF &lt;40 percent (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For all patients with LVNC, we suggest annual Holter monitoring to detect asymptomatic arrhythmias.",
"     </li>",
"     <li>",
"      Patients with LVNC should receive ICD therapy according to standard indications for secondary and primary prevention of SCA.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Patients with LVNC who survive an episode of sustained ventricular tachycardia or SCA should receive implantable cardioverter-defibrillator (ICD) therapy for secondary prevention of SCA.",
"     </li>",
"     <li>",
"      Patients with LVNC with an LVEF &le;35 percent and NYHA class II to III HF should receive ICD therapy for primary prevention of SCA.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Until further data are available, we suggest implantable cardioverter-defibrillator (ICD) therapy for primary prevention of SCD if one or more of the following features are present: syncope, non-sustained ventricular tachycardia, severe left ventricular dysfunction (LVEF &le;35 percent) OR family history of SCA. (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Patients with LVNC who have end-stage heart failure are candidates for cardiac transplantation evaluation.",
"     </li>",
"     <li>",
"      Patients with LVNC should be counseled to refrain from competitive endurance sports or weight lifting similar to patients with hypertrophic cardiomyopathy.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/1\">",
"      Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113:1807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/2\">",
"      Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008; 29:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/3\">",
"      Wald, R, Benson, L. Reply. Am J Cardiol 2005; 96:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/4\">",
"      Ritter M, Oechslin E, S&uuml;tsch G, et al. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc 1997; 72:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/5\">",
"      Weiford BC, Subbarao VD, Mulhern KM. Noncompaction of the ventricular myocardium. Circulation 2004; 109:2965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/6\">",
"      LAUER RM, FINK HP, PETRY EL, et al. ANGIOGRAPHIC DEMONSTRATION OF INTRAMYOCARDIAL SINUSOIDS IN PULMONARY-VALVE ATRESIA WITH INTACT VENTRICULAR SEPTUM AND HYPOPLASTIC RIGHT VENTRICLE. N Engl J Med 1964; 271:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/7\">",
"      Ali SK. Unique features of non-compaction of the ventricular myocardium in Arab and African patients. Cardiovasc J Afr 2008; 19:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/8\">",
"      Attenhofer Jost CH, Connolly HM, O'Leary PW, et al. Left heart lesions in patients with Ebstein anomaly. Mayo Clin Proc 2005; 80:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/9\">",
"      Friedberg MK, Ursell PC, Silverman NH. Isomerism of the left atrial appendage associated with ventricular noncompaction. Am J Cardiol 2005; 96:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/10\">",
"      Lilje C, R&aacute;zek V, Joyce JJ, et al. Complications of non-compaction of the left ventricular myocardium in a paediatric population: a prospective study. Eur Heart J 2006; 27:1855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/11\">",
"      Tsai SF, Ebenroth ES, Hurwitz RA, et al. Is left ventricular noncompaction in children truly an isolated lesion? Pediatr Cardiol 2009; 30:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/12\">",
"      St&ouml;llberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 2002; 90:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/13\">",
"      Zaragoza MV, Arbustini E, Narula J. Noncompaction of the left ventricle: primary cardiomyopathy with an elusive genetic etiology. Curr Opin Pediatr 2007; 19:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/14\">",
"      Ichida F, Tsubata S, Bowles KR, et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 2001; 103:1256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/15\">",
"      Rapezzi C, Leone O, Ferlito M, et al. Isolated ventricular non-compaction with restrictive cardiomyopathy. Eur Heart J 2006; 27:1927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/16\">",
"      Biagini E, Ragni L, Ferlito M, et al. Different types of cardiomyopathy associated with isolated ventricular noncompaction. Am J Cardiol 2006; 98:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/17\">",
"      Monserrat L, Hermida-Prieto M, Fernandez X, et al. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J 2007; 28:1953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/18\">",
"      Johnson MT, Zhang S, Gilkeson R, et al. Intrafamilial variability of noncompaction of the ventricular myocardium. Am Heart J 2006; 151:1012.e7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/19\">",
"      Henderson DJ, Anderson RH. The development and structure of the ventricles in the human heart. Pediatr Cardiol 2009; 30:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/20\">",
"      Chen H, Zhang W, Li D, et al. Analysis of ventricular hypertrabeculation and noncompaction using genetically engineered mouse models. Pediatr Cardiol 2009; 30:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/21\">",
"      Oechslin EN, Attenhofer Jost CH, Rojas JR, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000; 36:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/22\">",
"      Kovacevic-Preradovic T, Jenni R, Oechslin EN, et al. Isolated left ventricular noncompaction as a cause for heart failure and heart transplantation: a single center experience. Cardiology 2009; 112:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/23\">",
"      Patrianakos AP, Parthenakis FI, Nyktari EG, Vardas PE. Noncompaction myocardium imaging with multiple echocardiographic modalities. Echocardiography 2008; 25:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/24\">",
"      Kohli SK, Pantazis AA, Shah JS, et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J 2008; 29:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/25\">",
"      Pfammatter JP, Paul T, Flik J, et al. [Q-fever associated myocarditis in a 14-year-old boy]. Z Kardiol 1995; 84:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/26\">",
"      Murphy RT, Thaman R, Blanes JG, et al. Natural history and familial characteristics of isolated left ventricular non-compaction. Eur Heart J 2005; 26:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/27\">",
"      Kelley-Hedgepeth A, Towbin JA, Maron MS. Images in cardiovascular medicine. Overlapping phenotypes: left ventricular noncompaction and hypertrophic cardiomyopathy. Circulation 2009; 119:e588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/28\">",
"      Monserrat L, Barriales-Villa R, Hermida-Prieto M. Apical hypertrophic cardiomyopathy and left ventricular non-compaction: two faces of the same disease. Heart 2008; 94:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/29\">",
"      Pignatelli RH, McMahon CJ, Dreyer WJ, et al. Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 2003; 108:2672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/30\">",
"      Bleyl SB, Mumford BR, Thompson V, et al. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 1997; 61:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/31\">",
"      Xing Y, Ichida F, Matsuoka T, et al. Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity. Mol Genet Metab 2006; 88:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/32\">",
"      Spencer CT, Bryant RM, Day J, et al. Cardiac and clinical phenotype in Barth syndrome. Pediatrics 2006; 118:e337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/33\">",
"      Klaassen S, Probst S, Oechslin E, et al. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation 2008; 117:2893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/34\">",
"      Hoedemaekers YM, Caliskan K, Majoor-Krakauer D, et al. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J 2007; 28:2732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/35\">",
"      Hermida-Prieto M, Monserrat L, Castro-Beiras A, et al. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. Am J Cardiol 2004; 94:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/36\">",
"      Vatta M, Mohapatra B, Jimenez S, et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 2003; 42:2014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/37\">",
"      Chang B, Nishizawa T, Furutani M, et al. Identification of a novel TPM1 mutation in a family with left ventricular noncompaction and sudden death. Mol Genet Metab 2011; 102:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/38\">",
"      Sasse-Klaassen S, Probst S, Gerull B, et al. Novel gene locus for autosomal dominant left ventricular noncompaction maps to chromosome 11p15. Circulation 2004; 109:2720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/39\">",
"      Duru F, Candinas R. Noncompaction of ventricular myocardium and arrhythmias. J Cardiovasc Electrophysiol 2000; 11:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/40\">",
"      Salerno JC, Chun TU, Rutledge JC. Sinus bradycardia, Wolff Parkinson White, and left ventricular noncompaction: an embryologic connection? Pediatr Cardiol 2008; 29:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/41\">",
"      Lofiego C, Biagini E, Pasquale F, et al. Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart 2007; 93:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/42\">",
"      Menon SC, O'Leary PW, Wright GB, et al. Fetal and neonatal presentation of noncompacted ventricular myocardium: expanding the clinical spectrum. J Am Soc Echocardiogr 2007; 20:1344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/43\">",
"      Jenni R, Oechslin E, Schneider J, et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 2001; 86:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/44\">",
"      Frischknecht BS, Attenhofer Jost CH, Oechslin EN, et al. Validation of noncompaction criteria in dilated cardiomyopathy, and valvular and hypertensive heart disease. J Am Soc Echocardiogr 2005; 18:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/45\">",
"      Chin TK, Perloff JK, Williams RG, et al. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation 1990; 82:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/46\">",
"      St&ouml;llberger C, Finsterer J. A diagnostic dilemma in non-compaction, resulting in near expulsion from the Football World Cup. Eur J Echocardiogr 2011; 12:E8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/47\">",
"      Fazio G, Corrado G, Novo G, et al. Ventricular dysfunction and number of non compacted segments in non compaction: non-independent predictors. Int J Cardiol 2010; 141:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/48\">",
"      McMahon CJ, Pignatelli RH, Nagueh SF, et al. Left ventricular non-compaction cardiomyopathy in children: characterisation of clinical status using tissue Doppler-derived indices of left ventricular diastolic relaxation. Heart 2007; 93:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/49\">",
"      Towbin JA. Left ventricular noncompaction: a new form of heart failure. Heart Fail Clin 2010; 6:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/50\">",
"      Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005; 46:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/51\">",
"      Fazio G, Novo G, D'Angelo L, et al. Magnetic resonance in isolated noncompaction of the ventricular myocardium. Int J Cardiol 2010; 140:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/52\">",
"      St&ouml;llberger C, Kopsa W, Tscherney R, Finsterer J. Diagnosing left ventricular noncompaction by echocardiography and cardiac magnetic resonance imaging and its dependency on neuromuscular disorders. Clin Cardiol 2008; 31:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/53\">",
"      Thuny F, Jacquier A, Jop B, et al. Assessment of left ventricular non-compaction in adults: side-by-side comparison of cardiac magnetic resonance imaging with echocardiography. Arch Cardiovasc Dis 2010; 103:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/54\">",
"      Dodd JD, Holmvang G, Hoffmann U, et al. Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity. AJR Am J Roentgenol 2007; 189:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/55\">",
"      Burke A, Mont E, Kutys R, Virmani R. Left ventricular noncompaction: a pathological study of 14 cases. Hum Pathol 2005; 36:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/56\">",
"      Pitta S, Thatai D, Afonso L. Thromboembolic complications of left ventricular noncompaction: case report and brief review of the literature. J Clin Ultrasound 2007; 35:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/57\">",
"      Pastore G, Zanon F, Baracca E, et al. Failure of transvenous ICD to terminate ventricular fibrillation in a patient with left ventricular noncompaction and polycystic kidneys. Pacing Clin Electrophysiol 2012; 35:e40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/58\">",
"      Maile S, Kunz M, Oechslin E, et al. Intractable ventricular tachycardia and bridging to heart transplantation with a non-pulsatile flow assist device in a patient with isolated left-ventricular non-compaction. J Heart Lung Transplant 2004; 23:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41784/abstract/59\">",
"      Stamou SC, Lefrak EA, Athari FC, et al. Heart transplantation in a patient with isolated noncompaction of the left ventricular myocardium. Ann Thorac Surg 2004; 77:1806.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4924 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-221.179.173.170-82E6EA8F2F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41784=[""].join("\n");
var outline_f40_51_41784=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      GENETICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Identified genes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Tafazzin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Alpha-dystrobrevin (DTNA)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Sarcomeric protein genes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Additional loci",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Genetic evaluation and family screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Specificity of criteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10427926\">",
"      - Overreporting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Other echocardiographic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Cardiovascular magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - CMR criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Findings at autopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/4924\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4924|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?41/59/42929\" title=\"diagnostic image 1\">",
"      LV noncompaction short axis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4924|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/31/40435\" title=\"picture 1\">",
"      LV noncompaction autopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4924|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/2/3117\" title=\"table 1\">",
"      Methods to assess cardiovascular disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/45/40668\" title=\"table 2\">",
"      CHADS2 score and thromboembolic risk with and without warfarin",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=related_link\">",
"      Antithrombotic therapy to prevent embolization in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34874?source=related_link\">",
"      Clinical utility of cardiovascular magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/59/28601?source=related_link\">",
"      Evaluation and management of asymptomatic left ventricular systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/28/39369?source=related_link\">",
"      Evaluation of the patient with heart failure or cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/31/34297?source=related_link\">",
"      Indications and contraindications for cardiac transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/20/1351?source=related_link\">",
"      Inherited syndromes associated with cardiac disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/63/38906?source=related_link\">",
"      Overview of the therapy of heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/55/19322?source=related_link\">",
"      Secondary and primary prevention of sudden cardiac death in heart failure and cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/3/22586?source=related_link\">",
"      Ventricular arrhythmias and sudden cardiac arrest in hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_51_41785="Management of bladder dysfunction in children";
var content_f40_51_41785=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of bladder dysfunction in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/51/41785/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41785/contributors\">",
"     Kenneth G Nepple, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41785/contributors\">",
"     Christopher S Cooper, MD, FACS, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/51/41785/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41785/contributors\">",
"     Laurence S Baskin, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/51/41785/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/51/41785/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/51/41785/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder dysfunction, also referred to as voiding dysfunction, is a general term to describe abnormalities in either the filling",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    emptying of the bladder. It is a common problem in children and constitutes up to 40 percent of pediatric urology clinic visits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/1\">",
"     1",
"    </a>",
"    ]. In some children, bladder dysfunction is a component of bowel and bladder dysfunction, previously been referred to as dysfunction elimination, which involves abnormalities in both bladder and bowel emptying.",
"   </p>",
"   <p>",
"    Daytime urinary incontinence, a common feature of bladder dysfunction, can cause major stress in school-age children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/2,3\">",
"     2,3",
"    </a>",
"    ], and negatively impact upon a child's self-esteem [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/4\">",
"     4",
"    </a>",
"    ]. Thus, it is desirable to identify and treat these children as early as possible.",
"   </p>",
"   <p>",
"    The management of bladder dysfunction in children will be reviewed here. The etiology, clinical features, evaluation, and diagnosis of bladder dysfunction and management of nocturnal enuresis in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28793?source=see_link\">",
"     \"Etiology and clinical features of bladder dysfunction in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/50/25384?source=see_link\">",
"     \"Evaluation and diagnosis of bladder dysfunction in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/0/7178?source=see_link\">",
"     \"Management of nocturnal enuresis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of a child with bladder dysfunction is primarily directed at improving symptoms and avoiding renal damage. Therapeutic considerations include the underlying cause of bladder dysfunction, the age of the patient, symptom duration and severity, the motivation and attention span of the patient and family, and the presence of potential risk factors for renal injury such as recurrent urinary tract infections or vesicoureteral reflux. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28793?source=see_link&amp;anchor=H9#H9\">",
"     \"Etiology and clinical features of bladder dysfunction in children\", section on 'Dysfunctional voiding'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Data on effective treatment of bladder dysfunction in children are limited because of the following flaws in study design:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most studies are observational in nature without a control group. This is an important consideration because many studies use a reduction in the frequency of daytime wetting as the major outcome measure but do not take into account that the spontaneous resolution rate of daytime incontinence is estimated to be 14 percent per year [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      There are often confounding factors that make it difficult to determine which intervention, if any, was effective. As an example, a retrospective study that reported anticholinergic therapy was effective in reducing daytime incontinence failed to account for the effect of biofeedback therapy as a confounding variable [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/6\">",
"       6",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Oxybutynin'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      The study population has often not been well defined; as a result, it is difficult to compare the results of different studies. In 2006, the International Children's Continence Society (ICCS), a global multidisciplinary organization of clinicians involved in the care of children with lower urinary tract dysfunction, developed standardized definitions of bladder dysfunction to address this issue. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28793?source=see_link&amp;anchor=H5#H5\">",
"       \"Etiology and clinical features of bladder dysfunction in children\", section on 'Definition of bladder dysfunction disorders'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There is a lack of consensus among experts on the definition of successful treatment for bladder dysfunction. The ICCS has defined treatment outcomes for research purposes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/3\">",
"       3",
"      </a>",
"      ]. This stratified set of definitions has also been used clinically and is based upon reducing the rate of symptoms as follows:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Nonresponse: 0 to 49 percent decrease in symptoms",
"     </li>",
"     <li>",
"      Partial response: 50 to 89 percent decrease in symptoms",
"     </li>",
"     <li>",
"      Response: 90 to 99 percent decrease in symptoms",
"     </li>",
"     <li>",
"      Full response: 100 percent decrease or less than one symptom occurrence monthly",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Our approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our practice, we use a stepped strategy moving from the least to most invasive therapy in the management of children with bladder dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/7\">",
"     7",
"    </a>",
"    ]. Conservative measures, such as voiding behavior modification and treatment of constipation (if present), should be tried before the use of medications or invasive interventions.",
"   </p>",
"   <p>",
"    If conservative therapy fails to significantly improve the symptoms of bladder dysfunction, directed therapy toward the underlying cause of bladder dysfunction is used. These interventions include pharmacologic agents, pelvic floor relaxation techniques, biofeedback, or intermittent clean catheterization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CONSERVATIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conservative management is generally the initial approach to treating children with bladder dysfunction. It primarily involves voiding behavior modification including timed voiding schedules, and treatment of constipation, if present.",
"   </p>",
"   <p>",
"    Although no controlled trials have been conducted to study the effectiveness of this approach, retrospective studies have suggested reduction in symptoms in approximately 40 to 70 percent of patients treated conservatively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/4,7-9\">",
"     4,7-9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This was illustrated in a retrospective study from a single center of 63 children with daytime incontinence who were initially treated with voiding behavior modification that included a timed voiding regimen and treatment for constipation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/4\">",
"     4",
"    </a>",
"    ]. At a mean follow-up of 8.2&plusmn;3.2 weeks, the following results were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Four patients were dry (6 percent).",
"     </li>",
"     <li>",
"      Partial response with greater than 50 percent reduction of incontinent episodes in 38 percent.",
"     </li>",
"     <li>",
"      Slight response with 10 to 49 percent reduction of incontinent episodes in 37 percent.",
"     </li>",
"     <li>",
"      No change in symptoms in 19 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In another retrospective study of conservative therapy (ie, timed voiding, modification of fluid intake, and pelvic floor muscle exercises), symptom improvement was seen in 48 of 74 children including improved daytime urinary control, reduction in episodes of frequency and urgency, and a decrease in the rate of urinary tract infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Voiding behavior modification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of voiding behavior modification is to return the child to normal voiding habits. It encompasses the following components [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Provide information about normal voiding habits to the family and, if age appropriate, the child.",
"     </li>",
"     <li>",
"      Review the child's voiding habits, identify habits that deviate from the normal voiding process, and clearly describe to the family the way in which their child's voiding differs from the normal process.",
"     </li>",
"     <li>",
"      Set an individualized voiding regimen to establish regular voiding habits. This most often entails a timed voiding schedule with frequent voids scheduled every two to three hours during the day. Wristwatch alarms can assist the older child in remembering to comply with the timed schedule (timer watch) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/10\">",
"       10",
"      </a>",
"      ]. Establishment of a fixed timed schedule is particularly important in a child with attention-deficit disorder. In some cases, working with the school system to create an environment conducive to frequent voiding can be helpful.",
"     </li>",
"     <li>",
"      Review the proper posture during voiding and the need to avoid holding maneuvers, such as forcefully crossing the legs, or squatting with a hand or heel pressed into the perineum (Vincent's curtsy) (",
"      <a class=\"graphic graphic_picture graphicRef75506 \" href=\"mobipreview.htm?10/12/10440\">",
"       picture 1",
"      </a>",
"      ). They are encouraged to urinate before they have a sense of urgency, to empty their bladders completely, and to avoid abdominal straining.",
"     </li>",
"     <li>",
"      Document the voiding process in a diary after implementation of voiding behavior modification. This voiding diary should include the time and volume of each void, the time of each incontinent episode, fluid intake, the time of each bowel movement, and any episode of fecal soiling. Voiding diaries across the country vary in length (number of days) and are used both as a diagnostic tool and as a therapeutic tool. When the reliability of 24, 48, and 72 hour voiding diaries were evaluated, the 24 hour diary was reliable for recording the number of incontinent episodes but only marginally reliable for total voiding episodes; the 48 hour diary was reliable for both, and the 72 hour diary was the most reliable for both (37). Therefore, a one week diary (which is common practice at some centers) is not only time consuming and difficult to obtain with children in school, but likely not necessary.",
"     </li>",
"     <li>",
"      Establish a reward system to improve the child's compliance and self-esteem [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/4\">",
"       4",
"      </a>",
"      ]. The system should focus on rewarding the child for following the recommended program and not for \"being dry,\" as their incontinence is not something they can control.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Compliance with voiding behavior modification, especially timed voiding, can be labor intensive and requires a high degree of motivation from both the child and parents. It is more successful in older children between the ages of 9 and 12 years who are more motivated because of social pressures and respond better to instruction compared to those eight years of age and younger [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Treatment of constipation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anorectal and lower urinary tract function are interrelated. As a result, constipation is often associated with bladder dysfunction, with a reported frequency of constipation that ranges from 30 to 88 percent of children with bladder dysfunction. This relationship between abnormal bowel and bladder function is referred to as the dysfunctional elimination syndrome (DES) and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28793?source=see_link&amp;anchor=H17#H17\">",
"     \"Etiology and clinical features of bladder dysfunction in children\", section on 'Constipation and dysfunctional elimination syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with DES, it is proposed that stool evacuation from the rectal vault relieves abnormal pressure of the overactive bladder. The importance of treating constipation is supported by the findings in a large retrospective study of 234 children with chronic constipation, 29 percent of whom had daytime urinary incontinence and 34 percent of whom had nighttime urinary incontinence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/12\">",
"     12",
"    </a>",
"    ]. Resolution of constipation by disimpaction and maintenance therapy was associated with elimination of wetting in 89 and 63 percent of children with daytime or nighttime urinary incontinence, respectively.",
"   </p>",
"   <p>",
"    Laxative use appears to be beneficial in children with DES [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. In one observational study of 46 patients with DES and daytime urinary incontinence, polyethylene glycol without electrolytes (Miralax&reg;) resulted in an overall increase in frequency of bowel movements and improved urinary continence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/13\">",
"     13",
"    </a>",
"    ]. Daytime urinary dryness was reported in 18 patients, a decrease in daytime urinary incontinence in 26, and there was no change in urinary symptoms in only two children. Laxative therapy was also associated with an increase in voided urine volumes and a decrease in postvoid residual volumes.",
"   </p>",
"   <p>",
"    The treatment of constipation including laxative therapy is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/28/36298?source=see_link\">",
"     \"Treatment of chronic functional constipation and fecal incontinence in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other conservative measures used to treat children with bladder dysfunction include dietary modification and avoidance of urethritis and, in girls, vaginitis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dietary modification includes the elimination of dietary products that increase bladder activity, such as caffeine, orange juice, tomato products, and spicy foods [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/15\">",
"       15",
"      </a>",
"      ]. In addition, other dietary products may reduce the risk of urinary tract infections, which are associated with bladder dysfunction. These include cranberry juice and active yogurt cultures, which have a probiotic effect.",
"     </li>",
"     <li>",
"      Patients should be counseled to avoid bubble baths or cleaning the perineal areas with soap, which can result in (or worsen already existing) urethritis or in girls, vaginitis. Poor perineal hygiene increases the possibility of perineal and genital irritation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/15\">",
"       15",
"      </a>",
"      ]. Discomfort from these disorders during urination may contribute to voiding postponement with low voiding frequency and long time intervals between voids resulting in overdistension of the bladder. With continued bladder overdistension, the detrusor muscle becomes overstretched and hypoactive, leading to a weak or absent contraction referred to as an underactive bladder. &nbsp;(See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28793?source=see_link&amp;anchor=H8#H8\">",
"       \"Etiology and clinical features of bladder dysfunction in children\", section on 'Voiding postponement and underactive bladder'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Vaginal voiding (reflux of urine into the vaginal vault during urination) can also lead to vaginitis. Girls suspected of having vaginal voiding should be instructed to sit for an additional one or two minutes after emptying their bladders to allow the drainage of urine that has refluxed into the vaginal vault to occur. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28793?source=see_link&amp;anchor=H8#H8\">",
"     \"Etiology and clinical features of bladder dysfunction in children\", section on 'Voiding postponement and underactive bladder'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIRECTED THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;If conservative management fails to relieve the symptoms of bladder dysfunction, the underlying cause of bladder dysfunction should be identified, followed by appropriate therapy.",
"   </p>",
"   <p>",
"    Evaluation that includes renal and urinary tract imaging, urinary flow measurements,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    urodynamic studies differentiate among neurologic, anatomic, and functional causes of bladder dysfunction in children. The management of neurologic and anatomic lesions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/59/15288?source=see_link\">",
"     \"Urinary tract complications of myelomeningocele (spina bifida)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/48/37642?source=see_link\">",
"     \"Chronic complications of spinal cord injury\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/60/22472?source=see_link\">",
"     \"Overview of congenital anomalies of the kidney and urinary tract (CAKUT)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The interventions used in treating functional causes of bladder dysfunction include the following, which are discussed in the sections below:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pharmacologic therapy",
"     </li>",
"     <li>",
"      Pelvic floor relaxation measures",
"     </li>",
"     <li>",
"      Biofeedback",
"     </li>",
"     <li>",
"      Other interventions such as electrical stimulation therapy, botulinum toxin injection, surgery, or clean intermittent catheterization",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Functional causes of bladder dysfunction and their diagnosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28793?source=see_link\">",
"     \"Etiology and clinical features of bladder dysfunction in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/50/25384?source=see_link\">",
"     \"Evaluation and diagnosis of bladder dysfunction in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In our practice, these interventions are used for the most common functional causes of bladder dysfunction as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Overactive bladder &ndash; In children who fail an initial trial of conservative measures (ie, timed voiding schedule",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      treatment for constipation treatment), the next intervention is the addition of an anticholinergic agent, which can often be beneficial.",
"     </li>",
"     <li>",
"      Underactive bladder &ndash; Timed voiding is the primary treatment for underactive bladder. Anticholinergics should be avoided as they can increase incomplete bladder emptying. In some children, clean intermittent catheterization can be beneficial.",
"     </li>",
"     <li>",
"      Non-neurogenic dysfunctional voiding &ndash; Due to the concern over upper tract deterioration from increased pelvic pressure, a child with non-neurogenic dysfunctional voiding (defined as abnormal contraction of the sphincter",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pelvic floor musculature during voiding) is best managed by an urologist. Specialized testing with urodynamics is often required to evaluate the nature of bladder dysfunction and determine the most appropriate treatment regimen, which may consist of pelvic floor relaxation measures, biofeedback, or the administration of an alpha antagonist. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28793?source=see_link&amp;anchor=H9#H9\">",
"       \"Etiology and clinical features of bladder dysfunction in children\", section on 'Dysfunctional voiding'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PHARMACOLOGIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticholinergic agents and alpha-adrenergic receptor antagonists have been used in the treatment of bladder dysfunction in children, primarily in those who have failed conservative therapy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anticholinergic agents &mdash; Anticholinergic agents decrease the frequency of uninhibited detrusor (bladder muscle) contractions during the filling phase of the bladder [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/16\">",
"       16",
"      </a>",
"      ] and increase bladder capacity. They are used to treat children with overactive bladders (OABs)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      small bladder capacity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/17,18\">",
"       17,18",
"      </a>",
"      ]. The proposed mechanism of action involves blocking the muscarinic 3 receptor subtype, which primarily mediates detrusor contraction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/19,20\">",
"       19,20",
"      </a>",
"      ]. The most commonly used anticholinergic agent is oxybutynin.",
"      <br/>",
"      <br/>",
"      Although anticholinergic agents have been used as initial therapy in children with OABs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/4,21\">",
"       4,21",
"      </a>",
"      ], pharmacologic therapy is typically reserved for the patient who has not responded to a trial of conservative therapy.",
"     </li>",
"     <li>",
"      Alpha-adrenergic receptor antagonists &ndash; Alpha-adrenergic receptor antagonists, which act as smooth muscle relaxants at the bladder neck and proximal urethra, have been used in patients with non-neurogenic dysfunctional voiding",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      urinary retention.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13887223\">",
"    <span class=\"h2\">",
"     Anticholinergic agents",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Oxybutynin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most commonly used anticholinergic agent for overactive bladder (OAB) is oxybutynin, particularly the extended-release formulation (Ditropan XL).",
"   </p>",
"   <p>",
"    Although this medication is approved by the United States Food and Drug Administration (FDA) for the treatment of OAB in children, there has only been one small clinical trial published in abstract form that has evaluated oxybutyin's efficacy compared to placebo in reducing childhood daytime urinary incontinence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/22\">",
"     22",
"    </a>",
"    ]. There was no improvement in the frequency of daytime wetting between oxybutynin and placebo (RR 0.74, 95% CI 0.26-2.16) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/23\">",
"     23",
"    </a>",
"    ]. In adult patients, however, there are data that demonstrate oxybutynin compared to placebo reduces urinary incontinence. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=see_link&amp;anchor=H13#H13\">",
"     \"Treatment of urinary incontinence\", section on 'Antimuscarinics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Observational studies have reported that oxybutynin improves the symptoms of children with OAB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/5,6,21,24\">",
"     5,6,21,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of 81 children with daytime incontinence who were treated with oxybutynin for three months or longer, 31 patients were completely dry, 25 were significantly improved (more than 50 percent fewer daytime incontinent episodes), 19 were slightly improved (10 to 50 percent fewer daytime accidents), and 6 were unchanged in their symptoms at a mean follow-up of 1.2 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/6\">",
"       6",
"      </a>",
"      ]. A confounding unaccounted factor in this study was the use of biofeedback therapy in 27 patients.",
"     </li>",
"     <li>",
"      In another study of 144 children with OAB, two-thirds of the patients failed to improve with conservative management and were treated with anticholinergic medication [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/24\">",
"       24",
"      </a>",
"      ]. At a mean follow-up of 3.2 years, 68 of the 144 children (47 percent) had no OAB symptoms, and 61 (42 percent) had significant improvement.",
"     </li>",
"     <li>",
"      A third study of 30 children with OAB who failed to respond to timed voiding and limited fluid intake, demonstrated routine use of anticholinergic medication resulted in complete resolution of symptoms in 21 patients and significant improvement in 5, at a mean follow-up of 2.7 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/21\">",
"       21",
"      </a>",
"      ]. Almost 40 percent of patients who achieved complete resolution or significant improvement were dependent upon medication to retain continence at the time of last follow-up.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The extended-release formulation of oxybutynin (Ditropan XL) is administered once a day, while oxybutynin requires dosing three times per day. of 27 children with persistent incontinence while receiving oxybutynin, 13 patients became dry or had significant decrease in daytime incontinence at the first clinic visit after changing to the extended-release formulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/25\">",
"     25",
"    </a>",
"    ]. Increases in voided bladder volume and total bladder capacity were also noted after the medication change. The improved outcome may be explained with improved compliance due to once a day dosing. As a result, the preferred oxybutynin preparation to treat children with OAB is the extended-release formulation.",
"   </p>",
"   <p>",
"    We typically use the extended release form of oxybutynin at the 5 mg per day. This form is approved for children five years and older. As bladder dysfunction is generally defined only in children five years or older since daytime urinary continence normally occurs by four years of age. In younger children, the short acting form of oxybutynin is given at a dose of 0.2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose three times a day (or 1 mg per year of age per dose).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h4\">",
"     Side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oxybutynin blocks not only the muscarinic (M) 3 receptor subtypes but also the M1 receptor subtypes. This action accounts for the common adverse effects associated with oxybutynin, which appear to be more frequent in children than adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the previously discussed retrospective study of 81 children, 47 patients (58 percent) experienced no side effects from oxybutynin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/6\">",
"     6",
"    </a>",
"    ]. In the remaining children, the most common side effects and their frequency were as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      New-onset constipation (19 percent)",
"     </li>",
"     <li>",
"      Dry mouth (17 percent)",
"     </li>",
"     <li>",
"      Flushing (14 percent)",
"     </li>",
"     <li>",
"      Heat intolerance (4 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one study based upon voluntarily reported data up until January 2007 from the Food and Drug Administration Adverse Event Reporting System, central nervous system (CNS) side effects associated with oxybutynin were proportionally more common in children than adults (37 pediatric versus 143 cases in adults) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/27\">",
"     27",
"    </a>",
"    ]. The most common CNS complaint included hallucination, followed by agitation, sedation, confusion, amnesia, and nightmares. In most cases, symptoms occurred within one month of treatment with oxybutynin.",
"   </p>",
"   <p>",
"    Despite the presence of adverse effects, most children choose to continue oxybutynin with a reported discontinuation rate of 10 percent or less [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Abnormalities in memory have been reported in elderly adult patients treated with oxybutynin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/29\">",
"     29",
"    </a>",
"    ]. However, similar effects on memory or other cognitive functions appear to be absent or less frequent in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/20,30\">",
"     20,30",
"    </a>",
"    ]. In one study, neuropsychological testing found no associated cognitive impairment in children after four weeks of oxybutynin therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although one observational study reported fewer side effects with the use of the extended-release formulation of oxybutynin (Ditropan XL) compared to oxybutynin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/25\">",
"     25",
"    </a>",
"    ], another study reported similar frequency of side effects between the two different preparations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13887150\">",
"    <span class=\"h4\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because oxybutynin decreases detrusor contractions, its use is contraindicated in patients with underactive bladder (also known as lazy bladder syndrome), interrupted (fractionated) voiding pattern, history of urinary retention, or high postvoid residual volumes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13887075\">",
"    <span class=\"h3\">",
"     Other anticholinergic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tolterodine is a selective competitive muscarinic receptor antagonist that has not been FDA approved for use in children. It has been shown to improve detrusor compliance and bladder capacity in patients with OAB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a placebo-controlled trial of 711 children ranging from 5 to 10 years of age, patients were randomly selected to receive tolterodine (2 mg per day) for 12 weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/34\">",
"     34",
"    </a>",
"    ]. There was no overall difference in the number of incontinent episodes. However, a subset analysis demonstrated a decrease in the frequency of incontinence in children with a weight at or below 35 kg suggesting a possible under-dosage effect in heavier children.",
"   </p>",
"   <p>",
"    A retrospective study of 200 children with OAB reported that tolterodine therapy resulted in complete continence or significantly reduced frequency of incontinent episodes (greater than a 50 percent reduction) in approximately one-half of the patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/35\">",
"     35",
"    </a>",
"    ]. Other smaller observational studies suggest that tolterodine was effective in patients who failed oxybutynin therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/18,36\">",
"     18,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other selective antimuscarinic agents including darifenacin, solifenacin, and trospium, have been developed and approved for use in adults. However these agents have not been studied extensively in the pediatric populations. As a result, these agents cannot be recommended to treat children with OAB.",
"   </p>",
"   <p>",
"    There are few studies that compare different anticholinergic agents. In one retrospective study of 132 children with daytime incontinence and symptoms of OAB, oxybutynin compared to either short or long-acting tolterodine was more effective in controlling daytime urinary incontinence and frequency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13887264\">",
"    <span class=\"h3\">",
"     Our approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our practice, an anticholinergic agent is frequently added when children fail an initial four to eight week trial of conservative measures (ie, timed voiding schedule",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    treatment for constipation). Our agent of choice is the extended release form of oxybutynin started at an oral dose of 5 mg per day. If significant improvement is not noted after four weeks and there are no serious side effects, the dose is increased to 10 mg per day. Any side effect that is present should be tolerable to the patient before increasing the drug dose. In children who cannot yet take pills, oxybutynin elixir is used at a dose of 0.1 to 0.2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose given two or three times a day. Treatment effect should be seen within one week of medication initiation. In children who do respond to oxybutynin, medication is continued for six months, after which a trial off medication is attempted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Alpha adrenergic receptor antagonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alpha adrenergic receptor antagonists relax the smooth muscle at the bladder neck and proximal urethra. They are used in adult patients, especially in men with urinary retention due to benign prostatic hyperplasia.",
"   </p>",
"   <p>",
"    There are limited data on the use of these agents in children. Small studies have demonstrated improvement in children with daytime urinary incontinence and urinary retention.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a trial of 38 children with bladder dysfunction, patients were randomly selected to receive doxazosin or placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/38\">",
"       38",
"      </a>",
"      ]. Although the findings were not statistically significant, there was a trend towards a decrease in urinary incontinence frequency in patients who received doxazosin compared to placebo-treated controls (4 versus 14 incontinent episodes per week from a median baseline of 18 weekly episodes). In addition, patients treated with doxazosin compared to controls had a greater reduction in their bladder dysfunctional symptoms, which was assessed by a dysfunctional voiding symptom parental survey.",
"     </li>",
"     <li>",
"      In a retrospective study of 55 children (mean age 7.9 years) with bladder dysfunction and urinary retention, doxazosin, an alpha adrenergic receptor antagonist, reduced the average postvoid residual volume from 65 mL to 8 mL [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/39\">",
"       39",
"      </a>",
"      ]. There was also a decrease in daytime incontinence in 42 children with the use of this medication.",
"     </li>",
"     <li>",
"      In a retrospective study of 26 children with primary bladder neck dysfunction, treatment with an alpha adrenergic receptor antagonist resulted in improved mean average (5.5 to 12.6 mL per sec) and maximal (10.3 to 19.7 mL per sec) urinary flow rates [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/40\">",
"       40",
"      </a>",
"      ]. In addition, mean postvoid residual volumes decreased from 99 to 9 mL with alpha blocker therapy.",
"     </li>",
"     <li>",
"      In an observational study of 23 children with bladder neck dysfunction, the number of incontinent episodes decreased from 5.6 to 0.8 per day with tamsulosin therapy (selective alpha adrenergic receptor antagonist) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/41\">",
"       41",
"      </a>",
"      ]. In addition, increases in the average and maximum urinary flow rate and a reduction in post-void residual urine and abnormal uroflow patterns were observed during tamsulosin therapy. There was no significant effect on blood pressure (BP) with mean BP before and during tamsulosin therapy of",
"      <span class=\"nowrap\">",
"       98/55",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       110/61",
"      </span>",
"      mmHg, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These data suggest that there may be a role for alpha adrenergic receptor antagonists in children with bladder dysfunction. Because of its mode of action of blocking the alpha receptor resulting in smooth muscle relaxation of the bladder neck and proximal urethra, it would be expected that these agents would be particularly beneficial in children with non-neurogenic dysfunctional voiding and those with primary bladder neck dysfunction. Further trials are needed to determine whether this class of medication is beneficial and safe in children with specific disorders of voiding dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     OTHER TREATMENTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Biofeedback",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biofeedback therapy teaches children how to identify and control the muscle groups involved in voiding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. It can utilize non-invasive urodynamic monitoring, such as uroflow measurement and adhesive pads on the perineum to measure sphincter activity, to measure, record, and provide immediate feedback to the patient about their bladder function. The child observes real-time visual displays of urinary flow and electromyography (EMG) activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. The visual or auditory feedback allows the child to become aware of and gain control over their bladder function by teaching the child to learn how to voluntarily relax or contract their sphincter and pelvic musculature, thus modifying the observed measurements. This is in contrast to pelvic floor relaxation, in which the child learns to relax the pelvic muscle groups involved with voiding without urodynamic monitoring feedback.",
"   </p>",
"   <p>",
"    Biofeedback programs can also be tailored to children by utilizing interactive computer games that are controlled by pelvic floor contraction and relaxation, or urinary flow rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. The child can observe real-time visual displays of urinary flow and electromyography (EMG) activity and modify these measurements by changes in the contraction or relaxation of the sphincter or pelvic floor muscles.",
"   </p>",
"   <p>",
"    In several observational studies in children, biofeedback therapy appears to reduce symptoms associated with bladder dysfunction and decrease postvoid residual volumes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/11,44,46,48-52\">",
"     11,44,46,48-52",
"    </a>",
"    ]. This is illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of 39 children (mean age 11.2 years) with overactive bladders who failed to improve with conservative management and pharmacologic therapy, 23 patients had resolution of their urinary symptoms including incontinence and 4 had improvement of their symptoms with biofeedback therapy. Urodynamic studies performed six months after biofeedback training demonstrated no or decreased bladder overactivity in 10 and 18 patients, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another study of 87 children (mean age 7.8 years) with detrusor-sphincter dyssynergy (ie, non-neurogenic dysfunctional voiding), 47 patients demonstrated normal flow during voiding and a normal postvoid residual volume (defined as less than 20 percent of the voided volume) after biofeedback therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/51\">",
"       51",
"      </a>",
"      ]. In 28 cases, flow studies improved but postvoid residual volume remained elevated.",
"     </li>",
"     <li>",
"      In a third study of 81 patients (mean age 8.2 years) with bladder dysfunction who failed conservative therapy, 22 of 73 patients with urinary incontinence became dry and 36 had a reduction in episodes of wetting after biofeedback therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/44\">",
"       44",
"      </a>",
"      ]. Of the 50 patients with recurrent urinary tract infections (UTIs), 39 did not have a subsequent infection, while 11 continued to have recurrent infections. After biofeedback therapy, mean postvoid residual volumes decreased, and the mean average and maximal urine flow rates improved. In addition, abnormal urine flow patterns decreased from 89 to 31 percent of patients. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/50/25384?source=see_link&amp;anchor=H17#H17\">",
"       \"Evaluation and diagnosis of bladder dysfunction in children\", section on 'Shape of urine flow curve'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Biofeedback therapy may expedite the resolution of vesicoureteral reflux (VUR)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    recurrent UTIs in children with bladder dysfunction. In one study of 25 children with detrusor-sphincter dyssynergy and VUR, the resolution rate for VUR was 55 percent over one year with biofeedback therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/53\">",
"     53",
"    </a>",
"    ]. However, resolution of VUR was only in patients with low-grade reflux. Two studies have reported that with biofeedback recurrent UTIs resolved in 70 to 80 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our practice, biofeedback is reserved for children with bladder and sphincter dyssynergia that is contributing to persistent daytime incontinence despite an adequate trial of conservative therapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pharmacotherapy. It is also used for children with significant post void residuals who have recurrent urinary tract infections and constipation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Electrical stimulation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrical stimulation therapy, also referred to as neuromodulation, involves implantation of noninvasive devices that can stimulate pelvic muscle contractions",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    modulate detrusor activity. It appears to be beneficial in adults with urinary incontinence and urgency. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=see_link&amp;anchor=H30#H30\">",
"     \"Treatment of urinary incontinence\", section on 'Electrical'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although use in children with bladder dysfunction is limited, it is thought that electrical stimulation therapy would benefit patients with overactive bladder by stimulating spinal inhibitory pathways that reduce detrusor (bladder muscle) contractions (",
"    <a class=\"graphic graphic_figure graphicRef65433 \" href=\"mobipreview.htm?10/55/11125\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several small observational studies have suggested that electrical stimulation therapy decreases incontinence and urgency in children with bladder dysfunction who have failed to respond to both conservative management and pharmacologic therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/54-65\">",
"     54-65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These electrical stimulation therapies include noninvasive pelvic muscle stimulation via electrodes in the anus or vagina [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/55,56\">",
"     55,56",
"    </a>",
"    ], sacral nerve stimulation (SNS) via implanted or transcutaneous electrodes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/57,61-63,66,67\">",
"     57,61-63,66,67",
"    </a>",
"    ], or transcutaneous stimulation of the peripheral tibial nerve [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/60,64\">",
"     60,64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In particular, transcutaneous nerve electrical stimulation (TENS) of the sacral root S3, which requires placement of electrodes on the skin over the sacral area, appears to be a promising therapy in children with incontinence and overactive bladder (OAB) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/57-59,62,66\">",
"     57-59,62,66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our practice, neuromodulation is used in a select group of children who have overactive bladder refractory to behavioral and anticholinergic therapy. We use TENS sacral stimulation for 20 minutes twice daily as this is a regimen that appears to be safe and well tolerated in children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Botulinum toxin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Botulinum toxin A is injected directly using cystoscopic guidance into the detrusor muscle or external urinary sphincter. It is thought to block neurotransmitter release from the peripheral afferent nerve terminals and inhibit efferent muscular contraction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/65\">",
"     65",
"    </a>",
"    ]. Botulinum toxin A has been primarily studied in children with neurogenic detrusor sphincter dyssynergy or overactivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/65,68\">",
"     65,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Limited data on its effects in children with non-neurogenic dysfunctional voiding suggest improvement in symptom scores and a reduction of postvoid residual volume [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/69\">",
"     69",
"    </a>",
"    ]. In children with overactive bladder, botulinum toxin injection appears to improve symptoms and increase bladder capacity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/70\">",
"     70",
"    </a>",
"    ]. However, further studies are required to determine whether botulinum toxin injection has a role in the treatment of patients (both adults and children) with bladder dysfunction and whether it is safe and effective long-term. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=see_link&amp;anchor=H488386438#H488386438\">",
"     \"Treatment of urinary incontinence\", section on 'Botulinum toxin'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children with a neurogenic bladder, surgery is commonly used to alter the urinary tract for safe storage of urine",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    to achieve continence. In contrast, patients with non-neurogenic bladder dysfunction rarely require surgical intervention. In rare cases of non-neurologic bladder dysfunction, when markedly elevated bladder pressure develops, a child may require enlargement of",
"    <span class=\"nowrap\">",
"     his/her",
"    </span>",
"    bladder to reduce bladder pressure, and thus prevent renal damage. Bladder augmentation is usually achieved by adding an isolated segment of bowel to the bladder.",
"   </p>",
"   <p>",
"    Cystoscopy with urethral dilation is no longer routinely used to treat children with bladder dysfunction as there are little data to support the utility of this intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Catheterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children who postpone micturition, the bladder becomes overdistended and the detrusor muscle becomes overstretched and hypoactive leading to a weak or absent contraction referred to as an underactive bladder, which was formerly called \"lazy bladder syndrome\" or myogenic failure. In these cases, bladder emptying is often incomplete resulting in large postvoid residual volumes and an increased risk of urinary tract infection (UTI). Clean intermittent catheterization (CIC) is an effective and safe intervention for bladder emptying [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/72\">",
"     72",
"    </a>",
"    ]. It allows patients to attain continence and reduces the rate of recurrent UTIs. CIC should be done in association with an established timed voiding schedule. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Voiding behavior modification'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     LONG-TERM PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term outcome of children with bladder dysfunction is typically excellent with resolution of their symptoms. This was illustrated in a review of 199 patients treated at one tertiary center in the United States, in which 98 parents and 51 patients were contacted by phone at least 6.5 years after initial presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/73\">",
"     73",
"    </a>",
"    ]. At the time of follow-up, 91 percent of the patients no longer were incontinent and 82 percent no longer had urinary tract infections. This resolution of symptoms is most likely due to the natural history of bladder dysfunction rather than to medical interventions. One study suggested that girls with childhood incontinence compared to those without bladder dysfunction are more likely to have urge symptoms and incontinence in adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/51/41785/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/2/21538?source=see_link\">",
"       \"Patient information: Daytime wetting (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Management of a child with bladder dysfunction, defined as any abnormality in either the filling",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      emptying of the bladder, is directed at improving the child's symptoms and avoiding renal damage. Behavior modification should be geared towards rewards for following the treatment regimen rather than being dry, as being dry is out of their control.",
"     </li>",
"     <li>",
"      In our practice, a stepped approach is used starting with the least invasive therapy (ie, voiding behavior modification), and if the patient remains unresponsive, moving to more invasive",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      costly interventions (ie, medications or biofeedback). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Conservative management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial therapeutic measures include voiding behavior modification with timed voiding schedules, and treatment of constipation, if present. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Conservative management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who fail conservative treatment, directed therapy is focused on improving the symptoms of a specific cause of bladder dysfunction. Interventions include pharmacologic therapy, biofeedback, electrical stimulation therapy, surgery, and clean intermittent catheterization. The choice of interventions is based upon the underlying condition and severity of symptoms.",
"     </li>",
"     <li>",
"      If the patient fails to respond to initial treatment, our next intervention is based on the underlying condition as follows:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In children with overactive bladder who fail to respond to conservative therapy, we suggest a trial of an anticholinergic agent to reduce symptoms (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Our preferred agent is an extended release form of oxybutynin because its once a day dosing improves compliance. An alternative to pharmacologic therapy is neuromodulation; however, this is an expensive and not universally available treatment modality with limited data on its effectiveness in children. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Pharmacologic therapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Biofeedback'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=see_link&amp;anchor=H13#H13\">",
"       \"Treatment of urinary incontinence\", section on 'Antimuscarinics'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In children with underactive bladder and elevated postvoid residuals, we suggest timed voiding and a trial of clean intermittent catheterization (CIC) to improve urinary continence (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Catheterization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In children with non-neurogenic dysfunctional voiding (abnormal contraction of the sphincter",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pelvic floor musculature during voiding) or primary neck bladder dysfunction, we suggest biofeedback therapy to reduce symptoms (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Although alpha adrenergic receptor antagonists have been used in treating these conditions in children, data are limited and their routine use cannot be recommended based upon the available literature. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Biofeedback'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Alpha adrenergic receptor antagonists'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/1\">",
"      Farhat W, B&auml;gli DJ, Capolicchio G, et al. The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol 2000; 164:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/2\">",
"      Forsythe WI, Redmond A. Enuresis and spontaneous cure rate. Study of 1129 enuretis. Arch Dis Child 1974; 49:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/3\">",
"      Nev&eacute;us T, von Gontard A, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society. J Urol 2006; 176:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/4\">",
"      Allen HA, Austin JC, Boyt MA, et al. Initial trial of timed voiding is warranted for all children with daytime incontinence. Urology 2007; 69:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/5\">",
"      Bloom DA. Overactive bladder: paediatric aspects. BJU Int 2000; 85 Suppl 3:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/6\">",
"      Van Arendonk KJ, Austin JC, Boyt MA, Cooper CS. Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder. Urology 2006; 67:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/7\">",
"      Thom M, Campigotto M, Vemulakonda V, et al. Management of lower urinary tract dysfunction: a stepwise approach. J Pediatr Urol 2012; 8:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/8\">",
"      Wiener JS, Scales MT, Hampton J, et al. Long-term efficacy of simple behavioral therapy for daytime wetting in children. J Urol 2000; 164:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/9\">",
"      Desantis DJ, Leonard MP, Preston MA, et al. Effectiveness of biofeedback for dysfunctional elimination syndrome in pediatrics: a systematic review. J Pediatr Urol 2011; 7:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/10\">",
"      Hagstroem S, Rittig S, Kamperis K, Djurhuus JC. Timer watch assisted urotherapy in children: a randomized controlled trial. J Urol 2010; 184:1482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/11\">",
"      Heilenk&ouml;tter K, Bachmann C, Janhsen E, et al. Prospective evaluation of inpatient and outpatient bladder training in children with functional urinary incontinence. Urology 2006; 67:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/12\">",
"      Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics 1997; 100:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/13\">",
"      Pashankar DS, Bishop WP. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Pediatr 2001; 139:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/14\">",
"      Erickson BA, Austin JC, Cooper CS, Boyt MA. Polyethylene glycol 3350 for constipation in children with dysfunctional elimination. J Urol 2003; 170:1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/15\">",
"      Herndon CD, Joseph DB. Urinary incontinence. Pediatr Clin North Am 2006; 53:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/16\">",
"      Finney SM, Andersson KE, Gillespie JI, Stewart LH. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int 2006; 98:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/17\">",
"      Nijman RJ. Role of antimuscarinics in the treatment of nonneurogenic daytime urinary incontinence in children. Urology 2004; 63:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/18\">",
"      Bolduc S, Upadhyay J, Payton J, et al. The use of tolterodine in children after oxybutynin failure. BJU Int 2003; 91:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/19\">",
"      Yamanishi T, Chapple CR, Chess-Williams R. Which muscarinic receptor is important in the bladder? World J Urol 2001; 19:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/20\">",
"      Chapple CR, Yamanishi T, Chess-Williams R. Muscarinic receptor subtypes and management of the overactive bladder. Urology 2002; 60:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/21\">",
"      Curran MJ, Kaefer M, Peters C, et al. The overactive bladder in childhood: long-term results with conservative management. J Urol 2000; 163:574.",
"     </a>",
"    </li>",
"    <li>",
"     van Gool JD, de Jong TPVM, Winkler-Seinstra P, et al. A comparison of standard therapy, bladder rehabilitation with biofeedback, and pharmacotherapy in children with non-neuropathic bladder sphincter dysfunction. Presented at 2nd annual meeting of International Children's Continence Society, Denver, Colorado, August 23-26, 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/23\">",
"      Sureshkumar P, Bower W, Craig JC, Knight JF. Treatment of daytime urinary incontinence in children: a systematic review of randomized controlled trials. J Urol 2003; 170:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/24\">",
"      Hellerstein S, Zguta AA. Outcome of overactive bladder in children. Clin Pediatr (Phila) 2003; 42:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/25\">",
"      Van Arendonk KJ, Knudson MJ, Austin JC, Cooper CS. Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin. Urology 2006; 68:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/26\">",
"      Jonville AP, Dutertre JP, Barbellion M, Autret E. [Adverse effects of oxybutynin chloride (Ditropan) in pediatrics]. Arch Fr Pediatr 1993; 50:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/27\">",
"      Gish P, Mosholder AD, Truffa M, Johann-Liang R. Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases. J Pediatr 2009; 155:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/28\">",
"      Nijman RJ. Classification and treatment of functional incontinence in children. BJU Int 2000; 85 Suppl 3:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/29\">",
"      Kay G, Crook T, Rekeda L, et al. Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol 2006; 50:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/30\">",
"      Pathak AS, Aboseif SR. Overactive bladder: drug therapy versus nerve stimulation. Nat Clin Pract Urol 2005; 2:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/31\">",
"      Sommer BR, O'Hara R, Askari N, et al. The effect of oxybutynin treatment on cognition in children with diurnal incontinence. J Urol 2005; 173:2125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/32\">",
"      Youdim K, Kogan BA. Preliminary study of the safety and efficacy of extended-release oxybutynin in children. Urology 2002; 59:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/33\">",
"      Goessl C, Sauter T, Michael T, et al. Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia. Urology 2000; 55:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/34\">",
"      Nijman RJ, Borgstein NG, Ellsworth P, Djurhuus JC. Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials. J Urol 2005; 173:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/35\">",
"      Raes A, Hoebeke P, Segaert I, et al. Retrospective analysis of efficacy and tolerability of tolterodine in children with overactive bladder. Eur Urol 2004; 45:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/36\">",
"      Yucel S, Akkaya E, Guntekin E, et al. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed? Urology 2005; 65:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/37\">",
"      Reinberg Y, Crocker J, Wolpert J, Vandersteen D. Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence. J Urol 2003; 169:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/38\">",
"      Kramer SA, Rathbun SR, Elkins D, et al. Double-blind placebo controlled study of alpha-adrenergic receptor antagonists (doxazosin) for treatment of voiding dysfunction in the pediatric population. J Urol 2005; 173:2121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/39\">",
"      Cain MP, Wu SD, Austin PF, et al. Alpha blocker therapy for children with dysfunctional voiding and urinary retention. J Urol 2003; 170:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/40\">",
"      Donohoe JM, Combs AJ, Glassberg KI. Primary bladder neck dysfunction in children and adolescents II: results of treatment with alpha-adrenergic antagonists. J Urol 2005; 173:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/41\">",
"      Vanderbrink BA, Gitlin J, Toro S, Palmer LS. Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children. J Urol 2009; 181:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/42\">",
"      Schulman SL. Voiding dysfunction in children. Urol Clin North Am 2004; 31:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/43\">",
"      KEGEL AH. Stress incontinence and genital relaxation; a nonsurgical method of increasing the tone of sphincters and their supporting structures. Ciba Clin Symp 1952; 4:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/44\">",
"      Nelson JD, Cooper CS, Boyt MA, et al. Improved uroflow parameters and post-void residual following biofeedback therapy in pediatric patients with dysfunctional voiding does not correspond to outcome. J Urol 2004; 172:1653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/45\">",
"      Schulman SL, Von Zuben FC, Plachter N, Kodman-Jones C. Biofeedback methodology: does it matter how we teach children how to relax the pelvic floor during voiding? J Urol 2001; 166:2423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/46\">",
"      Herndon CD, Decambre M, McKenna PH. Interactive computer games for treatment of pelvic floor dysfunction. J Urol 2001; 166:1893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/47\">",
"      McKenna PH, Herndon CD, Connery S, Ferrer FA. Pelvic floor muscle retraining for pediatric voiding dysfunction using interactive computer games. J Urol 1999; 162:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/48\">",
"      Vasconcelos M, Lima E, Caiafa L, et al. Voiding dysfunction in children. Pelvic-floor exercises or biofeedback therapy: a randomized study. Pediatr Nephrol 2006; 21:1858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/49\">",
"      Combs AJ, Glassberg AD, Gerdes D, Horowitz M. Biofeedback therapy for children with dysfunctional voiding. Urology 1998; 52:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/50\">",
"      Yamanishi T, Yasuda K, Murayama N, et al. Biofeedback training for detrusor overactivity in children. J Urol 2000; 164:1686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/51\">",
"      Chin-Peuckert L, Salle JL. A modified biofeedback program for children with detrusor-sphincter dyssynergia: 5-year experience. J Urol 2001; 166:1470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/52\">",
"      Drzewiecki BA, Kelly PR, Marinaccio B, et al. Biofeedback training for lower urinary tract symptoms: factors affecting efficacy. J Urol 2009; 182:2050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/53\">",
"      Palmer LS, Franco I, Rotario P, et al. Biofeedback therapy expedites the resolution of reflux in older children. J Urol 2002; 168:1699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/54\">",
"      Groen J, Bosch JL. Neuromodulation techniques in the treatment of the overactive bladder. BJU Int 2001; 87:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/55\">",
"      Trsinar B, Kraij B. Maximal electrical stimulation in children with unstable bladder and nocturnal enuresis and/or daytime incontinence: a controlled study. Neurourol Urodyn 1996; 15:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/56\">",
"      Gladh G, Mattsson S, Lindstr&ouml;m S. Anogenital electrical stimulation as treatment of urge incontinence in children. BJU Int 2001; 87:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/57\">",
"      Hoebeke P, Van Laecke E, Everaert K, et al. Transcutaneous neuromodulation for the urge syndrome in children: a pilot study. J Urol 2001; 166:2416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/58\">",
"      Bower WF, Moore KH, Adams RD. A pilot study of the home application of transcutaneous neuromodulation in children with urgency or urge incontinence. J Urol 2001; 166:2420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/59\">",
"      Barroso U Jr, Lord&ecirc;lo P, Lopes AA, et al. Nonpharmacological treatment of lower urinary tract dysfunction using biofeedback and transcutaneous electrical stimulation: a pilot study. BJU Int 2006; 98:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/60\">",
"      De Gennaro M, Capitanucci ML, Mastracci P, et al. Percutaneous tibial nerve neuromodulation is well tolerated in children and effective for treating refractory vesical dysfunction. J Urol 2004; 171:1911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/61\">",
"      Humphreys MR, Vandersteen DR, Slezak JM, et al. Preliminary results of sacral neuromodulation in 23 children. J Urol 2006; 176:2227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/62\">",
"      Malm-Buatsi E, Nepple KG, Boyt MA, et al. Efficacy of transcutaneous electrical nerve stimulation in children with overactive bladder refractory to pharmacotherapy. Urology 2007; 70:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/63\">",
"      Roth TJ, Vandersteen DR, Hollatz P, et al. Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children. J Urol 2008; 180:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/64\">",
"      Capitanucci ML, Camanni D, Demelas F, et al. Long-term efficacy of percutaneous tibial nerve stimulation for different types of lower urinary tract dysfunction in children. J Urol 2009; 182:2056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/65\">",
"      Schurch B, Corcos J. Botulinum toxin injections for paediatric incontinence. Curr Opin Urol 2005; 15:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/66\">",
"      Hagstroem S, Mahler B, Madsen B, et al. Transcutaneous electrical nerve stimulation for refractory daytime urinary urge incontinence. J Urol 2009; 182:2072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/67\">",
"      Lord&ecirc;lo P, Teles A, Veiga ML, et al. Transcutaneous electrical nerve stimulation in children with overactive bladder: a randomized clinical trial. J Urol 2010; 184:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/68\">",
"      Schurch B, Hauri D, Rodic B, et al. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 1996; 155:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/69\">",
"      Petronijevic V, Lazovic M, Vlajkovic M, et al. Botulinum toxin type A in combination with standard urotherapy for children with dysfunctional voiding. J Urol 2007; 178:2599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/70\">",
"      Hoebeke P, De Caestecker K, Vande Walle J, et al. The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor. J Urol 2006; 176:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/71\">",
"      Metwalli AR, Cheng EY, Kropp BP, Pope JC 4th. The practice of urethral dilation for voiding dysfunction among fellows of the Section on Urology of the American Academy of Pediatrics. J Urol 2002; 168:1764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/72\">",
"      Pohl HG, Bauer SB, Borer JG, et al. The outcome of voiding dysfunction managed with clean intermittent catheterization in neurologically and anatomically normal children. BJU Int 2002; 89:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/73\">",
"      Saedi NA, Schulman SL. Natural history of voiding dysfunction. Pediatr Nephrol 2003; 18:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/51/41785/abstract/74\">",
"      Kuh D, Cardozo L, Hardy R. Urinary incontinence in middle aged women: childhood enuresis and other lifetime risk factors in a British prospective cohort. J Epidemiol Community Health 1999; 53:453.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6578 Version 18.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-EA571C30FB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41785=[""].join("\n");
var outline_f40_51_41785=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Our approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CONSERVATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Voiding behavior modification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Treatment of constipation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other measures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIRECTED THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PHARMACOLOGIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13887223\">",
"      Anticholinergic agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Oxybutynin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H13887150\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13887075\">",
"      - Other anticholinergic agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13887264\">",
"      - Our approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Alpha adrenergic receptor antagonists",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      OTHER TREATMENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Biofeedback",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Electrical stimulation therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Botulinum toxin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Catheterization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      LONG-TERM PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6578\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6578|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/55/11125\" title=\"figure 1\">",
"      Normal urinary voiding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6578|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?10/12/10440\" title=\"picture 1\">",
"      Vincents curtsy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/48/37642?source=related_link\">",
"      Chronic complications of spinal cord injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28793?source=related_link\">",
"      Etiology and clinical features of bladder dysfunction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/50/25384?source=related_link\">",
"      Evaluation and diagnosis of bladder dysfunction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/0/7178?source=related_link\">",
"      Management of nocturnal enuresis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/60/22472?source=related_link\">",
"      Overview of congenital anomalies of the kidney and urinary tract (CAKUT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/2/21538?source=related_link\">",
"      Patient information: Daytime wetting (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/28/36298?source=related_link\">",
"      Treatment of chronic functional constipation and fecal incontinence in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=related_link\">",
"      Treatment of urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/59/15288?source=related_link\">",
"      Urinary tract complications of myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_51_41786="Confluent and reticulated papillomatosis - back";
var content_f40_51_41786=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F67566%7EDERM%2F76296%7EDERM%2F54172%7EDERM%2F66671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F67566%7EDERM%2F76296%7EDERM%2F54172%7EDERM%2F66671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Confluent and reticulated papillomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDosHHr65p6ZpAPripF4BOOnavaOEUZ4FP28H0oX361KMAc4545oAaF9R70YyemPapBnHrTgvPai4DVGMZOfepNvTHAoHXGRj3p6qeO4ouAAY47UvP0pQMY/Wn9QMA+lK4FO9X93xkiuP1pOGrtbsERHPWuQ1hSSc96Lky2PIvGcQ5OK8xvF2zt616t40eBHZGkXeeijk5riYtBkup2eTgehOM1y4mceWzZthoyvojmUVnbailmPYVqWeiXEzDzMRg9O5rs7DRIrcfLCp9x1rZg04AZRF65yTjBrzXUS2PRjQb1Zy+m+GljBdoyw9Wrbh00RsNqncB1AyK6WG0QjAiJkyARng1fjs8cvGqsOgX+H8ah1TeNJR6HO29gxUfJweB/ntV+C1CxfOp44AA5J+layQmUfvOSOc9sVc+ziOTJClcYUgcis3OxsoGIqYRWWIjc21y3ABx/KrtpaJLG+Yxg9HOcfh61sxWcYiBCIshB+Y84NT2tkgiUhyDgj6n1x2o9pcOSxhTad/wIgZTORz64FX7e3xCB+8LEdCvHHvWs1ioj2BSGP+1k0rwhcgbioHpjP0rOVQ0jAz4rV2hQuq5PIGAw/wD1UyaLBydpbGCQcD6YrUeMxw4QggHDY6iq7RRn78bSOoyDt/ljrU8zL5bGXLH5ahm+RnP8J38fXtVdAoDbLVSo65cZPPXFb5swIiIxtXbnYvPXms2S3Marn5V9yMqD601ITiZptRNI2QZFA3crjOe3NRzQgKyHCIW+QjGB7GtxoZY4PuJySCUyOMdR71RuLWSNPNi+aUN3zwPQ0+cXLcoGyZVbeCGOMgYH5etMS1eMiRE3ll7AKSe/v0rZWCNiuGBZOGxzSyQuRu3hHB6jAJHcAU1MlxOdmtywBZNpByM9ee/vUM0DtITjsQTngj1Fb9yisFDAg8/d7/WqttaKWKuxVJG5DjjgenaqjO+5Lic/JaMQM4UYyD1xVO4tiy4ZQXHIHrXSGznSaSIhXCjKlDj5f89aqjTzPGS3lq+CyqW64/z0rRNESTZzFzp+9Rn5Wz1rFuNMdGLQKQc9McV3clqsREc+N5HBJ7ntURs1DOSMoBycckmqU7MxnSUjtv2Rp4rHxFrdldXEccsyK0UbMAXx6etfUmDv6V8LyWZSSKWMvBLGco0ZOV+hFeoeAvjPrHh947LxKr6tp/AWfP7+Mf8Asw/Wt/acxxyoSjsfS7phiaaAMEY4rO8MeKNG8U2YuNEvorlcZZM4dP8AeU8itdkFO5k0VJAA3OPwqN+QeM1ZdP8AGogACR2HeqTJZV2DuajlA9vwqzJjJ4OKrOMdu9WmSyEgDJwKiYAfWrOMn0qJ1G7kcVaZBUcd+tQyLgHjrVxk46c1E4yMVSYFJwRjAwfaomHOTwParMi9CO1QEdyM1qmIhPI6fnUD/SrR6dCKhYdzVJgcQnLc9alAz0qFT789qkVuentWgh6cgZHNSDDZJwfU4qMHJx3p6cde3agCUADinL0xnGO1Rqc8E07cSaAJlAIOOtSjAxjpUAb9R6UskyQxtJK6xooyzMQAB9aAJvXI4pR1AUE+1cBr3xP0XTWaGxZ9TuBwFhPyg+7dK8/1nxt4k1yMxmddPtG/5Z2/DEe7daxniIQNIUpT2R6x4q8YaPoUfl3d0kt0eFt4fnkJ+g6fjXkmveMNV1x2jtIxp9r3A5kI9z2/CsazsFV2ZdzSHksev51u2Wmngvzntnk/jXn1cZOWkdDtp4NbyMSz0xWJZ1Lt1LtyT7nNbAsoolVnCZLDABz/ACrWt7MIWJUSDGDjp9a0bK1KRqVUJIeNwFcblfc74U0l7qMm1tkYLDH94k7sHnH9KvpYhSpKttUfeP68VrwwCMj5Bj7oI6mraxQg8D3JasnPsaqLMiOxUZY4HHY9aligChmwGA52jnPFaTRMdphbaRwuBnd+dPs7M21sBM6lyckr3/8Ar1DldFqJQt7cTqryq0YXPA4wKvtbCOMug3BeAGPLH0qcJ8wKZz33dhT5SgABb5gOp6+lK7Y7KxCsbFUEkRXJwVA6egz61YtrYqwduFUdCeATVWOWQ7Ygpidm+Rgcgj69OtaUYKQGQxsGA3Y7sabBLUQRAxKxAJycjBB/GphHlY2O1R79T6VHLcIoWRlIZ+PmPOR60776gFlLHhVGMtjtzWXU1RTe1Z5DJ5ZJdePmOBz6Cmx2sygSTA+YSGbnG4Y7duK1VHmAMBtjHCqeo/wpkmxgpLbmI+cj+Zp3BR6lHymUmQlhnvjGPb6VXKR3DEqjFhxtI6++a0o3Vov3IJJJzuPOB3PtRFtVPlcZHr/T/CncdjJEEiRyI8h8pgdhKnjnvUbxSQhlG532jJGeAD1/U1p3LbyqySuyOcBT0Pv9KjT5FEYPJzggkk+vT09KLkuJnNEXdpAAjYwfm6j69+1K8QlXmMjHcjPPt61OoOX80lwGBB4A6ccfzFOiZsBY36ZJwMsPYegp3JsURE2CrRhj1ywwf8KrSosLIro7K5yDnIX6e9aeyaQ4T5pTkkBDgj/PekmtpEQNLHuzwSvr2IoTFYotHiBAhRvV8du9U5bf5yVBIHzdcBv8KmCSLc4XzfLB259s+lWJV2qGTbxnnofoTV81iWjGmtwzq0QG3JJA5APr61AYNu8RybXZsj5eD7Vq28KJleSsY6k4A9jUEsipu2xorAliWPHPGAatSZi4oyreBldYpYzG6kgx9Rj2qKexWRdkYHBwcjkVpxhNjzMv79sYU9R9KiR0mbAba65UqBjBz1rRzJ5TKs5b/Rr9b3S7uWyu0HDxNg/T3H1r2XwP8cSnl2XjOELngX0A4/4Gvb6ivLpLbczISAeisDk1SktGCMCh2c5x2+hrWNXozGpQUj7H0+9stXslu9Ouorq2kHyyQvkH8R0qYrgYFfHfhrxBrnhG4Nz4dujGnVrd/mjce6+vuK+gPh38W9H8T7LPUdumasf+WcrYjkP+w39DW8ZJ7HBOlKLO/KZHvUEiHnjqavSrj2zUDDHB5P0rRMyKZAx3NRuAevT0NWZBtPHHpUEh44q0Qyu/vUDdfep3GR6GoiMDHOasRXZOCSagYc81bkHGT1qu+SSTzzVxYmV2GCfSoCMdORirEgzux0qJscjNWhHCjBFKvJ9hzSDj2FPUenU1sA4c8dqeM4z0FUb/AFKy0uEzahdRW6DnMjYrhtZ+LOkW+U0qCa/lzww+RAfqetTKcY7saTex6TtJAx+VZms+IdJ0SPfqd9DAeoQnLH6DrXiWreOvEesI6R3H2GBudlvwf++utYUGmSTu8s7mR2OS7ks35muWpjIx0jqbQw85HpGufFppd0Xh3TywPAubk4H4L1rhdTvdb8QzJJq97LKoyBGDtQD/AHRxVmDTEXG0LnqDWpBakMAwwMZOa4amJlPc7aeDS3MS104RAKqDr1rUtrM5yFLOOAO1aUFkCVI5BHQ8Vow2oAYMuD6E4FczmztjSSKVvb7JFJQ/NxWrawsIWzGQx6DPIwasWVq4UsVVc5+Xrk+uauW9q2A+89O5/nWbkzTlKUVqyMwQFiSc5NW1yr4KhNp+bLYHSppleGIhNi7mBL+3fFVZrxEQho3JHG4r159P60m7jSsXLUpISQrFMjBJq9Au1WOeAPlAHAqhYXyPPiIGSNuclclfrWom8zhWQCJupUHINZtami2G+UWcFyFCc4Hr70x1lid3iTIzgepPtUcd+i3AieSPzSQo8wEbj6VbtZBNwGUt0HOfxpbDVmJsQrHnKyP1B/UZqXyD5asm0qyqpPSmTyRKmy5ypGSuSRx+FWLcOAcMhAywO7IP0p7IaVxskEkshcxsqPhSXOcH1x6Uy5YqVjMrKqLuJUYI54X0NaUcPygs7eY3LH1/DtVW8jtZIHTknqB1JYDH6UJjcdBgUXCKilWXYxfcuSOafDbHLMJNyuQQhTjHsRVfTLVoJGadysYO3BH8vr3rZhZgV3w7SeDjjHp9Aah+RcVcguF8sEkFOM5HJIpmCwdQoRFOCNpBI+taaRfNg7R2bJ7elZ86mO5CxhDj7oBx/OpLtYjnVVzFDks4yck/KPesxrv9w5ni2lQxbA+YkenataaII6rO8x35AbG3HsTVdYndTul3EYDgpjPpnNNMhrsU45/NDGFHXIyQeMZ5xTEJjO0/IfvoSuQWz146Vdig8gkEk55BHT8qrzRo1zGVy2G3shHUf/robCzKc4EYRlEe1pSOnY9SD7UwQiVl3HBVihcHAJ7E1YmQGRYysfXdjHUdRS4QTsPlVjhiFHIXpg07khCVc/fLFiDjofy9KkIIGXVUAAHJJG4njipViXLMoTyQRjp81EMZkUMMxbiQF6njvRcFEqSRoDwxVkYjKrnHrkVUiVCSY2YhRkeg56H/AOvWrNbhV27jgchwaqMrKFAZUXrgrnPrmi9xSjYx71fKkByyRdXXGQfcYqlNaOQGlDs/3hwAPqB61vYXYbaYt+9wQw6Z7gelST23yIrh+MAMBnBHetPaWM3C+py9yEW4cDcwxgc8jHTisvciSASI0bMcEZyc9DzW3e2hgvERnG+TkNj05xmiW282UkRxkkhmBwdw9j6j0rRSM3Eozxossc0LE54zu+6D3+lClZUbdksgwVI/PirMotTFCybjjlRjAxnufrUd3cyQosoiClsFig+8PY96adxNFZ7ZZDhkaOVecd/r9Ky72xZyCRhs+mOa6qErPCkg3bWHTHNVroLwxTgdcjoe1OM9dCJRutTb+H/xa1jw15dhrQk1TTR8qsx/fQD2J+8PavobQdc03xHpovtGuo7q36Hb1U+hHUGvka9ttxJADp346mmaNqmr+FdTS/0W6kt5yfmXJKSD0Zehrrp1r6M4a2G6xPsd0Peq7rzXCfDv4r6X4o2WOpKunauowY3P7uY+qN/SvQJBnnB5rpi+pwSTT1KpB46VE65zg81ZPy8jrUMnA/HpV3JKsg475qFwCATkY6VO5JB/ziopB16VSEys/OOv4VCy8jjFWWAGR2qI4x05/nVpiPCvEXxJ0DSC8STm+ul/5ZW4yM+7dBXnWs/FHX9UBj09U06A8bkG5yPqelcTaWOeBwTxjHP1rZtLLICjAC9SR1rkqYyT0Wh1ww9yk8V1f3Cy39xLPLnO+Ry2fzrVs9OQEErn8KvW1oEAwucc461qQQcoFU+pPp7VxSqOW530sOolK1tQq/dB9c1oW1vlgpHPT0q4toFjGASOmB1q3DAgiGMDHIb3rJyOtU0iG2tApEjABuiqTyau2lsFLBsZ6jccGrESboQcZB5cMOlWYYvMhO7JByMY6fSpci1ErwQI4SQYwCQrDpn/ABq9sdVZo1UyD5Rn27morWWF1aNIj+7bAOOCTVmQbDt37WzkAjqfaoe40iWOMsFJI47eh74qzvVoVDZCnPbjjpUKTpsaQ4QY4bHT2FUNOu7m7fmJ/LZmHYjcD0PpRZsexYupDdEKeAvOWOMHtmoZBcPcD7phRQCp5x3IrSuLQTMRKuwZyNv9T9afIixKI/4SM4A+ahMHEy/tRe6VYkViR98JjcPX610EGcQxh35BOTxn2PvWPYaU8N1vJyu7IzyQewro4YRGpCE8gEkt378UptFRTOd1PTzJcLIx2gMc5I79cVFayPayFVXy2j/ixwQDwPwrS1KD7TdJC5Ea7R8uOG+vtUdksVsUhO0rll2q24gcU09BW10Lks4aS2Lw+aoG9gWwV45HvU9jdW8pPlwNGwIUbxnPvirfkq9uSSMM2c8Hn1/KooyizYEi+44zwO1Re5aVi2oErnJCknCjocUscMpmZnMZ3dlA+WmRxhoy6hQxQbGP6dafaB2lVZonUICSynA9uPrUrY0tcXykVyHSMLjBUgkH8e1PinSMCML8xzggEhjjrUs5aNlLg+iZHGcfeb2qKwlaQfv0EiEkoSvCjHOeaLAhYS8rBgSr4B4GePWrMrZyQSu48Mecf/XNVzL5P74LlQMEkbS2emKWS6hRVVl3xnPCtwD9R6VLKQ3yjMpYu77WDbfMIH0x3qGcxPFi4ZHjU84xyc+1WQv2dP3eWBHChwQvP6VFcwKjkyKC6jdlVB69s/1phsUnVZNm2ZPmGQWPAGajlkJCu+VTJ2gDJYYpjW8DXBmaPAGG80DkfX256VaAZGQEeYWPzAjIxjjB7ChsnVlY7GBCANKByAMEeh96cS8MhYNuiJ64AA460+dTCyMxV2QYLDqoycjPcYqRVWVBhiVI+UYyD/8AWpA0NhEBTMQIVTk46E0pDG44LIM4xjI/CieBUddpcqQUZeo64zj0p1vlkUsi5HCBTnAPv1BpgQPCjg+YmcZyASAQf6+1DjCFSxJKkjccfhVwgGM5ABwRjHf+tZ2o24lt2J+6BnB/hHfIpJ6hJFWRbcSSqMD5wpU8McDsKsoimEqrE9/XI9KiY7ljZUDbipYkZPoOf61Bd3jRSRKUBMm4HnjIHGfSqszO6KlxOryYLbGj43sOPQHHoaoSPJDIEXD+UdrkDv1BrQuWUE7gZNzBGVjzyP5elZrRwOJGjfBQ7fLYnHPUgdc/4VcTJob50EqozBchhyBgd/0qSRo/NMZCJE4444X0rLuTCyMzy7VTCNhSCSO5FEuPsRAZiwIwc5OT3/CtOXqRexrywuse+InK8kY796bPFvjCvtBGffg1naJO7yeW5CORnyweo6dfr2rVwsgyAQOh5qXdOw7J6mWyhT8ucdM+1VNQtwImbCFCep7f4VoXChy+3IwQTnqPw71HKjz2xJRTJ0YdiauMjOUTk7m33shXKt1XacFcd8+tej/D/wCMd/ooh07xTvvbEYVLrrLEP9r+8PeuHaMAsi846jHNUb2zVgxX5uMA56V1U6rizlrUFP1PsXS9RstXsY7zTLmO5tpBkSIc4+vpUzjnjPNfHXhLxNrXg+++0aPdNGhP7yF+Y5fqv9a+gfBPxX0fxIyW18BpmpHgxythGP8AstXbCalseZUpShud42AelQPnnHfirL8gEHIPQ561XkBzxxWpkQN7DiopBkjgetTuvoeKif2596tCPi23iABYbgMZJXjGK1LSMmIMyY46dcUwwoFXc7HJBIA647Vr26nap28k8j1zXjPY9+nCzI4YcnCA9elaAhG44A2jBUH9akhXyyuOBnr0yfQ1aA24J+b046Vnc6UhYiofIKhWx9T+FWbSNWiKY3EH0weD6Ultbq77mABPII5q5b2/lIq7u+MZJrNssjaNPMwZOD1BGM89vWriRgoxRGIXjOD+tPiiON7E7Q3DHkjHT8KtGFWPOTEvOPf3pNoFFkFpFsHzbEH3gF5J9jUht3lLupyBjt1+lW9qlSB0Ax0/lToUcRrlcAZHDcH/AOvUuZSiUXtEdSjx/K3VV6n0NPtoooNiowVwOi8Z98Vbl3G3O18NknHc1h6cCNTaR/MkkfIw3YULVA9GbE92YGMZwT1+bp9B71gTT3i3UjDdknCDjaB3PrXRTRK0kbNyBxgnvSXVnCZIpxtBVhuUL94elNNIHFvYbpVpdL80rEqnO49W4rSvVMVsXQgSMQMdT749qcqfKzw7g0g5Q+lMa6S3GJ2RTtJVe+PQVO5eyM2/sZITvZ3eSRcfOcjnoDU1pFbIVGMvgFiq7cdulbFtGLkMxQngEA9azWs7i4uQixDYCVyeSx69aE7haxpgQSwsGK7QMEAjisu5RoEEUUbMShwUHTpls/0qex0m5ViAUWEHADL+PH+NSXWnSCRX8xzsGMk8LmktOo2m+hNps6KgSc5b+FjycY71oxs0hyHKRsPlGDke+K56KaKO5WOSH5C2MtkZ+bqPrXRMiqpUFQzHJ5P6+3rUvcuOxLOFuVKEsytxjGazLmSOBUhTgDk7cLx0/OrtlMPLZbjKMX+Qhcgn+7U7RbmWRjtAPzHAGfei9irXKYh8+IxrtUk7n3jcCR0ODUUkMPlsoaP5chvmxn1A/wDrVtQKNjbj8y9T3I96ozwM86bSjAAsFfofr71N9RuJWRIoY3PMq4UuFTLEnoM98VBctAQELlEBK7hLtBPcY7datTfO5jmMagJnC5+76/XrxVVYBc4e4m+WTJjKYUquP4sjrVIhkUsT7R5eSwz8+Rhl9/Wo1jljSZ2diE+7kfe7Yx6UltJGk7xyebkplUYfMcdAO2O9XjM0ioYVKq/DBhyO/T1pvYSWtyGVZBaoJATKRwwxjA7Y9vemkMqsUjGCMBewHXkelWGUMGlUfMGyrHAxnrx9O9CGKIyBHRc4PLdRn6e9Suw7Gcs0KoyTqA4VpGyp3FP6kVMpDbFjZ03DljwWx3X3qRri2liUo3mKOGRgcA9sVTutssgmCeYoH3j82OeCTnIoEW5DkM8chQ9Rn+ajv9KzZiWmDNG4ck7iBt4xnPuK01TKAAs9uAVCg9D2wfTNQXFuViZt0xjY7XVWxgZ7Z6YNNNCkZsK4VPL2lpAzJkY3DrmluE86LbG4EvHB4znrUl9EYhIYDukDMsaoemRyce/FZq3VzJCyOU8xAoXIyh3HknvVJN7GbaW4y3JDoJ8AuNx3JxjJwpPuaoXoW2mildvMUFmzn7wJ6VqAK7yxxTTOudrK2QQAMjaCOmaTUrWSdWVgqQMy7QcYOev61e25DVzFvleLfcQoyRsvzBugPGKz4yIZpA0bRoVIOD8px3z61uX7PvJL5jbk7DkE9MGozYolrEkikrtPI44x0qoy01IlG+xkyWyl/Ni4YBc7RjI9fxqa0d5J5GEm0Njdjnae+KpEiEsknzKMMAh6AkY4qP8A485WeIBcFsg/nj8jWqVyNjY1Ym3xMhKu4xIM5HA4x9aqWlyruQxwGAwCe9NnKz2LAsXwu8A88A1jzy7W3Qk7RyF7ChR6E3sad6Gt57hMKMjIPHXHSqMS+cpJO0H73Gfxqz9pFzFvHMnXIHf3qS3CNExZCH2/MOmfcU3oJamRPasJsEfu24zWdeWYdTk8jpx0rpWj81WUoVI5welU5IlKMxzu/nQpsUqSasaHhP4keJfC7JA7jUbBcfupiSUH+y3avbvB3xL0HxRGY1mFlejGYJ/lJ/3T3r5weDttOSKp3FqCOMhl5BBwfzrsp4lrSRwVcJfWJ9lso6jkEVA/A6V8y+E/iXr/AIZlRLiQ6hZA4MMx+YD2Ne5+D/HuieLEUWM4iu8Za3lIDD6etdsJxnscM6cobnzglsZrmKZx9wcA9vetSyQMxcrwf4QcfSnWse7azxnGOn1q1b52qq8LuwOO9eM2fQxiiaOMupAB2t8pPXAq2I2aT+LbjjI6022QNJlB8o+9j1+laUUTu+4DjoB3FZSZqkQxIUdNvQAnHIwO9XIkTG8AtwQD3NRy27u6KrnB+8QecZ5rShj2Iq4+UAAenSs5O5okJLFI0cflEAA8kdcVZQxqjKfvN6jv/jUEkaThVLMuDuIzgCnx/vdzAlUHQk/e+lT0HsTJGAgDckDjH9aUBDkKpJOec8D/AOvVhI96FQeDxnt+FEibEVWALMCSRnOOwpFWKspRQN+MOcemKWZ4bcyNKUWTG0MoxmpJURvlkVj25ODn3/Go5bWN2BHKr78fX9aYNEFjLbTZkZw3ODngg+uK1YXDhdhU7Bg5HUZrMFusdwqpByQfmbkNnocVet3gtnJdl3njJ/hA9R6UMSLib3G3auzBzgHPtWbLpAuNUR3mKgcldvHTpmtm3VGVnUEkcZXOD6H3qWaRWJjjABUc0amjimhsUS+S3lZXHOF/limwmWQtuXAUgALwTSW0ZWVmYkseOPWmzu1vKquD8x5LHjP0pDZajuVMjRqUOOcZzuH/ANai4uTHDjEbydVUjt6kd+tQxtHFKXHC42lhzg9cUXMDOqkHbjjIx0NTYfNoVLWwMsgaUhgRgbz90H+7U10vl2+2F2+Q/eI3Y/zmqt3fkKkcTbeiHBwSaVp9+3aoAP7pi3Kgj2FMnToV7dXlYqJXbng9cMemfT610Omo0KHzIgWXqFH6ZqHS9NXZG+GB/jUt94j1rUlmSNSVY4AyOAce9DfQuCtqxJXURqy4BXkc8+9NSEsytMVyozkqagt54dzgHLdPmHJ9OPQ025uwJNkZXEin5m4249qixbaWpT1mS3cfO+HQhSAdo3dvpVIwtP5skzRebIoLrncv0A7/AIVdk0+OTEpkweg55BJycn0pHVY541ErKj4GwAdc9RjpVrQxavuUdOto/ONzKwRg3Vj0HoB2qa4gMCtP8y5YkBQSWbtjmn35jikdAqEsc/IQSp7lvarGnw+ZYZjHyFTkLzx6j3oYJCKGlQFwqyDhAeB7j6VXeUL5YdIiSAHBJweecUkLl5mVZfMKODkcADGBkevrSSQusLOpcSZO8gdD7D0oSCWxnLBFHOxj2varKCsJYfmM1YlsmdS6TrEzkgbBhABzgj1NVL65/e27P9nlOS3yptY54yM8daWZ2ntxBMshAXAZhjB6gnvmm11JTRq6TKkkciKNuDjaB+Yp1yd0uDknPXbgqBzg+uaoWly0EIJfAfBjyOTkdDjqDVky/aLWWeObbtKxl3Hp/Oo5SubQrXFuRvkZFDkttXOCo7DNYzQJG3yEQzOrKwUhvkPP6GrsNzKVuASixKxLgdYx3+o96r3CQzSSo8SpGpWP5flDN1A9wfXtWiujJ2eplTuYZlkeQtIXALLztboQxPIPtW6DFMD5i5YvxvUAg9MHHrWWsiPLOs6pMSFDOox83TJz7d6htJHVHgWTYI94Ifp6rz6j1pvUmOi1K2oR/wBl6isscXmws+d5cnZnnAXp2qKx1R70ShljER+Rcn7pI+U7avySme2kjkiA8tfmb7w5A5596rwwpGhFyiqpChCBwSOgz161Sa6kyXYxby1YwxyRyEMiAspP3iTUUZSQyhQC6/Ngg9vStfXAJYkkjXaoQ7iRjI9fzrnwzxGQoAMFUUnIO3ua1iZs0LWIpbguxyB90nAOevH5GsS8jNuV2qWB+YEH69vSuj0hAxnLfOCAu09v/wBXSoNVtwLliiFTFgkDsfU1SlrYhx0MmyJjjJGCyqcn07cfXNW4bg+YEfGQCuM9xUkNoLkI6bDklXHTNS3No1uEkQ7ipznPOKqUkxRjYilkGw7GJK8nBzn2piFWj3EYwMjPerPlx+RI8X3iC/HY1DGXmtUYDEq8r6Y96hMsz54/7qnGMntVB4gGw/H9K27lH2BlXjAyn88VTdFf7u4jOMU7kuJjXEUb5CgM2MEntWeyPaXImtneOZMFXQ42n2Nbs8BSdjjhupIqrcRcnHIxz7mrU3F6GE6akjo4EKOWR9zEDgnp/wDXq7BAqEsFOTzjPH/1qS3jCLuCY4PerAy2yMKQrnLMB/Ks2daVizBFuJGeAcsQOKvxYGI2cuFyCRxxWbDIVkWFgVBc5buTWzFGmc52AdCM1lJWNIhGyFmVTkAdc9KtMGcIF/1fTJ/pTYYk8ttyDYBuFLayieMEsVQdMDPfpWdjXQcy7kG84PGSO5z+lWooQ7FVj6Docgc1HHbCR2ycqOc/5/lU0EbiViXJXIOcego6DSJRE6qq7iwzlj0yTQ4w26IqSp5z3qWPIOGVS4O4nPWmTj5jsYNIcbj2FSVsIYiwDTMMdduc4Pr+NVQ4aTb0Ck9+nt+PrVt42VV24znAGOR+NRfYcP8AMx3NjPPGBTRLLVkg6PjKrnnqPbNUtU0lLqVmb905wcnk4xjGfSpfMWBSGIOQCctz9KNRSW5tzBFLsH3Sx59+vfNMHYm0x4LODa8yhgOTvyRj0HvSpqK3l0VtuQpILYzz6e1cZb6XJcOscLYJPzM7c55zj9K7zTdLg0y3ZNxYMNzOfvE/h3zTcUteoRbfoWIvkK8A4B5Axg/WsPVZmFyixBUkZsh8cjjrzxitlZVkI3AtGCBgdz6GqeqxQ3EhLYyBgA9+OlShy2EsYHuLRnI9O/AHp71aubeOeFPP3bQf4ei02yuRbQvvXOCcDt9aq3Fzcz75bdQoJMfXqMUNaheyKtzcLNcGL5iVbG0jBJx6/hS2rM7hY4AqfxZ4Yn6D39aqy2x+0ByzeTGSwCH2/PPNWraZZRGzIyxA/dUkFSD696PISNwSSRW6sYQufvAHOR6VEwkYRuz+XKTuHGT0xjHpzWfJPhGWSJh5ZJ3B8nPbP5dqS1WQqwdj/qz85PAxyQBSsVzFua4lhmYxEOu/HmFRlj6464FXJlJtd5YGUHHTA+uBWXDPaGeNAo8wDDA9vxNWL67t5MFHysYLYxy3rx9aoVyO9mmMjw7c4BztIB4HvTrJ7glHkXy14BfAPPfjvkVlxXwbOCMtnI7/AIn8e1b0VtLDGqDySpYArvO4Z4wMVILe5YubFJkdFyzkkYU447EmpbazuLaFQJDnG3cflAx2x6VcjkhV02upkU7WG48dsijUXCW7IpO48/Kc/X6UrGmi1OaSRFvzHMipvPyuOd3vmtByGLPEJEVh989Kw7/UWGpW0LwhQOQWPBH/AOsVq6dcidC6bQuMc8847/41VrERd9DF163MTJI4E2PnRSMBD36fnU9m4CurjLuQIyXBJB6nPrV7UphFbhHId165cZx+VZ1vhWQoivHnO4/fOe2expPYm1noJJFGjRvAgWbJDuFPB/wpH82B4kDB1wy+WR17sOePQirUsjPNH5JdsK29eBx2Pv6UXC+cZN1vvkGBJ8v3hn68kd6SG9RgieeUxTlWjj5AICcH1I703U7VTGpPDqAAoPUAcH/69PnWO3E8kURjlIEayFtyP6kjpx6dqZFKzQhJyrMFZWB5OAOuf1pXbBJbGQQuGWKEyqW4ydpIHJDEe/IrIO5rgyeRlNpUFSHIPYnHcc8VrgxxXEe142aUj92wwGYccnpnGaoSvsBdFYYYHawwy/Njbnvx35q0zJonltjFbmGNiZWViYzznIyMep4/Ws/FzIHSYGKEqXBxkl+qj6VvJg4GxCpXZ5iZO3HKk/XpTBOskmyEIX6MuMYBzz+fFCm0DicS0s0a+Ud6lgGGTnGeev8AMVNbLHLZ75GRME9BnNaPiNF80rLH87PgE9M+p/DFZ1nbSScRYMZAJzgkAHp+f6VsmnqZNWLWjMyXEnmKPmGBjnIpmrXUaSv+7UkLg4PJ5q1pUd1ayiOaPfGuQzDt34qv4hVZYUmjXGOGI6r6ce9NfES1oUYwERpbZiyOPmXuT1q3ZTx3dsWXPAyA3Ue1ZdnEqShGJVOMLzk81oNbhGjfLDPynHXr6d6p2EhtvJ5bNG6kEEtk9AKtoqyKCgG0jseMVZa1i8rhvlIA2eue/PWqqhYZGhIGByGx2rN67FpEcqFwVT7pyOKy1VzO2BujDZywwcelbbqS5KBflAwT3qpNFtyWGGJ7U4ytoDRnTDsjNk9ciqksQPfn19a1ZE+dgpOeMk8flVeWMseQBknB61aYmtDYWDaoJHDDPJ7+lWVjHBHAGDyelOhQAh35XqB3qzChLkqO+Tkd6z5jTlFtYgzbmT5R6jk1fiIC7Tx6GoI1bhQMjqST1qaMkOcltwA4IxUOV3c1UbFoKZFAbIBH0ogt1jBVVAGRx61JGVZRtG4+vSpwPKU7iCoGDjvUORdkPjBUKq4PP8R6jHWmK0skwjRABkksT2HuKkAPmLwCo6Z7VIWxlAuFIx0oTG0V4hIJBvYZ6DI6mrdrsUjduAYdAKxNdmvFZBCjffClkJ3Z/wBmtfTfNCKZjl1A3EdfqfrVtaXIi9bErIgmAYlWJxj+YFRNLCtxIjygyA8KBnIpzWsgleYyDy8k7M8j1py2MbkSzqMbvm9fbFGg3cVoElUbSqZ/iGM47/Wq19HDBbSIqZMecZ4B9xWgUfDPbKFxnae+ahtLSfYr3gWQk5A6YyaEDRheH4rgBJpU8tU6ANzn1/Gta+1VFQqs+0twQRxk96uX1q8wCAqELZGOOe4+lVF0SCKZZtu7DYRAM5bv1psSTWiM77e6TxtE6bQC245wWHUH8KtQEvF5snzHHII6DP6VBq1iihVgKj5ifQ4NVp2ubKOKMZaRn2tn5RjHp/OlZMV2tzXuDB9md5n3OMkbuM+1V9O1SGMPC+RJna7MME1iI9xgCZCEVgFAGC/qR6dKu6RoUm7zp/kTBwrtknJ6/wBaGu47tvQ6Hy4Xt1lIMYZxhepI9/8APaqjxJNcFbYhuQGXH3RxyPeql3N8wbcxhOFDIeCM9vStHTXSBg8ZLMOflPDfhUjTvoQ3sUts0m8oEjwSCcg5qe1dJofKKxswXeCD1/D1pdTuHMHmQkiORuFIz16iow0MUHmCPa7EgYP3fqadgMq63QLs3GT95n1AGefen/ZxEqyIRJCwJG7OAOuMd6j2yPFGI3cshL7sfmfyqzczNHbg7t5X72Dkc+nr+FIRn+Upk2s5VpAG27cDjtnr6cVtWjRohSUOUZtwbGMjHrUQCyR25OC5JO5Vwy59uh/Gr6TQx23lXO8SFQVB+br6e/FMFoXIyqyFhEQwZWLk44A9B2qlfS7oppCwbecb8ZXb2+gzVG21bdJOkYVGRyFD5Py4+6anPm3MHnwqMEYCHACj+ufelsym7ozruKRrVmwWEaHO05/Inv3qzpMql8xyhWKqvzDg5PBHuKEVGiaM7sbxkE7cEcnP4+lQWWnzR3AeM53c4AOAPp+dXbQyWjNTVYBsXMMfmZxlCQcd8eprNuHQO25ts4IDI4wGX1Poa2p7dzBIjRqI3Xj5iOvc1l3FqTMUClnRRu2ckjGDg/zrNGklcm0pIopZFDEquHU9yOuR60xbhkvpE2n5R5oIGBj/AA7GoraORCgiOyToAyc4x0UjjHtSygRX0YIBTaFztwOev4UbgtEOa7K3RVYw0JyoKnOT3PFRT6chnuU8tis4TbtPyn1Y1taayXC+QUUqOrKu0jH0p3lKHPlEsuCoVeB69e1Tcu10crcaY0dlPC+J40IKnpgZ7D8sVjmdIblVlVpIw4Cq33s9gB9a6nX7aXeGjkwoGNo4Dehrmb2O4lu4lRo3iIIbaOB6gH9atPuYyVthVuVMxCO0ZRsvGp6AnofStHzj9uYFcMwZR/d4/nzWEkYW1EfmhUO0sowu51buff1rpIWins1knYiQZBHbnp70NdgXmY2rWTXx3Ff34XBAPB29R+VZy20trbvOFkALD5VGOD9fQ961UjaPVYnabhMhUA7Y6j355rSupA6RoHDDbjzFHU9qpNrQhpM5fRLyUagyNLmKQZ3EdCOoHrmr2qANCmY1VCQeBzjnrWZdbYLobxsMTbSBwu7PB+ueKt3k/nBfJdn8zPyjkFuhGa0fRozMOeVTI0iId68KCfzJFTi8KuCj8OAuSucN6j27VAYHaV2MZdXfBI4Lf4U27RkhiYo3lcrzwQT2461okiNTXtrppN6ucOGwM8ggenapS8bhVyobGT19aqxQJOyuU2ydAVOAOx4q+kSwOVZQf9o9+OtZzt0KjfqV0QnJYkFCCBjPFJPHlgQCoFWHjyhUAMQCctUYZXdo3Yg5AweCOKjqWRSW8xQOI3HmNsjJHDt7VUu4mQuhgmgkjG2SOY5YNjn8K3rmS1uLa0inuZoGiQxbfJZ0IyfmGOh+tVdWk+0upj8xlSNY1eQYZlAwGPuapOyuSnd2HQ4JJ/TtV+FSqqST14B7e5qqqgLnGGAHtx61et2ViNwxHwBjvWbZ0RJgrHAzxnjI6UoA2ENhh3yen/16crZJYrhc4yOtPWLkcDce+OgqUUyZACB/ET0wKsSb/MVcEHdz702NUYEHIPrjHFPZmS5QADaR97ril1KsTrh5RsXaBgDPap4wxPQMcZBJ4+tMUKRmNckjv+tTIdoCryxH4Y7CgojeLgKACnt1Oec0W6lySygAd/X3NK77cHeQOhGOhqCW/EDAEMNx+bHI9gaqxN0PupZZZ1gCYUY5HXHpUGo+ZHEBhjgEcHAGOhx3q9AZGcFlyG5LY+775/SrJgWRJOWLYwCO3riqRLVzP0OSUli+SWIYjsv09q2XXbnLbiemOAKzbYG2IjjQeYTnJPJNQ6hLKYTglWIx93IH1/GhoIuxJ5rx3nljBToxY8A1PLIoVBvVQxwNx6e9ZOkm7ijle5TzSDtAAzuPqfy4qG/luJUeVwQVOFPYntj1oaFfQ3ntEntSNwDnoV7/AP1qy3s0tXlaYhjKODIc/jz07c0ljcuHjjkUneAC6n7v1/kaZ4iinYI0ShwwwQTgHP8ACT26UDbuiGB0aTB+YgcZ74PatxJVksiGb5ycDgHB+tctYX5ggkeVMkthWxgADtV3Q7xEvGEhBickRryF47UNCiyW8SOKUhd5jQgEFuCD1OP61Ye8iitEiCJgEHOOcY6UfarM34ilKxADIJ4Den/6qu3MEFwgCqFVsEHHb2PapHsU4LqKYHkx+WR1IBPPGPapGVZbZy7bY/vA4wM57d89aV7aF828Sxkbh5jjvV1Z4rZSIwIwrDKHBY+vB496Boq29iWtztC56gt3PvVJNNmjZpgm1i2AW6Z9vb0rXWRxiWObAkGVUkEj6+wqAyXTufOeUKqkg4znsfoO9ANIWS0eBweEJLN6YwvU+3+NYupWV06o6AyJgElTkKPSti3vhbvtuJFk8zBjK9+O/wCVWL5jJaholG4nftXnAI+97D607kvY52e6jEUCkTccnyyAAPTnmtTSHt3kfaqnIDBmGQxB5GehPfNY4itRmaWRnDFkZsjH4f54rXtUCIhZ18o/KOQAq+n50mERl1btNJJcOrqGfqDkHHpWhDCkbI7+YkjkZDDlRx+fNS2rplhA8e5sL8x3AZPbH0qUn5FGSj7O5yQeasCpezzrbsFTCj729egzx+FUEvIS25XZJUfb5iDIA75qxdM5SNBsEjElSCQc9D+Pt0rFniaHJaFx5ahTg9fp6ZPrUDbsb9iDcTkzRjy/4GQZH1qh4gSSCRnDsBtwOOOO2Kk08yODFFIqvs+TIxjPUYpl/YSsu+4dk5GT15+n4Uh7oZo8jxXLlwodgGQR8bWPoO4roWddiOO5zgEbqxLUEoomPzJ0z/AP/wBdWmvbdYnBYEH5QvofWptqXF2RDq485WwOAAQT+efrXG6rHJb3GYiWmQ7uOh9fx5rsUlJkVpCXZiUcKAOR/wDWqndW0MxljiMZkJ3Fjjt3+lOJEtTko3gkSeOdCCAWUkDjPQVfsoluIpCrDeX3IFbHI7fQjPFUIdPeW6uFjjjBfKhcY2knv6/hWza2U8NxuQsJN/BY9TjHHt3zVvYyV7lDUIUhsgceVJhgX7hQcjB9f8KhgiPkC5kUhicgEnbj1/rWxewzJZiPCgqT8znOAT0Ht71iwXBtoVQsME7gm35QvQH8eaa1QpLUytW06T7SrSEsHAZyecnqP/1+9PtYZkhjMi+WV+ZRs+VeTkCt24u4gN0ysVXALKAcDoabpE0UsBUEnDnYw6+/1q+d2I5bnN3wlguhdAbkOdwXjHvj8qsW9x8iGUo0Z6gHj6D3rZu7RHR0UAAnePYd65i5thCQYGJXdhgeoPbHqSKqLuS1Y2kjC3EaxL8rncDn07H3q88W9dyqAQO/QVlaUJYWAkY7iAV3dcetbYw4B79M1nNWZUShKy8ApjcDk9gKh+zrsCox34+VienrWm6xswJ3DB4NLAwiuFdQrBOfnAIP1qeYqxLiW60u2WO/gt9qkSxeYUwSTzx61j3ivFceXLdfa32gearbgRjgfhW9JqUwZv3NmwIBB8kVi6oZZrvzSsWxhtdUTaMDvVKXNoSo8u5JbgmMN1OMfSrqfKACeQfm5/lVe3QBmIXdnHH901fiTCNvA9vb3+tQzdIdEu8AnOeOnerduoVyrHg5zntTYMZABC7eM9c1ajTcN3fpz1qS0KhDIuFJHUipVVcn92Tx0zzTVMYXzcce3Iz61GhZiH27ixztzxzTsNsuBRtVgxwecDp1p/mqo3qDgnjj9aghZ1WSRl2nsAOMiq6STTu0ZwI84y3OR6CmkJyKE5kDSXDv8gbcu7+L/Crei2RnVbi8+dCo2ce/X6Vl6+B5CbFON5IAzx7n2rYsppY7WMrExV8MGX+76Vo1oZLc2XYJIqoN28Y3dhirUKgn5cBWPykc/WiMRunZRkEEHOPakxIzhflZewB/PFI2IZIFeRwC5GMFj1H+fSq8VmdzeY+QvRRyNvvWx5KKoUrvI54GO3X3qrdACNyqoCeCR1zQS1bUzkvreOJlAIkLbVHTIx2/Gs/VkZoh5J8uQjl+pPoAaqzWjxSuyxFpD1AJ4/HtVjT4pGaKOQuWLY+YggDPr2PFNoi7Y9JG8hVwq8cDqPc0PeI0bKyFlODtz+HNWr7S5bcSvbrs3AqS2eSfb9Kyhp6wght+GXDEH7pHYfSgNUZF1NuIjt9gyzFgy5X0/wA5ot7eKWdZcYdiG+U5wR6DtVu/jW0UFI2kOQfl6g9adoVvJJqYZd8Y8zcMrnAPb2pkLc3bzTAbdAmVJ+855x709oGi0+CBCxI+UmPoCT+tajgyQMkTHdGMDcuckd/pWMdQuNzRSKqHsy/L+GPekjR2TL1sRBEVUgt94nGCc9ePWsyTfNej92Vj2n7/AFY/Xr0qZbhIVcxorvnO7rjnvWdqBuW8qW1ZVUsQQ/oe2fTNTYHI07eeCGWaQyYZYhgEf6w+n5d6qw6nJOJZYi6AKS7E4Hvx6+9c9CLkl48F9rFS7ZwF7nP41sXzGCw8r5QWGQ568eh/pQkLmLMcAQk3DHz0VfLIO4At0GPoahWd0YxtOqMSQzrz2P3h+NZ2l7p4S0vyAMS27t6c11UFlBPp8YuUXmILyAOeuc9+KdkJGFqFmhlje0jQqWBweTuxySOmD0q3al/OBZP3BTOc428c8U28ihtEVF3SJksGUH5VHIz646Uy0voIp5HPTcvB9hg/rjik1cL21K9yHjmWSFXEpdT6A46YrasjNJtlkLsrr83HQ9qxf7SN5O0UPmFtoUrggLz/AFqeG/MdyEJdmOEH4HGatrQlSVzYvA8I/dhfLUAq4zz6kipYHS5sjcN5W0/KQB1Pt7Ux5I761QB1RlQYbvwTzn+tS6U8NnEfPPzD5VYgDBPcVk9DZNMbb2lus3m7SjqN/TOB659al1loTpznMjZGPMHOfw7Ci5vreQEq+8q+W28H6fWuXN011eoFLM3Qhv5UhthfGSPTwIp8QKeVHJY9wPbvVN5WMMRQOH4ZmPTA/p0qzqsEttjyiJIAuMbcc9evaqCC5lf7Siquw4OerDGAuKfKZN6ls6huthvk3SABvmAznOCPxo06eS3vsSNEdycKRnmsq6lilaNSWVY5Aqgn5sYyc+3FS20u9xHJyxOQcjJ9Bn+dO1kFy/dTpDcrJLlUHzZA5PoR+Fa0MUzwrNGweLYDwc8Hrj3FMmsUurFI2kG9DksB93PWlNzHpkS4UygHGR2XFS12KjpuXri0WW3jTkZ7Dpz3/wDrVyeoaakLnyVJwpA2nGAPXv8ASt+z1iGVYyU2qSS47jtz6Vm3V4v2ld6kpghiSOfQH2pRTCTTMObZdafLDCrMVBQZ4bnk8VQszLYMdhZGOAxAGTxwRn9a1bqPy7lZA5RhlipGAvT8zVfXH86IDzElCsMMvAIx/LtWifQyZdHlXwMkR2SYxtBwAO4qnFaQSanu/jOdh64otC8xiunLAOhDEjj5fTtg8VRs5sXXmsjRuGzg9dvUin6Ek2ur5NzAvlkKpBBH58VrwuXUNjg888fnTZVh1B1kUhlPyA4706NDGnlxnORgt/SpburFJWdyrOpeVf3jK69MdDz3qXDGUo6uCO+OKia0HnSyKzqGxnnGe+Ks4YIOuF64PIolawK9yUW8kxiWKJ2Z8iNlHDEDJ/KoL9BHIInhaGZfvZctu9cj+WK24pvM0/ckM5ZYjAXVfkRSeWz64OMVj3jM188ZDJHEqwosv3yFGAW9zSsraAm29RgJ3YQ4wc49eKtQsflfHHXnqKqwII1+T8z+tWwS5UAD35pO3Q1jfqW0yFxuzuqeNhIuHYhR1x1xVOEufljA24ILepq2W+XaRgMeSD/KkWi1Gy7STyOPbilaMo/TBz1HIPr9KjQ7wRtUBf8AP400u5YJHn0z2NCKLkq7VyBhTyMNyB3qu0EzsyqQN+Ac/pU0ciq6ISC/Xk1cgGFzKd6gcDHJI6VS0IauVLLTGCqt029hwAPurmr5iIKpGSE+76CpIzhsEjb1HHU+lF5ciOFgnLA4VSapO40kkESNBI0bsAoGCB1qaNishLAZAyR6H39KxrKeee5LlQNnUjrg9sda3YYiVWWUcZ4Ap2sCdyO8mKSDaDwM5GcEHpms+6kkYKYhs2jnK/e961543WMuchQvAYkDNc/qDYZnDbtnVevf60EvQlt7hH2k87VII7t680wXiLNu8uNAw4OdoI7CpoP3kIVIeoP3ew9vcUxrUPs85A7qQuAOg9aYkie9uVi2/wCkTEhckq3HHQfT6VFZtHdvnYf3Rxkr1/xp82mxzTRSyluuCB0x2P1qW1X7EpVYyNpJzn8xRYe7IdVhh3iPy0ZnI6moIVmSdlb5T/EwI546irtxcmZlkXb5qKeXHUenFYuqXEyIm4eWwHzD3Pce1IGbdpIL0mOJQIxjcd3Y+tTz2SeYobaRjAwByexNcvaX00bmON8sxxu3AfXjuauXdxeSQAxuVBB+bGMmmTdMp6kQl6BCi7T8p56cYzWgNLM0IKSshVWJxg5/CshrvzJgzQbnxgEg8jHp65rae4itNPicpKsjruZmP6fhQ0JFaHSRaNlpCw7Rg5yevI9Peorpka2ZvL2vk70IOCB6D1x/Klt7y4urlSkR8thwxzgYPPStO9iWWCZSDgApnPHTIpWGcppV5DHqCpdggE7hk53f7VdFcXh8nyIzCSqh9x4B4I/nXNiAvqMaMhiOc7gMcf15p91b3EksaFmUEhF8wZJNV0IudTCpks18x1V2RVJb09B6Vyut6fuLeS6RxIerHAJ9R6963mjla3Bu8ERjAAxxjqCew9Kq/ZGmkBcOwLArvO75c/yoWgPUxLdZrazEjGbK5bluHPGOetaISHYbpNvmnaFBJz0J4/GptYtoirSIGwF5H9w9DjFZs6y/ZjHFJIfuqSRn5V45P51RHUk0Se6mmKxk7o87iDjnI49PoKu61HMVVkclyepbaw/ofpVvQtOSyQMEZSyZIJzgnvj+tOv0FzcIhEmFYbwxx+I/xqHqapNIwo55BbBUmQBCVl8zOduP15p2lyxp8pCtt+Y5PJGOvsM1LqqRafIVWRyXHykcD6E1n2VwkiSsAxUncQD94emR1qWhHWaisNxp7+VJEo4JA6D/ABqrbKkNuYnK7yCc46nH86xJ5HSIwsWXCkBl556496adSEMeWibygNqqeGDD1/Oml2C5au7NLhmkjiwrqoLqAxYelU7qDypY0UDYgKKduNq+nuc1attd3oDEPlUbMgZAHfPpV8X9tcRO7ImAMBc+vc/4Ummg0MyxuZlKF3LBhtIPGB6H/Cp7RGlYO52ptKbem7nn8cU68lgjQNCA+0BAewOOv0pdOuPKkVZlXYSPlJG7j+lLUa3LNtpUdtGJI8MSeMjP0HvVe4hMV66BfklBBb156e1a0upRIQq7VL+o6/n/ADqh5kZ2vEGdWOFA6qPUetSr9SmkUtS02VI5DKflOASDz7Vgz2qQxFWfOSFUDuvcn055xXVWs8kynzZPlPXd3PY+3SsLUYUtbpZFVmtQQWaTqM5yB9aqLM5LsbVlaKLOPKhgvIDHGMdP51zmu2sKSmVXPzbsFTwOcfh/9etWO9laSOGPhHX6n2zUdzYO0KifacHcNq8MPp+dC0d2DV0Y0Qkis2eEHB3Ejd0HHX0rUs5ftESsSOflI75HesewzHPPDJggcYOevt+GK1FQpGjRyZjzuZCMdKqRKLOUkQ4f5S2Mj+HHtUeNyDdwQeAB2/xpbUoRlEABG45PQntUsjbfqxzkDgexqGWa9vJbzWixfaYoWFuYRHISADuzuHrms7VJ45btWhcyhY1j3nq5HGa1LV7k2Fn9gWORVTD5RSwbJ4Oe1M1dlltrlm8jchjCmMAHfj51GOooexC0Zg2UDLNM5kJEnO0nhfpWgwDALk7R2/lVWLCg5BAI6E9KkE2M5zg9GHc1LbZulYuqQOOw4OOpwKkjJ+8GOMY/+vWcvzEAEgKeRnrV1H3bdq4x95ieTSsWmWo+oPBQHBJ7Gi0wSzTL8zcfKOlRo52KQcZ9BVhQA+wqpPU09R+ZIFVbhWCbpc4LE8H1xV5d3mMMdOWyeBWSrYmKr1C5Xce/rWtEf3Y3AsQMnvnNVYFuKZmE0aFQOMADvx1qy8SOjiUbhwPzFVEV2uRtjbywuOfWp0gm80h2x/CcZ4FUhBYy28UoiU5I6+x/z2rQ87ynSMjkjdu4AAx/OqsdnFbsMLhpDn5hnJ7VIGDPIGCsDyMr1PtVaBsSSzRSqoRvNJ7kfypl7ZQSIUkQMF6ngHp+tTpAY081VOMZAPQe/wBagkhwVSQJtZuWbOf8+1AMr6Yn7l4Y1MeMj5PmX2xVpEYxE4zIMBiRkYHf2qWJViBA8olRgkDA9vwoiZGDK5VBk8Z6H0+lO4rWKgu8RSOwG9znOcYHrTlZJYV8wAODnJGRn6+n1rM1GRbqVjFuLodoKnJJx0x3pygRQMjEB3AUkDBPr+VG5LY97u3Z4naXAGSQOcfT071kantvLhfLYEEcE4HHcn2rP1SzuCSY1Deh+7gf1qjPbvaWJE5kWYMAM5wB/PNFiOYvokMdym1AUHGc/eJrYiYPFI8mNgGQC3y+lcfHEfPXawJZiVOSCPb9a661KwWxDswCADHUDj+dOxMXcprJCk7EsELnJ3dT9PQVsTRxT2sbkK6EYBXkD3zXG63eSy3n+jopVVxtPGfUe1a2kX+6ySM/8e64Xk4B4x+NFgUjVOrWUEe1yVMZ2qiryR/h9aq32rQ3C7PMRFYBQD074zj+dUNTtoizujFyFGCOjY/nXMQ3Anv/ACuY2Q7PlHOM80WFzM6Gwxeu0UTGUhthd14Htz6etX7yX7ExkI3sF3AHPUcZ9an0PT1tUL3Mu8FhsAThfT8zUl39mM5V/nckAggHv0z7U0gs7FaDVjcOkJRY127flIwf8mtkxxRwEomQAuRnBPPb+tZ1rpsOn3Ql+WaQkqV4x3wKtsUFq6yOMLg9cYz2FNoE+5VF7Gt6xUxzA9S/HAPIH51biswyYSMbSfMEbL19Mj0rI3pbzCJo+rFcbRj71bcE5D+Zy4JPKdfbn8KTQ4u4s08MFvMk3zSKNrr1wcf0rKN9brcKxHJycH+EcdB/nrVnUYVmvCwlBVguSvr2A96iGkK8gd2GxDgZAzg+ntUF3Zi6xJNqOpoFjZoYiAw7Y7g+nbmm26w2EbROFEh4VmwAoPf3/nXSS28EAZEk2A5x2J/ziqF3psACyzckH1+UH2/ChomxRtil7d+Wsi7o+GOeWz3z2qPWrSI+UJ5GUg87MKBx1P6VsWltBbfNs4JwWxtJB7jsaz76yZ5xJEd6Bth3DOfQ0bC6GFYRMkjAxK5LHLqexB+9+VaFuAY8qVVc53AZ49DV+0t4TDtkAU4yiDj259aSCzbMoUDqQ+wdP9kUNgZV0m2TcNyxJwqgA4JPGfrTtKzNciK4YqcHzCRkDnoD+VMu7eczTedJhwNqgHjGRx9a1IdM8mzimU5lZdzr0+Xtz+NIaKPiKHMexTIxbbnae3qBRY36xQiMl2yuMDqOKbqjM0j5l+5wpA7e3+NQ2tpK7kSqViYMMg84HsPYGnZCvqalrsckxjLucqpGB+NXZ7MzQ4kXdwDjt06CsbS/3chUeYGb7oJzz6ityDUp5F2ooYj5cnnpxUuPYpNPchjgTbuIBkA3FupGP5j1pPNXygsmCPung8g9qsiNy0u8hUbjb0+vPvVSYyJO6JFujTODu5xjrioZdijd29ukwmkUKzEKG6YPt+Fc/JDI9+9xBK/lFOV3cN2xiuh1aBLm2YL/AKwDKjr8w9KoaQI5kkDRqnlEhihyDnn8s1SdlczktbImsgIlcsATxlsc/wCe9SsAysuDtxnp79/xp4yIyFAHqP1zTRl1y7FTngj0NTcdjXtIYFt4x9jjld4GlDsT8zD+EY9u1UdVjj+1ApGIVaNGCAfdBHQ+9Wo1ghtrZ9lxM5y+6GQqqNnGAB3rMvZlmuy6xyIG7SsWPuSTVO1iUtSjb7c7/wCHHAPentuYehU8H1qvGSy5VgC3A+lSINxxuO8nqRwBSNSdpkhgkdkbavB96uxSqYo2f5QwG0Y59s1WEDFFBIz785psQYysGDAE569fpQrMeqNZGVowABxyT2NWIv3zMWOAufnXqRVVV3IMZxnG0HgVahQKRg5Vjkg9zSLQ+yt9ryO7kljyCegrUjAc4OADjGBjJFUZFVyg75BIHOamgSVBkZKKOAB0H9Kd7jSsaMYKqAVJOen8gauxynyz0YDgn3qjA7ScfM2F5I7mtCEElfmUheciqSKv2HRRrIyl2JZupxio1j2XW/ylGM8FuAalkbLDkEdDnilUkzYlUqQOhPFUiWMxJJNkHeD2Hbjr6U0w5WIELtX+InkH1xVjzljRhkBcduM1XF2JVBicKynBGME+9MRJ8qxiMAKjOMsW/M1kXmIWaMZZW+VCDzntWjJIFAUrhi3DEZ3ZqveeXwzbQQcIvJximSzJtNOdJWf5lZgDhxkn/ClfqHZWYKTkn/PNX5Z9iGbdhMYJBzn3HpVd08+CNo22E8g7cYGffvQZtEVmPNYtITnHCr357etZHieRZ1CQ8l+mTwOegNdCzOseEAVQMbgOD7+wrmdQie7lJgZlHTp0x7UCe1jAtIJp54xtkKIxPTkc9MV2zxJBp/zlgRyCwHBz0Pqag0eyWJYmkXMy8qSOT7+lZ2ty3Et2UiDvkkGMjANUyEuUwLmGOa9kaIuQSyKhOM9yfbkGpIo/K3IGWIALuV+p78Ctq20kpGJZk3SGP5Vxjb361jXsct4HyiKiAfOo5+uR/Klclo1bnL2oYF1kZdxTd2x/P1rHERg23CR8AM20DP8AwL+lWpSZbtVt/NJ6P82ccD881qXh8q2khjTqBjAzxjkH3xTYIpwa2biIQJGAQ3ln5gO3p7Zz+FaN1D+5jSFw0inJVh1wMZ9awtJ0wM+9xKCTlVcfd56j2Nb9yI/ImO5nYdCODz/CPbjmkit0E90UmjBZfOII3AYzkHb+RqpcXTIy21wQisowy9xnGPY1kO0yzR7spsQbnJzntgf57UusTFGt3MXnS5CuD0I7fhWlrmbZ0TxI0nmgI5AARjlc55yM96gtb64lvpYvLACnoTjI7f1NO0N5JLctcYDKNvz8g/QevUZpbqOEX1uwDFGzzn8vwqJKxauX7QeVM0m0N5hBMfpjjkf1qxLdogKRxq833SuPlIB/MVmw3u67e3UrzyCB98HtmmXuppbbS4ZzgYxySO+fWlYvmsWbq3Fw7yIVD84B7kdh6VlHULlbxbf944I6A5HPbHuaqTaqZ7pAJHKrnK5zxn065pj3KJF5rzEbWzEVJU4HUUWI5r7Fye9RbvYCyJgA54P0A98VbudThtbXdEGG44UEZZefSua2ma4lkWQjgHc3zbj25/HNVxcpJIUuT91cHI/ipDudJHe7o1aNVAkPQnk8+nWpJ53s5GuJS46EY6E/j2qlChlSHyxlM7lBGS34+1DPcG6aK5jZ43BAJzgk9vrSDUItTE+phUwAxxkrkgn271vm6YWxhSMNI4KkFu2a5OaBredI0jImBJEgGDx2H61cs4JGuVlMhLA/KN3K/j3/AMaGik2iZ9NuFuZWkiwrcjHQge/9K1tLkiMogVQWXjaev0z3q/ZTARbJcMp6bhgk/Wi1t4VvRL8qEdFXgY9xUl2KRsvJvR5DoFPPLfd/z7VFqmmTEiezIQt94Hjt196s6zcJGwIIDAEbsdvSptLmbyvnk5J784PYZouOyehl6eJo4GiI3sBhWY8nJ5J/Gp4VLoWkKls/MB0PNaUqxBuQOmQMdMHmq0rKS53BVJ2kFex9KhjsZF0jRI4GN+3gZ9enNY+gyMks8bowjDfxe57VsXYWSVlU7gvDkDgj0qjqTiK3ee3jBz12j73vn2pp20M2tbkkkyvnDYIPsc/SlX5tqhcj1P8AWs3R4rxozLdMApbcBt5+taVvL5RicbXGcgSDIz3zSkgTNZbgCyt0TUVtdgwyDPXPB4HWsfUT+/O65FzkD94Cefar/wDaDdRb2bBv+mVZt5IZZvOZIlJXASNcKKCUrMxbLdFaght5X+HGPyq6jhVIOCpP6+lZcEm1UCggqDn5utTQzmQxnHzZwgPANU1dmkdEa+5pODznv6CrCcE55GMYxjn1rMh3hVwXY9FJq2pYAk/M2R8x/wA9KyehZqRngYA+U5IBqzG+c4IOOeO4qgJSudwH4dcVYhAKEqPm+tPoUmaMIBf94cDOeOeabJdXP26GJFOwDIfGc1WEqLMESQ+Z0KDrWrAUCqS/zE89PlFVew1rsXIiyRBxg45z3J9vSrkTgD5jtOMkA4rMNxHCNxbChSCQen+NTW1yjxFt3zgccckelUirmmh3MFYJuGSCf5UyVxgDcV3DnOeearOXlHDHjGVI/MUqoSQSxK5zjseKtEsoXd8WlVThT1CngEev1pYLqOODYGDKD8qj+ef6VHd2O8AsVZgpAfpjn/PFQvbPvUHLlcEAj1HPNNGTZrK7gqrpvOfu7un+IqGeNpF252KMn8OmRU6FghB27QdwU+lQTSJIwTIDdCvJI9h7U0gbG+SjDaxBAIH7tcbTjrz1p0jrhwpDOvO0gZ+tKZAyEK28Eck9azLu5+YKHUDAZgy8/WqsQ3bYsXdyqQsgKsHGNw5JPtWXYTQtHJKqkncQzdiR61dNsl0kY2AIBg8kH8qW502NrUom1UwNo6D/AOsKlhqWLe7SZCV2uBwqD+H3+tU55vInZmIz3B596yEhngjaM7goByM9B7e9ZT6gWj8gH58lVPGc9s0yGzS1PV1kVF3tGN+Xk25A9MYqpZ3gjgMSbTcFiwO3oc9ce9Zls0sv3+4wG4OBnqRUPyi4chsTvkkBshs//qosS2XrC7+z30vmMFRuXxyGHcj0rRk1Eq8aFAIjl89OfX3NYsKxm6a1VdmxRkgck46HHarF5byzSJHcPlZD9/OFx0BGOlGjA3Gu4doWBcsw4DHDH/63NUH1ieKWeOaFMqflK/dHbGfpyaW+04RWpMEhkl243FuearzWxt4MzMzKWPO3qcAD6UloDuVby/imnFuTlsHLA98g/hnpVe/Z5LpCiuxDkYycgDjH0rCuH+y3TY4bdvDEd/8APaul8OT+aI/PG5CDk7vvZ4HHpWq2M+pveYllZqgjDlE4Y59qWV5PJDS+QzEnamAQf/rUSiC5ADDMQ5XPO0j+lVypCyb9sm3vj5iD6emKi5oQTvIkyGPYzHhVThiPX6VHekRCOK/IDSfNux8qNznn3x0pghnmlWVdvIPzBu46HP8AMVcvdON5GEdXZgB8zHhhkYP1pXQDLPSd98JxOGMyg528j/62KNT0uSOb58rGvzDB4HPX8q14LXYqKrcoNoYccY9alhhN1H5UwA2NjOPX/wCtSbKUTlr63GxiJC3ILjBKgDuBUfkicRiI7sjOP7mP89K6prWIDyHAULn5Qf5H9ayILbyLl5dihJepJx06UrhYvaPLbrZmMDEgIX5ht69TVuYQKyiXKuSHGDwfYetZmoAwsJUbAJyQOn/6qwZrye61DDSuq7tmTwI/ceuOKVir2Ohubi2VdwYGXB2v/MelVrK8BmPIU52njH+RisS7tboTfuW3gggrn88D6Vo2h3Om7D5Hlqi9Ao7/AFp2ViU2arF5ZkXJxuyBnAY4461duDcRw7wyvHwpGfft71kXziG4iY53biSWXtnoPerNveSvbMjqAc5BAyee/wBaXKUmQ30pklLSSrnIYfLk4z/nit6wjEdsIi2epLNxknua5sWkplWJtwKkMWIxx9e/0rTkS5hiJhZxyMZHJPqTSZUdNTdk4DDOC1ZUkfmXJZTINhO4d8en0p1lNJJBh2ZjuAI4yarzymK8CpliwOW9Mn1qWWK0KoQUXJJw2ec5rMt7dYrhlQbVK8KT19a10wdoPQ9s9AKrMCXJJznn05qW9BNA64Tk8A9MVjRq1nqrN/rIG+YoTuG70x/WtmVw2NwIPfvzisu+WP7VCzp8w6sCePYUk7CkkbkETSQCdbGwRWBb945XjOM4z0rI1tXiupU8uGPaFysRJA/OrhuMpavJBMUdGtSwIAdT0I9wT9Kz9akf7WY9jxeSioA+N3yjqTVu1jKO5y6EBssclu/r9atxuqJgjLdBjvWdbuSzBTnsOOg71ZIwF+bk9/T6UNGqNKB8sFzwDycc/SrsTKTgsQoPp19qzIXZFXG5ht4/DvU8e9ljYNs3E8EZOahos1IQC+T83H0xV21JRRyCMDGexrMt5gqsG9ugzirULlc5brUjRd8pcNLGn75eQc9PapkkmePez7So4JH9P61CrAA7enXJqTflMZxjGARnI/wqkNopwC5a9ZJpmMPACfeGPeultgjDKqoXGcD+dYpkKkLGhMjfKAo5NTRXpXKsUUHgBjyPUD1q9yVodHFKuwkhWlPGSePrmor2bgKrgSL0z/MisS1d3WULJhf4cD7340+3M6yuJgrAnoTktiqQNmrDkRFhIpJHRxyKQXCRxMcBS3C57ioklBicsCR/DxkYqqLfcQwzvPZSCBVImxotI0iIV2N1BC84P09KqEAMreYuW+43p+FWogIhhPlX1DcH/wDXWddg/aMS7sdcnBA9CaYmQXV/HCRGpKgY4PU/WqNwjXT/ACbXi6gnOTnuRRq9i53MHZi6gFscDnI/CrlnarsjyDsUcjof/wBVVfQz6mlaIsVupOCQOCSeKZPLGQEMmQPmcgjJP0qSRdq9flUfKAeK527bZesYjEGPBPOMeuaRUnYumRbmUgOQQPmQHIbNcpqlqZNQWK3gPOR1OB25/nWvp8he7MdvkgLtyTzn1+lPvpre2mM8vzmMAnB+XOcY/GhMz8zHcBX8p2bzWQKWUcEY6iqthEXW4ljACKRh1GNpHHfvU97BPcTrOHRVkPKnIz7eoFaduUiW3TG1mzk9uKoi5zLTyW107F3MiryDxnJ5/Gt3DbFkYjci7kXoBn1FVdWmWK4ikiiVtpJyOR6c+tSreyapH9kjJjbbgMq4UH61LKRPZ6q80XkTMmYmKlu4x9K1Z7mNdPRpMFiuV3jHHYfpWdpejPby/wCl7DOR8zKuAfTHvUWvQedb8bgMbcA/jn3o0uGqWphaybd3FzFGpPRVAzj6j2rQ0aREjdo4lZmGA3Qbc9MfnWVIwSxUXXMyj5lcfeA/nTRciGKPaCgZgwA5Az64rTpYzW51kM7xjzG2lT8pJ78+lAn3K24nYTn5iFK/WqjETwhA/wA5wxHH+RVW2sGLybnY44AOcN7VFkaG5M0kan7PGPLcjJYY5/8Ar1FcXQtmhk2OsRXayhiAGz0q5bRqIPLZU2MOEPVcdsj+dPuImeMuUWQbcj3Hp/h71L0GkR6jfzGxEkC73Ub8dwM8j3qewvhOuY0xIeAP7w6gn9a4+eZ472NfOMJQkBcgDaOh/wAau3F8kd6l5BI3lEAEjPzADnH5UWBM1rxJpLptjnO4bct9498+1TTW8s8Lo4HPPPG32Hr9arTsssEd6iyIGzy3OB2z7Gnw386JuyfLCdQOQPX3qSvUr6hZSm2KpMzSFdu1hkLzkf8A665y8eSOY+bBtfaBvx97HXNdSZppbjzIzJtJIK44Of8AGrV5p8k1kzOAsw5UYHJppit2KWjTxtAqv/FnODlvxP8ASrdnpmZcRsipjCgj5ufWsu1mSC6ijfgqTvYnHJ5H1ro9MmLOzFuB0x0A9PrSbKiu5TktpbdA8ymVVYDcW5GM8j0/rUsNqbiJiHfywccDJPfP51sTGP7PtbDE85AqhHGFaRAzohP3QfSlcrlJYrZY5y8m1wem7rmp8RqSWIJ45XksKgFwrKRvAfqFbjFMDMZvlzsAxzwAe1Jlqw58RFguNucDj7v41WkCPKrsFVTkk5/zinyZYKpZs4K47ZqqyM4bflVYEbRwf/1VLYywrBWAIBxycHgiqsuTlwQCB1JwKZK3kwZyAg4yR6VEGEkEZzuQ8gjnOKkm+o2JzgbtxBPJY9KSZRK4TZvI6KM5JpXHy/Lgken9KgWQrgxuyyDJDA479jUDsWCsVxZWyyrdp5S7AUgLo6gkjpWVrlz5tyCsckaqqRqJl+cgDjI9605pobW1t/PutQR3jLbIXAUDJGRVDWLaFo53iubqV4kjdjcYO5H6EHqMelbJXRjezszi45dy5jboOCelWYpTzgrz2HesuGTa4KcjFXYJMtvAHHU1o0Uma0LnD4yuffAFWVmAQZyWz+Kj1zVBJiG8x8ZPUdKl81TnBCknJNZs1NeOZ3Vc4VemTzn6VYhlZTlyMfSs6InpHxkcY55qeJwFZc9Dz3LVAGzC7DB37iOcCrcTMxzjOTz8uPyrKhOFwSBgD2OKu28m3OGctk8+tIpF55IgGBDE8YyKqvbfvx5ZVI+Pm4O329qco8xkO7CY+6e3vUwDDJV2KjGTgHP/ANencTVy7bn9wI0WMZ7gYz9feoblpnmCxO645JU8/wD6vaqklzNEQYYVlbqRk4P4U61EsqMzjg9h1X2NaIlmrHOJsBUHGACOn4VbTbypO0E8ADrj9aoWxIIAIx2RT1FPWdi+CQi54YngCqTAtyTqowhxHjjAGPrVO53Om45dV68/eFZupSzxxiRFJiDffU55PTIqWxnN0pxnaMKS3BJ70yb9CW7he4jWNRs3fKwyefYVPaQC1jVHJ3eqjqO2anWRYwCMMvoW9abK7TMzxggLgAHnmi4W6jJpOD+7CvnAOc8VTjgVnMmV6gcjqPb6VOWaRtvHr16cU9WVUARRyOFAwf8A9VMlmHqHmxXmbZEyx2/3R+Ht6is+e1vPtEzzKJImGQFOMn1rZu4i80T4wq9m6Hnn603UZvIt4o4k5bop+83p9BxTRm0V7a2SdIpWTO3g4PDdgKx9RkVfMEIDODg5OGxnJwPwrRvry4t4kKFTIRjcFwoz1+prlLqZG1BZZN5VBg4+82ep5/lTRJEkUzt5i3USpI2dhOfYceorstB07yGR33fcwMHHy9/x71ycciS6jC0hjO3lRjaF9iew9q3bHX0eLY42uGyNnG76+1KV+hUbI0b68eO6VXWQpnjnJx6n0p1wii1IDLsbqWHI+lUJm+2SRygmIOQMNyWb/CtBgM7pXyRx5YGAPepGZ0tgvl7HjDkfxe9Y+oAedsRo0jB2nj36k1v3kIaMKOEKkdcED/GuevLQi1laN2xnBGOSOmT+NaQd9zOSsJZbrW8QRSAxMN3Iz+NbN4zyWpWIopJB5Ofoc9qyIF+yv5SlS0a7y4Xk/wCFTR6puHzBQynB+X24/Pmm12FexoQ+bayx4mUhzjDcEEfzOPzroUL+UPLBwep7H6en0rnrEtfQmVwQsW1g453Dt+Naom3KxkDlAPlIHfris5J9TSLK82iWN7dNI27cgPA5DAn/AOvUi6Vbw2uAS2Dn5uMc+nrS2l6zTEA4tiSxPfafftVm+O1DKqsAF5J7g96RdkZl5qnnW7pEGjypU4Hp7U/TTAYiGkycY+Y9PofyrC1bV42t8Qxn7SwK4BPXOO351TsY7mdRIHXBfBjDAkN3/CnYjm1NmPVvsWqOkUEm0tzjkHjnNb9jfxX1uPLU/Lxg9z/9asi10iTnLKJepDd/Vc+nvUtrpzacrukhUL9zA5//AFUm0UrocbDFyzySHby3XhWz1ArbhiWNEBY8Yww4xj1HrWRd3snmeaFBVeCSent9aVdThiVVIdlZM7QeoJ6k/WoepSaRszykRMrK2G7k/r+FVIbuNSYXlwuO3GR0BzUkc6S2e6X7rjpnn6iqlzaLNcbncgL95w3I44ApXKfkJdKBeq2/kYO0k84/z1rUkkUBOcn7xAbkViTxStKvO452jccZFX4ZgYwmVLDj5RwDSYImZwSdygEnP1qkLkec4kA46E8ZHt60+SUiQBvmUksPXNU5kY3BkDkEnapb+E/SpuNkeo3C8o0ZKspUZBOf8Ko2N/CE8tv3R+4oY/KfXHpVua2819zyFWPGfUeg9DXO3dnJBegc7WwoA7Ad2P17VUbPQj3lqdKsw+UA4PXd0yOmM0u75SI8DZ1LelZJkhns5IDKZCi8vgAZz1575qC1nQSSW5Ys8Z4ZhywHXFS1dFcx0C3cdrDBHeTAFwXjia3ExUZ657A1zWtandR6zcadNIJUuEW489VA80Y+X6AdhV2HUIDGBd2KSmLKo7OVcDOdpI6gVk+IbY/29FfSeTua3Xy0TOEUjgfgK2ja1jBp3uczGyod7MV78d6vQzKdpGF/rWdBISpUjJPXIqwCVx1z3HvVtKwRlqacDl3yOg6Ajv6VaibaTtJZj/d7VmxyKCpwckYABq5bSEDGQuep6Z9BUNG6dzUt2Jxt+UdMk4qza7APudc9Tx9Saxo5Tyx6k5APGM+gqzHOw+QNjPO4jpUOJVzZWT5xjAQnOc9qle++zsonVQp+6oYZPrgVnWReFmRn3g8hRjBPrV+O2V9iTFWHJ9v/ANdLROwaly1vVmk8lUlRgSucjHHrWtE4LBZG5PG4d81ipBHBwqbQfvBT17ZrQilyio3Bzznv70nboOLfUu+dg5JwDjg8Y59alEg2ZOG9AeKzxtcnJUgHkg8//XqUyhOCCMnGT6dqaGy55h2ZJIU/dwafGFJ2KpyQAT2z9areaFJJJLZ6kd6k8uXyy4c+V1Bzwa0RLJpUXypV2gMflyB19vxplnGI4zu2qc4xt59hUclzGY2OzY2BufOabIz4+fAPXPXGe4ppkvcmuWEuBwGB/iH64p4kC26FPn55+tVmcAqzAEZ6Yzn2ohkblWZVz3LbQPei1xJklwUVVBZWLZOM4P4Go/NbcQrOTjn6d+aZgFskhgM4PY44yBVec/eCk5xgNznPpTSE2R6lqUMAKyNjPzK6nIB7ViW959uu3yPlXlh6Dtz71Y1OJZZF3/Jt9sj0/wAataJDbxwF4kQcjhRheO5NVYyvdlu/X/RMPJsjGMsOSc+lcfZ2Yub8sNyqTyW5Jb39OK6bVSmGDyKoY5BUcH29qi0sqbYJGOnLcfePofWp2Quph3tuEeKOQKCpwgQYwPUmrEUKW9s7JGCm/Ltgkn8OtQ6vFIL4eazGLOGCL1PoPpU5W42x8ZjP/LPPAHYH1xVhqaEFxHqEo86PaFYbeg6D+dXpXJ8sLtBbIIY9azNOsltzkoGfHcc49AO1W3lJkaOQScdFHRT/AIVm1roWtht0jiMAqCD1U9SP896yLpozAyK5VTn5Q3c+1XruY+Scthl4IJ6f/WrnZJ45t7NKm0HgDgLz0+tXFESYa7feXDtDBEADKoByfxrP09JDLGJcIrg7VXvg85+lSajBHJiQbSoPzgg49gPXrUsURmKeVgeWFJVjyB6fpWq2MXudFZ7bYKodkDFsKTgAetXrSRpnlR2BdiVxj+IdDWPFveMB5Odnz7sYX61f0wGIKoPcEkAf5zzWcmao07RUSVlij2P99ceuO9WuZAN5Pzcnd69xVO3lMYCiQKTn5cHqKtq0ZIG1yv3gGPI9efSsnubIzNT0a3uNPIEZWQ5cYHPPaqui6S9m29lPz8knGU9vet4yBHYZLKcHgckfjTt8bwiRULgjg4pXewW1uV72V44lbOcfNkjJPvVI3xkuoEDkKy55Izk+v+FW7wDao3EMuNu3+RrmdXtpbi4O1QHB3EkkKMDrxQlcHoa+oWsm5EtVLR4HPTdSC1kgtwHYby4MhyMfhVrTwYLaITsGkVQM55zTbzAAcIMkhTv6HPtRzNDSuXIJ94jIGWJyFzjj0pJjtQfKuCCQo75qmxBuIzGQhBBYjt7VbjbfuX5hg5HfJzzUMsijugdj/OCSU+7/AJ4qZ2AwygnLEAA8HjvVOZUlmLlmEnYjsO9PZlYADdzlTz1NJgiQSMCrFVz2BHAzUNw6+SMAk5zyepojZWUEM29RgEnr7VA78jlsEjhh3/CoGPViWKtuDYz7jtTZVBXOfl4BNVo7vzBKRyFJU4HDetOlclRgDDDoTjkegqXdDuZmr2CSEvCAk3HJGOO3sahs4FimX7YJXjJJZQ21gvf5q05XBH8JJHCjqPaq8UbXV1HbxuqmQ7QxPQeprSMm1YhpbjmutIUbTY3ZA6f6UMY9uKw9d1eK71DbbwvGiwrHsZgxG0cZNX5otH+VVur18HiVIlwPwJzWNf2a6dduBKsyyqsqyEffRuQfat1oYyV3ZGAjsgTHQ+hzVpSWcbj3+tZNrL0Jb8fersMoHGQSf51o9zCnK5oxMBkdGPf0q6j5C8ndnvWZHIWLEYDfxEj9KtwyfL6ducE1DOmEjSy4GeOOoangtluqkYySvX0+tU0kZgNrZGOT3q4nzIpdd23kfjS2NLmhbsE+bOSMADsPfNX4JAVVVJIzncayo5EwA3A6denv7VK175CgSZO7j5ADkjvmo5bjNd7z5lZiVKnAGcgn+tWmkZWClgDj5ielYjSGaYErwVyN2cA9RwP51cjld3BLAFTwoGRmiwXNON8kBi+B8oH4dKn8wDILbVCgjjIqjHJycbuG5OKm3h4ipG3PJ+tKwy7Hgk+WX7DANWGc4yzNnOACeoqjHJtz5QIPQZ6/nStMCQB9w9P8/wBatJAXLh0KHLEIMLjqCaYrgjc25c9VU9KiJyxDlOeM7v0z6U5MxksSqHsByKZDJ5eXKso3EZZgeBkdPrUbSIg27lyuO3P/ANeqwYlgsWW5OQOn1qvb3bXE7pyzDIXjpj+dMnYuZMjhnyTncwz2H9KSeRtjYDB+uD/PPoKVgjbF7jnJPJ+o+vamMu0LlFdh0VgePahMTRlat50ltkSS793KLgHHvx+tWdOQi2AChBjg+g7fjS3G8sAihwB0IyT7fT3qaBTHGcN947gAcD6H3pt3RNjF1KCR3SMKzLku7c8e/wD9atGK7t7G1i3Nk8hcdz6ketTu0bR5cZAP97GPqfesRrM3kgRkk8sHkDsPX60J3JtbYmEcmquZc+XEOST/ABHtxVi3VrOKNJpiSeDkdB7VbtgI4vLjV5FXjGdoz/nmqN2++bdK6kkbSCMfgKV76Dt1HKiLhkDlvuqxOcjrTjPLuJbyxGvc9/TAqGVwrJDtJyPvH0+tZWrXgtFUrnATg/1z/SqUbg2NluUDzFyN2ej9NvpXNX8kD3TIjBSBxzgCr6RTXYMskmxWHAPXNUP7Mea4ZHzhTuwB1/8ArVqtDGTb2NPTNpt0V1wV5xnPIodXjusxYCL8vTG360+1CwgIEHIwS1JeXMhijMOGXOScdTn/ABpFEtqGjI86Ryd/rwQTx/Ot+B2YlyAFyR/vdBx7jFYEFzG06xSptkHzEAZx71qRSAIPLGWDfMAe/Q/SpkiomxFOrRNvyJM9CAR9c1ZDL5aFTztIKN90+1ZHngRqMqMjbgnqOhzVi0ldXIGBnkEryff24rNo0TLtyUkgXcHBxlQB09M022undPm+U4ywDcE/T1zUPmgqeFIxuG7qfXNQttBRlkIV2wVwAB9KkoW+v2cbhnduCEAcfXntVd3kLKCp2AZ346D6VZlCeY7KME4yQeT7ZqCdysZOc++PlJ9Ka0E9S7HOrxorkZOCFYY/OpS3yqmMbecdwf8ACuZtriWTVWjdikRAO1h1IHt0rfB4RQThjn1wKiSKixJblomUABvYYBNTpIHJKsck564B9xVZwquzMSuOvUhR7/WmnaiqwCjPRQeMf41JRa5G4kjBwMKeKrs+HD5woBXnuacSSSGJ9Mdz6UwktyD2yMcDHrzSGOZsjoCpwduemOtUZLox+eHUgDIBA4z1GPX0qY7Rh1bGcj5up96rTA7RuVCoGeeeaFYGirpNyTCylR2PXnB7kdvpViWb+M528Z4xzWZFaLC8si7A8h42nj8fakEhV2w8jsDn5un0puKEtNC7LcltxYcdSMdKggnla4iNqpFypHlmIfMW7fWqrzlmG4AAjH5VGXYzqsRIkz8mzrnPGPehRGzbmN8Wct4dgeRhkuLZgCfcA4Nc1rc93Ldy/bkKXDIPkddmBjgAdh6VtX1vrd1OGeNYXZQGUXIVmYdypbgn0rmb4SwzyR3ayech2ssh+YVsczZyFpcb0A6jPcdav248pid2SxzjHSubsrjJb5uR1HpWvaTr5m0gjjvW8oHnU6hvI4bI596twMVPXtjOKy45Vwh/Dg1ahfIHmcg9D6Vi0d0Jo04WC5JYgHhRV6KcbcjIUcc9TWSJQVOTx6YqxDKFA5LEf54pM6IyNdWBA55J5IPT6+1TgEnc4Dcn5W7fQ9qzIphhS/IJ5OBmplm5BXII+XHXIFKxZfSSVZVeIl4lGGC+/wDSrtswZBk5X0aslZhKzbmIAxjOe/rV6Fwi5IIyPlAPUetJoaVjRVykWfmPPzKT17ZqZZi6fOgII42+3aqBbzHUrtRgcDB6YqQSEdBk4xt29/qaSQGq8jiMBiMKMk5/nSxzrjlztHGQOgP+elUYZdwU5Hzc/NxkehpYnO9g0g2jgkD9P/r1SJbsaZkEcQKMGwcZbkY9KYZi8YZhliDz6j/CqTv+7KoGYKeOw/CnpyhMilVPOT6+n5UxXLSuTFyARng5zu+lPQc7gq7uefQelV2nEMY37ScZwOcDpSOpkIRDJjOc9x+VAi6zjZlyDuPA29foaZ5m7JYYCttzn1qDdk7fuds59O2acJcgsQA56be30oE2KpC7lUsFB4IbnNZl1qwFwYIwXZxgKG5z3b3ppMguJd87qr8BevH07Vj6jIkMwlSICaM8DptP19auMddSHI2b65LW4jBUEHLZGcfh0/GnWsi+WCcjacFj19uO/wBKztPLTKtxICCRtC7SWIHcD3q1J+7UlNsYU4YgZyfQUNdBI0DNtWRMqWPAB6YqnKwKs4Idgoy2MEfT/Gs+2vi8hRAJAvGVHP4561NM7cL5e6QfdJP+fypctir3Fiud4IVTsGeOm4+tZmp7mjbyzkr2PPXH5VZkcRFg4ZnYfdbp+NV5WkyHK5x1IOBnsfWqW5DRnPNJbxkEF++wkj68+tRxyqLgS7wr4xhWz/k1DrKTxozImRjbgngGs62ZrVYgiHcgDFgMn/8AVVmTbizpZCVAXcM9g/OfYf571BPIsaxGNOGY8A4yO1MVndgzDC44JJxk+9UbiVZYWzu25I3KOR24osW3pc0ZiExc5BLDAAP9al0q7E8fm5+Uk7lJyAc/r9a5WXUo7a0eKQF0jGDheR6GrWiXRjkjX59uQNpYcg/Shx0M41U3Y67UW/0KdUUP82UyMnn/AOvVnQ3mW2UTHa2MABjj8ahVi0RKZkJ6j+72p0QkHAG5sggZ5+uKz3Vjp8zWZmDEhSQOo3fr9KhWRlTexBY/xH+EduO9QeZld23YTwz54z9DTgG8pkdRxzkDPFRYole7aWHyy+WQdTgcVSUmSMtKqkKcBRxn3xSR/LddEKnhQQevp9akliPytuY7DnaeCT6Gm9AH2sEjMGkwD125Bx6DNXtwDHaH3kk4zyeOlQRyKtuGOCBwRnG45pkrDy1+XbJnjd6Y61mykW/MDY8wYyPXg+9NlOyLCqoAPzZ6/h+FV/MwCWBUDkDOcgetDkMqbmLA8n8OnWpLHrxnzWIbGc9CT1GKfG+chm+XqQTj8vWqYcAZJTnnrk9e1NVwcskgZicYHv3pNNjLTsGaMuG5OevX2+lU5iVO5SCobGT2Pp9KWSRl3bZFAbt6juMVWZgMHLBR0+bp74pICO4lB/1QPcM393NV2fGGxjOQcdRSTTAHgknuT39M+9V5HAXk8g9uuKuwmE0i7D82cHk46Cm6fqH2G9huGXf5LhsZ6jpwe3tVWQsHOMY+uadpl1Bb6nZy3nMCSAvxkD0JHfBwapIzk9C1c2+kK7NJfXsW47gstnl8H3zg/WqHiG8FzeIyRyxxpEkUYm++yqMBz9avXGotJNcafrt2t7aO2VuUbe0LHo6H09VrN8W3CNqUKw3EVwsdpCu+I5D4XnFWc0pWPK7efy8DAz61q2U5ONrZYHJyc1gVZtpvLY5546+ld8o3PITsdZBOSeADnOe9aNvN8o4w3oT0rmLe8JIJxkDOD3FatrIDECG+Y44H9K5pQsddOobcUylioILd/m5q2p+cH1PbtWNC8QYMoUMRye9XkcgDf94jpWVjrhO5qI+MksTz0qeMndgHIHJ471nQypxjkg9TVmF+cAkA9OaLG8ZGgkpIJ4yD1I6VbgzICHXJB6seKz4nXOMgjHrVtHzgEADPOOamxsjQUhwm4bkHGF5P4VbQrhcn5c/MCDn6VnwHB3KucDkk9fanh5Mk5YErnp0HcUhmkWRWAZVyvVQuSv1zTmuArhFVXcn7xHf3qkJCgCRllHPJ659T6VIkgcIEbKdTxjJ+goJZaSbMi7F/3pBztPpipEfy4f3aMo+8zcc571Ujky6qMAp0Zev41dj2SKQVLHdng5P0NU9iRwVd5OD5mckA5wv1qVGAJYneP4drYx7fWmR7HkILggDO0Hp/hSNKqkuWO7gccnHtipTuMdE4YMpPA56cH6e9MlAMqtn5egUjIyegqB2cZJ2rk5wDjHPfHc0GVVcKxUt15BJHpVLckbLEruckiRsbsHGPYAe1Z0mnRS3geYSOVwwBOFHufXFaAkyFO7JwecAN16f/AF6qTsHVo4wARkntnHqaq7JaRa+0LFFhEJZMZB9z/Ksprl5ZJUz5a7iB7/j/AEqZABBsUl8juMj1IpGjR8EkqoGQAM7h/SmIZbBI2MiyB2GNuM1I7naXYNgnjPUH0pPM2hn2lSDnGRwPpUMk8iRgtGNh+Xd1Jz0o8wsQ5kwDKDjOfLXqKWVnjC7SVXH3gf8AGlkn2h2diQq8bh3qu0vyDI3NgkluM/T2piFnlURj7oIPAYZx+FY05czp5Hyxt8rcZ31NIgbdvLH0OefakYRkhVkIOMfMevrTM27kh3eQ0ZfGeQPQCoo1UsDwwxkkdQKYzExSAHA9QagtnZCylmcHkD+7TQm1sZOoaOy3Ukxb91IeAedueR+taml28FokCSuu5CDu61oTJDJEUlkUF8Ak8bqinsjJ5RjYlVIznrwKZKpqLui614tvdsh3BXOVxxjuAK2UlRihYlcDJwe3uf8ACsoQQskbbQVTgAnBH/1qtCZigyoIz07D6e1Qzoin1NAzASFnUKCQQSMA+9LK/mRkow5OQQc8Z5qrJIUUB1DgYxz0+lKCHlkHAC4PzLx71JZIJFXKy7tvbPf3FPjnCOwUt5fJAJ6etUHQx4X5856Z5XNM3tghsHngjjpQ0Bri62c5C4HBY5B+o9abHKfmDcY4J7k+1UZHaN0ChdpGeTnntmh5f7q7mIwfT8/WosNFozLIzKY8sOMHpn0piToVZg4Xb0BHIPtVRpCdu2TBUdR6fSk5TDHAwOmcY9CaVh3NEshlLAjce+31FQl2E2w4VSflI45H+NUIXkH38kjkZ6H3qZnbzSSMZGORxSaLWpZBO5WAYsF/FfpVWeRC2UVgcev60NLt28EENjk5GKrTykkbGO0e/wDOpSAY7AKenXHIzn6VVkcnOD7DtmnSybjyQfTvVWQgAjsehqkTIbK+AVydo9O1QRhp5Vji+aSQhVUdST0FI7fNjt3GaNPukttUhkkUiE5V3U5KAgrux7Zz+FNHPOVkWJLK1R/Ke9kE+0kvHbs8IA6nd1IHdgMVgajHLZXEkNwAHUk9cggjIII7HrmurljnXUbW8VL55YI0RUhQGGQKuPllztVCOTn1Ncd4kvI2uYoo5BIlvCkBdDwxXqR7c4HsK0UTjnM4ilHQ0UV3o4C3bsQ/XoMitiIH5TubnGefaiisZ7msC9DIxwOMA+laNuSbjYT8uwn8aKKxZ1RL0Y24A6Vch5wD7miipR1w2LMBzGx6bc4xVuIlWxnPQ8+9FFLodCLsDny9vsee9ShiDt/u9+5ooqCxQSWEf8LZqzMTDaCRSdxPeiiq6GZLGxknRG6cAY6ilikbe7A4ZSCCOKKKkotO7RuMHJKhsnnnNMnmfDE4ODjke1FFJEkRciUIvyqE3cdyRVbexlUEk85JPU8UUVcQY52ZrYS7iC67iB0zmq0J8yNHbBJBPsOe1FFUQxskmwNhV4cjpUcbEyEnqRk0UUAiG5dlhd85O5RzzS8R7AADuA69vpRRTYjn9VncRqwP8eMdqsLM/lopPDLzRRVmX2h6OWC5x2PSqcjYnY4BKnAJFFFD2ExEdvtKx5+VgCfyp4wJyQBnZ/XFFFBK3LEkKzgeZk7MEVZhcyPk8Hbnjiiig06k8DHbk85JU57ilhYpwvAJGcUUVBsSLMwVlwpXrgimtIyscd+1FFJbjHjJV9zElCAM+hpWiUwxy87n5Pp0oopkleKQl/LIUqcE8dakdiDlfl+bHH0ooqChseXcliSQP6VEZGZ4yx3ZIHPpRRTKQ8n966jgKOMVE7sXxnADdqKKgsb5jNLtPQZFEn3nHogNFFQ9wKsUjNtBOAc5x3pkoGNoHA5AoopoiWxQdiX61Un+5v8A4qKKEc0zMvZXjBRWbYw5XJx+VYl47eYD1yOaKK6YHn1D/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Reticulated, hyperpigmented patches and thin plaques with fine scale are present on the upper back.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Confluent and reticulated papillomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 323px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFDAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDprmKe8Km5csFOQuMYqIRFXEUS7nPatm5jCpz29Kbp8H70yv8AeryWz6JRbJ7DSPkD3Dlm6gAcVppZ7ANpx6cVZtVyFAPHWrDjaoBwc++KRKumUAzowDAHHcVZilyMsOB14xmmFADt25z2pJCNmO4oTG1cfPdpHCWJHHYVymr6u7Dy4ss7fdUDk1p3aNITuOFPpVeCzEZBRMZ79zQ2VGKRjW+mSXDBr5mwTlol7+xNdHbWuFAVdi9AvtU0VqPl2ybT345rUitxgAsGz2PU/SkkVKV9WUo7cxr93GOw6ioLgblPzbT7DqfStp7Qrkyls9OO31qk8QJOc49M9abjYUZLcyow0w2IoWQdqtmNWCMCQf1qdokY4j+Vl5ViKrXMmVDngg5IBpbGmktiwZ8IBkg9qqzzDnJHQdao3F0I93OMc1garraRozl1VemSaLiVNt6GnqmoJEhGcvXHI17rWom10yBp5AfmboifU1f0jRtT8UzZjEtrp5OGmcYaQe3pXq/h/QrTSLFbS1jCIp5Pcn1NVGm5avYVStGirLVnJ+HPAiQXKXWrSC8uV5VBxGn0Hc16DaJsAAGNowB2piRhWI9DU5GFwBzW8YqOxwzqSqO8ncmDbeCeTT+p4GMetRoeBkZb3pX8wgFQMdxVGZE24D94c9agnkKOEVcJjGR2q9wwxxnuKo3u5XwhGe+cmolcqLuVpiMbmbj61XeQK4yrbW7k5pt45CiQKpJ7Dv71GjK8eWbcF7ZrC93Y2UdC/bOFgO488/nTfOTnt25qFFDsfmGTx8vSpHKBSnYEE+9WmyOVXHLh1xk7fyzUwxnnOOlRoN46YA96sDuo5NWiHoPVV28HJPA4qdRgYGN2M5xUabuCRgdKmTg98dq0JYSYOMdev1qldSMF2qfmfv6VdkwAc1lXkyQuHkJKAYJHbNJtJ6lwVwjiBGSeaGt1OcDOKhFwVzhTs9dtNmv4Y4y0r7QOvvVqUTp5H0MTWrUy3kSbRlE3NzjAJ4qI2eFVQvzE80lvcPc3kkkgwHPQ8nHb6VoOyjO7p1wK5JtSldG1mlZmQLeMzcjC1cWxQL9wc0tpHuO7PJAPPr1rWSJWVR1OKSVzOUtTGFnuIAXAx3o/s4EA4rooLZGYA8IelOktFj+gPXHWr9kZup0RzL6fx8pYfQ4xVSaG6hHyTsy/3X+YVvXWIyVwcH9KzZ1Mj5Xk/wAqzas7FxV1dnPzxzrN58MSRTjjcnRx6MKvW2oAx4uF8t+5IyPzqyERt4I6HqKkmsFcfMcH1HShXKY2G6ORgqyjuprStbsMRg9K5iW0aGXEJK8dR601by5t2JkXeoPJ6GmmiZRZ3sM24cnr6UkgDrjbXMWGtxMApfax7Nxit+C8DKAzjBrRSMXF3uV57cMc44PtWZcQAqQO/brW+ZI3XGSSemKpXMJJ6YXHWhoE31OSvrAyNjAzXPahod1CxlhxIvXb0P4V6BJGoByM/TvVO6HyDIwPQd6m5Td9i08YYjjIqSKIAkYAxjgU9MMRtHOevrVyGPaeCDU2uac1ie2QqACPmP6VJIBgDdn1NKgCocn5jTXIJAz+tU9EStSF1IPGMVXlXPIP4VOxJJBIxSRp0I796zZaKotskYzx0qUW47jK55X1qyAuRjIPX6VIAQwY4yaaRVxsUeUTB2/73Srlv5a53oqkc8nGf/rVVLDccdB60ZPpye/tWy02M3qWZ7jghOM/rWa0gJxnLDqaJ5CBjt1FZtzdKh3MwH41E5XKjElnucBuhxxWDqGpiPIBGPeszXtcSBG3SKobpjlj9BUXh/wnq/iuUS3W+y03OTu4eQf4VmrydkdKioR556Izn1G81a8a20m3e4n/ALw+4v1Ndt4b+HUaFLvX5vtV0MMIh/q0/Cu60TQLDRbNbawgSNAPvAct9TV4IEPoTW8aSjqziq4tz92Gi/ErwQxQRBIgAo6DFTKAQQKbINpyORTHYHDAcela3OZIjlBBJUgH1FIXJ5BBxUN1PFGu5ztI6CsufUpAD5KbB1y3U1Lkkawg5HRxsAoLfKPU1JHIuTt6euc5rjIb+WWR4mZpWf8AvGtGL9wAUUq+ME54NCd9UVLDtbnToo3Ek9TxxVO/couQB/Oq9jfiYeTKfn7Yp94nIGTtxzzRUehjGNpWZk3LqDl88dKz2YvKxRdoOM84qzdkO+W5A9qpNvS4YHG1QMfWuR7nTsaVjKScEYYcc1YZVYbuSc1lefLgeV1POcc1bt5S25S3zDGc9q0jIlrW5oJ9zg4qVHGTgnOOtVlJYAcAdqsxEBgP1rVMysXYVZyCzZ4q2I/7zCq0PUZqzknp0rVGU7kMylgeazbiIuHVwCp4rTkBznkiqc6nPHTNZTRpTdjnpkvLYN9lJmj6bWOGH0PesS+vPnCXIeNx/fXA/PpXatEw5yfy6VWmt0kXa6KwJ6MM1i4s7YV7dDkraSOQgIy5J4OetXnZ4/mI3DuKuzeHrJySsfln+9Gdv5VENCu4R/o14zKeNsybv1FCiVOrGWpSFzsOAQPStK0ui4BLDjtWXcwzWhZb223J/wA9Ihkfl1FRRSp9+1mEijtmjVE6SR1UE4GAx9qsvcg/KeSBXLQ6gM4kJBFXReKSCCeRVqbMnTL98olK8HOM8Dmst4xHGwjBBHX3qf7WNw+fH4047WwpOS3Wk9dRq6VjOjtZAinqxPHue9XxA2xQQCpGCR3q5GsauSB0GFPvUyzKucKvtkU4w1CVRmLdWbqoyoUfTn8ay7i0R0bCn/eHGTXUySIxAwuTyTnk1l3iKOC5XvjGaUooIyZylzYr1XJx2xyTVQvdWq4imkVT1XPAFdPMmOSWI7cY5rPliByhHToM1mXuR6brMykLKxIrcS/EqK3OTwawPso6DHFWocqcegpqTREoo1XcEZ5xVK5+bjByKVGOAQxFMfJb7wOe9FyErGlEpUDn5u3tV+EFfvd6rwJtO4+uOuMVd5z8rZz6jpVbMHqMckuB+hqpM4V+WwM1efCHGDmsi9CseHJwelKRrTV3qWRL5kilSfr2q0ik9OBUNmiKBu5IPFXjtDcnBpKJUmk9CJeCeefTFKWA69+M0jcDIxx2FR+YCRnt2q1oS3cmXGMZOO5qOabaMl8frUF1cxQRMznA9TXnvirxReJFIum2sspXvg4ocioUpSOm1jWYbVGBfHcZNcXJqt9rV19l0WFriU8bsfKvv71J4O8G6n4pKXusSmO0PPzcA/QV6/pNroPh2BYrExKQOdo3O31xRGm5avRFSr06PuxXMzmfB/w4jtJo7/Xn+13p5w/KpXpEUKQoFQbQOMYrFm8QJwLe1lb3bCg1Um8QXxBWOGGIHoTlq2jKnDRHFUjXru8jpy3YY9aoXd5bwMDLKoPpnJrmJbq9ugfNuH2+ifKKSOEK2SePU1Mqt9kVDC23ZqzaxHnEEMkg9TwKoTaleupCpHGO3GTUqxoPlPcVFMFQYYgHPX1+lQ5M0UIroUTK+4vMdxP8ROaguZ8wHBp2oTbY228Y6/WsWOfdDICT8pyKzvc3irK5Y026MGqqTyHBXP610M16hQNnj2rhLuc+VuHyuOQRxzUkmqxiz3XM5iQADav3mPpWlOpZWZc6fM7nQprGNXsoEIM0swVUB5xnk/TFdfeZi3EnJ7AGuT8FaQIw2rXNt5NxOMQq5yY4x6+5610lyQSrb8/3qTvZtnJUs5+6UWbc4ypJPFRumZGWRcN3I5OKmdwzEpjA6kd6ZcMXZyRg4GPXNZjEt5okO8AsCCM4pEwzM4J5PNV42MMY8xQTg4Hv6VJayoxOMYIyMdqcX0JkupoRqXGM1aiRxgkAgVSikTgA/N2FXreQNn5unB+taxsZvUvw5I6/pVtDxyOapwEtyDkVbGegNbIykMd1Kt1JqNl35yDzU5j4OB19aZ5JUDjn0pSTFForMmcqppPJB+nrVlVy5+vNKUzxjip5bl85TMADjA4FTqmB6A8VLsOeTTlRSQf0qlETmVJYicfKCD3xWVfeG7K6y8kQSQfxRnYT+IrocZ+lHl7sg9KHC+4Ko0cDeeFbpAWtLwuAeEnH/swrLudO1WzVmltZCn96P5x+nNeoiIDtnFKEwMHHNL2KZrHEyXmeOrqbRylJVYMOxGD+tadnqqvwX68c9a73WNLtNRhZbqBJAOhI+YfQ1wer+Ep7cNNpzecg6RSHDD6HvWcqTjqjeNaE9HoaEN7zgnIPFWhcfKPmrzz+1pLK58m5LpIOscvyn/69bVnrMUuBu5HYVlcp03udO0h5JJGRnNQvLkkDPPJNUo7tXHysD7ZqxG465zTvchKxFMQ4+7z05qBkGR+varbKGwc/hSCEFhmlYpMreWNvHWm4ZV5OOO1WtrY+UcUvlq+4/dx3osFyi0h2nHccVWaRzjaeT1rQlTyw2cEetYt9MURmTjB7UWBeR2IjAPOTnqKmXhPkH65pqbTGADyTzzTSDn5c4z1zVSMiNpWbIJxz+dU2jYy5fO0npVqRTuOeGx1FLgKQo59eanVm8ZWH20ZUAE8jt2FWQeOOvrUSdAMdBz9acd2DuNWTuOLZ6DAphiJwV7frRxs4PGfWlhkwSQfmHQYoD0GvZrKAZMYqOTTrdVwEAU1ZMr5wMe9M8zP3uTU3RSXchSyhiQBEG0cAZOKmRVXHAA+lNfcR64Pf0qZMBSwxgdR60LUew7YCOBzVaY9TwMCrMx8lM5JGcjHXHvWTeXDJMoByp6GiWg46j7edjyOByKmhmOXjOAw5HvWbZEbnDuV2tlQe+ac7jzgSfWktipxRq/aF8sYIyORVO5uMj5COKoTT7ThT0FUprrbEx3AU7kKIX1x94bjjvzXPz6gIVYAjJ6Cq+r6ssaO0jBVHUk8VkaJpup+Krsx2SNFag/PIeuKS8jZJJXb0JrvV90ojhVpZzwqIMnP9K7XwN4Pnmni1TxCOQQ0NsRwp9TXSeEvBenaIiukQmuO8knJ/CuseMKOB9OK1jStrI46uL5vcp/eU7vAOMADr+FUJmILFifnG0cdKdeSZP3iMdjUEn77yhEQMDnd0qZu7IhGyGk/II1Ue+e9I0bTRtlQFxwasW9ksx278BTwPWrcii3hYKoKj0FJLuVJpaGG42zxvJwV+Ur7GoLJ8PLjHyt09qdfvI7btmFHXjpVFZMXgJbac4OO9QnqOS0NqJwtwGK8MK0oMD5gOp5FZKOCFJ+lXUm/fBR908nmtVZGRt2x6AcDrVpX2tjGfes6BsrkH5u9SlZDHw3PYVqpW2M3G5rKRtBPemt8oJOAB1NULWWQIRP8AeHpTbp2nJQjP+z2FbRfMrmXJaVh8l9ArYMifWpUuYCMrMhI9DVHyCUCAAfhWVq8BgiDsBjOOBjFZy5oq50RpRk7XOnPzZII/CkXAXA61xduJ1XMc0oA7KxwKtxajeQnmYsOnzKDWarJhLDtaJnVIc1KjAZA6etcymq3vRViYH1GKmGpXp/hjz9K0VWJDoSZvtj8jTCCTxkc9RWEdQvQPmVD+FRnWLpQf3EbfiaPaxEqMjckzkkZ49KpTjCENnPXp2rLbxFMnDWf5PxVGbxOeB9kYZ77uKl1IlqnLaxl+LdNtdRtzHcQxyj1ZeR9K8e8S6VeaNK0mhzTNCi7milOcfQ17BdvJesWXCE85zmsm60Npt2ZFwV2nK5zXPzXkdS5oxtFnluneMb+wKrqFtNAx7sMqa7/RvFFvcxpu3KWHBI+U/jUF94RupMrHPCUP8MqZ+laPh7w7BpsPkyxCRc5UdR7/AP6qqST+EpTdrTR0FpNHMoYPnPvVwgAY7fSmWenWcYzGmwHsOlaCwIvCkYHekZtozwrBeSfyqJmUJgnnk89KuXIEak5JHesy4G/oc7T+YxRYQzcTb4brkgYPWsW9GeDx34rV/j2j7o5wOxqleJ8xwQORSZUWdGHKyA5DD29atRyDI/XHWqiLjaQalIwcgAMepq2RZMkkb7zH5SfWoTkEspGDyc06Vg8R5yKiAzkPgjPHPSkUifzSEAx97r7U/wA0EkDIA4BqnJJsXDjkZOQaqi4LSBUPJGDUtlRVzSeTcoIP4UkRwPfrUEeQeOVxiplOBjI4pMtKxOGPQnrTS4OVJ9vSoC2455+opWPXHQfzosF7MsiQeWclcLzk05ZVJwMAEYz6Gs9p3BPzdOMVW+0lOv3h36DFVdhualxMuXJA3cA+9VZtjKGAAIOQKzHug25t2T6iqc9+EQ5bA+tJu5S8i/dOOSDyOR+dVZrsRsckE9PwrC1DXI0UhmBx3NcpqfitHYi3/esegXp+dK9jSMXI6+71ZVYndyOOD1rmNW8TJkxQZll6bUPH4mqOlaLrfiScKitHETzgYFeneGvhxZaYUlvcTSjqvUVUYuWxFSpTpbvU4Hwz4U1PxHdxz6gGjtc9MYAFe26TY2+j2kdraQhIx1K9T9atxRJCgWNFRQMAYp+DtG3HBrWMOXY4qlV1d9izE5CjceT0xRE7sT5mcAVCSSQoyMH0qctke/eqMinqEW6F3CrnGAfSs23iYIH25LEcEfrWzcjdGUGM4z9KpSgxW3y/eIIrGa1NoSurDTHKWBQhSR/D2q/boAACwYNwQai04hgAx+UcVcjjgixIGzTiupM5a2M/ULYFJDtwx6gdK4rUYWinJJxg7hj/AD0NeiXrBoyRyvrXGatas4x/EpO0g1MlZl03pqNs7vzItoHzAdas2rySsc4HbOazbRZIJdpOVIxx0rTtsK7kKB+PWlYV0jet5CicfeAyau27EY3YwelZlnNkLngj0NXomAlJJyPSt0zJl2ZCIXZclgMgmsa3vyly5JHJzWx5uUGR8pHeuLv0tdL1Lyr9nSGQ5hl3YBz/AA56ZHvWnPy7FUY3lqdjBqUfG9VYVS1+6tHsXBOCSAB+Nc/51ugLR3LOvpgZrH1C+aedCcFEB2gevvROvaNjeOGXNdaHdB7EwKLc4bGScdaybny1cDIJyBj+Zrn4dQKQBdzZ+vAp0eoZLZIZscfWuWU01sUqTi9GdLpzpKMlRwa2FtkkHHBx1rlLCbyYlXI4Fa0OosgA3YHrVU2ramdSLvoaxscrletUbmAKMYwc80+PVAq4PHGM+tQ3F4JUwDn61rLla0MoqaepnTxjHTg1mahGmyRRyBnFWb65w3HQcVjSb/LV2Jw2f51g2tjojFtXNCHbsyOfWpSqiPd69qybGciFyc5LEVqxkFlCtiQj/gIH+NTFcxU24siMnUAHK8moWc85IqZvlX5uUU/QE/1qlMflPGcnBx2pNMpNMsxXLAZzyelTpeEYyQO31rK3lQFxz709ZArLnBY0ldCaRpXE28BtwBA59xVUuGGT6Z46U0HcPXINRknbxxjmquRYRgseWHfjFULogBu+OelWJpgq+5IBrMnkJyw78U9xJM7BZAWweOMZxSFj0zyOmajjjZfvEhe2ac2M4BGW9e1aPUzWgiFn3Flx7CpGHqTjHU0iHAB9Bjmhs47k56Ukh8xVlhLHoQME8elQwRYkwwPGSDWm6rsGTgnrjioiB/D26VElc1U9B6AgDGRSyABxgjPtTVJyOccUMM5APOM1QlJshd8cL1x+FQTzeWuTndUjAj73FYGtXrRZW2RpZT0VRmkWo3dizcX4j4ZgM9ayLzXreLJaUH8a4nxJNrfmRp5ckIkbaMCreieC73UMSXMgRD1Z2/xoSb2NWoQ+JlnUPF0anbBl/ZRWG+rarqLYtoWVT3PJr0/SPh9pUQU3VzCz+gPWu0sNC0izi/cRQkj+IkEmqVOT3JeKpx+FXPC9L8E6zrDbrhZdh9TwK9F8O/DOy0/bLe4kc9FFd400S7fLdVA42g8U83EJGQ67qpQitTGpXqT0WiG2lpbWUQihRET2HWh5CrhV5FRfa0GdpB9aryzM74ixg8Fu4+lNy0MY07luaYcIT/8ArqTzBjjn3rMmK4yxJf3NRqxLhUJ3exouzX2F1c2o7gP8oJz0wafv2ng/N+lZ0VpKk0bSH5W9+c+hrQKDf8ygE96fvdTnkknYoS3Wxm3bhx0B5Y022ZJWXnqCPzqS8RWIIGW6bvT6VPawqijc45wKytqaJq1yWyQrJtI+Rhj6VYnCxrsjjLNnjHamxSrvwBuC9AKswyh2DY2n071okrWMpt3uZ7HyLdxMCWPUDtWLcwPLhlwFJ5rpL9fk6bvUnqOaw7gyRTDG4KvOPUVlONmaQd0YOqu8D/KpLKwJ9vf6U5ZxG8bn7jdT6VLqxE8jNDkoRyT61npIjRbHPbIx3p7q5T8zaF8Fyq4yeBjrWhZzjICsCVGAc9a5uIAwh8g7eas2lxiVXbdzxijm7ismdfDISwBB/OrF1ZW2o2xt7y3SWFhyrDINZVtMrKrKTjvWpFMox1K9q3i7mLOQ1P4c2x3No+o3Nmx6Ju3p+Rrl7zwj4ps8+X9nvkHXYdjV7GGQjIalXb8oHSk6UXsaRxdWOjd/U8HeTVrPK3ulX0frhdw/Skg1y3SSNWLRyscASKV/OveGVSCMDn1qld6VZXaFLi2glDDkOgNJ0PMtYvvE8st9W4Bcg5/KtSDU0I4cZ/lWvqXw806VWbTJZrOTrhDuT8jXHan4P8RWRdrdYryNT1jbY35Gs3SlHoaKtTnomdGL0OBtYUpuuQScnsfavOptYutOfy9QtbmAg8l0OB+Iqa38V2kmF+0LuHTJwf1qC/ZvdHcSy73y3PPApCmbUP8AdIBx6Zrn7fV4ZcFZFPHrV1dUiKjJGB1HrSsD0NeO2SKGLgZHXNLNLgEgDZWWNTDsDuwP1qGW/HZs+tUiW+5oSzZ4PzHt6Cqhm3NxyAc1Sa9Gcg1H9oBI5OOposTzF8SHHI/Kp0OFzzjHas/7TkHripYpmI7j3NKwKp3NMsFjzyCSBTSfmPTpiqwlJODxTvMDHgfLnvSsNMhuwAGyenIasuUgz4znnj61pXPzgL/CPWs4RMW4z2PHU0DTR2itj7rDI6g0+MgsRxyfpVJZAvXPJ4NSNLjPOfYdq0TsY8pYdgASMY9qj4HJOQailmQLgDnHb0pFddoyRgU7gk0PZxx24pBJgkZ9jVeWTKfPjNUXum3OOgH3vapuUo3NZXyBg854qxCRkYA57ntWHFcgMNw/Grcd18vB6UXsaJGwkSzMVfoeScVaisrSPO2JeQMHHNZFvdAcZ54PFaEE6kswPXjnrS5iuW+5ZOn2z8tFGxzxuXNSLYRDPyL09BTYZuM7hj3qcXax4zgiqVnuTJPoVZrKJnCmMEn0FRS6fEuUMfpkY7Vbl1OOL5sDcfeqh1dGaZwBgHA/Ch8q6jipPoM+yheAuPSpFgzgYANRHUVIA4yBj8Kmju14IIxgVOhbTGvAAOg4qBmWDJJ564Jp1zqChHyw9q5rVNTUyDnBxxzQ2ug4xb3NDU9RG0gEY9qt+H7mIWSzkgyPk5PauB1HUcr97GRgVQbxELOzS1jkklvGPywQjJ/E9qdOfLK7NKkPdSR6FrfiGOzUTO4+8FA/vEnAFdVuV0j5wHA6HBIryvw74UuLm8i1HxBKWmUh0tw2QnoK9Qt9rAbgGIGOO30rRSbu2cVbluuUm2bxv3ZXpnH6YpJSI4SrZC1bQEgcYx90mq92ibOcHPpUsyUtbEdo6q5x6dakFwqn5wS3sMVnxvh1GQPUg9avkIQrEgHpz1pLYclqM+1SMGJjI+tVRK88h449a0nKNGVftjJHQ+1ULmUwKqRDgnn/AAokrbscXfoVJoIjFJEAFJ/U+tcner9juiTwCcnI4z613UlqLhUcgh+oxXM67bMZSs0e4YwOeKm9txxd9DHlnETKRny39+M1etJcrjIBJ4x2ql5DRoqSgtHjg0MvkKGjYgdx6U5RBPobtnLPFJgn5T1K81r22pkFVf06+lc5pN4HcpI2MjAI/rV19okAU8k9PWhNpXQNXep1kd6u3nuKmhug3H65rmYZnVSSTx0zUyX2yVHGB2q+d9SORdDphLyBUiuCeTkGskXSAks455605LgMpXcBj0NapmbiaTThcDpzj0qF5lIYk59sZqg0oI5bIz0NR/alIIz0p8wclwuora4Q/aIo5UPUMAa5PWfBWhX7OWtVjbH8AxXSTXIY4UAHtUEsn7vOeMUpSVtSoRlH4dDy3Uvhm8Pz6bdOncDcRXN32i+JNOY/vJHT/aGa9uabC4ckAc1WM6zR4kAA/XFYy5eh1Qq1V8Wp4V/aOtwcSR7vXIIp66/eqcvCfwavZL2y0+7Q5tlPHZcVzt34XgmZvJQrn+9g1HLbqaqqpbxOCTxQinMqSr+GRVu08U2c52xy/OOzAg10v/CuYbr/AFsxH+4oFSWnwm0+GbzftVyWPGPlx/KnYhyi3sZ9vqsLYy9attexMo2sHJ7ZratvAmlWwy5lc+hIxWjFoOn2q7ooowev3aauiJ8m8TFgbeDwxHSpW+5tIx/M1fuGjX7qpgdCBjFUJ3UgBc5Jp6E2ZE2MnjjPWq7sAvJwf5UTyMAR0xzis64mLE9cDoDSsiXc60swXC8juMU4EqMA5+lVjPzgNx+VBlPcAMOuKRqixFkMzAf/AFqlwGXLde3FVDJzjPUUvmkAZbI6UgsPl+ZWGOnpWZcxyBiwG0GtATArkHn0qCeQEbgec469KBrQpxncPvf/AK6kVnVTz1qOaVQ2BVaS42/SgaNGC4IOScHpVyO8x689RXOvfAHimG+HUnkds0rFpo6v7fsAIJwfSlOosevBB4xzXKm/Qrgtx9aQ3yhfv7SfTtRY0SRv3V5u24OSSM5qBrorBt3Dc78f1rDl1SMLtLCs251uGCQSSSqFUdScUJA2dgb0B85AGOlN/tPsWA4rzK98YwB28ti+egUVkXHiq7myIYsDtuOf5U1EXPHqz1DUdcSPqxPoK5DVvFMMUj4fc3QKvJrlFk1LUXAdnweMAYFddonglhEk92oIY8A0KJLrKK0MOGXVtfuBDaI8aseo64+tem+DvCdvoYE8mJ75xyW5x+PrWpo1la2Uax20apjjP9Sa24LYl96su4+vUCmlcwnUctxY18tgznjq3PU1tWRiiQORtZuevArPMTFESMAgnk1aaJmQLGOnGT3qldGbs9DSW4Dodpzkckd6yL9yxZULBehGOKnVGtky7Z4yTVC6mVSS6ZyeSD1FTJ3CEbPQfapwNxUsPfpVss8qbT8qA4GP51mRSEAGIhW7hh3q6l80MW0qGbPTtRFrZhJO4s0nkoFQt6nPeq3nKWJnYg9hije00wMinHQe1NMAZzgHb656VLLS7l+3u3dkVQNoHX0q1IsU6EMufU4rPsYfLU8c55PStRVAU4B7ZHrVw21MppJ6HP6vZp5Z2HafTGK5W5mVA6k7scED0r0C7iV42Hc9zXCa1pUsczOsZ3ZyGHemJGfBc7HJVhgHIrXivFZPmz69a5uVAeYgFYfeXFTWkqyHaeHHbpUOLWxpodVb3jOCqnIHWrMUhkbjg9sisOz3pJtZgQO/Q4rWt8oRg5APY0JN7ibS2LsxkTaM89eatQTZjAHBPWq7SK8ZZlBxT7SNrg4hGAOdwq7O+goPmJZbjGBnp61XFyCBkjd3rR/s6KMbpQHPqx/pSwW5aUqkSgZxkDihqXU3UUlcyRO7OCkbN2ztNO8u7kxtjEa/7RrceIxqd2AOp47U2LyfMVXkBc8cHilZsV4pXMmHSn3l5pHbd2BwKtpYxIMpH9STW9FbQhcGUZqCZ7ePOMY9BT9n3M/a3eiMc2wwxI+6cU1UjR9mcnGevak1PUIUSQITgtzg1yNzrbLNHKpxtYo351m0kbRTkrnaJjPyhcgd+M1G7lfSsmDUvMjUs3fIp8+oKqYIzVXuJRsWppSR2qhPKwxyCOvWq0t7g8tyTgVQmviWYHBGaQ7E11IpByBk981QaQnlhgVDPeB1+nX396oy3BC53HHriqWgmXLwSC3jZ8BJDhCTjPv9KxdQlZbwwGPy5UADLuzn3z3z1rSONRt4hJBeExKY/MhTcrDrjnoaz513XvzwSQbEWJUkPzBQOM+5qjNPU3luAzHf9CKRrrDEDAA9TWDJfqOV+97GqkuqKCdxzTSuFzpzeZBJzTZNR2gZbHY8VyMurlVwpBB561RudY3Z+c596Vh83c7VtSCnhuD3NV31RSDh8Z9a4GbVpNrc8DuTgCs2bXlXIEjOfRR/Wly30Qc6W56Q2qKRsYjOOuao3GqIF+UjivOn1u5c/u0xnjLHNRD7deNgtIQeo6Cq5LC9onsdbe+JrdGKmUbu4XmsebxOx4hSQj1YgVZ0nwjNdEHYzZ644ArqLHwH5agzNGmfxp8pLq2OJHiG9blUXP1zQda1Nx8m0Z/2Sa9KtfCFonJm3f7qirP/AAilor48xsY9BSsrXGqvmeU+bql023fJ+AxV+x8LX184372J7csa9WsdA0yBxuQyt155FbNxPFbxKkKhQOyjFHKHO2/dPN7L4euFHn7FP+22f0rWg8F2sBw0oIHUKAK3mvCzkyPke9DqZcFWCj0qHrsVeS3ZFYaNZ2xDRQ5YYwzc4q5dwTtIER8KOoHQCpPtUcEOCApA6k9aqW00t7KEbAUnjbmlykpvc0rEEMi4yRz04H1rVS6VMBdrtnnPIrPtbcq7wjd5QOTnjNbulWEcceY2DHuxHSiPZBOz3L9sT5Sn+JuSxGPyp8soiydpOTxmqvnSrNggEZ+9nmo7m5OcKck9Tiq5kEYF9WSf5ZAB34p0kEYV9qqRj0rJt5SNu8Etg/lWnaSCRTgc+maSdwlHlehnuoR8lfl46CkWJJBnBBz1Bq3LDG0mZXH9DUWzYCT8w+vWlbUaaJbe3GAQ7E9DnpVtQqJ8vI68DFULabDctgZ5A7VeQqFzISd3TH9apCaaIVG1zuwc89amRW2/KpZu1K7qOVGMD8KZ9p2JgDIPoelMiWuxWnWcMpwAO4zWTq9vOAsgy6Z5A7VrXMpLAJ0IzRGS4xJ+ZGKlu+hSVkcPeWaz/MU2MejY4Nc5qytbYJyGHf1r1Se3iKkbcA8E4zXN6ho8dwWA4B/hPNO9tw31ONt9WkYKrYOBwe9b+m3r7MOwIzwawdW8PT2rF4iT745qhBqU9mxjuF4/vDnFGwNcy0O+a9ZYy2cn2rqPC13bPp370ojs3Jxk15THqkgbqXQjqKc3id9JwzIXtX5yvVGqoys7jjDoz2ySSwZCGy2PTiuU1XU/7PvCltKwik5Az90964qDxrZ3Ay9/FDxyCDms7W/EunTOhgvUfaOWY96qpLmjobU4JSs3dHdTa2zqwLkjHr1qCDVgJ1LOCdvNeZTeKLdVCrcIfxqt/wAJRCSc3cQJ9M1z8smaPkS0PZTrIYZ3cHpzVaXWOCQ4wO1ePS+L44x8lyj/AEBrOuPGTknaXP0Wq5ZGS5F1PWL3VRIXXd94A4zWNaATfaCQxG7NeajxOxk3SGXH06Vs2PjW1t4nDFiT6qaOR9h+0itmejpcCFOW+bGagl1TKHDEkD1rzW68brIxKZC/Q1mXHi52zsJz9Kapt9BOtFbs9MvNUVU+9k/WqD6wuCdw7YBry+48QySNyT69Kh/t5yfmd/yq/ZS7GcsTDoz09tSDH5W5+vFK1+pHzMCK80j18A/e/wC+hWhZeIWhnSaGRRInKsPX6UcjRCrJ7M9H+121xbWayak0EkcZQxhG2jknPHeq01xHHKRFOJ1wD5hBB+mDzxXMJ4z1Dr9sIP8AuD/Cql1r0t5cGa4l8yRgAWYAdPpTaBTtuV7zWjuJDbfxrObWWZuGfj0Fc3fX6pfuswJAxhh2q1bTwyjEcik/XmtlTsrs5/bqUnFPY121ZjniQ/XimvqTtjYig+p5ql5ePXFTQwlmwKnlSK5mNkaW4YeY5c+nb8qu22mSyKC/yrVi0hSA5YZaum0uGJmDTn5ewFF+iEUNJ0FpXURxF2HdugrudH0G3hw92QSOdg4FUI78QgCJdqgemMVaTW8oeMt396hOw2pPY6VLmCNAqAIo6AVEbs5wxzXLHVB5ozyasnVgBgqWHrSbuUocqN0XXlgZxgHHSp/tyvwcA+tc5/akbKCQBTW1GPkhV96mxol5G3LdPyUIP0NRx3POXfB9OvFYkmo545J7ACpLBbiZifKOD3oskXqbUksbDcqF29WPFCvcuuBsHoqjFSWWmzSYLAgH0FbtrpaQ/e6dzmldIFrucyI5pptr5Iz6V1ukWH2eFRuUseSfSrVtbW0aBgqk5wOP1qWJHWSRm5B4C4qGxy1VkLAWZijx4Hqe9WY4wJSyueDnANJKd8amME9wBUlgFU7W++BjmlfUWyJHDysNqgA9zxUlvEisAACwHb9aLsSgEwr09agtmQzkyEA9wD3o2YbomzCpC+Vls4FPJETk5K/yq0oRwXUAEeveoJyGTfgHjpVvQlO7KkpQycv93nGDg5qSQILdnXLAjsKy5SzhwQcA8YHT3oS9KYiBBdgcE/1qOY0sW4ZDK5G0KB97AqaVpUXBPPfjkCptIbzGICfMByat3oQ8KCWx1HeqtdXFze9YoiTMe49/WrdsBy7KMc8j1qqsgBbKj0JHartvtLY4GRyD3FCJlsRCWIzFcZxxnFObaSCDlfUikuIVVvlGT/So1ugMrKCCOKd7CtfYeUUqe+ePpVZrOFiflKkHJqwLiBmOxuTUbS4f7pVSMDmndCsyhdWKMrKxUg1zOseHLeYNiMH3FdpJzns9VZEAUL+Zo2CN0eQajoN9ZlzbHev9zoRXN3skmDFcIyn0avdbq2V4+QM+tclrmmwXAaK4txtIwCOtK/c0TZ5VHZxuTvB9sU6TRlkH7tGJrc1DwteQkyadIHTsrdRWZJd3+mti+tZFXpuA4pobtcii8KSSjd5ZH1NXIfBsZU79o9+uKlstft3ChZee4Nadtqisfv8ABpktPoZ8fgq3LfNKmB6LUy+C7bd8siAepXrWol5EWznJ+tOfUQjjqFHrQZPmKa+D7PHMin/gIqhf+B7dxvgkRvqMVsnUiGLIRk96VtRBA+cfjxiq5ieWXc42XwXKqkrHu+jdKz5vCsked0Ep/Gu/e+DALyATxjvSm5GBluR71Sd9iG7bnmj+HmwSIpQaoS6OwJxHIMdzXpN3e4csMbcd6zLi6Vx2C+lUm0S7djzuawZMgN09RVKW3eMnI/Ku51Ca1aMiRVye44xXKXexS21jg9Mc/hWsZMwnFENnpupXD2wt1ZVuQ5jd3CrtT7zZ7AetP1a6uLadbW4srSCWJV+eH/loMcNuzhg3XNbEE1xN4bluE09srbGzN2ZgqmDfltinktzgkcVzvim6Yao0Ulq1mbaJLeK3Zt5VFHy5bvnrmtlHmOWU5Q2Zlauc6jNjscfpVQE5B5yKkupPMuZn/vOTUVbxVkkznqS5pNl221G5hwFkLL/dfkVq2+tSDmSFW+hxWJFGXYYBrTt7J3A3DFZVIw6mtGdV6RZsR6+oI3QPz6NWhB4nhVQDBNn6isVbBQAcn6Vs6b4WubuISRxOUPO48VyyVNHfH2zLS+JLaQcmZPquRU8evQZ4lOc+hq5YeA55Yy7si84x1NdDpfgG2j5uCznPQDFZPk6HTFzW7Rzi6skp/ducnvirVtLc3DYt4Z39wK9E07wzZ2qkRW0efdcnFawsNke2JdvXoMVm2jWLPPLbQ9VnwJAqL6E81tWXhabzAZH6+ldZb2c0RLyyfKvQYq5bndIqLGRnv6UuYuzMrT/D0MAyVDOOcnmtu106KJgQijPIzVuQQw8v9KjaRZFVkRsDpUOQRVy3F5SjAK5HXFTyeSxXeh3Dpx/SqlgCswXZndzjFb/kJsDMDv8AWhaoJWiZrsMoqoAMce1VIomjdpJAw9Oc/pVye3KSM29hn8qcF3fKoOfU1DetiloNtzuON4XtwORTLiVY5CB1z97FRXEbQSZlyATx9KWMQyjcxLEjqO9K/QVtbifbJJeHPsP6URBvOPI3dMAcUqRqhBG5cjmo52kKALz26VOpSsbVrOUtyH7dMVXubkHIOAO3Y1DBKyKFZdzgbjxVWTMoG8LtIyea0b0ISSGyOpBwxYdqY8MfBQAYPJqeKJQFUPwBgCrUNtE0ZYnj3H60h3sSaW5CEx8EHrnrViQMWLNhgeuKakkUCHawC9qRplkB2ZUHuapPQnrcRwWjZRk59BVWC4eORtsZCp1JBNTLcvCgIwc9c04Puhyed3T0zRvsFxtzdyNHiMjkZBqsqtKFLffB+bPXP+FKYbkzqFGFB+7ViSMojdRzmpepV0kMtbcu3zYBzziprpzAMeWSCcUlmJllK5JU881avX8uP7m709qpJWIbd9StGGdgwbCjjmqV+0it7CtS2ljdAp4zTbq3SSM/MPbFXuhKVpamVBJ9oTIXBHqMVBd2fmY3deuQKv8A2VrcFhjgcgGqNzcOx/d8EHBFTstStW/dMZ9PdXynTvnvVW5sY51KNGpH90jNdBDIJcrL8r9veorq1ZhlTtb19aENvXU831jwPpt5vZEME395On5Vx9/4Q1rTyz2Fy00Y5A6/pXt0ludmGXnHWqEsG0lRgN6U1JoHrseESanq1gxjurNWIOSQCpNLH4qXP76OaI9c43Yr2m706C5UrNAsg/2lBrktU8D6dcliiGFv9nkD8K1UovdGb5ujOMi8TW46XgyTkh1wKsJr8TNn7TA2ec5wKj1L4fXMZJtmSX2U4NcvqHhm8tiwmt3XHqtWlB9TKTqrZJnVvrrMpVZouT0DfyqtJrBGMyAjqPmrh5NMlXjBxVWS0lAxtPtWqpRf2jmliJx3gdpdas7HJlRR7tWdNrCrnNwhP+9XKvbyd1P41C0TBsbT+ArWNCPc55Yyf8tjbuNUibJaZn9gKz5tRU/6tD/wI1SZSOxpuDzwa2jTijCWInLc6+yv7XUNM8u+mubSUWLWQ2WzSRsu/cHGPxBHeuf8R3Ud1fxmCOaO3hgjt4jMuHdUGNx+v6Vv297qE2i6ZDoutx2Qtoys0EtyIWV9xO7n7y4xjHT0pfEuqxX+magJtQjvSGgSDnJMyj97Ig6qh/U1S0ZL1Rxp60q9aSnxDMqj3qzI2dNhCqp7mui02xmu3CxLn37VU0Kwa6JYjCKefpXp9hBDYWsb26Aqa82tU1sexQppRRFofhiCKMPd/O5HQ111tBHCgSNRtXgelVIDvBw42OuAPQ1dtlEUCrk5B/Cudu7N+hZiVVO44C1fixgE9O1YzuZblICCAeuK2SGEeIyDgcA1I+UsGbYoVMbj2xVuFTtG7k9KxY5ibgK/3geucVpyyNGoCEYPNRc15bFxmRWIdlBNNaIwMHHzuegPSqQQSSqzEnHJ9zWtaW7lw7HIxkCpu5Fr3RbayMqF5U3sO2cVba1cJhQqjvgUiXi7v3Y6d6sR3O8HcPmPemuUn3upWjgkQqQPoS1XIllZ9uTkVWYSFyMEnt7VesQySfOCG/vZ6URXQcn1J/seU+ds+mKpyB4nClcc/nW2owMn5Se/rUF2i7d20Zx1rSUNNDOM+5lSyh1zk9cH/Cqpi8uUbkUZ6kdKmOPNHy/uwfu56VqxJG8XzDIPWs+XmNX7pjMCWwQAM5BHcU5kBU5zycZxWwIYVKqq4OOhqFkRH5B2g85ocQUrlOGKQMSCPmGCTSyQBAvmNkY7VpFFI3R7cE+lVbi2eZgM4x60+UnmuzLuC3JABzwasRRkxgDcvHXNTpZkuMk7lq8qnPzAAYxxRYG7GGLN1I3ncrdO1X0tg0BOTnGMelWWQMVDEEetMj3RkgnIPIz1o5SbsovCwiwMbhyCaSMM3zKxJ9MfrViaaSSMpwoJ5XHNPt4I0UsxYseAScYxTSHccJiuPlGT1Pap2WJztJB4yaqwESBwfu54NaKRKEXb96qsS2kZ82In+VWyP1p8lyjR7nwD1xV9wvG8Y98VUezVmYDaV9+tDTWw009yrAnncphQDwfWrDWm9fmfkdMDip4bdYDtU9Dx9KnZ8OBn86cY6akylroVDGgUZ9OaqvbQkFtvPoK0HIYkg+31qnI6SEoG6dsdKbSJuzG1CFVcMF4I6+lSxriNc5q265yp59Khbg5BzxU8utxuV1YqSqpb6VRmt43cuc7uvFaMqZ6cVWmUfU/zpNFRdikyqc4NVZokJ9B+tW3Qk5A6VWl6gAdevtQDKEltGRz196pz2qHBK5X860bmMvEUBxnvWdFDJDuD/d6imJMxNT0O1u1J8mM574FYEvgyyky0m6Ngf4Txiu1Py9/lPtVPUl3wsEbBHPpVX6ib6HA3Pg2PJ8m4H0asu48JXSAlfLb3FdhE5+04Y9aszu0qrsyiqeQe9ONRkyhbc8xutAuo+Gt847is240+WMDdAeuOleo3s4iKAg/PwBVaYIUJYAY/lWyqswlTT6HO6fEItPsre0sLFzPZytG8sKyM90pyUOfbHFcj44Rl1ndJHHDK9vEzwIoUQsV5Tj0/PmvR72x006bbyrps98ZULNLHIyhGBxtG0cEcV5l4ot0h1B2htJbSNgP3Urlmz/eyeea6qM+bc4q9PlV0Y1TWgzcoPXioDWn4egFzq8CN0OT+QreTsmc0Vdo9B8N/6LDHGy5DkZPpmu2tUBiCEcA9K5DTY8qg6Dbt/HNdPp7ubfaW+crjPvXkz3PcjsbtuAqAKMD6VcQ9j3rNhkCqu9iAMZz3q7C4OGzlTUjsW4SBOSQOn3j1q3CztcDDfu6w2Z5bhlUnbjIxWzp6kKcnt09Km5tblRZezEsu/JweorVt1jnXYMHbxz1qorAA89R1qpDchJOM8HH/ANeoloVC8zehto0bOfer0cm1SGIAPGM9qztPkaVRn86fdDYVMnPPGDReyuhWvKzZoW1oC+8YIJ4GKfIVjchB8w60lrcRiIfNgY79RVto45QpYY9MVXLpoK7vqQRyy53E59BVsTS7hsXJPb0pVhWNT16elSxyCMhQud3oKFFoHJPoXYwTFu25P16VVmlZjh1A+oqwkg/u9PemySoSRtA/CrZmt9islpvUseGNPCeSeMlvU/zpguxvUIOO+e1TD58t+NRoaO/UWKZZCwwMjqR3pkqGSNgDgmorbaxfcCqk8D0qxHzvC/gc0MnZlPfJFyvB/u+oqP8AtIrL++2qOme1W5Im65zx3rJvLeQMw2A7+i+1Gw73NmORH3FWDZ7iiRyqsAeMday7BDBwFYDH4Us9yEUsScDqKTYWLBkWMHkn0oUtKwfG3aMEZrM+0M0hyfkHfvik+0SRqhOWANF9Q5TUlkSMMc/OOvtVRbh7hxGOQe+ODTWdZVLLkNnmrULxLFwctnJ9TQ0C7Fi0iWPceOTnBH8qtSSeUMqRjH41RMjtkc49qUorDEudtOJNhyI9yWd2yo5C9CKtgbT/ALAHTvmo49qjA49M96JZ1RSMAEc4J61Wwr30JQQQNwHHSmEbiD0FV/M80LjpjkU8yfKST8w9eKdxMSbC/dPfmoPkX5gAPekdy2OVDemarTzog8tjz6j1qWyuUeXHUHI9ulVGk3sVA247+tQxh/NbZkIfSmiFkkL78+1LmvsOyRFfTvFGPL5z61Wt7h3OHGexNXHww6ZH51jzvJDNhQNv0pSumVGzVi3Mx2nHX3qhczojgNwfarUknyA87T2rI1J0DDcDnHGDTJjqyyXBXKnJ/mKqTscjjNRxOrfMp59KfKw2kEAdsmnF3IkrFSYHOc8VQvQXidc4JrRmySFHI7VmTsOS3UVQjLuYVhsyDtLj+Kq+T5ILnOBk1LeAzpszgZzUBGF29exNCG3pqVpAsqhmXtxmqdy4SN2b7qrz71bf72BzxVJ7iS2l86FtrqcqeuKZD1HS6gk+i2Ai1s6cyJteJUfA5PJ29/WvOPGD77xv9ON+cAfaCG59vm54rudQ8TaqsbFLsLjp+7Tn9K848SajcalqBnu5PMl2hS20DgdOBXZQV3c4cS/dsZZra8IAtrkGOwY/pWNXR+Bo86q0hHEafzrpqfAzko6zR6JFtLAKBuA5A6Vp2UjJcInO1weQO9ZloMOoxywJzWpatyOpx0rzJbntQ2LTvuvVjbdg1qqjRW5AIwo4zxWUlwskcU4TOGwR3FakEq3IeID7y9Se9ZmrvZE+lFX3EnmtSNjG5ctgAc1g6ZMsDMkuQ2efat8bXi453Diktglo9SxDcrcRMEJwOpHWo4FAzv6nsKpWgeAzEg5HQ+tTaazPPy/J9ah6m0VZOx02myjyAiKRj0p97IXlWMZLfyptvlWXAAyPzqaSMSEdj6jrTadrGd0pXIbOSNZf3v4+lbcFxGoUAkselc/KixzAAtk9a17TCp6tSjJrQuequax+V89Se59KmtnG04IY1SEwI9sc05JSoXaoPPAFXcytoWnDhgcDHpVa5ZsjaQuf0qfdkkjqT3qndxPuDAn39KT1Kix1uhd/fGRWnEu1MDBHtWLDIwYAAkg9B2rVVwTGVfkDmmkKQkhfayttVB780zc6yqsbNtIqdipY7vrn1qGfLshAKt1z/hQK/ckldmGSoBXH41E7ZwzcHocdqlLKXw57dM9KZIc8hSM9KH3EU5y22Qg/eGOPSqLJ+8AJAGMVotggAryeCB/OqsilSc49ye9Syk1YpH5Q5Ybge+MGpYAzRLwT9fSnOFAG0H5m7+lMLl2IUFRz0oQ3qW4RtkK5+UjkGnwIqS4Y4K9BjrVSG4DvhQCR0GeTTnmJk7qfemgL6gqrdB35p6yt5isQeRg8VTt2kkzuIwepp4nZZimOvc0bBa5fTgEEcdRTJeeuRj2qJWP8ZpwIZDnkjjJqr3M2rD5DmM7eo6ViXlxKZApVvetPcAxAI96gkjDMNoIz3Hapkr7FwaT1K9ur7ASSDnjPpVe+KbiFGWPXFabAKh46VlXUZMpKLkGpasiou7uNtXYLtJHBxUzMSCeCOxqgQwcDpnuKtt8q4boeaI32JnYZJMsYy3Q8jFY99dGRiFOR61oXEZKkE5B6ADp71U+zRoC2MtjnNN3aFFpGfK85UFeVFViplBEh+b+VacjqBjB+vpWMS/2k4zjNFhp3H28TRlix47d6jdw2fmyR2qW4mKAHByTjiqbDYzHIBNNaEPXcJ5jGpCNg1lXUoJweoprRSI7u0md3aqlwRvZzyfWqWorJbDHkBLFePas+/V5ZwQ+2IDnBxUlzLsUt6dKzPtEs8hPSMAhjjiqExZbnzYpEiVgQBye4rMS4NverJKscgU5McnKn0Bq3DvSQqMbDzxWdqaASqzgbicgHvVJGcmbjxvdWC3Mlh4fhQoZlWfcrBM43EZ4Ga8x8YQtBrs0TpZxuqruW0B8sHGeM9+me1d3d3SwWOnS38AEU0MliT5oBkhY8Nj+HBJ5PBxXDeMyy615DQtClvBHDFucOXRR8r7hwcjnNd1BHBiHqYtdt4BhH2aabqxlC4x2Aria9B8AKBpDMe8xz+VaVfgZjh/4iOutkIAPcHAq1BkXBU8qRTYiAqIccc+5qdz/pAwOGrzpRPWiyS0CtMIguI2Yk+5zWpahI2dEPzA5I71n2qlZ2AIJPKj0qZy2RMQVfvj2qGjZO+hoT2yyHePlOQTWik4hjUkZ4wBVO3kV0VxzuHSmIzLMqSHK7uT61D02HHXRm3CwlhIGMOOSaq+S1vKpXHHQnpTxuhixEeAefatKNQ0Y3gHIqWrlJ21LlpO00I2nDetXJJ/LQEkk/SswkwoqwL1OBWhDl4/3uCRSDTcsRotwoLgLjkGp7aFo93pUMeFyAAfXmrCzptO09OTimgu9kTLIm4IQSe9W4flzswQvNVHjDHco6/nU6PhVAVqYm9B7XKq4U9/aqtxeMWIUEL9etSRp5rZ6HsKd9nBypOSe4p20C6RFC5aNtjcnkH3prmV2Hlhsgc89asRwCPJ27c9aeY1jXKk564oeugJjonYDGSCo+anfaFY9GwvTJqo2SpJ+8e3qKWFH2OWGD6ZoQepYE/BbbkjtTnk3A5OQQagACqGjGT0IqvJvDdeT1pBZD57jYhOGJ4xjqKXz90fmMCGxjB71Tbh0Zs5z90ChiuCzgZJ/M0raDsWJZlbgDBAwppnlhlQcDHVhx+FPtl8sYYZL8An+VTsoydgIUUgK3kqm3qrMetRKCshDjMmcAg1Ym55J4K8e1QIju4C9u+arQLlhSxAbGSTznjFOz5jnJwcHBpyxCKPliWPY0iAl+OjDFHUEJHIFiPzHcOc9qbJOSvHepZVIQ5OWz6YqoI2L5P3evFHoJWJoJMnGc+pNTScfcbn0qozbOce3vVeWdgWK54xQga1Lxk6ZPB7VWMu5yF4wOajjkMoyoIJ6imzgqvyDmi4JaiyMmRwCc8nFMlfPFNhVtgLj5vSopOAcZNFxNDZJCOOpqhfSMitg4PSrEjc5/I+lZ13I2G2kMcelO4ktSukplQkmopphGueOPTvVaK4Icr+IFQX10C4jCZJ6n0qU7LUpx11A3yMw34Q9s1VuSXmD7sAdqrXiATRBeh/GnyyI2UU/MvWn5A0lsR3E2dwH3exHes2eQKhZzhBzmnrN+8bcPlHTHas+8mMgdZeIxgqvrVrUmWhWvXWV1Bb5EBZiKgcrcQrHGSqZ+aluP9XI7dWOMA8U61iKrFGANx6DPU1VrGTdysT5ayySjBAKpnpntWfNBNeaisUcbSS/cVe7GrcjSSl95wgY7R6Y71UlXAIyc9frWqatYxtqW5dObU9KtDd6XfyiKPZHNayovmJkkAhj2JPIrgfF5uBrHl3NmbIQwpFFblgxSMD5cnue9dpqp06y0/TmutKlupriIyNItw6KfmIwAO/HIrD8WaTp8UF69laz2stqkEx3yl9yy/wALA/dYH06iuui9Djr7nIDrXo3gZPL0VDg5dy/4V51ECzhVGSeAK9U0OH7NZQwkj5EUH645qqz0sThl71zoI1wwJ6EdKlKlsE5GDxUcRyoJ54qzESNwYDawxk+tcLPST0L1tH86sSSQOMCpHCvOsTE7iKdZKBEzZAJwBlutPEY+0I2cMB09azktS4svQKEiULjjtSPGGbf/AHTxUoBzjPHrUcCN9om3/wCrb7tQy4svxyefD+7H0q9buQFDcH3rN01GiZ1LblPI9q0vLEhQ85B4FSUyYuRMnTjqD2rWTGzP8u1Yc8MhmVkORjB9q1YWwEDdcUht6FpwTGxU8nv61DCmQNuenJ96sIc4wwz6AVIyjGRjPoaLApWJFkCIuWycc0n2hdxK9f5e9QpJkkMRxxirCxRqQSRgdqaBj7djtZtxOelW4mAXng1Ai/L8uBjoDTHd1BI5Pf2pi3L7fKgI/I1Xkf5WbGT0GKI5cx5Y5IPHvS7lD9QC3ah7gisu5iH2n2xVzYzLu3EDHfvTsfMBj60MNwzzu+vFNPoMiRgPun5R607aAykEEN1FIgCsc9Dwv1qKaIkgFuvQelTbQZDdRhmYAkMPu1SVOcFsd8461pyYCqSM7c5NRSEKOnGODnFTfUuJHG4cAqDnGOvSro5wvJBFZ8kmwgx/eHBHcfSljaV3+9sJ6UvMbiWANw2KQDnOT1xTZVEC7ifv8jHNPGS3zYBxg+hqRkUKNwG3GBmqTJasRyM/lxhiDkZGetWIWjESI+7c3QjoKjYAqCpGQOuO1Kjkd1A7U0tSGJv/AB5x0qNjkk8/SgSDzWBz16elIWCHBJ9aAIpcFcnn0Peo8kqDgY9DUhcEcge1R5z3X6UCuRyShQAeOeMd6XzA23IwR29KjlUOeSM9sVCowDuPPqOaRVkySc+aOGKkc8VRvJWVCVPzD2qSVzvChcg857CoZVBzgnOOg6UC2Me7upHjfk5BA/Os95ZdzqGO0Hg+tasyICQB94+vGaqSqFH3R70WKujLh3Rzh5Tw3A5/lVRZn+2yq4BCqSAfXtV8x75wZDnHTtim+Wu45UZPU4prclyKCtI84LBQSuSfSmzbLdWlY5LnA9qdO4ScoBgHvVe8QtGNzcDvTtqSyk0ZlO5WwazrhN0iIuWA+9mtKJvlIXnHA+tV5sLkjg5zVrsS2Z8v765SJQSq8AjgA96HDvcHJBRfu4qVCyTtIvBK4/8A1CmXH7vaAclu9WjLW5VuMHCDhfWqM+FBJ5q9L6k8Vm3j4QnuPSmtyZFxb5dF06FpbrUWa5QziK2ZFSJSSAfmB+Y4PTFcR4uNxbXTWwvZ7iyudt8hk4LlxwXH94dK3zrU0NmtvLbWl3BFkxC4i3FMnJAOeme3Suf8ZLO2pxzXU/nSz28U2doUKGXhQB0AHFdtLc4K/cn8F6Z9pumupF3RwnC57t/9au6tlIlkAHFM0axSysooI/uoBz6nvVlBtuHx6ZrKdTmZ00qfIkXrZhgVdUhgCaoR9RV1eQMdPWsWdCNO227NrLliQf8A69XQynbvUE7s59vSs+0yVXI5xV9eikgHnPPpUNu40i1G2UwM8cDNTq2NpxyarRbsjJFWOqYrMsliYq27qBk4rRt5BJAJFBPFUbVQBt2844zV+2AVdoABH5VLKbHWUxlXL8Y61dzzgZBPSqoG3IHy59KeXIIAHFIpFyOUsAgVl9/Wpopxvwck9MmqySEAA56cZ7VKmWZcH5qYyw+C4YIfTI7VYiODyeKrxnJPP41MhyOMZ6YpAWUYjJz16Z7e9CgmQE/iagVucEEk96nU7iDkYJ5qtydiIpIr78jaDwpqVX3S5ZR05HpT2GCpwMetRof3hPc9hU2He6LEZyd5JAAqOOQ8ueCTzTsZjIY7R7dqHjUR8AH61TBMPMO7HQnp7UhkjOOT8vPNQqzCQNkYwRih2wjk53Yxg1JSGyTKyAkgBicD1qlcSqcgnkYwBUlxuKbUALH1qh5cgOWAGP71QbqxZWUM5ycHGD9KnjuF4x26CqAACnOcH3pWfbCzKMEY24qkgL32skgAHCjOB3qyrktuJyJBge1Z0C7iHZsgj7tXYshETA54JzjA9qXUUkThiP3ZILA9c9KUnAAbDY6VAflTGWIXtTiQiAkscfiapXMWLzuz39PWmuVBPzCgkli2M8dqhc5PAA9s0CElcDjnBqJmAHIyD61G0oYsI2zj1pN7YywzSCwb1zkHpUcj5HyEg4546UH7zE4yO570wMWz8wDZoAjychjlhUU2Wz6GpieMHqf1qGdvLjJbn2AzTSE3cpSqqoFAyM9D2qrKAPmK8Dv6VZDebyNyjupqG4HJHOPSgRkyFmfJxtzjinMOu08D1qSVG38YEY796jcE/dIGOvuKdrCbMgOxlkcgEA4WoJdxTaec8EjjBq9eRFY2ZVwD3z/SqkCYVg3KnqfUVaE31KuzyvkOeOTVO5bO4Ac9j3q7M6Mx8rlQSKosvdhk56DtVWIbISpUryCcYBFMnOQW6ACpTgKx545xVN3dlIxjPJHrVEleVhliOtZxlRLmOSSFJ0U5MTk7X+uOauS4AO481XsrX7fqVvaq4TzX2lsZx9B3PFNESILnV7Ebh/wjunMB6tJ/jXM+JbxtSu0n8iK3ARIVjiJKqqjA6810d7e6EjmM6deSYJBZrsK/124wD7VleJNNjsbyFIXdoZIknj8xcOFcZAYeorqg7HJVjzI9CWMKcY7UmzLHAqy64HvikjjJJHT3rlO61yFOOMc1diwccDk81WZQMY4BqxCflwcg+ooGkaMGEGQPlzxVxDnrxiqNudnXj29auR57DIP6VMhlyNs9OlWojznqe1UoSN6ljgY4xVpDzkkEdsVD8xoux5HY5qwH4749aqRggZPNTxYC7TyDUsstxnODyaeM5yD8vp6VXjcqfm/CrIXCliByc0rDRYjbGQSBU6tyFyPqO1VY8YyOQakQ/Lg8UDtcuBivIAOakTk8Nk5z8tVVJA6c9s0qE4JOQfakMuAsfYipYmcZBIxmqsbYBJzipkwuSScHmmiWTs4IAznikicKo4GOuaiyxxgZP1xgUp67c4GRnijZgWoJNwOenrT1YbWORxxVORjt2o2cdQKRS+QPfmmO11cnkOTnoQOmKpyn5TgEE8561bbLswcYTGVIquyqHBzjPf0qWtS42EdzgYx061QupWJPPHYYq5IAcYxnuazi2+5xIu3nAGev4VKNYpInRVdRu4zU4tlEO4tgj7o/GmQbSgB6LnNWGYCNfmJH+eKpAxdikj5RjqcCpEbK8c46Gq29i54Hvj0qaE7jyMAdDSsJ7EwJHy7tpPJOP0pgbLMUzj0qOViHALZB9BTSTuIYbV7EHrTuZND5GY9fujtVdmweuc1OB8nBAFQPgqCPu+/egVyJsr0U57013OMqCR3FHVtwJ/HpSMVyc4zjjFIZECdoA6H1ppwM7SMnv3qQknGNpXrmomI3cqc+tOxN2JyCe/0qObG0MG4HUU4sBnb+JqGWQMuM8+1NIRXlYKc9s1XlYPwDSu3OAcHOcGop/lOQRuNFgIJW25wMiqjHd1GDVonnGTkH86qzsNuX454pklSdyRlsbTwKqyghMp16ZNTXUgkUZXcAfpVV5GkQbcgCqJRVlQRsxAIyM8VTIbPBzk4PqParAk8yMr84OSTzx7VEV6MSMDmtHaxGrK0gzuxnjrVWYqADnHFWZXyoAGDnk561QuPu/MfxoApzMC+Ocd6rLFK15HFBxOWHl/Nt+btz2qZ3AOBz9KqLbSXlytvGhkllYKqDqSaqJnI3PL8U+b+++xmVTgtJ5BcH3J5zXM6/BdpfP/aDb7psO7bw+c9ORxXQX2mGe4DXeraSLoKI2Hmc/KMDcwGCexNY97YS2dybe5ULIuDwcgg8ggjqDWqZnynoEkeMZ+lOSPI4qVV3YB/CnzLtXAG1sYFYXOpFCRfn6cZ71NEgwD70Mh3ensasW6n0HP8AKi4EiEEjceexxViMshHNMClVOAO2KnQblwQAf5VLYyxGeQVHPerCnHGKqxKQQc4+lWoskgn14qWx2LSsMZyB6VYjJU5PQ1TUZGCT61ZDMwBC/nSKRZXGd3+RVqNsDruFUkcbhnjNTRSJjAoDUuBuMqAPWhMEkZ561Du9GqRXI4ABpMZYXtk5Hoe9PD9jkEdutRYyAQMn60q5zjORSBMuIwCgnt1FT7gMn171SjkIOCv4ipgeeeh6GmkS2WA/HPUUbs85IH9arhihyckZ60p/1nUj2oGixvRU78cGnrIuAFHA796qryxIPSlLEfeIz/KmFtSwWJUk5+melRgLzuwwHQA0xpAAWJ59KrXEoCKo4Y8nAqGaRLLFVdkH8XQH1qBsMU3YLd+Kiz5uNpJHQnpSKx3AN1B4A9Kk1SJoidpP8JJNSKdxI6dB9KjVwOOnsTTg3KkjPuKoLihlEhQZLA+mKfHkPt5wOf8A61RMcs3Udyc9famiQJgs2DjO30oJuSseSwPB7UjEqpOCT6E1EH8whjkDOAP604uCCy8/XtRYm5IrllAK/L0NNZh1II9j3qvuyTubJPOBQdxX5T09adidBjEAgnnOaYWG3OST70pcgk7cfjmoWbIyuBTsFxXYAklf1qNZA+8Ybchxn1ph3sThh9DTMtznBoExZpCflzgk/gahdvl65x2FKTv3DIGDUZdFGAxHt3oZJG67stkL+FVpWbKg/n1qeSTHBHJ6VXmYkktgY9KAIXfBY8YA4qhOxCDdlj09quMR8wJH4is27lABX+VNARzuGkLkgDbjGOhqtNJ9zIyhJLY7elNJJz3FRyb88HHGa0utyHHQbtCiVmJXOSoIx9B/OqkhHl9CPY+tOl+5liWIPGarO5OQDyfanKV3oSo2I5GCFsVl3r5wo/Gr0vyqfWqOwl8kHnmgGV1TavSpNLle21GK5gUPKrjCkZ3dtv41K0XHBq5o8qWOoW1zIm5YpNzAdfqPcdaFIjlH6hYadZ4a+0vVrUPnanmLt9wGxn8+az9ZaWW8QyW/2ZBDGsMec7Y8fLz39c1ox3UdrPcW0kr32mTn5wQQST0dc9GH61B4hlgnv4zZymaFbeKIOV25KjHI9aq5NjsIAC5NOlHIpLc/ITjk96XAyfXvUGyZXZNzKTnj3qzEm1QMHNIFBznAJqzDwOcelJsYscYUfN1P405V6elSRqCmck0RICW/L6Umxiqu3gZ49asxjGOv0xTSmRxj3p6DAXIwakpImUZUAg08NgDGaSM4wSeO9SEAHIIzSuNDkkwemajidvOAIOCe9Ox6ZpF4bLYIouVYvgDBORgVMpwOmT61SjZlXIAPoAasI46569vShk2LasVUgDilR+M/nUKsMZU+1KzMpyAStILFpG57YPSpDJgAEVQMh7kHPan5PHNFwsXS/pnaeMe9Kpboccd/WqRmkRcdfcUn2g5G4Nu7U7hY0lfaAOKPM4A7nmqSzDqRg9sinxyjq4+lK4rWLI+csCQR0x70rAsgHWmeagXIPTtTGnywA4HYigdwdORtG0dwKjYO8g24UDgkjrTmnGDgjdnOaRW3Nlmxj0pWNFLqSiI7cs2G9u1KFxgjk+majMqpznmovO4+TkHnNArtliZsHavfqT2qLKEgrhifXrUbybhgZyaiLgEkD7vX3pjT0LjKCrAH8TUBHygAsqnoQMGoZLrAUkqF7A+tR/ankyG5z3HamKzLYOMHeOO1Qks2/P3fTPWo0I5B5J4z60PhW+UH86ZDDzOnBH1pGkORx9cVGSwOT8oNIAxzyfypMBHZT98Y71Cy5YNlh9KVtxPBOO9Ju2k4bI9KLg1oRuGGMPkdelMJGMnr607d1HbOcelQszKvX/GkwCViAcMGz+lUJZGwQSPY1LLJntx/KqjDd7UwTK87k/K3P6VUcHK8cd81ddNzZx+dQOQoywAPoKYrlfysLgH61FIcAgDOKsbyMqeSaqTuMkYyR6U1uIqTKT8xOB3qpIMDodvUZq0zbu+W7VVcfXnnpV3RLIDmQtnoBmoFGWLMu0DgDvVxlCrwOSKhWMnkjkmlcViPbntjFPjhee4jhiALO20ZOB9fpS8dF6dantJRBdxSyIWQZDqvXaRg/jg0kxNEv2G1+0LB5d5K7p5izIVG5f7yoeSO45yRWRfWzW07R7lYYDI69HVuQw/Cum+zxi4iux5ckkQXbN9pVYjtGFZlPzAgAZUVjao8U0yiAloo0EasRgtjq2O2Tk1ZB0tv0b8KsSAYX60UUMtbjsYepIhyx74ooqWUW05QfXFOgGH/ABoopLcZZjA547VNcKBtwKKKT3KQsQGRxT2ABGPWiioZZKVAOAOKXau8cd6KKQDmABIA4p0RJXn1oooYiUjbnbxxUiMfIY55FFFAMUjBUjrjrQQF+7xnk0UU2JCqTtHuKMDIoooH1DAZGzzQ33c0UUgQKx3gZ4xT16YoooKZDL/rgOwOKlh5357GiimtwewsY3Bg3I3Yp+AEGKKKSE9hvdj3Apv/ACzA7UUVYirJyjE880sZwNo+7t6UUUGkth0RwJP9k8UISZTk9qKKDJ7h61GPn3BskYoooJRXk+79MU/Ax07UUVLKexXn6ioLjhRj0ooo6DXQqNy/NRHvRRVEleUkheehFV3+Zsnk9KKKSAhk45HeqdyMEYooqhFcffHuajnH70jsKKKQnuQS8JxUIPP4UUUw6DyAMADtmnH7o+tFFC3JZE6gtkgZqOQ/e+lFFWQf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Reticulated, hyperpigmented patches and thin plaques with mild scale are present on the chest and inframammary areas.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Confluent and reticulated papillomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Close view of hyperpigmented, reticulated thin plaques in confluent reticulated papillomatosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Confluent and reticulated papillomatosis of Gougerot and Carteaud",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 444px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hyperpigmented, scaly papules and plaques on the trunk, which become reticulated toward the periphery are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Figure used with permission from Andrew Montemarano, DO. Reproduced from: Wolff, K, Goldsmith, LA, Katz, S, et al. Fitzpatrick's Dermatology in General Medicine, 7th ed, McGraw-Hill Professional 2008. Copyright &copy; 2008 Andrew Montemarano, DO.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41786=[""].join("\n");
var outline_f40_51_41786=null;
var title_f40_51_41787="Causes of methemoglobinem";
var content_f40_51_41787=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72527&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72527&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of methemoglobimemia in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Inherited disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cytochrome b5 reductase deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemoglobin Ms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Chemical and environmental substances",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Aniline dyes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Diaper and laundry marking inks, leather dyes, red wax crayons",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chlorates",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chromates",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydrogen peroxide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Naphthalene",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Mothballs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Nitrates",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Nitrate containing food, well water",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Nitrites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Nitrite containing food",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Benzocaine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Teething ointments and rings, topical spray and creams",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dapsone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phenacetin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Quinones",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulfanomides",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41787=[""].join("\n");
var outline_f40_51_41787=null;
var title_f40_51_41788="EB lab monitoring";
var content_f40_51_41788=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Laboratory and imaging tests for monitoring patients with epidermolysis bullosa",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Test",
"       </td>",
"       <td class=\"subtitle1_single\">",
"        Frequency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"8\">",
"        Blood chemistry",
"       </td>",
"       <td>",
"        Renal function tests: BUN, creatinine, electrolytes (Na, K)",
"       </td>",
"       <td>",
"        Every six months unless abnormal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Liver function tests: ALT, AST, ALP, bilirubin, albumin",
"       </td>",
"       <td>",
"        Every six months unless abnormal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone profile: Ca, P, albumin, ALP, Vit D, PTH",
"       </td>",
"       <td>",
"        Every six months unless abnormal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trace elements: Zn, selenium, Mg, Cu, Ag",
"       </td>",
"       <td>",
"        Annually unless abnormal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamins (B1, B2, B3, B12, C, A)",
"       </td>",
"       <td>",
"        Annually unless abnormal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total iron-binding capacity or transferrin, serum iron, ferritin, soluble transferrin receptor",
"       </td>",
"       <td>",
"        Every three to six months depending upon degree of anemia and iron or transfusion requirements",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urine dipstick test, protein and blood",
"       </td>",
"       <td>",
"        At each visit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        24-hour urine collection for albumin/creatinine ratio, protein excretion, creatinine clearance",
"       </td>",
"       <td>",
"        If renal function test is abnormal",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Hematology",
"       </td>",
"       <td>",
"        Full blood cell count",
"       </td>",
"       <td>",
"        Every three to six months depending upon the degree of anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Red cell folate, serum folate",
"       </td>",
"       <td>",
"        Annually",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        Radiology",
"       </td>",
"       <td>",
"        Radiograph: lateral thoracic and lumbar spine",
"       </td>",
"       <td>",
"        Annually from the age of four years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Whole spine dual energy radiograph absorptiometry (DEXA) scan",
"       </td>",
"       <td>",
"        Annually",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Radiograph of left hand",
"       </td>",
"       <td>",
"        If evaluation of bone age is indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Echocardiogram for heart muscle",
"       </td>",
"       <td>",
"        Annually from the age of two years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal ultrasound for ureteric effects",
"       </td>",
"       <td>",
"        Annually in patients with JEB and JEB-PA",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Microbiology",
"       </td>",
"       <td>",
"        Wound swab",
"       </td>",
"       <td>",
"        If with clinical evidence of infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urine culture",
"       </td>",
"       <td>",
"        If with positive dipstick",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Endocrinology",
"        <br/>",
"        (in cases of pubertal delay)",
"       </td>",
"       <td>",
"        Female: LH, FSH, estradiol; pelvic ultrasound to assess ovaries and uterus if indicated",
"       </td>",
"       <td rowspan=\"2\">",
"        As required for delayed puberty",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Male: LH, FSH, testosterone",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Original figure modified for this publication. Martinez AE. Tests to monitor in patients with severe types of epidermolysis bullosa. Dermatol Clin 2010; 28:271. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41788=[""].join("\n");
var outline_f40_51_41788=null;
var title_f40_51_41789="Mediator release in sepsis";
var content_f40_51_41789=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59298&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59298&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Potential outcomes of mediator release in sepsis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 438px; height: 332px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41789=[""].join("\n");
var outline_f40_51_41789=null;
var title_f40_51_41790="Predictors of adverse outcome sickle cell disease";
var content_f40_51_41790=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F59314&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F59314&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 543px\">",
"   <div class=\"ttl\">",
"    Predictors of adverse outcome sickle cell disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 523px; height: 249px; background-image: url(data:image/gif;base64,R0lGODlhCwL5APcAAP///4CAgAAAAMDAwEBAQP+ZM/8AACBzOQAzmf/Mmf+zZv/mzaCgoP9AQCAgIBAQEFBQUHBwcJC5nEBmszAwMPDw8P+AgNDQ0ICZzODg4FiWa7CwsJCQkP+goP/AwMjczv8gIP9gYP8QEGBgYP9QUP/g4P+fQFCWc//Zs//w8P+wsP+QkP9wcP/Q0MDN5v+5c/8wMP/Gjf+/gP+sWf/fwKDGs//TpvD28//z5v+mTf/582afd5C8phBAnxBwQODm/6Cz/zyFUmCA/xBA/yBN///s2WCAv9Dj2fDz/7DA3wBmMy58RVBzuaCz2SBNpvL386zLtXSohJCm0/Dz+dDZ/4KwkHCN/wAz/7rUwnCNxrDA/5Cm/0Bm/+Dm8+Ds5p7CqTBZrNDZ7EqNXjBZ/8DN/zCDWYCZ/2CggOTu51Bz/yB5Tdbl23CpjbDQwMDZzUCMZoCzmXB2c7+MWb+mjIBmTYCmkwBGI4CGg4BAQK8AAO/CloBfP79yJu+PL49WHICJr2CGc4CPzyBGMiAyfwAjr79wcHBzgJ+AgAAv7++AgM+vj4+JgwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAALAvkAAAj/AAEIHEiwoMGDCBMqXMiwocOHECNKnEixosWLGDNq3Mixo8ePIEOKHEmypMmTKFOqXMmypcuXMGPKnEmzps2bOHPq3Mmzp8+fQIMKHUq0qNGjSJMqXcq0qdOnUKNKnUq1qtWrWLNq3cq1q9evYMOKHUu2rNmzaNOqXcu2rdu3cOPKnUu3rt27ePPq3cu3r9+/gAMLHky4sOHDiBMrXsy4sePHkCNLnky5suXLSyswCMCggsEMHDhjHk06JgUBBARQKHjhwYPTBErLni2xQgQCFyBscLhBAAQAEATsHhhAQAQAAgQMHBCgufMBtKPTDi5gwIjfDYsHAKCdYGvfAhgs/3fenMB26ehHC+BAgHns7AK2dx+YgYKDBwJGJGyevqyH//81xEIDDw2YkYEdNNBCQQkuuFEDLKglXHsEYMcQB8YBEMF6BAU3QAUOVIcQf/2NZcCJJzbUgAEPreiQBQZ4gJCLHlhQAgAuAlDjjRsZQGBaI7gWongNZSCAAwOEmAFysY2Q3wb4LXkQiSWGdSKAAJQQQgMQpgBABzauUIKLKtj4pQVeDqRCAySAwKKWXLKQZgckQNjCiiF0UOaNYKZAo40euGnBf2a2sCUJHRDkQZ0NrCCQBR2s0EAIaVowqY9qVRDcA8c9xECIDhCJGgCaJkfBcFOeVyVYJ1oAqY4NWP8QggEh4GiACDG62IEBjooAAkEqGACDBW7CKiutAMBIArEruAkDC7v2+quLMHrQAa4NgBljCcLKSgJBslpqQKInwuBmrSwYsCymbF0g5UlUruoViux2sCWmK6bpYgoiwBCsowORYMCNOdq7IoG+CpRCCtUCwK+/vNqabIwST+xBCwaAwMIKaSq8AgkwGGABAJimgGnCJP+IFgEj9CbABSjFKy9XKQ6ULgse4MuiQDnOGnLHFbt4c84EsvsoxQD4bICX1FKcY8Nr4goDQTCIsMIKIqcsEKbsGn3WhA5QoB+8qs48VQodyFhQq67aqsKuBOZYcc7qFgSjBSoUu+LbmAr/vMKiNYosI93fStzw3i1U60EIKngggggEZexBuiN3HbcBfKv89QAPjBDAeybJbHZTJawQMglqR04vAC1gq/NAcrupQkF+Zlxs6z6WHAKuIJRQgpuFy84zi1DjukK1JYQsrIMC7Zp75T9i2oKbB6tl33ojgF6S6KMj1YLpIiAKtEYm/+pR+aNxTkEGD3AQc9ndG9UCCyCIwLhIWI/sUf7xb8R9/z5RAf00NjsA0iQ3BEhgp0IHPwPuRAW70xjzHDiT0yRnVGSjoE7QRoJ+rWCCWGmQYsKjHM+9T4M24aCwxPSVHY0wSQO4zQlRGJPSna4D47OICuoUAhnBKQQtYFii/0qAtyxtCYg6skAL0qajOsmJIHDq0pl2SAIHJahRzcNbl7a0IBdekQQFFIwDAuAk38yQhiz5XtXE15FdLWtZJeiXBR4HgPoBAGsdiOOw6AgjXOFNXekqnEA8EKtZ1WpFIAjZr27mN1uBwE0iQKTFAEACFhBrYIO5wAU0BQHPZBCNKZlf/e4HEqwNK1FYC4G4ArdDEaQglauEUQEF5qpiEcRgrwNAyADgK1e9Lmcja5oPLeWm1AVmAwHIQABg9klQkkSAj2RBGEUiLgNYklaushG3DDkxVbqKiEhbUTb1J5Ch5dJFGctmomiUNWHq0V5IC8yGqgOBsTHQmSKBoK9YAP9C/OHMjRjz1+QWpDwZBbRx/GzYHdXlAQgSZG9wCxqLaGmtYLIImIaLUc5QtyJj/qVzFHCPSJhDHvPgsyMc9GA/n+kmdXlJBcqDAZ8ypqaYgjN1l6zbQHBXvRzta3e3sqiO2kk8is2qX/EETHXak72RkudzDTzpRFQIAxZK9SgEsE9w3NfMq0bEhurCoVeT8h3VePKeY3WIGsMn1rQuZQDMPKNbDyJK+01zrkiJwDIf4ICzbi+qboUmAfHqlAcwAAKuWeBfCQsAfUqQsU+pjgMg8Dm5XjWlVV0pZJUy2fjIsKv4pKpVNxsVDD0gAw5QLEn+R0GwspG0VXFXBT5kWQr/rvW1sJ3Khy4wgN7Ctbb9qyspc2uVpV4Qg2gFoGClSVytJHMzziFSckfnWH42lzGslQ5mP3hdrxz3gtpbLWBpI1oeddcrCXxNeu3JEM1wxq/0CY10DZJd0kDQR209r1geAB0NsXchsFGNQRgggAdUaD/jxYwoQWAm/ZYlP6SCQHgT0pvfBAdVADBSXxdS38m8smpIdPBZ5pmcBBOkO/MRCIYogB+uAoCkzjFpaegUVhGvhT0EcDFDUByfEz8pSgKBcXlM7JjFeTCHNs4Lho6zIR1jaDup6S99iawYIkbTvEn2i4aTJIAljUrDUHoAfIlDZcOgDcR3zfJfPnUkUb2H/80OiOuUI3PfbCG5LFNoAgYwEIahZGECM/nzQwSNEUE3YQJ9JsihE92UDgtmfr4a7VrC0IMeTMAJCHCBUPQ8kwkg4CGedkioERJqF2CgCwAYtalRDZILnCZJOhbvYmxoP82mxdNJEEgS+uwCJkwgC1OYAgaaAIAuYCDXXTDCBIzQZz13QQqoPvQEpFCQXk9g2gIZthSWPQWBSJvaABg2BibQhDAwgQnd5jQA/rxsRlf72MrONQCS4GtwE0TYE2ACspX963SfGtqhlgIGsm1vXecb08XmN7C97essJAHTGHBBEk4NAD1PodSndgHEXbBqAIRB2UwgtkZYzN/PTpcwKv8EI12MgIAeMAHa80YAE7IgcwA4oQcAkAICmtCFHoABA5VOdcszTfMsMAEBBceAEca9cwAgAAFgwLQR1o0AoyPd6VDvAQKcAAYETH3UTsBAFnrgBIRgoOWeRkAXkiDzohcEDD3AQNfD4IIJKN3rQtd63T/N8jCEAe8DYfvPEV73u0/97EzAgBOMoHVyN+HqZBd6uDPdhMbrOdNdgLrSmbCRCYkUtIExMgzyO5cpsPzpPTA3AvaM8LPTuwdT0PnSPb33bgOA7HtGAKAHEnsmdH3gugfAFIKP+7MDOvhn13TwVf1nrZs901TvNQK6DXeC/N3uLB94E5S9/OkLpNRVp7n/u4+O6lFv39OAjrzwL/5p4fuc7dQOdfIlP3kX/N0JWZCC7TPSPgJswAH/NRKOZhclMEAsgGV1YXt7x3R7tmfF5nV4d3ZLt2ddMGpOF3Z7JnICAXdSoHPAt3vBt3UNSGzIB33dF3P61nXPp2nJN2oWCAAuoHsN6AJFF4OAZoFgR3ZgUBAu+Gk1GIK7933tBwAs13XdJn/QN2rzlwQToHU7qBHFcUFStlh/cWb241F3sWxJ4AJd5wI6xwQSN3UA0HXQ93dgsIVZEAYWeHQRp24CsXU0uHpOB4KAxoYuwGklqHw3+Glnd2wI93cDNxDzl3weyHacRxCV1gReeGgIkASP/7eHA6GET1dwk+eHn4ZrjwgARycFvbZ3uwaDT3eISKhpuBYGyecCRrCFQbcR7KEbKTGAcLFDYXVndiEFZHiG2YZpNVdxWxd4t1iBQ2h6Whd3ivZ0nvaBbwhowthyyDh/JzgFXecECKdzrJZt0Dd/Yydz+ycQqrd1u9Z4JyiEApF53ndvniaNn0Zpuhd8y+gEa6d14IZp8jaK8waPydcFt+huF8EA8wVcdAFpICBpeYEEQEAGVMEEYrgSbJeQHDF8ZRcTEsYSsJgWpVM/1tUXZCAEQ8AFBjkVTFCNKnF0muYRHigTn+JbciZrdIE2eJJmePEDZkAERGAGP6BmCJEa4P/lj2uhT6NHi3RBkFwwBELQkTaJENDVHP0ogGUmFgX4SA3GFxm5kUCABAqxBh9wlR/wBAwBBRqwBg7BlV55EVWgAQCwBhoABQVhlmhpFmM5ErP1ljpJFh92hX4BkzJJkw2hAQewlwfwAQwhAX3pEIDpl38ZmAehlwCABhLgl4OZmIt5FlAgASJBYNVBAaqllDspMIjiF0AplESZlwfwBVeplWOpAVHglR8gAWsABanZl1ggAWgAAJGplQOxBjugAXrpl6V5mgLxAVFgmligl1EABa8Zm7OJmIr5AWggnFCQnADwBKUpmQchAVDwBaZJm9a5A1hgENapAVUQmx9wm1X/8ARr8JipiZriqZWRiQZfYJy4+QUFEZ7vKRDUaZ1RoJVPIAEaoJ30GZlnaZs7oJ7SuZthmRFhgySVBXpiYSgehIB5EZVcMJUSIZwSIJ1BIAFVsARBAACAuQQHUKF9CQWhCQAaShBosARLoJ+BeaEZuqEfcABioJ87EAQwWgUiCp8lipgvqpo0KgZVsKMAEAQpWgUbehB7KQY0GgUAUAUHUAU7cADbORBR0KQSIAYfgAUHsANMugNokKUA8KRogKVa6qV66aEfwKROOqIDIQFRoKJoeaRJCgBikKJicABeeaQeGgR1qqSIGaQYWqIasVQxNGEiMZFVYWWP1Rd2OZM1/0kResmXvTmWHsqhUEqfffkESyAGWAqfA/EFB4CWjXmmGjCpYCoQihmYmKqpI6qjH0qpfgmkKNqmsWmkZPkEB0CWmfqcXjoQT7oDj/mkFUqjAKCXmEqWwCoBwkqsAqGhIEqWA/EEX7ADdSqZt6qrXXmrbNqq1dqY1dqnojqpGgGAFBAAnOJUJbWUZ5MgtOKSd9GZQykRN1ADbjAQuTkQYooFdeqqluqXU1qntLmvrnqv+dqnAAsA/XoAWsmqkhmqrWqbNLoEs1oQ1QoA1TqxEysQTxAFdQqlelmhFSqbBzClaNmxHjusBzAQB3ChFbqWAjGnX+Cp1Oqst/qiGuCxfv+5rYHZrScrsCerES5TYO/yEUIGVWBBY7i1FxAqoRHhBmfgA28wrwJBobAJmBKABcLamPr6ors6EC+6Ax+Qm1RrtSfrqVGQmiBqnnu5A1F7skBKtVfZqmf5tXa6A0vwrxQrs8YKpYDJqQIRBaLJpC+bpVeqpLZ6AHULAJ7qtVjApz37pR/6AZFJECl7ptqKtyS6BKz5BW9KltxKlogZtsK6ERcQABwQtFS4FTwpkHmxqHgZEV4AB2qgBmzgBQXxqHuZlXUaBFdrmFhLo1FKEEyaqZeau6GLrIaLBWhAo2obpJVqsgAApMkruK36pCmLlkugpJJruU/wpEtQBQUhAR7/2r30SaO7OqXYy6Hkq7YEm7HhK50CIaK3WrkCUa22uZdBsJ04e7Oee7JPQLyNixEcgGFxCRUMGpAOihfu+pkPUQNvoARn0AYeYatF2hESfBFrcAAR+xepkVqmq5JVsWAX2RdaIARXEKFUGRFH0LRlUAM3ABIw+xEvbBGvmUkRYEEBWKjoShQVWWt/QQVWMAREsAWNChFewANq4AOzW5QPoRmpQaghYahAQWvDxRc/sAVEMARWQAUTUQMnoAQnAMFK/BAkBgFT6MFLkXKJwplAwAVXIARaMBFHwAY+UAY80MJhDBFZ1RkqAcU6YbSktxcjXMJKCxE3wANlgMRHcMcT/1EBb0lbCioUqXvAeOHDQCzEE9EGXXwCNaDIFUGZA2CZA7wTBay6q2vFWKzFEuEFcqwGPEC7nFwRB/p5J+cTIGxrdgGUbfzG8FoDh3wGifzKFyGoJne6PbHDIeYXgWzCl3wGSvAGmwzMBjoC41quj1wTUsyuk/zDQTzERMwGsQsHrgzNGfGzpxXKLoHGgFHFV5zFExGvb+ADZwC14swRo1u6r5jDJ+HHPlkXuOzG7czFXszC8+wR/KgpN5wQ7qXHB9FbY0ZmNRHJgJHMg/wQ8drFdGzHA+0RDsABZRRrChFgqzFgyVHGJ4bPIDHKkpzNlczND9EGKtzKE9FbApEBA/+wJARwmQLBALjREDd9EDqdkmlVmTftxAZRYcAhHAXBPiONYC9Ry+lsyuwsES49xzBdEckhECiWlFgtIjum1cVB0mP1ANqRoDvWYykmEAkUZeNxrixhzLZ8y2ucy8vsA6wczhZx1dxh1kSyASzDH8XB0f5XEJwxutxBJDgWAcokIqHR0Pg0T5980PRl1j02EBxwWmodZE8lYydxzU89BleQBhPtEClM12zwy4EaH5/TY6PSG+MaInltYMkRtAV21aPiJHoVUl9dHFp9UhUQwBWwTA6xZBrCIQOBk1I4IiY9VX4MGFRgBmMwBKB9whARx7Fb2h/xXaodG6lh08rx1cP/PYUCJhCjEhyUBR3aAWFqtmVKwiQAwFufvB6MzccRoc89bAVX7M8SQd2ya9rXrRx5vR2jkhpo3d0i4t0DgVyjUgHSnBzIdCTIlWVw5mYEcdmpEhIQjcwaSQRWoMCi7c3wLM8igdfdMSobEgD/R+DmzdXiDTq1zQExtB7FsQFbldE7ltwKgdJqrJFjENWua8jwDMYmIeLZTSob7NrebeArfuCxQa4FdhxfXQH4AdTOVB0MANbEfBFO3RcEmQZXMAaWnMo+/sA2kQFVzgCvAc3xITYoac4L4dZ1uQWeDdos7RBFXAYODOQ2UVYQIOVKbNw5CS/m8VTPgdmCHgCHkAgg/1YIhT7oL7bozdFfQ/tUkO7oATDpjm7pi47pha7pgs7pkh5kf+DciEAIg2AIjB7p5AEd8WrndiAIcfDpjX7phJ7ps77ptd7ptw7rqM7ojNXbDhDoogHosh7r5IEHeVBjxG7ryY7ry67rlO7pqZ7r0d7s077rjy7tz+HD9x0Iym7tcQAImVwHd0Dr1H7qz47t117u6W7tlY7u7U5a7iKRJm0t+ywXIwzEG04RFR3QGE3jQtGKAmzGi0GQOs7jEbHvmtzv/i4UJIbU1TwYW97lX77LmSzQC38UPaYpRP0R8s3PQMDlcq7vAJ3wF68UDj/MAh8YET8GoU3RI2/xJa8Uwf+RVcQ9y8jM5V4+5w6B8DAf85mxKTiNw4Fx7zkv8hWv8D6fFx2fFkQ/8Qf/8kif9Hqx9GVx74xq9Pwu9YJB9WFBBRlu8IQM9VrvF0Or2XKh7RqOyhSf9XCxAAugAwCgAwuAAx1RBAqAAg+hADGAEXaP9zGgAAbx93bh4iZR9jbeFWgP9i5/9HRRAAXwAgCwAAWQAB0h+ZTvEAUA+A2R+Qhh+QCAApTv+Z9/+XSxwfbM5l1v30Kp9k/P+Hbh+AXg9pMvEDagAC9AAwaxAC+g93Cv+wqgADYAADiQAAtAAyhg+TqQAHg//LhPEAmgADLA+b4P/AKBA39/+yhQADmQAEX/oPzCnwA04PmgDwDRrwCUP/4AUPt6T/cDoQN/LwNF8P3Fj/dfcQERECK+EfBPfPhWARA/zBAZIkQLAIQJFS5ceKPGCSUnatxgWNHiRYwZNW7k2NEjgAIzTOSgUSABgBgFYrwoQENhyRcpXwBIICOBggIoFhQwUUDBzpM5TACwkVOhzAQ+adrEiUKHCRM1FaQ0oaCIUKI5gQLACWBGgRwKuBYAIENlghkLFIpEawLHzp5iP86lW9cugAoMHgjgC+GuxwAB/g4mXLjijy1jCh6k64UHRIkUDU+mXBmjTxQ+TQIwMQOAjgIzE7JMkCAHWR02XnxNsDMGwq1JaYhcOBKh/9LUq00WRYEQB0i5smlv7bp1LACWL1orLKISQEkbri1Pp44wAl8BIxiMIFBdYWDv4S0jVmywcY0zanxEFt/ePUelODcrBa4QZ+nSXk3YKNp6M4CtcAjJOYXoU0ok/kxKSq2E6BPwq9eII8u4rnSQ4auWEtoKKOPe87AjAihgoIIPwfvwxI3IuyINxjy6oQ02ylDiDR6OQPHG6nDQiSGldtqMJRqSskGhol5YgAYZQMphgZT8OwnA/+QrYiGcaMhMLLCYNKm5tFCYKcvfpITypOJCc6krGaJLaciERlqApSI6xHFOhAbIAKEL7nTPRDpxRAKIMVYEAomP3IBDxjLgcP+jT0YJoyEGoYzkUS6zTtKBJRNeW8i0AkIDIDPNnITtv8w8W+gqzcQC9b7nMDwpqQKmLHVUMskaa6iuEugp01O/yqE3ORs9kQDBAAiguz2LFdY9xNIQlNCOjuDhDSXKYKMNyZbVlqMiVAspBgbpTKm3ysbd9ly7LiDgAQcIWBfZ9vhEl7IfgBCCoDQG7cixE3xQ44wavJh3YIZ0QFIoGVD4TViodLCsYYIjzmgA7Ph6YIP35JWYrnrvHSKNLajYFz31TuBB4I0JLuKmkBKYMmWYY54uAgZQ1Fjmi5DQwopAuTBDZI5ejHHGGnE+VwcUZBhJBhocNvppqOcaoIILBrD/eoALMlY2aoR05vkKn8nwyFBEFeVaWCa/UsCGl8+eCwWr3I5YgAEIqBhe8W7GmQwzAh3DCrGjnbbaa7OV+0YdXxgpBpcOr2uBBBZ2/NwAMmAgsMBqTvZpvrm44m8toN1I2n7/DXhyHB+N1AbJDaPhBQVkUAsHGWIvQocEesMhAZdotx1Al3d8cyqnfaud+E95f+GFl+FeGyEUeCe+9ikh/835FxpHffuO9B6Yii08J8KK0AXvd72TuT+xW5ZmAJe6zJRTDofOdB0KK97on8F+mngyCSaZKGQBCqhJAZKEkxz4CiUqYcmQEHiaqoClf2qJCadap74PuUuD7oqA1iQG/740DIEIQgDCD8znA/TZCIPvMZgMEKaw8BRlf70pClMKALmWKC41BmQZDhtHGk4tJGk4EUtXvEKWkZQmPhPaTK5uCIDdKeA04VqhhyqGHbyFx3uMAqEISWhCjpAOhSZTYRXbszKc7K9t7WHZWXhYGhwIyCxJSopN4LgghNwHP0dRyU6KaKuugAU/vSlTrSaov6Q90Ywpy0sARsSQC2QOI1tEkc7MID4hhOyEKVxke5CmtBwwrXjvsQG44sclGjBpShhSCypVicesGAlJ9mnJlY5zHNIsIHrHkdAEd2IknFCxk+GZWtWuljWOUEAAdqMAQyrWQYtQ0j1UsBcRwEY+MP+O7jFjLNoww5M2n7BtTjQ4TWgcNptOzeB6EkQIOkOyO0XSpJyiQUgR4rLEPKJGaTwxZC/xaJbOxNOb3qGb3bDIkQ0IwC8QEADGFFKzC/AlIQPAXGCIVcnOiRBkgQvjNjk50OosQDWL0x5ITRq1yl0Oc5rTSAAEIBiXbi0hGRCAAyZa0WPJ1Dsd85sVSugRMX70pJTRUQwQmKYLDlWpT6sA1gDzUmNBlSEMdWhFpEkYvoXwY2bgaEfPR8alGkYHkFMAVAi4gFGGVa04YwB2KECijXBAAB28DgcWUgG7sdSqOiVMvb42hi8WyqNgXetfROpCn8QAhoVl7NPYFYDrjID/IzR1wAAcIIA7LRMAGVAmsSoXTb7WhQxbSANBwiY6bZ4BUWfoZmPnUtSjRse1s3XsAKyTRYww4LIO0JxmKVYx2+71Lj/YGSaBALQw1oAN1FLDCcxGW4+M9SZmbU1aoXvdiFltBBHQrl82Nxcy3AtsZigfR7ygXOY61w2Gwy5GDnuaqSy2vfPd2BX5gtvqXLUio0WuRrzQBji8AYVvgAO26JsR2IIlTcI8cIMHhlNJfrcyLwrwgAuMMgcXjKzURWuGPQwzYzpVwoO5gaFOoIYZseF0H1bIWG2A2PgmlcUzRtd1DjpiupgYxW9QcRlnrMvp+mTBNCZyyh5gtwA4AJrx/wptRtyg2mqx1scfxkGQdDMD5dBAxo2yGlyrpqeLMIAAF1CXXv8SAfyWucg4o5sAKhAA7zI5xzxY1IxdXDueEHBH9RWAXWkq1Yu41E4BCC5hLlcRijV5zfNqKAEgQAH8Uke/iwZyWYUcHevy2aY2LpaYCWBXAFwAAu6iWwYIDYBDo1owpt4Ady6wAQIsuU4BuAADBpDqDYx6BFaD6gZovWiJRSAACRWAmb0zaSpb+StY5t2WZVbThrILqteJAEM5kIEHPOBYdEs0AOyGkG//1m7suqxeXbqXbaNaoXAm9EspJllgp4zMHkL2fO+Mk6rkjsFuWyYEsh1TADzWpZ8udv9UeS2Yb3tbAADodrgBHVWHfluuFHAkw+f6gLfGO2IVQDMEqirnH0fP0rHDdBWXmVBhQ7WmKxW0wRu+cIVbHOEL73ZCWh5zYxmUuwLI9gPgqvF5GZQvH9eiomdb5QRcOcvOVp9v3wxVhhL6chSDQN24DXWFRmAvMo95zRFyc4lzt61Vn6tc4wz0c0G1ApD24HXjJJU863upmv262kewF20D4DoYv7pgLnDZR9Mcqg7fGtgXvoHLKrSpg+8z2tFFAIceq+1rdfFNvlKVGJTc8Zv3prso0C4COODslaFoRS861CMlXT4KyPK+Of/6RdqX7tMpPeZOv8i3G7UnMyCg5mH//3vgLySnEA5McGtPfOMTH3PJV/6pGd585x8fwsZfxBz0YPkC9IEPfpDDAoogfZwyX/niR/6sm0/+6Zt//Oov//PPz/70u3/98m8/+CuK/vAHP2KRvDa9PVt/6MO/+4O//KO/+LO/AKCDPZAD2OkU1ksARZiDATTAAkTA4iPACbTA6AtADFy+DrxACsxADgxBDyRBENRAASxB/UOXtrIYZAK5mFkAGbSBBNC9kOi9DltBHYSuB6i6DaCA0Ts2ozuRsZJB/IAdKeqUG4yd0vC+HXzC+aKbr4u06ag3wniL1CsNBdjCnnDALYyB0tAJGYRCMvywz4OsB5C1opuMOAGy/xrcQvnIsy3Ej1RywjK8Q2C7gL0QgIzDMY6AnOPBELDYQuVoQhlkOjxMRI0TscnzCMiJDhnMNEWcxOBzF5sZQkrMRE3MuUvcRE/8RIW4Dg1SQyEERVPcRKGbvbzBxFNsRVe8Cyt8RW2xGspAs4oQsxeUxcmAtao7kVjUxUaRqMlINeGTQmA0jIjCDjDzw2OcG5hDCI4jgBHIGorKmkN7M726nAy4tlTjAA4yNSnkgAD4uWakiwC4mA3IO3pjxXIMxmcEAArQtnjMgIjqoMt6tcZLiHErqIUbgbkKAAqgKLpxKWNrx+5BlttjRoNMu2esRwBIKLtyAAqIKIq7jmW0G/+4+jaGgoBTi6nsWMi6cKkrokKGaKRHWohtHLZJYkeQxBFh5Lpu88cIoICZpIBmUoiEi7kKGAFlaiiXuiySbMlosq+gVIjO4kOUzDZlWjLpS0ih3Ba+wJyAqyyGyhpi44DfUsOc/LYRwMq6cqlcy8en9I6EWqiGCsXG2wu4akqWHEsrqphQUybeSoi9yJq6XIitXLhz5LkOErQKuEu3lDSoAjh9lEK7KTTha8vAXMwMAzjCBDfDNEaG+EXGrMz2kiu6EksAoCp4FIBc/A7FtEzRhC7KsizMAgDNGruEsqlo+j/oe03YjE3ZnE3arE3bvE3czE3d3E3exE3EHE3D0K3/muotZNE6PvxMhbBAd+nN3lxO5tRN53zO3IxO6bRN6qzO2rzOAgTOjaHMyvDOyQDP8AzN7yTP8uROtxFPw1BPwmDP9jTP8WQU90RPOpnPv7BPu8DP/ITP9eTP/qRPrtHPkPTP95RPAh0MATXHAwVQHKHFPnHQOYHQCP1NFJHQBqVQBs1QDd1QDu1QD/1QEA1RER1REi1RkLoaC30PRjRJcmwPRkRRDLWMlOQAuGLR95jRtUTR97gAcTxJGzVRRrmiE4mk2TvKm2wPIoUXIRUPobtJI32PJkWIJW2Pu0GIJwXSPuGLqxmW+0KIstzMs2wPg1JSbovRytiACqiAyxqA/y/lzPZAUzWVQi1N0eqomT97SIUCU6LD0hO5r148EYpBFsd8OGKaPT810+m4LHCEKUIVD0VFzX5DVMsYgOtgVEvl0znhSH98gGV0j0Ctu0v11NnTVJ7r1OrAzKgKVfdA1c0MgE011Tq1m74czEbFVC6VVNqjO1StKxVVRcjE1cKILITYVc0MD2HFS8l0j8MkVlCz1Q8ZAIrb1BYVDx7lw6kpzUdF0ombGmh1VZ6bVstgKAcoPmw9zfYQ1+LrVml10YrkiwwoV1h11vDgLL6YSC7FDtsSzrlUVuCi1+Ok0ooRDH0tSOq4osrpSXttD391AIcaWHl9WIiNWImdWIqtWP+LvViMzViN3ViO7ViP/ViQDVlZdNjJMM6EFdkio9OMiLX0HLOLaCow+9GE2ADbYruEEDNw7Yhrq4BpI4B4RVn6esmO8FW6IFrq8LqJqtU6ibqEeNIMsJo7UZcHQMx2GQwG+DwSUdOiBFroEto3czSMMTXbElvU7I5Iwphc+7SJ4o5dqzhWa6txvZMBGLUIaNEBYNus8UaPQ4hUO7TLyTUIyBp/dMrQ89Jf87WswY5iadOG8rSaaapHS1rNoSjA/VrNcaRjYQBRgwC4elol49tk5doDE9p4BEjP7LZuW6a/fKuypDaLozhicYAHAAC5YoC9G7PWzdOkhV3ImivOTLj/b7MbiaypzqzahODZYlndAehBm5OqQd2a/vO3hLi75uU7jNuLzOLDvRheyRpHNY2zuRLdDHvJiCIWf2w3wUhdd3mArGEoEolHMNUTcPzB2S1bhIi6JHtHhpJfjMOLPAXehUs4ZeK65JTMiGKXnyPM50XLmnIonl2yltOsCO6OCe7MZXpBSxTfBnvJQF0+1FU5aLMtAMY5hKCppZRShHwpqSxMhaA7zRrhEUZai6Paj2zeYmHWjGirF6xgHpZTKsxgDQ5aFRaMbLM1DtBcnts2wTjOmqoAuRq2PJWrtp05z5TSytpGhWJTeBvW7Cg9qnIpu9pI48Q5h9vbmRJLf2Sozsn1x13brJoyzZ+10iM1OPvtYdsyWoR4gC0O4vYSUlHjC4bVu5o63zrOU+Pk3K+7rItRtyMVyazJX921OUVGU4ZKQzwBvAEeYYWr34Qw3rZCOPaFVOzg290i2ISIKHPzYTqWYFVGtILj40m8DlNGkbba08K4u5wdjMKF5UnMtly+kXVBTsI44unwR2DlZWROZmVeZmZuZmd+ZmiOZmmeZmquZmu+ZmzOZm3eZm7uZm/+ZnAOZ3EeZ3IuZ3M+Z3ROZ3VeZ3ZuZ3d+Z3jWuIAAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This graph shows the estimated probability of developing severe sickle cell disease (defined&nbsp;as death, stroke, frequent pain, or recurrant acute chest&nbsp;syndrome)&nbsp;by the age of 10 years (y-axis) according to the following factors: leukocyte count (x-axis); severe anemia (Hgb &lt;7 g/dL) during the second year of life, and dactylitis before the age of 1 year. In this cohort of patients, 3 percent were classified as being at high risk, 53 percent were classified as being at medium risk, and 44 percent were classified as being at low risk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Miller, ST, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000; 342:83.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41790=[""].join("\n");
var outline_f40_51_41790=null;
var title_f40_51_41791="HAE pathways";
var content_f40_51_41791=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F87451&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F87451&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 647px\">",
"   <div class=\"ttl\">",
"    Pathways involved in kinin-mediated angioedema and actions of drugs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 627px; height: 438px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br/>",
"     <ol>",
"      <li>",
"       Morgan PB. Hereditary angioedema&mdash;therapies old and new. N Engl J Med 2010; 363:581.",
"      </li>",
"      <li>",
"       Longhurst H, Cicardi M. Hereditary angio-oedema. Lancet 2012; 379:474.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_51_41791=[""].join("\n");
var outline_f40_51_41791=null;
